Question,Question Type,QID,Answer,Title,EM,F1,Question Words,Answer Words,Question Length,Answer Length
What is recommended when considering initiating or continuing long-term opioid therapy?,What,0,assessing suicide risk,Recommendations,1,1.0,"['What', 'is', 'recommended', 'when', 'considering', 'initiating', 'or', 'continuing', 'long', '-', 'term', 'opioid', 'therapy', '?']","['assessing', 'suicide', 'risk']",14,3
Which strategies may be helpful for those at higher risk of adverse events related to opioid therapy?,Which,1,"checking the PDMP, performing a  UDT, placement in an inpatient setting or monitored environment, and/or providing OEND",Recommendations,1,1.0,"['Which', 'strategies', 'may', 'be', 'helpful', 'for', 'those', 'at', 'higher', 'risk', 'of', 'adverse', 'events', 'related', 'to', 'opioid', 'therapy', '?']","['checking', 'the', 'PDMP', ',', 'performing', 'a', ' ', 'UDT', ',', 'placement', 'in', 'an', 'inpatient', 'setting', 'or', 'monitored', 'environment', ',', 'and/or', 'providing', 'OEND']",18,21
What can be a continuous predictor of adverse outcomes?,What,2,age,Recommendations,1,1.0,"['What', 'can', 'be', 'a', 'continuous', 'predictor', 'of', 'adverse', 'outcomes', '?']",['age'],10,1
Who may disagree with the recommendation to use non-opioid modalities in lieu of LOT to treat their pain?,Who,3,Some patients with SUD,Recommendations,1,1.0,"['Who', 'may', 'disagree', 'with', 'the', 'recommendation', 'to', 'use', 'non', '-', 'opioid', 'modalities', 'in', 'lieu', 'of', 'LOT', 'to', 'treat', 'their', 'pain', '?']","['Some', 'patients', 'with', 'SUD']",21,4
What is a good predictor of overdose death?,What,4,Prescribed opioid dosage,Recommendations,1,1.0,"['What', 'is', 'a', 'good', 'predictor', 'of', 'overdose', 'death', '?']","['Prescribed', 'opioid', 'dosage']",9,3
What is the stance regarding the abuse deterrent formulations for LOT?,What,5,do not recommend for or against,Recommendations,1,1.0,"['What', 'is', 'the', 'stance', 'regarding', 'the', 'abuse', 'deterrent', 'formulations', 'for', 'LOT', '?']","['do', 'not', 'recommend', 'for', 'or', 'against']",12,6
Who are more likely to attempt suicide?,Who,6,Patients with a history of TBI who use chronic short-acting and  long-acting opioids,Background,1,1.0,"['Who', 'are', 'more', 'likely', 'to', 'attempt', 'suicide', '?']","['Patients', 'with', 'a', 'history', 'of', 'TBI', 'who', 'use', 'chronic', 'short', '-', 'acting', 'and', ' ', 'long', '-', 'acting', 'opioids']",8,18
What should providers carefully rule out and avoid?,What,7,potential drug interactions prior to initiating LOT,Background,1,1.0,"['What', 'should', 'providers', 'carefully', 'rule', 'out', 'and', 'avoid', '?']","['potential', 'drug', 'interactions', 'prior', 'to', 'initiating', 'LOT']",9,7
What combinations of drugs are dangerous?,What,8,"i)Opioids with benzodiazepines (compared to patients with no prescription, the odds ratio [OR] and 95% confidence interval [CI] for drug-related death was OR: 14.92, 95% CI: 7.00- 31.77 for patients who filled a prescription for opioids and benzodiazepines; OR: 3.40, 95%  CI: 1.60-7.21 for patients who filled only an opioid prescription, and 7.21, 95% CI: 3.33-15.60 for patients who filled only a benzodiazepine prescription) (see Recommendation 5) [66,67], ii)Fentanyl with CYP3A4 inhibitors, iii) Methadone with drugs that can prolong the QT interval (the heart rate’s corrected time  interval from the start of the Q wave to the end of the T wave) (e.g., CYP450 2B6 inhibitors)",Background,0,0.06060606060606061,"['What', 'combinations', 'of', 'drugs', 'are', 'dangerous', '?']","['i)Opioids', 'with', 'benzodiazepines', '(', 'compared', 'to', 'patients', 'with', 'no', 'prescription', ',', 'the', 'odds', 'ratio', '[', 'OR', ']', 'and', '95', '%', 'confidence', 'interval', '[', 'CI', ']', 'for', 'drug', '-', 'related', 'death', 'was', 'OR', ':', '14.92', ',', '95', '%', 'CI', ':', '7.00-', '31.77', 'for', 'patients', 'who', 'filled', 'a', 'prescription', 'for', 'opioids', 'and', 'benzodiazepines', ';', 'OR', ':', '3.40', ',', '95', '%', ' ', 'CI', ':', '1.60', '-', '7.21', 'for', 'patients', 'who', 'filled', 'only', 'an', 'opioid', 'prescription', ',', 'and', '7.21', ',', '95', '%', 'CI', ':', '3.33', '-', '15.60', 'for', 'patients', 'who', 'filled', 'only', 'a', 'benzodiazepine', 'prescription', ')', '(', 'see', 'Recommendation', '5', ')', '[', '66,67', ']', ',', 'ii)Fentanyl', 'with', 'CYP3A4', 'inhibitors', ',', 'iii', ')', 'Methadone', 'with', 'drugs', 'that', 'can', 'prolong', 'the', 'QT', 'interval', '(', 'the', 'heart', 'rate', '’s', 'corrected', 'time', ' ', 'interval', 'from', 'the', 'start', 'of', 'the', 'Q', 'wave', 'to', 'the', 'end', 'of', 'the', 'T', 'wave', ')', '(', 'e.g.', ',', 'CYP450', '2B6', 'inhibitors', ')']",7,148
What does place patients at elevated risk for opioid overdose?,What,9,"opioids taken PRN (as needed) for chronic cancer pain versus regularly scheduled doses, or simultaneous PRN plus regularly scheduled",Recommendations,1,1.0,"['What', 'does', 'place', 'patients', 'at', 'elevated', 'risk', 'for', 'opioid', 'overdose', '?']","['opioids', 'taken', 'PRN', '(', 'as', 'needed', ')', 'for', 'chronic', 'cancer', 'pain', 'versus', 'regularly', 'scheduled', 'doses', ',', 'or', 'simultaneous', 'PRN', 'plus', 'regularly', 'scheduled']",11,22
What may patients decline?,What,10,"offered treatments (e.g., OT) and may also decline risk mitigation strategies (e.g.,  UDT, pill counts) that are recommended in the course of clinical care",Recommendations,0,0.29629629629629634,"['What', 'may', 'patients', 'decline', '?']","['offered', 'treatments', '(', 'e.g.', ',', 'OT', ')', 'and', 'may', 'also', 'decline', 'risk', 'mitigation', 'strategies', '(', 'e.g.', ',', ' ', 'UDT', ',', 'pill', 'counts', ')', 'that', 'are', 'recommended', 'in', 'the', 'course', 'of', 'clinical', 'care']",5,32
Who are at an increased risks of acute OT extending into LOT?,Who,11,"patients with mood disorders, those who refill  the initial prescription, higher prescribed dose (greater than 120 mg MEDD), and initiation using long acting opioids",Recommendations,0,0.29629629629629634,"['Who', 'are', 'at', 'an', 'increased', 'risks', 'of', 'acute', 'OT', 'extending', 'into', 'LOT', '?']","['patients', 'with', 'mood', 'disorders', ',', 'those', 'who', 'refill', ' ', 'the', 'initial', 'prescription', ',', 'higher', 'prescribed', 'dose', '(', 'greater', 'than', '120', 'mg', 'MEDD', ')', ',', 'and', 'initiation', 'using', 'long', 'acting', 'opioids']",13,30
What does increase the risk of acute post-operative OT progressing into LOT?,What,12,"a  history of depression, SUD, catastrophizing, higher preoperative total body pain, history of back pain, and  preoperative use of sedative-hypnotics or antidepressants",Recommendations,0,0.0909090909090909,"['What', 'does', 'increase', 'the', 'risk', 'of', 'acute', 'post', '-', 'operative', 'OT', 'progressing', 'into', 'LOT', '?']","['a', ' ', 'history', 'of', 'depression', ',', 'SUD', ',', 'catastrophizing', ',', 'higher', 'preoperative', 'total', 'body', 'pain', ',', 'history', 'of', 'back', 'pain', ',', 'and', ' ', 'preoperative', 'use', 'of', 'sedative', '-', 'hypnotics', 'or', 'antidepressants']",15,31
Why is future research needed to optimize care for chronic-pain patients with and without cannabis use?,Why,13,Given the increasing use of cannabis among patients with chronic pain and the lack of RCTs comparing  outcomes of prescribing LOT versus other therapies for patients with and without cannabis use and  cannabis use disorder,Recommendations,0,0.8,"['Why', 'is', 'future', 'research', 'needed', 'to', 'optimize', 'care', 'for', 'chronic', '-', 'pain', 'patients', 'with', 'and', 'without', 'cannabis', 'use', '?']","['Given', 'the', 'increasing', 'use', 'of', 'cannabis', 'among', 'patients', 'with', 'chronic', 'pain', 'and', 'the', 'lack', 'of', 'RCTs', 'comparing', ' ', 'outcomes', 'of', 'prescribing', 'LOT', 'versus', 'other', 'therapies', 'for', 'patients', 'with', 'and', 'without', 'cannabis', 'use', 'and', ' ', 'cannabis', 'use', 'disorder']",19,37
What may help determine earlier in the course of treatment which patients are most likely to  benefit from a specific non-pharmacologic therapy or non opioid pharmacologic therapies alone or as part of a multimodal approach?,What,14,Further studies,Recommendations,1,1.0,"['What', 'may', 'help', 'determine', 'earlier', 'in', 'the', 'course', 'of', 'treatment', 'which', 'patients', 'are', 'most', 'likely', 'to', ' ', 'benefit', 'from', 'a', 'specific', 'non', '-', 'pharmacologic', 'therapy', 'or', 'non', 'opioid', 'pharmacologic', 'therapies', 'alone', 'or', 'as', 'part', 'of', 'a', 'multimodal', 'approach', '?']","['Further', 'studies']",39,2
What should not be used for treatment of acute pain?,What,15,Long-acting opioids,Recommendations,1,1.0,"['What', 'should', 'not', 'be', 'used', 'for', 'treatment', 'of', 'acute', 'pain', '?']","['Long', '-', 'acting', 'opioids']",11,4
Which opioid/opioid formulation is preferred over the others?,Which,16,no single,Recommendations,1,1.0,"['Which', 'opioid', '/', 'opioid', 'formulation', 'is', 'preferred', 'over', 'the', 'others', '?']","['no', 'single']",11,2
What does risk of overdose include?,What,17,the use of opioids for acute pain,Recommendations,1,1.0,"['What', 'does', 'risk', 'of', 'overdose', 'include', '?']","['the', 'use', 'of', 'opioids', 'for', 'acute', 'pain']",7,7
Which factors increase overdose risk when opioids are used for acute pain?,Which,18,"high prescribed dose, history of SUD, and history of  mental health concerns",Recommendations,1,1.0,"['Which', 'factors', 'increase', 'overdose', 'risk', 'when', 'opioids', 'are', 'used', 'for', 'acute', 'pain', '?']","['high', 'prescribed', 'dose', ',', 'history', 'of', 'SUD', ',', 'and', 'history', 'of', ' ', 'mental', 'health', 'concerns']",13,15
When is the relationship between OUD and duration of therapy magnified?,When,19,when patients have a history of  previous opioid or non-opioid SUD,Recommendations,1,1.0,"['When', 'is', 'the', 'relationship', 'between', 'OUD', 'and', 'duration', 'of', 'therapy', 'magnified', '?']","['when', 'patients', 'have', 'a', 'history', 'of', ' ', 'previous', 'opioid', 'or', 'non', '-', 'opioid', 'SUD']",12,14
Why only nine key questions (KQs) were prioritized from many possible KQs?,Why,20,Because a comprehensive review of the evidence related to LOT was not feasible,Specifications,0,0.9523809523809523,"['Why', 'only', 'nine', 'key', 'questions', '(', 'KQs', ')', 'were', 'prioritized', 'from', 'many', 'possible', 'KQs', '?']","['Because', 'a', 'comprehensive', 'review', 'of', 'the', 'evidence', 'related', 'to', 'LOT', 'was', 'not', 'feasible']",15,13
What is the utmost concern for patients who receive OT beyond 90 days?,What,22,the heightened risk for developing OUD,Recommendations,1,1.0,"['What', 'is', 'the', 'utmost', 'concern', 'for', 'patients', 'who', 'receive', 'OT', 'beyond', '90', 'days', '?']","['the', 'heightened', 'risk', 'for', 'developing', 'OUD']",14,6
What are some alternatives to opioid therapy?,What,23,self-management strategies and other non-pharmacological treatments,Recommendations,1,1.0,"['What', 'are', 'some', 'alternatives', 'to', 'opioid', 'therapy', '?']","['self', '-', 'management', 'strategies', 'and', 'other', 'non', '-', 'pharmacological', 'treatments']",8,10
What is the recommendation regarding initiation of long-term opioid therapy for chronic pain?,What,24,recommend against,Recommendations,1,1.0,"['What', 'is', 'the', 'recommendation', 'regarding', 'initiation', 'of', 'long', '-', 'term', 'opioid', 'therapy', 'for', 'chronic', 'pain', '?']","['recommend', 'against']",16,2
When should non-opioids be recommended over opioids?,When,25,When pharmacologic therapies are used,Recommendations,1,1.0,"['When', 'should', 'non', '-', 'opioids', 'be', 'recommended', 'over', 'opioids', '?']","['When', 'pharmacologic', 'therapies', 'are', 'used']",10,5
What is the stance regarding alternatives to opioid therapy such as self-management strategies and other non-pharmacological treatments?,What,26,recommend,Recommendations,0,0.33333333333333337,"['What', 'is', 'the', 'stance', 'regarding', 'alternatives', 'to', 'opioid', 'therapy', 'such', 'as', 'self', '-', 'management', 'strategies', 'and', 'other', 'non', '-', 'pharmacological', 'treatments', '?']",['recommend'],22,1
What does the work Group recognize?,What,28,not all clinical practices are linear,Algorithm,1,1.0,"['What', 'does', 'the', 'work', 'Group', 'recognize', '?']","['not', 'all', 'clinical', 'practices', 'are', 'linear']",7,6
What does the simplified linear approach depicted through the algorithm and its format allow?,What,29,to assess the critical information needed at the major decision points in the clinical process,Algorithm,0,0.9600000000000001,"['What', 'does', 'the', 'simplified', 'linear', 'approach', 'depicted', 'through', 'the', 'algorithm', 'and', 'its', 'format', 'allow', '?']","['to', 'assess', 'the', 'critical', 'information', 'needed', 'at', 'the', 'major', 'decision', 'points', 'in', 'the', 'clinical', 'process']",15,15
Who does assess the critical information needed at the major decision points in the clinical process?,Who,30,the provider,Algorithm,1,1.0,"['Who', 'does', 'assess', 'the', 'critical', 'information', 'needed', 'at', 'the', 'major', 'decision', 'points', 'in', 'the', 'clinical', 'process', '?']","['the', 'provider']",17,2
What does the algorithm include?,What,32,"an ordered sequence of steps of care, recommended observations and examinations, decisions to be considered, actions to be taken",Algorithm,1,1.0,"['What', 'does', 'the', 'algorithm', 'include', '?']","['an', 'ordered', 'sequence', 'of', 'steps', 'of', 'care', ',', 'recommended', 'observations', 'and', 'examinations', ',', 'decisions', 'to', 'be', 'considered', ',', 'actions', 'to', 'be', 'taken']",6,22
How much does the risk increase at a range of 50 to <100 mg MEDD compared to risk at <20 mg MEDD?,How,37,approximately 2.6 times,Recommendations,1,1.0,"['How', 'much', 'does', 'the', 'risk', 'increase', 'at', 'a', 'range', 'of', '50', 'to', '<', '100', 'mg', 'MEDD', 'compared', 'to', 'risk', 'at', '<', '20', 'mg', 'MEDD', '?']","['approximately', '2.6', 'times']",25,3
How much does the risk increase at a daily dosage range of 20 to <50 mg MEDD?,How,38,approximately 1.5 times,Recommendations,1,1.0,"['How', 'much', 'does', 'the', 'risk', 'increase', 'at', 'a', 'daily', 'dosage', 'range', 'of', '20', 'to', '<', '50', 'mg', 'MEDD', '?']","['approximately', '1.5', 'times']",19,3
What was the tasks of Interagency Pain Research Coordinating Committee?,What,40,"summarizing advances in pain  care research, identifying gaps in research, and developing recommendations regarding ways to minimize  duplicative efforts, disseminate pain care information, and expand public/private research partnerships  and collaborations",Background,0,0.06451612903225806,"['What', 'was', 'the', 'tasks', 'of', 'Interagency', 'Pain', 'Research', 'Coordinating', 'Committee', '?']","['summarizing', 'advances', 'in', 'pain', ' ', 'care', 'research', ',', 'identifying', 'gaps', 'in', 'research', ',', 'and', 'developing', 'recommendations', 'regarding', 'ways', 'to', 'minimize', ' ', 'duplicative', 'efforts', ',', 'disseminate', 'pain', 'care', 'information', ',', 'and', 'expand', 'public', '/', 'private', 'research', 'partnerships', ' ', 'and', 'collaborations']",11,39
Who published the National Pain Strategy?,Who,41,The Committee,Background,0,0.33333333333333337,"['Who', 'published', 'the', 'National', 'Pain', 'Strategy', '?']","['The', 'Committee']",7,2
What was the purpose of  Interagency Pain Research Coordinating Committee?,What,42,coordinate pain research efforts  throughout federal government agencies,Background,1,1.0,"['What', 'was', 'the', 'purpose', 'of', ' ', 'Interagency', 'Pain', 'Research', 'Coordinating', 'Committee', '?']","['coordinate', 'pain', 'research', 'efforts', ' ', 'throughout', 'federal', 'government', 'agencies']",12,9
When was the National Pain Strategy published?,When,43,March 2016,Background,1,1.0,"['When', 'was', 'the', 'National', 'Pain', 'Strategy', 'published', '?']","['March', '2016']",8,2
How was the National Pain Strategy published?,How,44,in response to the  call from the National Academy of Medicine to increase awareness of pain as a significant public health  issue in the U.S.,Background,1,1.0,"['How', 'was', 'the', 'National', 'Pain', 'Strategy', 'published', '?']","['in', 'response', 'to', 'the', ' ', 'call', 'from', 'the', 'National', 'Academy', 'of', 'Medicine', 'to', 'increase', 'awareness', 'of', 'pain', 'as', 'a', 'significant', 'public', 'health', ' ', 'issue', 'in', 'the', 'U.S.']",8,27
When was the Interagency Pain Research Coordinating Committee created?,When,45,March 2010,Background,1,1.0,"['When', 'was', 'the', 'Interagency', 'Pain', 'Research', 'Coordinating', 'Committee', 'created', '?']","['March', '2010']",10,2
How was the Interagency Pain Research Coordinating Committee created?,How,46,With the passage of the Patient Protection and Affordable Care Act (PPACA) in March 2010,Background,0,0.0,"['How', 'was', 'the', 'Interagency', 'Pain', 'Research', 'Coordinating', 'Committee', 'created', '?']","['With', 'the', 'passage', 'of', 'the', 'Patient', 'Protection', 'and', 'Affordable', 'Care', 'Act', '(', 'PPACA', ')', 'in', 'March', '2010']",10,17
What was the aim of the National Pain Strategy?,What,47,"decreasing the  prevalence of all types of pain (acute and chronic) in the U.S., as well as the disability and morbidity  associated with pain",Background,1,1.0,"['What', 'was', 'the', 'aim', 'of', 'the', 'National', 'Pain', 'Strategy', '?']","['decreasing', 'the', ' ', 'prevalence', 'of', 'all', 'types', 'of', 'pain', '(', 'acute', 'and', 'chronic', ')', 'in', 'the', 'U.S.', ',', 'as', 'well', 'as', 'the', 'disability', 'and', 'morbidity', ' ', 'associated', 'with', 'pain']",10,29
What are some talking points for educating/re-educating the patients currently on OT? ,What,48,"“Doctors used to think that opioids were safe and effective when used for long periods of time to treat chronic pain.”, “New information has taught us that long-term opioid use can lead to multiple problems including loss of pain relieving effects, increased pain, unintentional death, OUD, and problems with sleep, mood, hormonal dysfunction, and immune dysfunction,”, “We now know that the best treatments for chronic pain are not opioids. The best treatments for chronic pain are non-drug treatments such as psychological therapies and rehabilitation therapies and non-opioid medications.”",Algorithm,0,0.37383177570093457,"['What', 'are', 'some', 'talking', 'points', 'for', 'educating', '/', 're', '-', 'educating', 'the', 'patients', 'currently', 'on', 'OT', '?']","['“', 'Doctors', 'used', 'to', 'think', 'that', 'opioids', 'were', 'safe', 'and', 'effective', 'when', 'used', 'for', 'long', 'periods', 'of', 'time', 'to', 'treat', 'chronic', 'pain', '.', '”', ',', '“', 'New', 'information', 'has', 'taught', 'us', 'that', 'long', '-', 'term', 'opioid', 'use', 'can', 'lead', 'to', 'multiple', 'problems', 'including', 'loss', 'of', 'pain', 'relieving', 'effects', ',', 'increased', 'pain', ',', 'unintentional', 'death', ',', 'OUD', ',', 'and', 'problems', 'with', 'sleep', ',', 'mood', ',', 'hormonal', 'dysfunction', ',', 'and', 'immune', 'dysfunction', ',', '”', ',', '“', 'We', 'now', 'know', 'that', 'the', 'best', 'treatments', 'for', 'chronic', 'pain', 'are', 'not', 'opioids', '.', 'The', 'best', 'treatments', 'for', 'chronic', 'pain', 'are', 'non', '-', 'drug', 'treatments', 'such', 'as', 'psychological', 'therapies', 'and', 'rehabilitation', 'therapies', 'and', 'non', '-', 'opioid', 'medications', '.', '”']",17,113
Which factors require immediate attention and possible discontinuation?,Which,49,"untreated SUD, unstable mental health disorder, medical condition that acutely increases opioid risks (e.g., compromised or worsening cognitive or cardiopulmonary status), other factors that acutely increase risk of overdose (recent overdose, current sedation, recent motor vehicle accident), acutely elevated suicide risk",Algorithm,0,0.6774193548387097,"['Which', 'factors', 'require', 'immediate', 'attention', 'and', 'possible', 'discontinuation', '?']","['untreated', 'SUD', ',', 'unstable', 'mental', 'health', 'disorder', ',', 'medical', 'condition', 'that', 'acutely', 'increases', 'opioid', 'risks', '(', 'e.g.', ',', 'compromised', 'or', 'worsening', 'cognitive', 'or', 'cardiopulmonary', 'status', ')', ',', 'other', 'factors', 'that', 'acutely', 'increase', 'risk', 'of', 'overdose', '(', 'recent', 'overdose', ',', 'current', 'sedation', ',', 'recent', 'motor', 'vehicle', 'accident', ')', ',', 'acutely', 'elevated', 'suicide', 'risk']",9,52
What other factors can acutely increase risk of overdose?,What,50,"recent overdose, current sedation, recent motor vehicle accident",Algorithm,1,1.0,"['What', 'other', 'factors', 'can', 'acutely', 'increase', 'risk', 'of', 'overdose', '?']","['recent', 'overdose', ',', 'current', 'sedation', ',', 'recent', 'motor', 'vehicle', 'accident']",10,10
What are the benefits of continuing opioid therapy?,What,51,"modest short-term improvement in pain, possible short-term improvement in function",Algorithm,1,1.0,"['What', 'are', 'the', 'benefits', 'of', 'continuing', 'opioid', 'therapy', '?']","['modest', 'short', '-', 'term', 'improvement', 'in', 'pain', ',', 'possible', 'short', '-', 'term', 'improvement', 'in', 'function']",9,15
What are the risks of continuing opioid therapy?,What,52,"increase in all-cause mortality, increase risk of unintentional overdose death, increase risk of developing OUD, risk of developing or worsening - depression, falls, fractures, sleep disordered breathing, worsening pain, motor vehicle accidents hypogonadism, prolonged pain, nausea, constipation, dry mouth, sedation, cognitive dysfunction, immune system dysfunction, reduction in function, reduction in quality of life",Algorithm,0,0.03773584905660378,"['What', 'are', 'the', 'risks', 'of', 'continuing', 'opioid', 'therapy', '?']","['increase', 'in', 'all', '-', 'cause', 'mortality', ',', 'increase', 'risk', 'of', 'unintentional', 'overdose', 'death', ',', 'increase', 'risk', 'of', 'developing', 'OUD', ',', 'risk', 'of', 'developing', 'or', 'worsening', '-', 'depression', ',', 'falls', ',', 'fractures', ',', 'sleep', 'disordered', 'breathing', ',', 'worsening', 'pain', ',', 'motor', 'vehicle', 'accidents', 'hypogonadism', ',', 'prolonged', 'pain', ',', 'nausea', ',', 'constipation', ',', 'dry', 'mouth', ',', 'sedation', ',', 'cognitive', 'dysfunction', ',', 'immune', 'system', 'dysfunction', ',', 'reduction', 'in', 'function', ',', 'reduction', 'in', 'quality', 'of', 'life']",9,72
What is the basis of the shared decision making process for chronic pain treatment planning?,What,53,the foundation of a  patient-centered assessment of risks and benefits and a clinical synthesis performed by the provider,Specifications,1,1.0,"['What', 'is', 'the', 'basis', 'of', 'the', 'shared', 'decision', 'making', 'process', 'for', 'chronic', 'pain', 'treatment', 'planning', '?']","['the', 'foundation', 'of', 'a', ' ', 'patient', '-', 'centered', 'assessment', 'of', 'risks', 'and', 'benefits', 'and', 'a', 'clinical', 'synthesis', 'performed', 'by', 'the', 'provider']",16,21
What does the patient-centered assessment incorporate?,What,54,"a patient-centered interview, and exploration of  patient values, goals, questions, concerns, and expectations",Specifications,1,1.0,"['What', 'does', 'the', 'patient', '-', 'centered', 'assessment', 'incorporate', '?']","['a', 'patient', '-', 'centered', 'interview', ',', 'and', 'exploration', 'of', ' ', 'patient', 'values', ',', 'goals', ',', 'questions', ',', 'concerns', ',', 'and', 'expectations']",9,21
What does include severe respiratory instability or sleep disordered breathing?,What,55,"any co-occurring condition that significantly affects respiratory rate or function such as chronic obstructive pulmonary disease (COPD), asthma, pneumonia, sleep apnea, or a neuromuscular condition (e.g., amyotrophic lateral sclerosis)",Background,0,0.0689655172413793,"['What', 'does', 'include', 'severe', 'respiratory', 'instability', 'or', 'sleep', 'disordered', 'breathing', '?']","['any', 'co', '-', 'occurring', 'condition', 'that', 'significantly', 'affects', 'respiratory', 'rate', 'or', 'function', 'such', 'as', 'chronic', 'obstructive', 'pulmonary', 'disease', '(', 'COPD', ')', ',', 'asthma', ',', 'pneumonia', ',', 'sleep', 'apnea', ',', 'or', 'a', 'neuromuscular', 'condition', '(', 'e.g.', ',', 'amyotrophic', 'lateral', 'sclerosis', ')']",11,40
Who showed a weak but positive association with opioid-related toxicity/overdose and overdose-related death?,Who,56,Two large observational studies of patients with a  history of COPD and sleep apnea who were prescribed opioids,Background,1,1.0,"['Who', 'showed', 'a', 'weak', 'but', 'positive', 'association', 'with', 'opioid', '-', 'related', 'toxicity', '/', 'overdose', 'and', 'overdose', '-', 'related', 'death', '?']","['Two', 'large', 'observational', 'studies', 'of', 'patients', 'with', 'a', ' ', 'history', 'of', 'COPD', 'and', 'sleep', 'apnea', 'who', 'were', 'prescribed', 'opioids']",20,19
Which patients are especially at risk for OUD and overdose?,Which,57,those who are  younger than 30 years of age,Recommendations,1,1.0,"['Which', 'patients', 'are', 'especially', 'at', 'risk', 'for', 'OUD', 'and', 'overdose', '?']","['those', 'who', 'are', ' ', 'younger', 'than', '30', 'years', 'of', 'age']",11,10
Who are at risk for OUD and overdose?,Who,58,All patients who take opioids chronically,Recommendations,1,1.0,"['Who', 'are', 'at', 'risk', 'for', 'OUD', 'and', 'overdose', '?']","['All', 'patients', 'who', 'take', 'opioids', 'chronically']",9,6
"How many studies examined age as a predictor of OUD,  respiratory/CNS depression, and/or overdose?",How,59,Seven,Recommendations,1,1.0,"['How', 'many', 'studies', 'examined', 'age', 'as', 'a', 'predictor', 'of', 'OUD', ',', ' ', 'respiratory', '/', 'CNS', 'depression', ',', 'and/or', 'overdose', '?']",['Seven'],20,1
How to determine the situations where the benefits of LOT clearly outweigh the risks?,How,61,through individual clinical assessment,Recommendations,1,1.0,"['How', 'to', 'determine', 'the', 'situations', 'where', 'the', 'benefits', 'of', 'LOT', 'clearly', 'outweigh', 'the', 'risks', '?']","['through', 'individual', 'clinical', 'assessment']",15,4
What is not an absolute contraindication to LOT?,What,62,Continuing OT for longer than 90 days,Recommendations,1,1.0,"['What', 'is', 'not', 'an', 'absolute', 'contraindication', 'to', 'LOT', '?']","['Continuing', 'OT', 'for', 'longer', 'than', '90', 'days']",9,7
What should be weighed heavily in the risk benefit calculus for LOT?,What,63,continuing OT beyond 90 days’ duration,Recommendations,1,1.0,"['What', 'should', 'be', 'weighed', 'heavily', 'in', 'the', 'risk', 'benefit', 'calculus', 'for', 'LOT', '?']","['continuing', 'OT', 'beyond', '90', 'days', '’', 'duration']",13,7
What must be determined through individual clinical assessment?,What,64,There may be some situations where the benefits of LOT clearly outweigh the risks.,Recommendations,1,1.0,"['What', 'must', 'be', 'determined', 'through', 'individual', 'clinical', 'assessment', '?']","['There', 'may', 'be', 'some', 'situations', 'where', 'the', 'benefits', 'of', 'LOT', 'clearly', 'outweigh', 'the', 'risks', '.']",9,15
Which four domains were considered to make the recommendations?,Which,65,"confidence in the quality of the evidence, balance of desirable and undesirable outcomes (i.e., benefits and harms), patient or provider values and preferences, and other implications, as appropriate (e.g., resource use, equity, acceptability)",Recommendations,0,0.09999999999999999,"['Which', 'four', 'domains', 'were', 'considered', 'to', 'make', 'the', 'recommendations', '?']","['confidence', 'in', 'the', 'quality', 'of', 'the', 'evidence', ',', 'balance', 'of', 'desirable', 'and', 'undesirable', 'outcomes', '(', 'i.e.', ',', 'benefits', 'and', 'harms', ')', ',', 'patient', 'or', 'provider', 'values', 'and', 'preferences', ',', 'and', 'other', 'implications', ',', 'as', 'appropriate', '(', 'e.g.', ',', 'resource', 'use', ',', 'equity', ',', 'acceptability', ')']",10,45
What is GRADE?,What,66,"Grading of Recommendations Assessment, Development and Evaluation",Recommendations,1,1.0,"['What', 'is', 'GRADE', '?']","['Grading', 'of', 'Recommendations', 'Assessment', ',', 'Development', 'and', 'Evaluation']",4,8
What was used to make the recommendations?,What,67,"a systematic approach considering four domains as per the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach",Recommendations,1,1.0,"['What', 'was', 'used', 'to', 'make', 'the', 'recommendations', '?']","['a', 'systematic', 'approach', 'considering', 'four', 'domains', 'as', 'per', 'the', 'Grading', 'of', 'Recommendations', 'Assessment', ',', 'Development', 'and', 'Evaluation', '(', 'GRADE', ')', 'approach']",8,21
Which opioid/opioid formulation did not have enough evidence to be recommended for or against?,Which,68,"any specific opioid or opioid formulation,  specifically the following:  Short-acting versus long-acting opioids (for LOT for chronic pain), Route of administration/delivery among alternatives such as transdermal, buccal, sublingual, or pumps, Abuse deterrent formulations of opioids compared to non-abuse deterrent formulations, Tramadol and other dual-mechanism opioids. Buprenorphine for pain (compared to other opioids), Methadone (with QT monitoring). ",Recommendations,0,0.13559322033898305,"['Which', 'opioid', '/', 'opioid', 'formulation', 'did', 'not', 'have', 'enough', 'evidence', 'to', 'be', 'recommended', 'for', 'or', 'against', '?']","['any', 'specific', 'opioid', 'or', 'opioid', 'formulation', ',', ' ', 'specifically', 'the', 'following', ':', ' ', 'Short', '-', 'acting', 'versus', 'long', '-', 'acting', 'opioids', '(', 'for', 'LOT', 'for', 'chronic', 'pain', ')', ',', 'Route', 'of', 'administration', '/', 'delivery', 'among', 'alternatives', 'such', 'as', 'transdermal', ',', 'buccal', ',', 'sublingual', ',', 'or', 'pumps', ',', 'Abuse', 'deterrent', 'formulations', 'of', 'opioids', 'compared', 'to', 'non', '-', 'abuse', 'deterrent', 'formulations', ',', 'Tramadol', 'and', 'other', 'dual', '-', 'mechanism', 'opioids', '.', 'Buprenorphine', 'for', 'pain', '(', 'compared', 'to', 'other', 'opioids', ')', ',', 'Methadone', '(', 'with', 'QT', 'monitoring', ')', '.']",17,85
What is an example of opioid medications?,What,70,gabapentin in neuropathic pain states,Recommendations,1,1.0,"['What', 'is', 'an', 'example', 'of', 'opioid', 'medications', '?']","['gabapentin', 'in', 'neuropathic', 'pain', 'states']",8,5
What should be considered for non-opioid pharmacologic agents?,What,71,Potential contraindications and long-term  risks of use,Recommendations,1,1.0,"['What', 'should', 'be', 'considered', 'for', 'non', '-', 'opioid', 'pharmacologic', 'agents', '?']","['Potential', 'contraindications', 'and', 'long', '-', 'term', ' ', 'risks', 'of', 'use']",11,10
Why should the potential contraindications and long-term  risks of use be considered for non-opioid pharmacologic agents as well?,Why,72,"these also can carry risk  of harm, depending on the specific patient and chosen medication",Recommendations,0,0.9655172413793104,"['Why', 'should', 'the', 'potential', 'contraindications', 'and', 'long', '-', 'term', ' ', 'risks', 'of', 'use', 'be', 'considered', 'for', 'non', '-', 'opioid', 'pharmacologic', 'agents', 'as', 'well', '?']","['these', 'also', 'can', 'carry', 'risk', ' ', 'of', 'harm', ',', 'depending', 'on', 'the', 'specific', 'patient', 'and', 'chosen', 'medication']",24,17
What are the adverse effects of LOT?,What,73,"increased mortality, OUD, overdose, sexual dysfunction, fractures, myocardial infarction, constipation, and sleep-disordered breathing",Background,1,1.0,"['What', 'are', 'the', 'adverse', 'effects', 'of', 'LOT', '?']","['increased', 'mortality', ',', 'OUD', ',', 'overdose', ',', 'sexual', 'dysfunction', ',', 'fractures', ',', 'myocardial', 'infarction', ',', 'constipation', ',', 'and', 'sleep', '-', 'disordered', 'breathing']",8,22
What is the state of research on the effectiveness of LOT for non-end-of-life pain?,What,74,limited,Background,1,1.0,"['What', 'is', 'the', 'state', 'of', 'research', 'on', 'the', 'effectiveness', 'of', 'LOT', 'for', 'non', '-', 'end', '-', 'of', '-', 'life', 'pain', '?']",['limited'],21,1
How many opioid prescriptions were written in 2012?,How,75,259 million,Background,1,1.0,"['How', 'many', 'opioid', 'prescriptions', 'were', 'written', 'in', '2012', '?']","['259', 'million']",9,2
Why is an empathetic and non-judgmental approach highly recommended for communication with a patient?,Why,76,"in order to build trust and facilitate frank discussions relating to the social, economic, emotional, and cultural factors that influence patients’  perceptions, behaviors, and decision making",Specifications,0,0.9583333333333334,"['Why', 'is', 'an', 'empathetic', 'and', 'non', '-', 'judgmental', 'approach', 'highly', 'recommended', 'for', 'communication', 'with', 'a', 'patient', '?']","['in', 'order', 'to', 'build', 'trust', 'and', 'facilitate', 'frank', 'discussions', 'relating', 'to', 'the', 'social', ',', 'economic', ',', 'emotional', ',', 'and', 'cultural', 'factors', 'that', 'influence', 'patients', '’', ' ', 'perceptions', ',', 'behaviors', ',', 'and', 'decision', 'making']",17,33
What does this CPG not do?,What,77,"does not provide recommendations for the management of pain with LOT in children or  adolescents, in patients with acute pain, or in patients receiving end-of-life care",Specifications,0,0.9583333333333334,"['What', 'does', 'this', 'CPG', 'not', 'do', '?']","['does', 'not', 'provide', 'recommendations', 'for', 'the', 'management', 'of', 'pain', 'with', 'LOT', 'in', 'children', 'or', ' ', 'adolescents', ',', 'in', 'patients', 'with', 'acute', 'pain', ',', 'or', 'in', 'patients', 'receiving', 'end', '-', 'of', '-', 'life', 'care']",7,33
What is this OT CPG designed to do?,What,78,assist healthcare providers in managing or co-managing patients on or being  considered for LOT,Specifications,1,1.0,"['What', 'is', 'this', 'OT', 'CPG', 'designed', 'to', 'do', '?']","['assist', 'healthcare', 'providers', 'in', 'managing', 'or', 'co', '-', 'managing', 'patients', 'on', 'or', 'being', ' ', 'considered', 'for', 'LOT']",9,17
What outweigh any potential  modest benefit of prescribing LOT in this population?,What,80,"the lack of evidence of efficacy of LOT and considerable evidence of  significant harms of overdose, death from overdose, and increased risk of suicide",Recommendations,1,1.0,"['What', 'outweigh', 'any', 'potential', ' ', 'modest', 'benefit', 'of', 'prescribing', 'LOT', 'in', 'this', 'population', '?']","['the', 'lack', 'of', 'evidence', 'of', 'efficacy', 'of', 'LOT', 'and', 'considerable', 'evidence', 'of', ' ', 'significant', 'harms', 'of', 'overdose', ',', 'death', 'from', 'overdose', ',', 'and', 'increased', 'risk', 'of', 'suicide']",14,27
What does not guarantee coverage of civilian sector care?,What,81,inclusion of recommendations for specific testing and/or therapeutic interventions within these guidelines,Introduction,1,1.0,"['What', 'does', 'not', 'guarantee', 'coverage', 'of', 'civilian', 'sector', 'care', '?']","['inclusion', 'of', 'recommendations', 'for', 'specific', 'testing', 'and/or', 'therapeutic', 'interventions', 'within', 'these', 'guidelines']",10,12
Who had higher rates  of OUD?,Who,82,those diagnosed with CNCP and an alcohol use or non-opioid drug use disorder,Recommendations,1,1.0,"['Who', 'had', 'higher', 'rates', ' ', 'of', 'OUD', '?']","['those', 'diagnosed', 'with', 'CNCP', 'and', 'an', 'alcohol', 'use', 'or', 'non', '-', 'opioid', 'drug', 'use', 'disorder']",8,15
What was associated with 28 times increased  odds of therapeutic opioid addiction compared to patients with CNCP without a lifetime history of SUD?,What,84,the presence of a lifetime history of SUD for patients with CNCP,Recommendations,1,1.0,"['What', 'was', 'associated', 'with', '28', 'times', 'increased', ' ', 'odds', 'of', 'therapeutic', 'opioid', 'addiction', 'compared', 'to', 'patients', 'with', 'CNCP', 'without', 'a', 'lifetime', 'history', 'of', 'SUD', '?']","['the', 'presence', 'of', 'a', 'lifetime', 'history', 'of', 'SUD', 'for', 'patients', 'with', 'CNCP']",25,12
What is not the intention of this guideline?,What,1,to serve as a standard of care,Specifications,0,0.9090909090909091,"['What', 'is', 'not', 'the', 'intention', 'of', 'this', 'guideline', '?']","['to', 'serve', 'as', 'a', 'standard', 'of', 'care']",9,7
How to use a CPG?,How,2,"the use of a CPG must always be considered as a recommendation, within the context of a provider’s  clinical judgment and patient values and preferences, for the care of an individual patient",Specifications,0,0.9130434782608696,"['How', 'to', 'use', 'a', 'CPG', '?']","['the', 'use', 'of', 'a', 'CPG', 'must', 'always', 'be', 'considered', 'as', 'a', 'recommendation', ',', 'within', 'the', 'context', 'of', 'a', 'provider', '’s', ' ', 'clinical', 'judgment', 'and', 'patient', 'values', 'and', 'preferences', ',', 'for', 'the', 'care', 'of', 'an', 'individual', 'patient']",6,36
What are the limitation of this CPG?,What,3,"As with other CPGs, there are limitations, including significant evidence gaps. Further, there is a need to  develop effective strategies for guideline implementation and evaluation of the effect of guideline  adherence on clinical outcomes.",Specifications,0,0.17142857142857143,"['What', 'are', 'the', 'limitation', 'of', 'this', 'CPG', '?']","['As', 'with', 'other', 'CPGs', ',', 'there', 'are', 'limitations', ',', 'including', 'significant', 'evidence', 'gaps', '.', 'Further', ',', 'there', 'is', 'a', 'need', 'to', ' ', 'develop', 'effective', 'strategies', 'for', 'guideline', 'implementation', 'and', 'evaluation', 'of', 'the', 'effect', 'of', 'guideline', ' ', 'adherence', 'on', 'clinical', 'outcomes', '.']",8,41
How are the standards of care determined?,How,4,on the basis of all  clinical data available for an individual patient and are subject to change as scientific knowledge and  technology advance and patterns evolve,Specifications,1,1.0,"['How', 'are', 'the', 'standards', 'of', 'care', 'determined', '?']","['on', 'the', 'basis', 'of', 'all', ' ', 'clinical', 'data', 'available', 'for', 'an', 'individual', 'patient', 'and', 'are', 'subject', 'to', 'change', 'as', 'scientific', 'knowledge', 'and', ' ', 'technology', 'advance', 'and', 'patterns', 'evolve']",8,28
What is EBPWG?,What,5,Evidence-Based Practice Work Group,Introduction,1,1.0,"['What', 'is', 'EBPWG', '?']","['Evidence', '-', 'Based', 'Practice', 'Work', 'Group']",4,6
What does this CPG intend to do?,What,6,"provide healthcare providers with a framework by which to evaluate, treat, and manage the individual needs and preferences of patients with chronic pain who are on or being considered for long-term opioid therapy (LOT)",Introduction,0,0.0,"['What', 'does', 'this', 'CPG', 'intend', 'to', 'do', '?']","['provide', 'healthcare', 'providers', 'with', 'a', 'framework', 'by', 'which', 'to', 'evaluate', ',', 'treat', ',', 'and', 'manage', 'the', 'individual', 'needs', 'and', 'preferences', 'of', 'patients', 'with', 'chronic', 'pain', 'who', 'are', 'on', 'or', 'being', 'considered', 'for', 'long', '-', 'term', 'opioid', 'therapy', '(', 'LOT', ')']",8,40
When was the Department of Veterans Affairs (VA) and Department of Defense (DoD) Evidence-Based Practice Work Group (EBPWG) was established and first chartered?,When,7,2004,Introduction,1,1.0,"['When', 'was', 'the', 'Department', 'of', 'Veterans', 'Affairs', '(', 'VA', ')', 'and', 'Department', 'of', 'Defense', '(', 'DoD', ')', 'Evidence', '-', 'Based', 'Practice', 'Work', 'Group', '(', 'EBPWG', ')', 'was', 'established', 'and', 'first', 'chartered', '?']",['2004'],32,1
"How does the Department of Veterans Affairs (VA) and Department of Defense (DoD) Evidence-Based Practice Work Group (EBPWG) advise the “…Health Executive Council on the use of clinical and epidemiological evidence to improve the health of the population across the Veterans Health Administration and Military Health System,”?",How,8,by facilitating the development of clinical practice guidelines (CPGs) for the VA and DoD populations,Introduction,1,1.0,"['How', 'does', 'the', 'Department', 'of', 'Veterans', 'Affairs', '(', 'VA', ')', 'and', 'Department', 'of', 'Defense', '(', 'DoD', ')', 'Evidence', '-', 'Based', 'Practice', 'Work', 'Group', '(', 'EBPWG', ')', 'advise', 'the', '“', '…', 'Health', 'Executive', 'Council', 'on', 'the', 'use', 'of', 'clinical', 'and', 'epidemiological', 'evidence', 'to', 'improve', 'the', 'health', 'of', 'the', 'population', 'across', 'the', 'Veterans', 'Health', 'Administration', 'and', 'Military', 'Health', 'System', ',', '”', '?']","['by', 'facilitating', 'the', 'development', 'of', 'clinical', 'practice', 'guidelines', '(', 'CPGs', ')', 'for', 'the', 'VA', 'and', 'DoD', 'populations']",60,17
What are CPGs?,What,9,clinical practice guidelines,Introduction,1,1.0,"['What', 'are', 'CPGs', '?']","['clinical', 'practice', 'guidelines']",4,3
What was the mission of the Department of Veterans Affairs (VA) and Department of Defense (DoD) Evidence-Based Practice Work Group (EBPWG)?,What,10,"to advise the “…Health Executive Council on the use of clinical and epidemiological evidence to improve the health of the population across the Veterans Health Administration and Military Health System,” by facilitating the development of clinical practice guidelines (CPGs) for the VA and DoD populations",Introduction,0,0.05128205128205127,"['What', 'was', 'the', 'mission', 'of', 'the', 'Department', 'of', 'Veterans', 'Affairs', '(', 'VA', ')', 'and', 'Department', 'of', 'Defense', '(', 'DoD', ')', 'Evidence', '-', 'Based', 'Practice', 'Work', 'Group', '(', 'EBPWG', ')', '?']","['to', 'advise', 'the', '“', '…', 'Health', 'Executive', 'Council', 'on', 'the', 'use', 'of', 'clinical', 'and', 'epidemiological', 'evidence', 'to', 'improve', 'the', 'health', 'of', 'the', 'population', 'across', 'the', 'Veterans', 'Health', 'Administration', 'and', 'Military', 'Health', 'System', ',', '”', 'by', 'facilitating', 'the', 'development', 'of', 'clinical', 'practice', 'guidelines', '(', 'CPGs', ')', 'for', 'the', 'VA', 'and', 'DoD', 'populations']",30,51
What is LOT?,What,11,long-term opioid therapy,Introduction,1,1.0,"['What', 'is', 'LOT', '?']","['long', '-', 'term', 'opioid', 'therapy']",4,5
Which opioid delivery for opioids has significant potential for harm from OT?,Which,12,either transdermal or buccal,Recommendations,0,0.8571428571428571,"['Which', 'opioid', 'delivery', 'for', 'opioids', 'has', 'significant', 'potential', 'for', 'harm', 'from', 'OT', '?']","['either', 'transdermal', 'or', 'buccal']",13,4
Which delivery mechanism has no evidence of benefit ove traditional opioid delivery systems in patients with chronic pain? ,Which,13,either transdermal or buccal,Recommendations,0,0.6666666666666665,"['Which', 'delivery', 'mechanism', 'has', 'no', 'evidence', 'of', 'benefit', 'ove', 'traditional', 'opioid', 'delivery', 'systems', 'in', 'patients', 'with', 'chronic', 'pain', '?']","['either', 'transdermal', 'or', 'buccal']",19,4
What are the risks associated with a fentanyl transdermal delivery system (or patch)?,What,14,"Unique pharmacokinetic profile, Continuous delivery, even after the patch is removed due to depot effect, Increased rate of delivery, Unpredictable variation in rate of delivery  - Due to alterations in temperature due to external heat, skin integrity, and amount of  adipose tissue, Among patients with fever, skin damage, or cachexia",Recommendations,0,0.7027027027027027,"['What', 'are', 'the', 'risks', 'associated', 'with', 'a', 'fentanyl', 'transdermal', 'delivery', 'system', '(', 'or', 'patch', ')', '?']","['Unique', 'pharmacokinetic', 'profile', ',', 'Continuous', 'delivery', ',', 'even', 'after', 'the', 'patch', 'is', 'removed', 'due', 'to', 'depot', 'effect', ',', 'Increased', 'rate', 'of', 'delivery', ',', 'Unpredictable', 'variation', 'in', 'rate', 'of', 'delivery', ' ', '-', 'Due', 'to', 'alterations', 'in', 'temperature', 'due', 'to', 'external', 'heat', ',', 'skin', 'integrity', ',', 'and', 'amount', 'of', ' ', 'adipose', 'tissue', ',', 'Among', 'patients', 'with', 'fever', ',', 'skin', 'damage', ',', 'or', 'cachexia']",16,61
What is the stance regarding prescribing long-acting opioids for acute pain?,What,15,recommend against,Recommendations,1,1.0,"['What', 'is', 'the', 'stance', 'regarding', 'prescribing', 'long', '-', 'acting', 'opioids', 'for', 'acute', 'pain', '?']","['recommend', 'against']",14,2
What to do for patients who are currently prescribed doses over 90 mg morphine equivalent daily dose?,What,17,evaluate for tapering to reduced dose or to discontinuation,Recommendations,1,1.0,"['What', 'to', 'do', 'for', 'patients', 'who', 'are', 'currently', 'prescribed', 'doses', 'over', '90', 'mg', 'morphine', 'equivalent', 'daily', 'dose', '?']","['evaluate', 'for', 'tapering', 'to', 'reduced', 'dose', 'or', 'to', 'discontinuation']",18,9
What is the stance regarding prescribing long-acting opioids as an as-needed medication?,What,18,recommend against,Recommendations,1,1.0,"['What', 'is', 'the', 'stance', 'regarding', 'prescribing', 'long', '-', 'acting', 'opioids', 'as', 'an', 'as', '-', 'needed', 'medication', '?']","['recommend', 'against']",17,2
What is the stance regarding opioid doses over 90 mg morphine equivalent daily dose for treating chronic pain?,What,19,recommend against,Recommendations,1,1.0,"['What', 'is', 'the', 'stance', 'regarding', 'opioid', 'doses', 'over', '90', 'mg', 'morphine', 'equivalent', 'daily', 'dose', 'for', 'treating', 'chronic', 'pain', '?']","['recommend', 'against']",19,2
When may serious harm occur in patients?,When,21,should patients be prescribed additional (or different) opioids if prior administration of opioids led to serious adverse effects or was not tolerated,Background,1,1.0,"['When', 'may', 'serious', 'harm', 'occur', 'in', 'patients', '?']","['should', 'patients', 'be', 'prescribed', 'additional', '(', 'or', 'different', ')', 'opioids', 'if', 'prior', 'administration', 'of', 'opioids', 'led', 'to', 'serious', 'adverse', 'effects', 'or', 'was', 'not', 'tolerated']",8,24
Who has a significantly increased risk  of all-cause mortality compared to patients with CNCP who are taking an analgesic anticonvulsants or a  low-dose antidepressant?,Who,22,patients with CNCP on long-acting OT,Recommendations,1,1.0,"['Who', 'has', 'a', 'significantly', 'increased', 'risk', ' ', 'of', 'all', '-', 'cause', 'mortality', 'compared', 'to', 'patients', 'with', 'CNCP', 'who', 'are', 'taking', 'an', 'analgesic', 'anticonvulsants', 'or', 'a', ' ', 'low', '-', 'dose', 'antidepressant', '?']","['patients', 'with', 'CNCP', 'on', 'long', '-', 'acting', 'OT']",31,8
Which specific safety precautions should all clinicians be aware of regarding transdermal fentanyl?,Which,23,"Transdermal fentanyl should not be used in opioid-naïve patients; Patients need to be informed that: Heat (e.g., sun exposure, heating pad, febrile condition) can increase the rate and quantity  of absorption, Proper application includes: being sure to take old patch off; never applying damaged patch  or a patch to non-intact skin; proper disposal to avoid exposure to children and pets, and precautions taken against possible diversion of remaining drug in used patch; Adjusted dose (i.e., decreased patch size) should be used in patients with renal or hepatic  insufficiency and considered in elderly patients and those with febrile illness ",Recommendations,0,0.17142857142857143,"['Which', 'specific', 'safety', 'precautions', 'should', 'all', 'clinicians', 'be', 'aware', 'of', 'regarding', 'transdermal', 'fentanyl', '?']","['Transdermal', 'fentanyl', 'should', 'not', 'be', 'used', 'in', 'opioid', '-', 'naïve', 'patients', ';', 'Patients', 'need', 'to', 'be', 'informed', 'that', ':', 'Heat', '(', 'e.g.', ',', 'sun', 'exposure', ',', 'heating', 'pad', ',', 'febrile', 'condition', ')', 'can', 'increase', 'the', 'rate', 'and', 'quantity', ' ', 'of', 'absorption', ',', 'Proper', 'application', 'includes', ':', 'being', 'sure', 'to', 'take', 'old', 'patch', 'off', ';', 'never', 'applying', 'damaged', 'patch', ' ', 'or', 'a', 'patch', 'to', 'non', '-', 'intact', 'skin', ';', 'proper', 'disposal', 'to', 'avoid', 'exposure', 'to', 'children', 'and', 'pets', ',', 'and', 'precautions', 'taken', 'against', 'possible', 'diversion', 'of', 'remaining', 'drug', 'in', 'used', 'patch', ';', 'Adjusted', 'dose', '(', 'i.e.', ',', 'decreased', 'patch', 'size', ')', 'should', 'be', 'used', 'in', 'patients', 'with', 'renal', 'or', 'hepatic', ' ', 'insufficiency', 'and', 'considered', 'in', 'elderly', 'patients', 'and', 'those', 'with', 'febrile', 'illness']",14,121
What is associated with little evidence for sustained analgesic efficacy but a substantial increase in risk for OUD?,What,24,progression from acute to long-term OT,Recommendations,1,1.0,"['What', 'is', 'associated', 'with', 'little', 'evidence', 'for', 'sustained', 'analgesic', 'efficacy', 'but', 'a', 'substantial', 'increase', 'in', 'risk', 'for', 'OUD', '?']","['progression', 'from', 'acute', 'to', 'long', '-', 'term', 'OT']",19,8
What information should be discussed with patients at initiation of OT and continuously thereafter?,What,25,progression from acute to long-term OT is associated with little evidence  for sustained analgesic efficacy but a substantial increase in risk for OUD,Recommendations,1,1.0,"['What', 'information', 'should', 'be', 'discussed', 'with', 'patients', 'at', 'initiation', 'of', 'OT', 'and', 'continuously', 'thereafter', '?']","['progression', 'from', 'acute', 'to', 'long', '-', 'term', 'OT', 'is', 'associated', 'with', 'little', 'evidence', ' ', 'for', 'sustained', 'analgesic', 'efficacy', 'but', 'a', 'substantial', 'increase', 'in', 'risk', 'for', 'OUD']",15,26
When should the providers discuss with patients that progression from acute to long-term OT is associated with little evidence  for sustained analgesic efficacy but a substantial increase in risk for OUD?,When,26,at initiation of OT and continuously thereafter,Recommendations,1,1.0,"['When', 'should', 'the', 'providers', 'discuss', 'with', 'patients', 'that', 'progression', 'from', 'acute', 'to', 'long', '-', 'term', 'OT', 'is', 'associated', 'with', 'little', 'evidence', ' ', 'for', 'sustained', 'analgesic', 'efficacy', 'but', 'a', 'substantial', 'increase', 'in', 'risk', 'for', 'OUD', '?']","['at', 'initiation', 'of', 'OT', 'and', 'continuously', 'thereafter']",35,7
Why should the providers discuss with patients that progression from acute to long-term OT is associated with little evidence  for sustained analgesic efficacy but a substantial increase in risk for OUD?,Why,27,to ensure that the patient  understands the associated risks and benefits of LOT,Recommendations,1,1.0,"['Why', 'should', 'the', 'providers', 'discuss', 'with', 'patients', 'that', 'progression', 'from', 'acute', 'to', 'long', '-', 'term', 'OT', 'is', 'associated', 'with', 'little', 'evidence', ' ', 'for', 'sustained', 'analgesic', 'efficacy', 'but', 'a', 'substantial', 'increase', 'in', 'risk', 'for', 'OUD', '?']","['to', 'ensure', 'that', 'the', 'patient', ' ', 'understands', 'the', 'associated', 'risks', 'and', 'benefits', 'of', 'LOT']",35,14
What is necessary to more accurately determine how long it takes for OUD to occur and whether the  nature of the pain is one of the factors that can influence either of this phenomena?,What,28,Research,Recommendations,1,1.0,"['What', 'is', 'necessary', 'to', 'more', 'accurately', 'determine', 'how', 'long', 'it', 'takes', 'for', 'OUD', 'to', 'occur', 'and', 'whether', 'the', ' ', 'nature', 'of', 'the', 'pain', 'is', 'one', 'of', 'the', 'factors', 'that', 'can', 'influence', 'either', 'of', 'this', 'phenomena', '?']",['Research'],36,1
What is necessary to more accurately determine how long it takes for OUD to occur?,What,29,Research,Recommendations,1,1.0,"['What', 'is', 'necessary', 'to', 'more', 'accurately', 'determine', 'how', 'long', 'it', 'takes', 'for', 'OUD', 'to', 'occur', '?']",['Research'],16,1
What can be determined more accurately by research?,What,30,how long it takes for OUD to occur and whether the  nature of the pain is one of the factors that can influence either of this phenomena,Recommendations,1,1.0,"['What', 'can', 'be', 'determined', 'more', 'accurately', 'by', 'research', '?']","['how', 'long', 'it', 'takes', 'for', 'OUD', 'to', 'occur', 'and', 'whether', 'the', ' ', 'nature', 'of', 'the', 'pain', 'is', 'one', 'of', 'the', 'factors', 'that', 'can', 'influence', 'either', 'of', 'this', 'phenomena']",9,28
What to inform patient regarding progression from acute to long-term OT?,What,31,progression from acute to long-term OT is associated with little evidence  for sustained analgesic efficacy but a substantial increase in risk for OUD,Recommendations,0,0.7428571428571429,"['What', 'to', 'inform', 'patient', 'regarding', 'progression', 'from', 'acute', 'to', 'long', '-', 'term', 'OT', '?']","['progression', 'from', 'acute', 'to', 'long', '-', 'term', 'OT', 'is', 'associated', 'with', 'little', 'evidence', ' ', 'for', 'sustained', 'analgesic', 'efficacy', 'but', 'a', 'substantial', 'increase', 'in', 'risk', 'for', 'OUD']",14,26
Who are the target population for the VA/DoD OT CPG?,Who,32,"Service Members,  Veterans, and their families—that has unique characteristics and needs related to the military culture and communities to which they return",Background,0,0.37037037037037035,"['Who', 'are', 'the', 'target', 'population', 'for', 'the', 'VA', '/', 'DoD', 'OT', 'CPG', '?']","['Service', 'Members', ',', ' ', 'Veterans', ',', 'and', 'their', 'families', '—', 'that', 'has', 'unique', 'characteristics', 'and', 'needs', 'related', 'to', 'the', 'military', 'culture', 'and', 'communities', 'to', 'which', 'they', 'return']",13,27
What was the considerations behind the recommendations made in the CPG?,What,33,"the implications they would  have within the VA/DoD healthcare settings, particularly regarding considerations such as resource use, accessibility, and equity related to each recommendation and the urgent need for rigorous attention to the balance of risks and benefits for patients within the VA/DoD specifically",Background,0,0.3404255319148936,"['What', 'was', 'the', 'considerations', 'behind', 'the', 'recommendations', 'made', 'in', 'the', 'CPG', '?']","['the', 'implications', 'they', 'would', ' ', 'have', 'within', 'the', 'VA', '/', 'DoD', 'healthcare', 'settings', ',', 'particularly', 'regarding', 'considerations', 'such', 'as', 'resource', 'use', ',', 'accessibility', ',', 'and', 'equity', 'related', 'to', 'each', 'recommendation', 'and', 'the', 'urgent', 'need', 'for', 'rigorous', 'attention', 'to', 'the', 'balance', 'of', 'risks', 'and', 'benefits', 'for', 'patients', 'within', 'the', 'VA', '/', 'DoD', 'specifically']",12,52
What are the examples of dual-mechanism opioids?,What,35,tramadol and tapentadol,Recommendations,1,1.0,"['What', 'are', 'the', 'examples', 'of', 'dual', '-', 'mechanism', 'opioids', '?']","['tramadol', 'and', 'tapentadol']",10,3
What are the differences between tramadol and tapentadol?,What,36,"While both are dual-mechanism opioids, they differ in their affinity for the mu  opioid receptor, resulting in partial versus full agonist effects",Recommendations,0,0.8648648648648648,"['What', 'are', 'the', 'differences', 'between', 'tramadol', 'and', 'tapentadol', '?']","['While', 'both', 'are', 'dual', '-', 'mechanism', 'opioids', ',', 'they', 'differ', 'in', 'their', 'affinity', 'for', 'the', 'mu', ' ', 'opioid', 'receptor', ',', 'resulting', 'in', 'partial', 'versus', 'full', 'agonist', 'effects']",9,27
What is included in the dual-mechanism opioids?,What,37,formulations of an opioid medication with a selective serotonin reuptake  inhibitor (SSRI) or a serotonin-norepinephrine reuptake inhibitor (SNRI),Recommendations,1,1.0,"['What', 'is', 'included', 'in', 'the', 'dual', '-', 'mechanism', 'opioids', '?']","['formulations', 'of', 'an', 'opioid', 'medication', 'with', 'a', 'selective', 'serotonin', 'reuptake', ' ', 'inhibitor', '(', 'SSRI', ')', 'or', 'a', 'serotonin', '-', 'norepinephrine', 'reuptake', 'inhibitor', '(', 'SNRI', ')']",10,25
What was the efficacy of long-acting opioids used once-daily compared to twice-daily use?,What,38,non-inferior,Recommendations,1,1.0,"['What', 'was', 'the', 'efficacy', 'of', 'long', '-', 'acting', 'opioids', 'used', 'once', '-', 'daily', 'compared', 'to', 'twice', '-', 'daily', 'use', '?']","['non', '-', 'inferior']",20,3
Which one is the strongest predictor of developing OUD among opioid dose and duration of OT?,Which,40,duration of OT,Recommendations,1,1.0,"['Which', 'one', 'is', 'the', 'strongest', 'predictor', 'of', 'developing', 'OUD', 'among', 'opioid', 'dose', 'and', 'duration', 'of', 'OT', '?']","['duration', 'of', 'OT']",17,3
What is CNS?,What,42,central nervous system,Background,1,1.0,"['What', 'is', 'CNS', '?']","['central', 'nervous', 'system']",4,3
Which areas in the CNS are involved in the chronic pain?,Which,43,"chronic pain is thought to be  associated with alterations in brain centers involved with emotions, reward, and executive function as well  as central sensitization of nociceptive pathways across several CNS areas.",Background,0,0.1176470588235294,"['Which', 'areas', 'in', 'the', 'CNS', 'are', 'involved', 'in', 'the', 'chronic', 'pain', '?']","['chronic', 'pain', 'is', 'thought', 'to', 'be', ' ', 'associated', 'with', 'alterations', 'in', 'brain', 'centers', 'involved', 'with', 'emotions', ',', 'reward', ',', 'and', 'executive', 'function', 'as', 'well', ' ', 'as', 'central', 'sensitization', 'of', 'nociceptive', 'pathways', 'across', 'several', 'CNS', 'areas', '.']",12,36
Which areas in the CNS are involved in the acute and subacute pain?,Which,44,primarily nociceptive processing areas,Background,0,0.8571428571428571,"['Which', 'areas', 'in', 'the', 'CNS', 'are', 'involved', 'in', 'the', 'acute', 'and', 'subacute', 'pain', '?']","['primarily', 'nociceptive', 'processing', 'areas']",14,4
How was an age of 30 years chosen as a clinically reasonable threshold?,How,46,An age of 30 years was chosen based on how age was categorized in the six studies that showed an inverse  relationship between age and OUD or overdose.,Recommendations,0,0.8636363636363636,"['How', 'was', 'an', 'age', 'of', '30', 'years', 'chosen', 'as', 'a', 'clinically', 'reasonable', 'threshold', '?']","['An', 'age', 'of', '30', 'years', 'was', 'chosen', 'based', 'on', 'how', 'age', 'was', 'categorized', 'in', 'the', 'six', 'studies', 'that', 'showed', 'an', 'inverse', ' ', 'relationship', 'between', 'age', 'and', 'OUD', 'or', 'overdose', '.']",14,30
How have OTAs been described in the 2010 OT CPG?,How,47,"as coercive rather  than therapeutic, lack respect for individual autonomy, can be a barrier to pain care, and may be harmful  to the patient-provider relationship",Recommendations,0,0.9777777777777777,"['How', 'have', 'OTAs', 'been', 'described', 'in', 'the', '2010', 'OT', 'CPG', '?']","['as', 'coercive', 'rather', ' ', 'than', 'therapeutic', ',', 'lack', 'respect', 'for', 'individual', 'autonomy', ',', 'can', 'be', 'a', 'barrier', 'to', 'pain', 'care', ',', 'and', 'may', 'be', 'harmful', ' ', 'to', 'the', 'patient', '-', 'provider', 'relationship']",11,32
What did the 2010 OT CPG reflect?,What,48,prior  practice of using opioid treatment (or pain care) agreements,Recommendations,1,1.0,"['What', 'did', 'the', '2010', 'OT', 'CPG', 'reflect', '?']","['prior', ' ', 'practice', 'of', 'using', 'opioid', 'treatment', '(', 'or', 'pain', 'care', ')', 'agreements']",8,13
What can have potential adverse outcomes in patients who do not have depression?,What,49,the combined use of antidepressants and opioids,Recommendations,1,1.0,"['What', 'can', 'have', 'potential', 'adverse', 'outcomes', 'in', 'patients', 'who', 'do', 'not', 'have', 'depression', '?']","['the', 'combined', 'use', 'of', 'antidepressants', 'and', 'opioids']",14,7
What does increase the AOR of  overdose?,What,50,the combination of zolpidem and opioids,Recommendations,1,1.0,"['What', 'does', 'increase', 'the', 'AOR', 'of', ' ', 'overdose', '?']","['the', 'combination', 'of', 'zolpidem', 'and', 'opioids']",9,6
Who can have potential adverse outcomes with the combined use of antidepressants and opioids?,Who,51,patients who do not have depression,Recommendations,1,1.0,"['Who', 'can', 'have', 'potential', 'adverse', 'outcomes', 'with', 'the', 'combined', 'use', 'of', 'antidepressants', 'and', 'opioids', '?']","['patients', 'who', 'do', 'not', 'have', 'depression']",15,6
What can happen with the combined use of antidepressants and opioids in patients who do not have depression?,What,54,"potential adverse outcomes (e.g., risk of overdose)",Recommendations,1,1.0,"['What', 'can', 'happen', 'with', 'the', 'combined', 'use', 'of', 'antidepressants', 'and', 'opioids', 'in', 'patients', 'who', 'do', 'not', 'have', 'depression', '?']","['potential', 'adverse', 'outcomes', '(', 'e.g.', ',', 'risk', 'of', 'overdose', ')']",19,10
What is not as strong as the evidence for harm associated with the combination of  opioids and benzodiazepines?,What,55,"the evidence for harm associated with the combination of opioids and Z-drugs (e.g.,  zolpidem, eszopiclone)",Recommendations,0,0.47058823529411764,"['What', 'is', 'not', 'as', 'strong', 'as', 'the', 'evidence', 'for', 'harm', 'associated', 'with', 'the', 'combination', 'of', ' ', 'opioids', 'and', 'benzodiazepines', '?']","['the', 'evidence', 'for', 'harm', 'associated', 'with', 'the', 'combination', 'of', 'opioids', 'and', 'Z', '-', 'drugs', '(', 'e.g.', ',', ' ', 'zolpidem', ',', 'eszopiclone', ')']",20,22
When to consider consultation with local risk management and/or counsel?,When,56,When there is evidence that the patient is diverting opioids,Background,0,0.1142857142857143,"['When', 'to', 'consider', 'consultation', 'with', 'local', 'risk', 'management', 'and/or', 'counsel', '?']","['When', 'there', 'is', 'evidence', 'that', 'the', 'patient', 'is', 'diverting', 'opioids']",11,10
What should the clinician communicate to patients?,What,57,that drug diversion is a crime and constitutes an absolute contraindication to prescribing additional medications,Background,1,1.0,"['What', 'should', 'the', 'clinician', 'communicate', 'to', 'patients', '?']","['that', 'drug', 'diversion', 'is', 'a', 'crime', 'and', 'constitutes', 'an', 'absolute', 'contraindication', 'to', 'prescribing', 'additional', 'medications']",8,15
What are some examples of synthetic opioids?,What,58,"methadone, fentanyl, tramadol",Background,1,1.0,"['What', 'are', 'some', 'examples', 'of', 'synthetic', 'opioids', '?']","['methadone', ',', 'fentanyl', ',', 'tramadol']",8,5
What is a crime and constitutes an absolute contraindication to prescribing additional medications?,What,59,drug diversion,Background,1,1.0,"['What', 'is', 'a', 'crime', 'and', 'constitutes', 'an', 'absolute', 'contraindication', 'to', 'prescribing', 'additional', 'medications', '?']","['drug', 'diversion']",14,2
What to keep in mind for patients with OUD?,What,60,sudden discontinuation of opioids due to suspected diversion may place them at high risk for illicit opioid use and resulting opioid overdose (see Recommendation 17),Background,0,0.9361702127659575,"['What', 'to', 'keep', 'in', 'mind', 'for', 'patients', 'with', 'OUD', '?']","['sudden', 'discontinuation', 'of', 'opioids', 'due', 'to', 'suspected', 'diversion', 'may', 'place', 'them', 'at', 'high', 'risk', 'for', 'illicit', 'opioid', 'use', 'and', 'resulting', 'opioid', 'overdose', '(', 'see', 'Recommendation', '17', ')']",10,27
What may not reliably detect synthetic or semi-synthetic opioids?,What,61,Routine UDT,Background,1,1.0,"['What', 'may', 'not', 'reliably', 'detect', 'synthetic', 'or', 'semi', '-', 'synthetic', 'opioids', '?']","['Routine', 'UDT']",12,2
What to do when there is evidence that the patient is diverting opioids?,What,63,discontinue opioids according to Recommendations 14 and 15 and assess for underlying OUD and/or psychiatric comorbidities,Background,1,1.0,"['What', 'to', 'do', 'when', 'there', 'is', 'evidence', 'that', 'the', 'patient', 'is', 'diverting', 'opioids', '?']","['discontinue', 'opioids', 'according', 'to', 'Recommendations', '14', 'and', '15', 'and', 'assess', 'for', 'underlying', 'OUD', 'and/or', 'psychiatric', 'comorbidities']",14,16
"When may consultation with a pain specialist, psychiatrist, or SUD specialist be warranted?",When,64,When there is evidence that the patient is diverting opioids,Background,0,0.19999999999999998,"['When', 'may', 'consultation', 'with', 'a', 'pain', 'specialist', ',', 'psychiatrist', ',', 'or', 'SUD', 'specialist', 'be', 'warranted', '?']","['When', 'there', 'is', 'evidence', 'that', 'the', 'patient', 'is', 'diverting', 'opioids']",16,10
How to confirm suspicions regarding drug diversion?,How,65,by a negative mass spectrometry/liquid chromatography UDT for the substance being prescribed in the absence of withdrawal symptoms in someone who is receiving opioids,Background,0,0.975609756097561,"['How', 'to', 'confirm', 'suspicions', 'regarding', 'drug', 'diversion', '?']","['by', 'a', 'negative', 'mass', 'spectrometry', '/', 'liquid', 'chromatography', 'UDT', 'for', 'the', 'substance', 'being', 'prescribed', 'in', 'the', 'absence', 'of', 'withdrawal', 'symptoms', 'in', 'someone', 'who', 'is', 'receiving', 'opioids']",8,26
What could also by itself be a sign of diversion?,What,66,A negative UDT for the prescribed opioid,Background,1,1.0,"['What', 'could', 'also', 'by', 'itself', 'be', 'a', 'sign', 'of', 'diversion', '?']","['A', 'negative', 'UDT', 'for', 'the', 'prescribed', 'opioid']",11,7
What are some examples of semi-synthetic opioids?,What,67,"oxycodone, hydrocodone, hydromorphone",Background,1,1.0,"['What', 'are', 'some', 'examples', 'of', 'semi', '-', 'synthetic', 'opioids', '?']","['oxycodone', ',', 'hydrocodone', ',', 'hydromorphone']",10,5
Why is it important that providers who suspect diversion base treatment plans on objective evidence?,Why,68,"Because suspicion is subjective and may be based on impression, bias, or prejudice",Background,1,1.0,"['Why', 'is', 'it', 'important', 'that', 'providers', 'who', 'suspect', 'diversion', 'base', 'treatment', 'plans', 'on', 'objective', 'evidence', '?']","['Because', 'suspicion', 'is', 'subjective', 'and', 'may', 'be', 'based', 'on', 'impression', ',', 'bias', ',', 'or', 'prejudice']",16,15
How does the updated CPG guideline fulfil its system-wide goal to improve the patient’s health and well-being?,How,69,by providing evidence-based guidance to providers who are taking care of patients on or being considered for LOT,Introduction,1,1.0,"['How', 'does', 'the', 'updated', 'CPG', 'guideline', 'fulfil', 'its', 'system', '-', 'wide', 'goal', 'to', 'improve', 'the', 'patient', '’s', 'health', 'and', 'well', '-', 'being', '?']","['by', 'providing', 'evidence', '-', 'based', 'guidance', 'to', 'providers', 'who', 'are', 'taking', 'care', 'of', 'patients', 'on', 'or', 'being', 'considered', 'for', 'LOT']",23,20
What is the system-wide goal of the updated CPG guideline?,What,70,to improve the patient’s health and well-being by providing evidence-based guidance to providers who are taking care of patients on or being considered for LOT,Introduction,0,0.9787234042553191,"['What', 'is', 'the', 'system', '-', 'wide', 'goal', 'of', 'the', 'updated', 'CPG', 'guideline', '?']","['to', 'improve', 'the', 'patient', '’s', 'health', 'and', 'well', '-', 'being', 'by', 'providing', 'evidence', '-', 'based', 'guidance', 'to', 'providers', 'who', 'are', 'taking', 'care', 'of', 'patients', 'on', 'or', 'being', 'considered', 'for', 'LOT']",13,30
What is the expected outcome of successful implementation of this guideline?,What,71,"to assess the patient’s condition, provide education, and determine the best treatment methods in collaboration with the patient and a multidisciplinary care team, optimize the patient’s health outcomes and function and improve quality of life, minimize preventable complications and morbidity, emphasize the use of patient-centered care",Introduction,0,0.04878048780487806,"['What', 'is', 'the', 'expected', 'outcome', 'of', 'successful', 'implementation', 'of', 'this', 'guideline', '?']","['to', 'assess', 'the', 'patient', '’s', 'condition', ',', 'provide', 'education', ',', 'and', 'determine', 'the', 'best', 'treatment', 'methods', 'in', 'collaboration', 'with', 'the', 'patient', 'and', 'a', 'multidisciplinary', 'care', 'team', ',', 'optimize', 'the', 'patient', '’s', 'health', 'outcomes', 'and', 'function', 'and', 'improve', 'quality', 'of', 'life', ',', 'minimize', 'preventable', 'complications', 'and', 'morbidity', ',', 'emphasize', 'the', 'use', 'of', 'patient', '-', 'centered', 'care']",12,55
What to follow up or review during opioid therapy?,What,73,benefits and risks,Specifications,1,1.0,"['What', 'to', 'follow', 'up', 'or', 'review', 'during', 'opioid', 'therapy', '?']","['benefits', 'and', 'risks']",10,3
When to consider tapering opioids to taper and discontinue?,When,74,If benefits do not outweigh harms,Specifications,1,1.0,"['When', 'to', 'consider', 'tapering', 'opioids', 'to', 'taper', 'and', 'discontinue', '?']","['If', 'benefits', 'do', 'not', 'outweigh', 'harms']",10,6
What kind of opioids to use when starting therapy?,What,75,immediate-release,Specifications,0,0.6666666666666666,"['What', 'kind', 'of', 'opioids', 'to', 'use', 'when', 'starting', 'therapy', '?']","['immediate', '-', 'release']",10,3
What to follow up or review before starting opioid therapy?,What,76,benefits and risks,Specifications,1,1.0,"['What', 'to', 'follow', 'up', 'or', 'review', 'before', 'starting', 'opioid', 'therapy', '?']","['benefits', 'and', 'risks']",11,3
When to consider tapering opioids to lower doses?,When,77,If benefits do not outweigh harms,Specifications,1,1.0,"['When', 'to', 'consider', 'tapering', 'opioids', 'to', 'lower', 'doses', '?']","['If', 'benefits', 'do', 'not', 'outweigh', 'harms']",9,6
What is not an absolute contraindication to LOT?,What,78,Age <30 years,Recommendations,1,1.0,"['What', 'is', 'not', 'an', 'absolute', 'contraindication', 'to', 'LOT', '?']","['Age', '<', '30', 'years']",9,4
When may LOT be appropriate?,When,79,only if risk mitigation strategies are employed and patients are titrated off LOT as soon as it is  appropriate,Recommendations,1,1.0,"['When', 'may', 'LOT', 'be', 'appropriate', '?']","['only', 'if', 'risk', 'mitigation', 'strategies', 'are', 'employed', 'and', 'patients', 'are', 'titrated', 'off', 'LOT', 'as', 'soon', 'as', 'it', 'is', ' ', 'appropriate']",6,20
"Who are known to have less chronic pain, depression, and  PTSD when their pain is aggressively managed starting soon after injury?",Who,80,Hospitalized patients  recovering from battlefield injuries,Recommendations,1,1.0,"['Who', 'are', 'known', 'to', 'have', 'less', 'chronic', 'pain', ',', 'depression', ',', 'and', ' ', 'PTSD', 'when', 'their', 'pain', 'is', 'aggressively', 'managed', 'starting', 'soon', 'after', 'injury', '?']","['Hospitalized', 'patients', ' ', 'recovering', 'from', 'battlefield', 'injuries']",25,7
What should be weighed heavily in the risk-benefit determination for initiating LOT?,What,81,"Similar to other risk factors, age <30 years",Recommendations,0,0.5454545454545454,"['What', 'should', 'be', 'weighed', 'heavily', 'in', 'the', 'risk', '-', 'benefit', 'determination', 'for', 'initiating', 'LOT', '?']","['Similar', 'to', 'other', 'risk', 'factors', ',', 'age', '<', '30', 'years']",15,10
"Why should an optimal approach to care should include a robust,  signature informed consent process?",Why,82,Given the recognized risks of opioid therapy,Recommendations,1,1.0,"['Why', 'should', 'an', 'optimal', 'approach', 'to', 'care', 'should', 'include', 'a', 'robust', ',', ' ', 'signature', 'informed', 'consent', 'process', '?']","['Given', 'the', 'recognized', 'risks', 'of', 'opioid', 'therapy']",18,7
What did VA establish in 2014 regarding OT and treatment alternatives?,What,83,"a requirement for  signature informed consent, consistent with VA policy for other treatments or procedures with a  significant risk of complications or morbidity",Recommendations,0,0.3846153846153846,"['What', 'did', 'VA', 'establish', 'in', '2014', 'regarding', 'OT', 'and', 'treatment', 'alternatives', '?']","['a', 'requirement', 'for', ' ', 'signature', 'informed', 'consent', ',', 'consistent', 'with', 'VA', 'policy', 'for', 'other', 'treatments', 'or', 'procedures', 'with', 'a', ' ', 'significant', 'risk', 'of', 'complications', 'or', 'morbidity']",12,26
Which long-acting agents can be used for acute pain?,Which,86,oxycodone/acetaminophen extended release [ER] tablets,Recommendations,1,1.0,"['Which', 'long', '-', 'acting', 'agents', 'can', 'be', 'used', 'for', 'acute', 'pain', '?']","['oxycodone', '/', 'acetaminophen', 'extended', 'release', '[', 'ER', ']', 'tablets']",12,9
What kind of approach is highly recommended for communication with a patient?,What,87,An empathetic and non-judgmental (versus a confrontational or adversarial)  ,Specifications,1,1.0,"['What', 'kind', 'of', 'approach', 'is', 'highly', 'recommended', 'for', 'communication', 'with', 'a', 'patient', '?']","['An', 'empathetic', 'and', 'non', '-', 'judgmental', '(', 'versus', 'a', 'confrontational', 'or', 'adversarial', ')', ' ']",13,14
What can can be a gateway to LOT?,What,88,acute OT,Recommendations,1,1.0,"['What', 'can', 'can', 'be', 'a', 'gateway', 'to', 'LOT', '?']","['acute', 'OT']",9,2
What is CARA?,What,89,the Comprehensive Addiction and Recovery Act,Background,1,1.0,"['What', 'is', 'CARA', '?']","['the', 'Comprehensive', 'Addiction', 'and', 'Recovery', 'Act']",4,6
What is the primary focus of the CARA?,What,90,opioid abuse treatment and prevention,Background,1,1.0,"['What', 'is', 'the', 'primary', 'focus', 'of', 'the', 'CARA', '?']","['opioid', 'abuse', 'treatment', 'and', 'prevention']",9,5
When was CARA enacted?,When,91,"July 22, 2016",Background,1,1.0,"['When', 'was', 'CARA', 'enacted', '?']","['July', '22', ',', '2016']",5,4
What is the aim of CARA?,What,92,addressing the epidemic of overdoses from prescription opioids and other prescription drugs and heroin,Background,1,1.0,"['What', 'is', 'the', 'aim', 'of', 'CARA', '?']","['addressing', 'the', 'epidemic', 'of', 'overdoses', 'from', 'prescription', 'opioids', 'and', 'other', 'prescription', 'drugs', 'and', 'heroin']",7,14
What can cause a toxidrome?,What,93,Fentanyl analogs that may be used to create counterfeit opioid analgesic pills,Recommendations,1,1.0,"['What', 'can', 'cause', 'a', 'toxidrome', '?']","['Fentanyl', 'analogs', 'that', 'may', 'be', 'used', 'to', 'create', 'counterfeit', 'opioid', 'analgesic', 'pills']",6,12
Which opioids are responsible for a recent rise in death rates?,Which,94,"Synthetic opioids such as fentanyl analogs, potent opioid receptor agonists",Recommendations,1,1.0,"['Which', 'opioids', 'are', 'responsible', 'for', 'a', 'recent', 'rise', 'in', 'death', 'rates', '?']","['Synthetic', 'opioids', 'such', 'as', 'fentanyl', 'analogs', ',', 'potent', 'opioid', 'receptor', 'agonists']",12,11
What are some examples of synthetic opioids?,What,95,"fentanyl analogs, potent opioid receptor agonists",Recommendations,1,1.0,"['What', 'are', 'some', 'examples', 'of', 'synthetic', 'opioids', '?']","['fentanyl', 'analogs', ',', 'potent', 'opioid', 'receptor', 'agonists']",8,7
What can be caused by fentanyl analogs that may be used to create counterfeit opioid analgesic pills?,What,96,a toxidrome characterized by significant CNS and profound respiratory depression requiring multiple  naloxone doses for reversal,Recommendations,1,1.0,"['What', 'can', 'be', 'caused', 'by', 'fentanyl', 'analogs', 'that', 'may', 'be', 'used', 'to', 'create', 'counterfeit', 'opioid', 'analgesic', 'pills', '?']","['a', 'toxidrome', 'characterized', 'by', 'significant', 'CNS', 'and', 'profound', 'respiratory', 'depression', 'requiring', 'multiple', ' ', 'naloxone', 'doses', 'for', 'reversal']",18,17
"Why is it important to consider patients’ values and concerns, address misconceptions, express empathy, and fully explain to patients with one or more risk factors that they may not benefit from, and may even be harmed by, treatment with OT?",Why,97,"As patient values and preferences may be impacted by other clinical considerations, some patients with one or more risk factors for adverse outcomes may differ with the clinician’s assessment that the risks of OT  outweigh the potential for modest short-term benefits.",Background,0,0.05128205128205127,"['Why', 'is', 'it', 'important', 'to', 'consider', 'patients', '’', 'values', 'and', 'concerns', ',', 'address', 'misconceptions', ',', 'express', 'empathy', ',', 'and', 'fully', 'explain', 'to', 'patients', 'with', 'one', 'or', 'more', 'risk', 'factors', 'that', 'they', 'may', 'not', 'benefit', 'from', ',', 'and', 'may', 'even', 'be', 'harmed', 'by', ',', 'treatment', 'with', 'OT', '?']","['As', 'patient', 'values', 'and', 'preferences', 'may', 'be', 'impacted', 'by', 'other', 'clinical', 'considerations', ',', 'some', 'patients', 'with', 'one', 'or', 'more', 'risk', 'factors', 'for', 'adverse', 'outcomes', 'may', 'differ', 'with', 'the', 'clinician', '’s', 'assessment', 'that', 'the', 'risks', 'of', 'OT', ' ', 'outweigh', 'the', 'potential', 'for', 'modest', 'short', '-', 'term', 'benefits', '.']",47,47
What should be done for patients for whom LOT is initiated?,What,98,"should be carefully monitored, and ongoing assessment of risk should be performed with vigilance for the development of additional risk factors and adverse outcomes",Background,0,0.9545454545454545,"['What', 'should', 'be', 'done', 'for', 'patients', 'for', 'whom', 'LOT', 'is', 'initiated', '?']","['should', 'be', 'carefully', 'monitored', ',', 'and', 'ongoing', 'assessment', 'of', 'risk', 'should', 'be', 'performed', 'with', 'vigilance', 'for', 'the', 'development', 'of', 'additional', 'risk', 'factors', 'and', 'adverse', 'outcomes']",12,25
Why must the clinician carefully weigh harms and benefits and educate the patient as well as his or her family or caregiver prior to proceeding with treatment?,Why,99,Given the insufficient evidence of benefit for LOT,Background,1,1.0,"['Why', 'must', 'the', 'clinician', 'carefully', 'weigh', 'harms', 'and', 'benefits', 'and', 'educate', 'the', 'patient', 'as', 'well', 'as', 'his', 'or', 'her', 'family', 'or', 'caregiver', 'prior', 'to', 'proceeding', 'with', 'treatment', '?']","['Given', 'the', 'insufficient', 'evidence', 'of', 'benefit', 'for', 'LOT']",28,8
"What to do if there is uncertainty about whether the benefits of OT, such as improved function (e.g., return-to-work), outweigh the risks?",What,100,Consider consultation with appropriate specialty care providers,Background,1,1.0,"['What', 'to', 'do', 'if', 'there', 'is', 'uncertainty', 'about', 'whether', 'the', 'benefits', 'of', 'OT', ',', 'such', 'as', 'improved', 'function', '(', 'e.g.', ',', 'return', '-', 'to', '-', 'work', ')', ',', 'outweigh', 'the', 'risks', '?']","['Consider', 'consultation', 'with', 'appropriate', 'specialty', 'care', 'providers']",32,7
What are the risk factors with the greatest impact on the development of opioid-related adverse events?,What,101,the duration and dose of opioid analgesic use,Background,1,1.0,"['What', 'are', 'the', 'risk', 'factors', 'with', 'the', 'greatest', 'impact', 'on', 'the', 'development', 'of', 'opioid', '-', 'related', 'adverse', 'events', '?']","['the', 'duration', 'and', 'dose', 'of', 'opioid', 'analgesic', 'use']",19,8
How often is it recommended to evaluate the benefits of continued opioid therapy and the risk for opioid-related adverse events?,How,102,at least every three months,Recommendations,1,1.0,"['How', 'often', 'is', 'it', 'recommended', 'to', 'evaluate', 'the', 'benefits', 'of', 'continued', 'opioid', 'therapy', 'and', 'the', 'risk', 'for', 'opioid', '-', 'related', 'adverse', 'events', '?']","['at', 'least', 'every', 'three', 'months']",23,5
What to do if the veteran is actively suicidal?,What,103,consult with mental health provider before beginning taper,Specifications,0,0.0,"['What', 'to', 'do', 'if', 'the', 'veteran', 'is', 'actively', 'suicidal', '?']","['consult', 'with', 'mental', 'health', 'provider', 'before', 'beginning', 'taper']",10,8
What is the estimation of the lifetime prevalence for mild symptoms of OUD among patients receiving long-term opioid therapy?,What,104,approximately 28%,Specifications,1,1.0,"['What', 'is', 'the', 'estimation', 'of', 'the', 'lifetime', 'prevalence', 'for', 'mild', 'symptoms', 'of', 'OUD', 'among', 'patients', 'receiving', 'long', '-', 'term', 'opioid', 'therapy', '?']","['approximately', '28', '%']",22,3
Which conditions can complicate pain management?,Which,105,"mental health disorders, OUD and other SUD, moral injury, central sensitization, medical complications, sleep disorders",Specifications,1,1.0,"['Which', 'conditions', 'can', 'complicate', 'pain', 'management', '?']","['mental', 'health', 'disorders', ',', 'OUD', 'and', 'other', 'SUD', ',', 'moral', 'injury', ',', 'central', 'sensitization', ',', 'medical', 'complications', ',', 'sleep', 'disorders']",7,20
What is the estimated lifetime prevalence for OUD among patients receiving long-term opioid therapy?,What,107,"about 41%: approximately 28% for mild symptoms, 10% for moderate symptoms and 3.5% for severe symptoms of OUD",Specifications,0,0.19999999999999998,"['What', 'is', 'the', 'estimated', 'lifetime', 'prevalence', 'for', 'OUD', 'among', 'patients', 'receiving', 'long', '-', 'term', 'opioid', 'therapy', '?']","['about', '41', '%', ':', 'approximately', '28', '%', 'for', 'mild', 'symptoms', ',', '10', '%', 'for', 'moderate', 'symptoms', 'and', '3.5', '%', 'for', 'severe', 'symptoms', 'of', 'OUD']",17,24
What is the estimation of the lifetime prevalence for moderate symptoms of OUD among patients receiving long-term opioid therapy?,What,108,10%,Specifications,1,1.0,"['What', 'is', 'the', 'estimation', 'of', 'the', 'lifetime', 'prevalence', 'for', 'moderate', 'symptoms', 'of', 'OUD', 'among', 'patients', 'receiving', 'long', '-', 'term', 'opioid', 'therapy', '?']","['10', '%']",22,2
What to do if suicide risk is high in patients?,What,109,consult with mental health provider before beginning taper,Specifications,1,1.0,"['What', 'to', 'do', 'if', 'suicide', 'risk', 'is', 'high', 'in', 'patients', '?']","['consult', 'with', 'mental', 'health', 'provider', 'before', 'beginning', 'taper']",11,8
What may increase the risk of overdose and other adverse events in patients with chronic pain and OUD?,What,111,Either tapering the opioid analgesic or continuing to prescribe the opioid without providing OUD treatment,Specifications,1,1.0,"['What', 'may', 'increase', 'the', 'risk', 'of', 'overdose', 'and', 'other', 'adverse', 'events', 'in', 'patients', 'with', 'chronic', 'pain', 'and', 'OUD', '?']","['Either', 'tapering', 'the', 'opioid', 'analgesic', 'or', 'continuing', 'to', 'prescribe', 'the', 'opioid', 'without', 'providing', 'OUD', 'treatment']",19,15
What needs to be addressed for patients with chronic pain who develop OUD from opioid analgesic therapy?,What,112,BOTH pain and OUD,Specifications,1,1.0,"['What', 'needs', 'to', 'be', 'addressed', 'for', 'patients', 'with', 'chronic', 'pain', 'who', 'develop', 'OUD', 'from', 'opioid', 'analgesic', 'therapy', '?']","['BOTH', 'pain', 'and', 'OUD']",18,4
"What to do if the veteran is suicidal, have high suicide risk or actively suicidal?",What,113,"If suicidal, then activate suicide prevention plan. If high suicide risk or actively suicidal, consult with mental health provider before beginning taper.",Specifications,0,0.5333333333333333,"['What', 'to', 'do', 'if', 'the', 'veteran', 'is', 'suicidal', ',', 'have', 'high', 'suicide', 'risk', 'or', 'actively', 'suicidal', '?']","['If', 'suicidal', ',', 'then', 'activate', 'suicide', 'prevention', 'plan', '.', 'If', 'high', 'suicide', 'risk', 'or', 'actively', 'suicidal', ',', 'consult', 'with', 'mental', 'health', 'provider', 'before', 'beginning', 'taper', '.']",17,26
What to do if the veteran is suicidal?,What,114,activate suicide prevention plan,Specifications,1,1.0,"['What', 'to', 'do', 'if', 'the', 'veteran', 'is', 'suicidal', '?']","['activate', 'suicide', 'prevention', 'plan']",9,4
What is the estimation of the lifetime prevalence for severe symptoms of OUD among patients receiving long-term opioid therapy?,What,115,3.5%,Specifications,1,1.0,"['What', 'is', 'the', 'estimation', 'of', 'the', 'lifetime', 'prevalence', 'for', 'severe', 'symptoms', 'of', 'OUD', 'among', 'patients', 'receiving', 'long', '-', 'term', 'opioid', 'therapy', '?']","['3.5', '%']",22,2
What to ensure before initiating an opioid taper?,What,116,screening and treatment is offered for conditions that can complicate pain management,Specifications,0,0.9600000000000001,"['What', 'to', 'ensure', 'before', 'initiating', 'an', 'opioid', 'taper', '?']","['screening', 'and', 'treatment', 'is', 'offered', 'for', 'conditions', 'that', 'can', 'complicate', 'pain', 'management']",9,12
Who needs to have both pain and OUD addressed?,Who,117,Patients with chronic pain who develop OUD from opioid analgesic therapy,Specifications,1,1.0,"['Who', 'needs', 'to', 'have', 'both', 'pain', 'and', 'OUD', 'addressed', '?']","['Patients', 'with', 'chronic', 'pain', 'who', 'develop', 'OUD', 'from', 'opioid', 'analgesic', 'therapy']",10,11
What are some examples of mental health disorders?,What,118,"PTSD, anxiety disorders, depressive disorders",Specifications,1,1.0,"['What', 'are', 'some', 'examples', 'of', 'mental', 'health', 'disorders', '?']","['PTSD', ',', 'anxiety', 'disorders', ',', 'depressive', 'disorders']",9,7
Who may benefit from an alternative management strategy?,Who,119,Those patients receiving opioid analgesics who do not meet DSM-5 criteria for OUD,Recommendations,1,1.0,"['Who', 'may', 'benefit', 'from', 'an', 'alternative', 'management', 'strategy', '?']","['Those', 'patients', 'receiving', 'opioid', 'analgesics', 'who', 'do', 'not', 'meet', 'DSM-5', 'criteria', 'for', 'OUD']",9,13
What is the alternative management strategy that is beneficial for patients receiving opioid analgesics who do not meet DSM-5 criteria for OUD?,What,120,close follow-up and CBT,Recommendations,1,1.0,"['What', 'is', 'the', 'alternative', 'management', 'strategy', 'that', 'is', 'beneficial', 'for', 'patients', 'receiving', 'opioid', 'analgesics', 'who', 'do', 'not', 'meet', 'DSM-5', 'criteria', 'for', 'OUD', '?']","['close', 'follow', '-', 'up', 'and', 'CBT']",23,6
What is the clinical practice guideline based on?,What,122,a systematic review of both clinical and epidemiological evidence,Introduction,1,1.0,"['What', 'is', 'the', 'clinical', 'practice', 'guideline', 'based', 'on', '?']","['a', 'systematic', 'review', 'of', 'both', 'clinical', 'and', 'epidemiological', 'evidence']",9,9
Who developed the guidelines?,Who,124,a panel of multidisciplinary experts,Introduction,1,1.0,"['Who', 'developed', 'the', 'guidelines', '?']","['a', 'panel', 'of', 'multidisciplinary', 'experts']",5,5
What does the literature say about the the benefit of LOT?,What,125,there is currently no evidence in the literature documenting the benefit of LOT that demonstrates  improvement in pain and function,Recommendations,1,1.0,"['What', 'does', 'the', 'literature', 'say', 'about', 'the', 'the', 'benefit', 'of', 'LOT', '?']","['there', 'is', 'currently', 'no', 'evidence', 'in', 'the', 'literature', 'documenting', 'the', 'benefit', 'of', 'LOT', 'that', 'demonstrates', ' ', 'improvement', 'in', 'pain', 'and', 'function']",12,21
What to do if a  decision is made to initiate LOT?,What,126,a careful assessment of benefits and risks should be made to ensure that  the benefits are expected to outweigh the well-documented risks,Recommendations,1,1.0,"['What', 'to', 'do', 'if', 'a', ' ', 'decision', 'is', 'made', 'to', 'initiate', 'LOT', '?']","['a', 'careful', 'assessment', 'of', 'benefits', 'and', 'risks', 'should', 'be', 'made', 'to', 'ensure', 'that', ' ', 'the', 'benefits', 'are', 'expected', 'to', 'outweigh', 'the', 'well', '-', 'documented', 'risks']",13,25
What to do once opioid therapy is initiated?,What,127,all opioid risk mitigation strategies outlined in this guideline (see Recommendation 7) should be put into  place,Recommendations,1,1.0,"['What', 'to', 'do', 'once', 'opioid', 'therapy', 'is', 'initiated', '?']","['all', 'opioid', 'risk', 'mitigation', 'strategies', 'outlined', 'in', 'this', 'guideline', '(', 'see', 'Recommendation', '7', ')', 'should', 'be', 'put', 'into', ' ', 'place']",9,20
What kind of treatment plan should be integrated into the patient’s care prrior to considering LOT?,What,128,multimodal,Recommendations,1,1.0,"['What', 'kind', 'of', 'treatment', 'plan', 'should', 'be', 'integrated', 'into', 'the', 'patient', '’s', 'care', 'prrior', 'to', 'considering', 'LOT', '?']",['multimodal'],18,1
Which model was adopted after the biomedical model of pain care?,Which,129,"a biopsychosocial, multimodal, interdisciplinary model",Background,1,1.0,"['Which', 'model', 'was', 'adopted', 'after', 'the', 'biomedical', 'model', 'of', 'pain', 'care', '?']","['a', 'biopsychosocial', ',', 'multimodal', ',', 'interdisciplinary', 'model']",12,7
What happens in the biomedical model of pain care?,What,130,"the pain experience is reduced to a pain generator and pain treatment is aimed at fixing or numbing pain with medications, interventions, or surgery",Background,1,1.0,"['What', 'happens', 'in', 'the', 'biomedical', 'model', 'of', 'pain', 'care', '?']","['the', 'pain', 'experience', 'is', 'reduced', 'to', 'a', 'pain', 'generator', 'and', 'pain', 'treatment', 'is', 'aimed', 'at', 'fixing', 'or', 'numbing', 'pain', 'with', 'medications', ',', 'interventions', ',', 'or', 'surgery']",10,26
"Why did the National Academy of Medicine issue a call for the transformation of pain care to a biopsychosocial, multimodal, interdisciplinary model?",Why,132,"As the cost, potential harm, and limited effectiveness of the approach in the biomedical model of pain care to chronic pain was becoming apparent",Background,1,1.0,"['Why', 'did', 'the', 'National', 'Academy', 'of', 'Medicine', 'issue', 'a', 'call', 'for', 'the', 'transformation', 'of', 'pain', 'care', 'to', 'a', 'biopsychosocial', ',', 'multimodal', ',', 'interdisciplinary', 'model', '?']","['As', 'the', 'cost', ',', 'potential', 'harm', ',', 'and', 'limited', 'effectiveness', 'of', 'the', 'approach', 'in', 'the', 'biomedical', 'model', 'of', 'pain', 'care', 'to', 'chronic', 'pain', 'was', 'becoming', 'apparent']",25,26
What is the aim of the pain treatment in the biomedical model of pain care?,What,133,"fixing or numbing pain with medications, interventions, or surgery",Background,1,1.0,"['What', 'is', 'the', 'aim', 'of', 'the', 'pain', 'treatment', 'in', 'the', 'biomedical', 'model', 'of', 'pain', 'care', '?']","['fixing', 'or', 'numbing', 'pain', 'with', 'medications', ',', 'interventions', ',', 'or', 'surgery']",16,11
Which was the dominating period of the biomedical model of pain care?,Which,134,the 1990s and the first decade of the 2000s,Background,0,0.2857142857142857,"['Which', 'was', 'the', 'dominating', 'period', 'of', 'the', 'biomedical', 'model', 'of', 'pain', 'care', '?']","['the', '1990s', 'and', 'the', 'first', 'decade', 'of', 'the', '2000s']",13,9
What is the trend in pain management and care in the U.S.?,What,135,The U.S. is in the midst of a cultural transformation in the way pain is viewed and treated,Background,0,0.25,"['What', 'is', 'the', 'trend', 'in', 'pain', 'management', 'and', 'care', 'in', 'the', 'U.S.', '?']","['The', 'U.S.', 'is', 'in', 'the', 'midst', 'of', 'a', 'cultural', 'transformation', 'in', 'the', 'way', 'pain', 'is', 'viewed', 'and', 'treated']",13,18
What indicate that developing brains (age <30 years) are at increased risk of abnormalities and  addiction when exposed to substance use early in life?,What,136,"Studies in other areas (e.g., use of different  substances)",Recommendations,1,1.0,"['What', 'indicate', 'that', 'developing', 'brains', '(', 'age', '<', '30', 'years', ')', 'are', 'at', 'increased', 'risk', 'of', 'abnormalities', 'and', ' ', 'addiction', 'when', 'exposed', 'to', 'substance', 'use', 'early', 'in', 'life', '?']","['Studies', 'in', 'other', 'areas', '(', 'e.g.', ',', 'use', 'of', 'different', ' ', 'substances', ')']",29,13
What are the risks of substance use early in life?,What,137,increased risk of abnormalities and  addiction,Recommendations,0,0.631578947368421,"['What', 'are', 'the', 'risks', 'of', 'substance', 'use', 'early', 'in', 'life', '?']","['increased', 'risk', 'of', 'abnormalities', 'and', ' ', 'addiction']",11,7
What kind of rationale is there to explain the the relationship between age and OUD and overdose?,What,138,good neurophysiologic rationale,Recommendations,0,0.8,"['What', 'kind', 'of', 'rationale', 'is', 'there', 'to', 'explain', 'the', 'the', 'relationship', 'between', 'age', 'and', 'OUD', 'and', 'overdose', '?']","['good', 'neurophysiologic', 'rationale']",18,3
What are at increased risk of abnormalities and  addiction when exposed to substance use early in life?,What,139,developing brains (age <30 years),Recommendations,1,1.0,"['What', 'are', 'at', 'increased', 'risk', 'of', 'abnormalities', 'and', ' ', 'addiction', 'when', 'exposed', 'to', 'substance', 'use', 'early', 'in', 'life', '?']","['developing', 'brains', '(', 'age', '<', '30', 'years', ')']",19,8
What are the necessary risk mitigation strategies?,What,140,"OEND, UDT, PDMP, face-to-face follow-up with frequency determined by risk",Algorithm,1,1.0,"['What', 'are', 'the', 'necessary', 'risk', 'mitigation', 'strategies', '?']","['OEND', ',', 'UDT', ',', 'PDMP', ',', 'face', '-', 'to', '-', 'face', 'follow', '-', 'up', 'with', 'frequency', 'determined', 'by', 'risk']",8,19
Which factor can help identify non-adherence to a comprehensive pain care plan?,Which,141,attendance at appointment,Algorithm,1,1.0,"['Which', 'factor', 'can', 'help', 'identify', 'non', '-', 'adherence', 'to', 'a', 'comprehensive', 'pain', 'care', 'plan', '?']","['attendance', 'at', 'appointment']",15,3
What is MEDD?,What,142,morphine equivalent daily dose,Algorithm,1,1.0,"['What', 'is', 'MEDD', '?']","['morphine', 'equivalent', 'daily', 'dose']",4,4
Which factors may indicate the need for more frequent follow-up?,Which,143,"non-adherence to comprehensive pain care plan (e.g., attendance at appointment), unexpected UDT and PDMP results, non-adherence to opioid prescription (e.g., using more than prescribed and/or running out early), higher risk medication characteristics (e.g., high-dose opioids, combination of opioids and benzodiazepines), patients with mental health, medical, or SUD comorbidities that increase risk for adverse outcomes",Algorithm,0,0.03636363636363636,"['Which', 'factors', 'may', 'indicate', 'the', 'need', 'for', 'more', 'frequent', 'follow', '-', 'up', '?']","['non', '-', 'adherence', 'to', 'comprehensive', 'pain', 'care', 'plan', '(', 'e.g.', ',', 'attendance', 'at', 'appointment', ')', ',', 'unexpected', 'UDT', 'and', 'PDMP', 'results', ',', 'non', '-', 'adherence', 'to', 'opioid', 'prescription', '(', 'e.g.', ',', 'using', 'more', 'than', 'prescribed', 'and/or', 'running', 'out', 'early', ')', ',', 'higher', 'risk', 'medication', 'characteristics', '(', 'e.g.', ',', 'high', '-', 'dose', 'opioids', ',', 'combination', 'of', 'opioids', 'and', 'benzodiazepines', ')', ',', 'patients', 'with', 'mental', 'health', ',', 'medical', ',', 'or', 'SUD', 'comorbidities', 'that', 'increase', 'risk', 'for', 'adverse', 'outcomes']",13,76
What are the indications for tapering and discontinuation?,What,145,"risks of OT outweigh benefits, patient preference, diversion",Algorithm,1,1.0,"['What', 'are', 'the', 'indications', 'for', 'tapering', 'and', 'discontinuation', '?']","['risks', 'of', 'OT', 'outweigh', 'benefits', ',', 'patient', 'preference', ',', 'diversion']",9,10
What are the characteristics of higher risk medication?,What,146,"high-dose opioids, combination of opioids and benzodiazepines",Algorithm,1,1.0,"['What', 'are', 'the', 'characteristics', 'of', 'higher', 'risk', 'medication', '?']","['high', '-', 'dose', 'opioids', ',', 'combination', 'of', 'opioids', 'and', 'benzodiazepines']",9,10
What is an example of non-adherence to opioid prescription?,What,147,using more than prescribed and/or running out early,Algorithm,1,1.0,"['What', 'is', 'an', 'example', 'of', 'non', '-', 'adherence', 'to', 'opioid', 'prescription', '?']","['using', 'more', 'than', 'prescribed', 'and/or', 'running', 'out', 'early']",12,8
What does OEND refer to?,What,148,Overdose Education and Naloxone Distribution,Algorithm,1,1.0,"['What', 'does', 'OEND', 'refer', 'to', '?']","['Overdose', 'Education', 'and', 'Naloxone', 'Distribution']",6,5
What to consider at the time of re-examining at a follow-up visit?,What,149,"changes in co-occurring conditions, diagnoses/medications, and functional status when conducting the risk/benefit analysis for LOT",Recommendations,0,0.1,"['What', 'to', 'consider', 'at', 'the', 'time', 'of', 're', '-', 'examining', 'at', 'a', 'follow', '-', 'up', 'visit', '?']","['changes', 'in', 'co', '-', 'occurring', 'conditions', ',', 'diagnoses', '/', 'medications', ',', 'and', 'functional', 'status', 'when', 'conducting', 'the', 'risk', '/', 'benefit', 'analysis', 'for', 'LOT']",17,23
What is the relationship between the length of OT and opioid-related harms?,What,150,"The longer the patient is on opioids, the greater the potential for change in patient status and development of opioid-related harms.",Recommendations,1,1.0,"['What', 'is', 'the', 'relationship', 'between', 'the', 'length', 'of', 'OT', 'and', 'opioid', '-', 'related', 'harms', '?']","['The', 'longer', 'the', 'patient', 'is', 'on', 'opioids', ',', 'the', 'greater', 'the', 'potential', 'for', 'change', 'in', 'patient', 'status', 'and', 'development', 'of', 'opioid', '-', 'related', 'harms', '.']",15,25
What to be aware of during follow-ups?,What,151,signs of diversion,Recommendations,1,1.0,"['What', 'to', 'be', 'aware', 'of', 'during', 'follow', '-', 'ups', '?']","['signs', 'of', 'diversion']",10,3
What to do at follow-up visits?,What,152,a clinician should re-examine the rationale for continuing the patient on OT,Recommendations,1,1.0,"['What', 'to', 'do', 'at', 'follow', '-', 'up', 'visits', '?']","['a', 'clinician', 'should', 're', '-', 'examine', 'the', 'rationale', 'for', 'continuing', 'the', 'patient', 'on', 'OT']",9,14
What is included in the ongoing OT prescribing practice?,What,153,"pharmacy review, informed consent, UDTs, and checking state PDMPs",Recommendations,1,1.0,"['What', 'is', 'included', 'in', 'the', 'ongoing', 'OT', 'prescribing', 'practice', '?']","['pharmacy', 'review', ',', 'informed', 'consent', ',', 'UDTs', ',', 'and', 'checking', 'state', 'PDMPs']",10,12
What may change the risk/benefit calculus for LOT?,What,154,"Alcohol use, pregnancy, nursing of infants, and lab abnormalities",Recommendations,1,1.0,"['What', 'may', 'change', 'the', 'risk', '/', 'benefit', 'calculus', 'for', 'LOT', '?']","['Alcohol', 'use', ',', 'pregnancy', ',', 'nursing', 'of', 'infants', ',', 'and', 'lab', 'abnormalities']",11,12
What is the most common method of abuse?,What,155,consumption  of a large number of intact capsules or tablets,Recommendations,0,0.6153846153846153,"['What', 'is', 'the', 'most', 'common', 'method', 'of', 'abuse', '?']","['consumption', ' ', 'of', 'a', 'large', 'number', 'of', 'intact', 'capsules', 'or', 'tablets']",9,11
What is the aim of most abuse deterrent formulations?,What,156,"to present a physical barrier to prevent chewing,  crushing, cutting, grating, or grinding of the dosage form, or present a chemical barrier, such as a gelling  agent, that will resist extraction of the opioid with use of a common solvent",Recommendations,0,0.5833333333333334,"['What', 'is', 'the', 'aim', 'of', 'most', 'abuse', 'deterrent', 'formulations', '?']","['to', 'present', 'a', 'physical', 'barrier', 'to', 'prevent', 'chewing', ',', ' ', 'crushing', ',', 'cutting', ',', 'grating', ',', 'or', 'grinding', 'of', 'the', 'dosage', 'form', ',', 'or', 'present', 'a', 'chemical', 'barrier', ',', 'such', 'as', 'a', 'gelling', ' ', 'agent', ',', 'that', 'will', 'resist', 'extraction', 'of', 'the', 'opioid', 'with', 'use', 'of', 'a', 'common', 'solvent']",10,49
"What can be added to interfere with, reduce, or defeat the euphoria  associated with abuse of an agent intended for oral use when taken nasally or parenterally?",What,157,an opioid  antagonist (naloxone or naltrexone),Recommendations,1,1.0,"['What', 'can', 'be', 'added', 'to', 'interfere', 'with', ',', 'reduce', ',', 'or', 'defeat', 'the', 'euphoria', ' ', 'associated', 'with', 'abuse', 'of', 'an', 'agent', 'intended', 'for', 'oral', 'use', 'when', 'taken', 'nasally', 'or', 'parenterally', '?']","['an', 'opioid', ' ', 'antagonist', '(', 'naloxone', 'or', 'naltrexone', ')']",31,9
What is the VA/DoD Guideline for Guidelines?,What,0,"a document that details the process by which VA/DoD guidelines will be developed, including the use of the  GRADE methodology",Background,1,1.0,"['What', 'is', 'the', 'VA', '/', 'DoD', 'Guideline', 'for', 'Guidelines', '?']","['a', 'document', 'that', 'details', 'the', 'process', 'by', 'which', 'VA', '/', 'DoD', 'guidelines', 'will', 'be', 'developed', ',', 'including', 'the', 'use', 'of', 'the', ' ', 'GRADE', 'methodology']",10,24
What did the CDC guideline development process include? ,What,1,notice in the Federal Register for a public review and comment period as well as peer review,Background,1,1.0,"['What', 'did', 'the', 'CDC', 'guideline', 'development', 'process', 'include', '?']","['notice', 'in', 'the', 'Federal', 'Register', 'for', 'a', 'public', 'review', 'and', 'comment', 'period', 'as', 'well', 'as', 'peer', 'review']",9,17
What are differences in the recommendations between the CDC guideline and the CPG?,What,2,based on a slightly different evidence base and revised based on the feedback of individuals who were considering a larger group of potential patients relative to the VA/DoD,Background,0,0.9565217391304348,"['What', 'are', 'differences', 'in', 'the', 'recommendations', 'between', 'the', 'CDC', 'guideline', 'and', 'the', 'CPG', '?']","['based', 'on', 'a', 'slightly', 'different', 'evidence', 'base', 'and', 'revised', 'based', 'on', 'the', 'feedback', 'of', 'individuals', 'who', 'were', 'considering', 'a', 'larger', 'group', 'of', 'potential', 'patients', 'relative', 'to', 'the', 'VA', '/', 'DoD']",14,30
Which factors were considered for the framework for recommendations in this CPG?,Which,4,"balancing desired outcomes with potential harms of treatment, equity of resource availability,  the potential for variation in patient values and preferences, and other considerations",Specifications,1,1.0,"['Which', 'factors', 'were', 'considered', 'for', 'the', 'framework', 'for', 'recommendations', 'in', 'this', 'CPG', '?']","['balancing', 'desired', 'outcomes', 'with', 'potential', 'harms', 'of', 'treatment', ',', 'equity', 'of', 'resource', 'availability', ',', ' ', 'the', 'potential', 'for', 'variation', 'in', 'patient', 'values', 'and', 'preferences', ',', 'and', 'other', 'considerations']",13,28
What kinds of pain education groups should be offered to Veterans?,What,5,Cognitive Behavioral Therapy (CBT) or Acceptance and Commitment Therapy (ACT) for Pain,Specifications,1,1.0,"['What', 'kinds', 'of', 'pain', 'education', 'groups', 'should', 'be', 'offered', 'to', 'Veterans', '?']","['Cognitive', 'Behavioral', 'Therapy', '(', 'CBT', ')', 'or', 'Acceptance', 'and', 'Commitment', 'Therapy', '(', 'ACT', ')', 'for', 'Pain']",12,16
What is an example of Bio-Psycho-Social Model?,What,6,PHI’s “Whole Health” approach,Specifications,1,1.0,"['What', 'is', 'an', 'example', 'of', 'Bio', '-', 'Psycho', '-', 'Social', 'Model', '?']","['PHI', '’s', '“', 'Whole', 'Health', '”', 'approach']",12,7
What to use to educate the Veteran?,What,7,"Bio-Psycho-Social Model e.g., PHI’s “Whole Health” approach",Specifications,1,1.0,"['What', 'to', 'use', 'to', 'educate', 'the', 'Veteran', '?']","['Bio', '-', 'Psycho', '-', 'Social', 'Model', 'e.g.', ',', 'PHI', '’s', '“', 'Whole', 'Health', '”', 'approach']",8,15
What should the clinicians offer to reduce opioid risk?,What,8,slow tapering of opioids to reduce opioid risks while not “cutting off” the Veteran,Specifications,0,0.47058823529411764,"['What', 'should', 'the', 'clinicians', 'offer', 'to', 'reduce', 'opioid', 'risk', '?']","['slow', 'tapering', 'of', 'opioids', 'to', 'reduce', 'opioid', 'risks', 'while', 'not', '“', 'cutting', 'off', '”', 'the', 'Veteran']",10,16
What is CIH?,What,9,Complementary and Integrative Health,Specifications,1,1.0,"['What', 'is', 'CIH', '?']","['Complementary', 'and', 'Integrative', 'Health']",4,4
What are some examples of Complementary and Integrative Health (CIH) interventions?,What,10,"acupuncture, meditation, yoga",Specifications,1,1.0,"['What', 'are', 'some', 'examples', 'of', 'Complementary', 'and', 'Integrative', 'Health', '(', 'CIH', ')', 'interventions', '?']","['acupuncture', ',', 'meditation', ',', 'yoga']",14,5
"How may LOT affect patients with migraine headaches, tension-type headaches, occipital neuralgia, or myofascial pain?",How,11,may result in worsening of the underlying headache  condition through factors such as central sensitization and withdrawal,Background,0,0.967741935483871,"['How', 'may', 'LOT', 'affect', 'patients', 'with', 'migraine', 'headaches', ',', 'tension', '-', 'type', 'headaches', ',', 'occipital', 'neuralgia', ',', 'or', 'myofascial', 'pain', '?']","['may', 'result', 'in', 'worsening', 'of', 'the', 'underlying', 'headache', ' ', 'condition', 'through', 'factors', 'such', 'as', 'central', 'sensitization', 'and', 'withdrawal']",21,18
What is an ineffective treatment modality for patients with myofascial pain?,What,13,LOT,Background,1,1.0,"['What', 'is', 'an', 'ineffective', 'treatment', 'modality', 'for', 'patients', 'with', 'myofascial', 'pain', '?']",['LOT'],12,1
"What treatment modality may result in worsening of the underlying headache condition in patients with migraine headaches, tension-type headaches, occipital neuralgia, or myofascial pain?",What,14,LOT,Background,1,1.0,"['What', 'treatment', 'modality', 'may', 'result', 'in', 'worsening', 'of', 'the', 'underlying', 'headache', 'condition', 'in', 'patients', 'with', 'migraine', 'headaches', ',', 'tension', '-', 'type', 'headaches', ',', 'occipital', 'neuralgia', ',', 'or', 'myofascial', 'pain', '?']",['LOT'],30,1
What is an ineffective treatment modality for patients with occipital neuralgia?,What,15,LOT,Background,1,1.0,"['What', 'is', 'an', 'ineffective', 'treatment', 'modality', 'for', 'patients', 'with', 'occipital', 'neuralgia', '?']",['LOT'],12,1
What is an ineffective treatment modality for patients with tension-type headaches?,What,16,LOT,Background,1,1.0,"['What', 'is', 'an', 'ineffective', 'treatment', 'modality', 'for', 'patients', 'with', 'tension', '-', 'type', 'headaches', '?']",['LOT'],14,1
What is an ineffective treatment modality for patients with migraine headaches (with or without aura)?,What,17,LOT,Background,1,1.0,"['What', 'is', 'an', 'ineffective', 'treatment', 'modality', 'for', 'patients', 'with', 'migraine', 'headaches', '(', 'with', 'or', 'without', 'aura', ')', '?']",['LOT'],18,1
"What is an ineffective treatment modality for patients with migraine headaches (with or without aura), tension-type headaches, occipital neuralgia, or myofascial pain?",What,18,LOT,Background,1,1.0,"['What', 'is', 'an', 'ineffective', 'treatment', 'modality', 'for', 'patients', 'with', 'migraine', 'headaches', '(', 'with', 'or', 'without', 'aura', ')', ',', 'tension', '-', 'type', 'headaches', ',', 'occipital', 'neuralgia', ',', 'or', 'myofascial', 'pain', '?']",['LOT'],30,1
When should an assessment of current suicide risk be made?,When,19,at every phase of treatment,Recommendations,1,1.0,"['When', 'should', 'an', 'assessment', 'of', 'current', 'suicide', 'risk', 'be', 'made', '?']","['at', 'every', 'phase', 'of', 'treatment']",11,5
Who recommends restricting the availability of lethal means for patients considered to be at intermediate or high acute risk of suicide?,Who,20,The VA/DoD Suicide CPG,Recommendations,1,1.0,"['Who', 'recommends', 'restricting', 'the', 'availability', 'of', 'lethal', 'means', 'for', 'patients', 'considered', 'to', 'be', 'at', 'intermediate', 'or', 'high', 'acute', 'risk', 'of', 'suicide', '?']","['The', 'VA', '/', 'DoD', 'Suicide', 'CPG']",22,6
How to determine the acuteness of suicide risk in patients?,How,21,"presence and severity of suicidal ideation, level of intention to act, existence of risk factors, limited or absent protective factors, etc.",Recommendations,0,0.975609756097561,"['How', 'to', 'determine', 'the', 'acuteness', 'of', 'suicide', 'risk', 'in', 'patients', '?']","['presence', 'and', 'severity', 'of', 'suicidal', 'ideation', ',', 'level', 'of', 'intention', 'to', 'act', ',', 'existence', 'of', 'risk', 'factors', ',', 'limited', 'or', 'absent', 'protective', 'factors', ',', 'etc', '.']",11,26
What should be done at every phase of treatment?,What,22,an assessment of current suicide risk should be made,Recommendations,0,0.7692307692307693,"['What', 'should', 'be', 'done', 'at', 'every', 'phase', 'of', 'treatment', '?']","['an', 'assessment', 'of', 'current', 'suicide', 'risk', 'should', 'be', 'made']",10,9
What is considered to be an important risk factor for OT?,What,23,suicidality,Recommendations,1,1.0,"['What', 'is', 'considered', 'to', 'be', 'an', 'important', 'risk', 'factor', 'for', 'OT', '?']",['suicidality'],12,1
Which medications are lethal?,Which,24,Opioid,Recommendations,1,1.0,"['Which', 'medications', 'are', 'lethal', '?']",['Opioid'],5,1
Who will have greater mortality?,Who,26,"patients who require  higher doses of opioids, even in those who benefit from such therapy",Recommendations,0,0.6363636363636364,"['Who', 'will', 'have', 'greater', 'mortality', '?']","['patients', 'who', 'require', ' ', 'higher', 'doses', 'of', 'opioids', ',', 'even', 'in', 'those', 'who', 'benefit', 'from', 'such', 'therapy']",6,17
"Who will have greater mortality, co-occurring medical conditions, and other adverse events?",Who,27,"patients who require  higher doses of opioids, even in those who benefit from such therapy",Recommendations,1,1.0,"['Who', 'will', 'have', 'greater', 'mortality', ',', 'co', '-', 'occurring', 'medical', 'conditions', ',', 'and', 'other', 'adverse', 'events', '?']","['patients', 'who', 'require', ' ', 'higher', 'doses', 'of', 'opioids', ',', 'even', 'in', 'those', 'who', 'benefit', 'from', 'such', 'therapy']",17,17
What should be considered when a closer follow-up is needed?,What,28,healthcare resources and patient adherence should be considered,Recommendations,0,0.7692307692307693,"['What', 'should', 'be', 'considered', 'when', 'a', 'closer', 'follow', '-', 'up', 'is', 'needed', '?']","['healthcare', 'resources', 'and', 'patient', 'adherence', 'should', 'be', 'considered']",13,8
Who will have co-occurring medical conditions?,Who,29,"patients who require  higher doses of opioids, even in those who benefit from such therapy",Recommendations,1,1.0,"['Who', 'will', 'have', 'co', '-', 'occurring', 'medical', 'conditions', '?']","['patients', 'who', 'require', ' ', 'higher', 'doses', 'of', 'opioids', ',', 'even', 'in', 'those', 'who', 'benefit', 'from', 'such', 'therapy']",9,17
What should be individualized based upon patient characteristics and preferences?,What,30,"Recognizing the lack of evidence of long-term benefit associated with LOT used alone and the risks of  harms with use of opioids without risk mitigation, dosing determinations",Recommendations,0,0.14814814814814814,"['What', 'should', 'be', 'individualized', 'based', 'upon', 'patient', 'characteristics', 'and', 'preferences', '?']","['Recognizing', 'the', 'lack', 'of', 'evidence', 'of', 'long', '-', 'term', 'benefit', 'associated', 'with', 'LOT', 'used', 'alone', 'and', 'the', 'risks', 'of', ' ', 'harms', 'with', 'use', 'of', 'opioids', 'without', 'risk', 'mitigation', ',', 'dosing', 'determinations']",11,31
Who will have other adverse events?,Who,31,"patients who require  higher doses of opioids, even in those who benefit from such therapy",Recommendations,0,0.6363636363636364,"['Who', 'will', 'have', 'other', 'adverse', 'events', '?']","['patients', 'who', 'require', ' ', 'higher', 'doses', 'of', 'opioids', ',', 'even', 'in', 'those', 'who', 'benefit', 'from', 'such', 'therapy']",7,17
What must be factored into clinical decision making on a case-by-case basis?,What,33,"Patient values, goals, concerns, and preferences",Recommendations,1,1.0,"['What', 'must', 'be', 'factored', 'into', 'clinical', 'decision', 'making', 'on', 'a', 'case', '-', 'by', '-', 'case', 'basis', '?']","['Patient', 'values', ',', 'goals', ',', 'concerns', ',', 'and', 'preferences']",17,9
Why non-opioid  treatments are preferred for chronic pain?,Why,34,Given the lack of evidence  showing sustained functional benefit of LOT and moderate evidence outlining harms,Recommendations,1,1.0,"['Why', 'non', '-', 'opioid', ' ', 'treatments', 'are', 'preferred', 'for', 'chronic', 'pain', '?']","['Given', 'the', 'lack', 'of', 'evidence', ' ', 'showing', 'sustained', 'functional', 'benefit', 'of', 'LOT', 'and', 'moderate', 'evidence', 'outlining', 'harms']",12,17
What needs to be considered when considering the initiation or continuation of LOT?,What,35,"consider whether LOT will result in clinically meaningful  improvements in function such as readiness to return to work/duty and/or measurable improvement in  other areas of function, such that the benefits outweigh the potential harms",Recommendations,0,0.06060606060606061,"['What', 'needs', 'to', 'be', 'considered', 'when', 'considering', 'the', 'initiation', 'or', 'continuation', 'of', 'LOT', '?']","['consider', 'whether', 'LOT', 'will', 'result', 'in', 'clinically', 'meaningful', ' ', 'improvements', 'in', 'function', 'such', 'as', 'readiness', 'to', 'return', 'to', 'work', '/', 'duty', 'and/or', 'measurable', 'improvement', 'in', ' ', 'other', 'areas', 'of', 'function', ',', 'such', 'that', 'the', 'benefits', 'outweigh', 'the', 'potential', 'harms']",14,39
What does the STORM tool do?,What,36,"incorporates co-occurring medical and mental health conditions, SUD, opioid dose,  co-prescribed sedatives, and information about prior adverse events and generates estimates of patients’  risk or hypothetical risk when considering initiation of opioid therapy. It quantifies risk for poisoning or  suicide-related events and for drug-related events, accidents, falls, and drug-induced conditions over a  three-year window. Further, it provides suggestions as to what alternative treatments have not been tried  and what risk mitigation strategies need to be applied.",Specifications,0,0.02631578947368421,"['What', 'does', 'the', 'STORM', 'tool', 'do', '?']","['incorporates', 'co', '-', 'occurring', 'medical', 'and', 'mental', 'health', 'conditions', ',', 'SUD', ',', 'opioid', 'dose', ',', ' ', 'co', '-', 'prescribed', 'sedatives', ',', 'and', 'information', 'about', 'prior', 'adverse', 'events', 'and', 'generates', 'estimates', 'of', 'patients', '’', ' ', 'risk', 'or', 'hypothetical', 'risk', 'when', 'considering', 'initiation', 'of', 'opioid', 'therapy', '.', 'It', 'quantifies', 'risk', 'for', 'poisoning', 'or', ' ', 'suicide', '-', 'related', 'events', 'and', 'for', 'drug', '-', 'related', 'events', ',', 'accidents', ',', 'falls', ',', 'and', 'drug', '-', 'induced', 'conditions', 'over', 'a', ' ', 'three', '-', 'year', 'window', '.', 'Further', ',', 'it', 'provides', 'suggestions', 'as', 'to', 'what', 'alternative', 'treatments', 'have', 'not', 'been', 'tried', ' ', 'and', 'what', 'risk', 'mitigation', 'strategies', 'need', 'to', 'be', 'applied', '.']",7,105
What does the OTRR do?,What,37,"allows VA providers to review clinical data related to opioid  pain treatment within the electronic medical record (EMR), providing an efficient way of monitoring the  data",Specifications,1,1.0,"['What', 'does', 'the', 'OTRR', 'do', '?']","['allows', 'VA', 'providers', 'to', 'review', 'clinical', 'data', 'related', 'to', 'opioid', ' ', 'pain', 'treatment', 'within', 'the', 'electronic', 'medical', 'record', '(', 'EMR', ')', ',', 'providing', 'an', 'efficient', 'way', 'of', 'monitoring', 'the', ' ', 'data']",6,31
Which electronic tools are currently used in the VA?,Which,38,the Opioid Therapy Risk Report (OTRR) and the Stratification Tool for  Opioid Risk Mitigation (STORM),Specifications,1,1.0,"['Which', 'electronic', 'tools', 'are', 'currently', 'used', 'in', 'the', 'VA', '?']","['the', 'Opioid', 'Therapy', 'Risk', 'Report', '(', 'OTRR', ')', 'and', 'the', 'Stratification', 'Tool', 'for', ' ', 'Opioid', 'Risk', 'Mitigation', '(', 'STORM', ')']",10,20
What can facilitate clinical risk assessment and adherence to risk mitigation?,What,39,There are electronic tools,Specifications,0,0.6666666666666666,"['What', 'can', 'facilitate', 'clinical', 'risk', 'assessment', 'and', 'adherence', 'to', 'risk', 'mitigation', '?']","['There', 'are', 'electronic', 'tools']",12,4
Which pain can lead to well-localized nociceptive mechanism pain?,Which,40,Pain arising from persistent peripheral stimulation,Background,1,1.0,"['Which', 'pain', 'can', 'lead', 'to', 'well', '-', 'localized', 'nociceptive', 'mechanism', 'pain', '?']","['Pain', 'arising', 'from', 'persistent', 'peripheral', 'stimulation']",12,6
Which pain could be mechanical or chemical/inflammatory in nature?,Which,41,Pain arising from persistent peripheral stimulation,Background,1,1.0,"['Which', 'pain', 'could', 'be', 'mechanical', 'or', 'chemical', '/', 'inflammatory', 'in', 'nature', '?']","['Pain', 'arising', 'from', 'persistent', 'peripheral', 'stimulation']",12,6
Which pain may lead to poorly localized symptoms?,Which,42,"Neuropathic pain due to injury or disease of the central or peripheral nervous system (e.g., spinal cord  injury, diabetic neuropathy, radiculopathy)",Background,0,0.787878787878788,"['Which', 'pain', 'may', 'lead', 'to', 'poorly', 'localized', 'symptoms', '?']","['Neuropathic', 'pain', 'due', 'to', 'injury', 'or', 'disease', 'of', 'the', 'central', 'or', 'peripheral', 'nervous', 'system', '(', 'e.g.', ',', 'spinal', 'cord', ' ', 'injury', ',', 'diabetic', 'neuropathy', ',', 'radiculopathy', ')']",9,27
What are the causes of chronic pain?,What,43,"Pain arising from persistent peripheral stimulation could be  mechanical or chemical/inflammatory in nature typically leading to well-localized nociceptive mechanism pain. Mechanical or inflammatory pain with a visceral origin may produce a less localized pain.  Neuropathic pain due to injury or disease of the central or peripheral nervous system (e.g., spinal cord  injury, diabetic neuropathy, radiculopathy) may lead to poorly localized symptoms such as diffuse pain,  burning, numbness, or a feeling of skin sensitivity.",Background,0,0.0,"['What', 'are', 'the', 'causes', 'of', 'chronic', 'pain', '?']","['Pain', 'arising', 'from', 'persistent', 'peripheral', 'stimulation', 'could', 'be', ' ', 'mechanical', 'or', 'chemical', '/', 'inflammatory', 'in', 'nature', 'typically', 'leading', 'to', 'well', '-', 'localized', 'nociceptive', 'mechanism', 'pain', '.', 'Mechanical', 'or', 'inflammatory', 'pain', 'with', 'a', 'visceral', 'origin', 'may', 'produce', 'a', 'less', 'localized', 'pain', '.', ' ', 'Neuropathic', 'pain', 'due', 'to', 'injury', 'or', 'disease', 'of', 'the', 'central', 'or', 'peripheral', 'nervous', 'system', '(', 'e.g.', ',', 'spinal', 'cord', ' ', 'injury', ',', 'diabetic', 'neuropathy', ',', 'radiculopathy', ')', 'may', 'lead', 'to', 'poorly', 'localized', 'symptoms', 'such', 'as', 'diffuse', 'pain', ',', ' ', 'burning', ',', 'numbness', ',', 'or', 'a', 'feeling', 'of', 'skin', 'sensitivity', '.']",8,92
What are some examples of poorly localized symptoms?,What,44,"diffuse pain,  burning, numbness, or a feeling of skin sensitivity",Background,1,1.0,"['What', 'are', 'some', 'examples', 'of', 'poorly', 'localized', 'symptoms', '?']","['diffuse', 'pain', ',', ' ', 'burning', ',', 'numbness', ',', 'or', 'a', 'feeling', 'of', 'skin', 'sensitivity']",9,14
Which pain may produce a less localized pain?,Which,45,Mechanical or inflammatory pain with a visceral origin,Background,1,1.0,"['Which', 'pain', 'may', 'produce', 'a', 'less', 'localized', 'pain', '?']","['Mechanical', 'or', 'inflammatory', 'pain', 'with', 'a', 'visceral', 'origin']",9,8
What is the purpose of Opioid Taper Decision Tool?,What,46,"assist Primary Care providers in determining if an opioid taper is necessary for a specific patient, in performing the taper, and in providing follow-up and support during the taper",Specifications,0,0.07692307692307693,"['What', 'is', 'the', 'purpose', 'of', 'Opioid', 'Taper', 'Decision', 'Tool', '?']","['assist', 'Primary', 'Care', 'providers', 'in', 'determining', 'if', 'an', 'opioid', 'taper', 'is', 'necessary', 'for', 'a', 'specific', 'patient', ',', 'in', 'performing', 'the', 'taper', ',', 'and', 'in', 'providing', 'follow', '-', 'up', 'and', 'support', 'during', 'the', 'taper']",10,33
Who recommends at least quarterly checks of the state database system?,Who,50,The CDC,Recommendations,1,1.0,"['Who', 'recommends', 'at', 'least', 'quarterly', 'checks', 'of', 'the', 'state', 'database', 'system', '?']","['The', 'CDC']",12,2
What are used throughout the country for detection of multi-sourcing of controlled substances?,What,51,State database queries,Recommendations,1,1.0,"['What', 'are', 'used', 'throughout', 'the', 'country', 'for', 'detection', 'of', 'multi', '-', 'sourcing', 'of', 'controlled', 'substances', '?']","['State', 'database', 'queries']",16,3
What does the VA/DoD Guideline for Guidelines provide?,What,52,"information regarding the process of developing guidelines, including the identification and  assembly of the Guideline Champions (“Champions”) and other subject matter experts from within the VA  and DoD, known as the “Work Group,” and ultimately, the development and submission of an updated OT  CPG",Specifications,0,0.052631578947368425,"['What', 'does', 'the', 'VA', '/', 'DoD', 'Guideline', 'for', 'Guidelines', 'provide', '?']","['information', 'regarding', 'the', 'process', 'of', 'developing', 'guidelines', ',', 'including', 'the', 'identification', 'and', ' ', 'assembly', 'of', 'the', 'Guideline', 'Champions', '(', '“', 'Champions', '”', ')', 'and', 'other', 'subject', 'matter', 'experts', 'from', 'within', 'the', 'VA', ' ', 'and', 'DoD', ',', 'known', 'as', 'the', '“', 'Work', 'Group', ',', '”', 'and', 'ultimately', ',', 'the', 'development', 'and', 'submission', 'of', 'an', 'updated', 'OT', ' ', 'CPG']",11,57
What methodology was used in developing the 2017 CPG?,What,53,"the VA/DoD  Guideline for Guidelines,[1] an internal document of the VA and DoD EBPWG",Specifications,1,1.0,"['What', 'methodology', 'was', 'used', 'in', 'developing', 'the', '2017', 'CPG', '?']","['the', 'VA', '/', 'DoD', ' ', 'Guideline', 'for', 'Guidelines,[1', ']', 'an', 'internal', 'document', 'of', 'the', 'VA', 'and', 'DoD', 'EBPWG']",10,18
What is recommended when risks of long-term opioid therapy outweigh benefits?,What,54,tapering to reduced dose or to discontinuation of long-term opioid therapy,Recommendations,1,1.0,"['What', 'is', 'recommended', 'when', 'risks', 'of', 'long', '-', 'term', 'opioid', 'therapy', 'outweigh', 'benefits', '?']","['tapering', 'to', 'reduced', 'dose', 'or', 'to', 'discontinuation', 'of', 'long', '-', 'term', 'opioid', 'therapy']",14,13
What should be avoided unless required for immediate safety concerns?,What,56,Abrupt discontinuation,Recommendations,1,1.0,"['What', 'should', 'be', 'avoided', 'unless', 'required', 'for', 'immediate', 'safety', 'concerns', '?']","['Abrupt', 'discontinuation']",11,2
When is it recommended to taper to reduced dose or to discontinuation of long-term opioid therapy?,When,57,when risks of long-term opioid therapy outweigh benefits,Recommendations,1,1.0,"['When', 'is', 'it', 'recommended', 'to', 'taper', 'to', 'reduced', 'dose', 'or', 'to', 'discontinuation', 'of', 'long', '-', 'term', 'opioid', 'therapy', '?']","['when', 'risks', 'of', 'long', '-', 'term', 'opioid', 'therapy', 'outweigh', 'benefits']",19,10
What was the recommendation in the 2010 OT CPG?,What,58,"use of an opioid pain  care agreement, monitoring for appropriate opioid use, and, with patients’ consent, obtaining a UDT",Recommendations,1,1.0,"['What', 'was', 'the', 'recommendation', 'in', 'the', '2010', 'OT', 'CPG', '?']","['use', 'of', 'an', 'opioid', 'pain', ' ', 'care', 'agreement', ',', 'monitoring', 'for', 'appropriate', 'opioid', 'use', ',', 'and', ',', 'with', 'patients', '’', 'consent', ',', 'obtaining', 'a', 'UDT']",10,25
What is OTAs?,What,59,opioid treatment agreements,Recommendations,1,1.0,"['What', 'is', 'OTAs', '?']","['opioid', 'treatment', 'agreements']",4,3
What should be done before the opioids are prescribed?,What,60,Risk mitigation for LOT should begin,Recommendations,0,0.8,"['What', 'should', 'be', 'done', 'before', 'the', 'opioids', 'are', 'prescribed', '?']","['Risk', 'mitigation', 'for', 'LOT', 'should', 'begin']",10,6
When should risk mitigation for LOT occur?,When,61,"concurrently with the therapy  (e.g., ongoing UDT, OEND) and in response to adverse events (e.g., needle exchange programs for those  who develop an intravenous drug use disorder)",Recommendations,0,0.0,"['When', 'should', 'risk', 'mitigation', 'for', 'LOT', 'occur', '?']","['concurrently', 'with', 'the', 'therapy', ' ', '(', 'e.g.', ',', 'ongoing', 'UDT', ',', 'OEND', ')', 'and', 'in', 'response', 'to', 'adverse', 'events', '(', 'e.g.', ',', 'needle', 'exchange', 'programs', 'for', 'those', ' ', 'who', 'develop', 'an', 'intravenous', 'drug', 'use', 'disorder', ')']",8,36
When should risk mitigation for LOT begin?,When,63,before the opioids are prescribed,Recommendations,1,1.0,"['When', 'should', 'risk', 'mitigation', 'for', 'LOT', 'begin', '?']","['before', 'the', 'opioids', 'are', 'prescribed']",8,5
How should risk mitigation for LOT begin before the opioids are prescribed?,How,64,"through an informed consent  discussion, reviewing the patient’s history, checking state PDMPs, or instructing patients about using drug  take back programs to dispose of unused medication",Recommendations,0,0.8837209302325582,"['How', 'should', 'risk', 'mitigation', 'for', 'LOT', 'begin', 'before', 'the', 'opioids', 'are', 'prescribed', '?']","['through', 'an', 'informed', 'consent', ' ', 'discussion', ',', 'reviewing', 'the', 'patient', '’s', 'history', ',', 'checking', 'state', 'PDMPs', ',', 'or', 'instructing', 'patients', 'about', 'using', 'drug', ' ', 'take', 'back', 'programs', 'to', 'dispose', 'of', 'unused', 'medication']",13,32
What kind of evidence is there to support the use of OTAs and UDT?,What,65,weak,Recommendations,1,1.0,"['What', 'kind', 'of', 'evidence', 'is', 'there', 'to', 'support', 'the', 'use', 'of', 'OTAs', 'and', 'UDT', '?']",['weak'],15,1
Which factors can describe and characterize pain as a symptom?,Which,67,"quality (e.g., sharp versus dull), intensity, timing, location, and  whether it is associated with position or movement",Background,0,0.9714285714285714,"['Which', 'factors', 'can', 'describe', 'and', 'characterize', 'pain', 'as', 'a', 'symptom', '?']","['quality', '(', 'e.g.', ',', 'sharp', 'versus', 'dull', ')', ',', 'intensity', ',', 'timing', ',', 'location', ',', 'and', ' ', 'whether', 'it', 'is', 'associated', 'with', 'position', 'or', 'movement']",11,25
How to characterize pain as a symptom?,How,68,multifaceted,Background,1,1.0,"['How', 'to', 'characterize', 'pain', 'as', 'a', 'symptom', '?']",['multifaceted'],8,1
How should the guideline not be interpreted as?,How,69,as prescribing an exclusive course of management,Introduction,0,0.9090909090909091,"['How', 'should', 'the', 'guideline', 'not', 'be', 'interpreted', 'as', '?']","['as', 'prescribing', 'an', 'exclusive', 'course', 'of', 'management']",9,7
What are the guidelines based upon?,What,70,the best information available at the time of publication,Introduction,1,1.0,"['What', 'are', 'the', 'guidelines', 'based', 'upon', '?']","['the', 'best', 'information', 'available', 'at', 'the', 'time', 'of', 'publication']",7,9
What is not the intention of the guideline?,What,71,define a standard of care ,Introduction,0,0.888888888888889,"['What', 'is', 'not', 'the', 'intention', 'of', 'the', 'guideline', '?']","['define', 'a', 'standard', 'of', 'care']",9,5
What are the guidelines designed to do?,What,72,provide information and assist decision making,Introduction,1,1.0,"['What', 'are', 'the', 'guidelines', 'designed', 'to', 'do', '?']","['provide', 'information', 'and', 'assist', 'decision', 'making']",8,6
What should the guidelines not be construed as?,What,73,a standard of care,Introduction,0,0.0,"['What', 'should', 'the', 'guidelines', 'not', 'be', 'construed', 'as', '?']","['a', 'standard', 'of', 'care']",9,4
What is the stance regarding the initiation of long-term opioid therapy for chronic pain?,What,74,strongly recommend against,Recommendations,1,1.0,"['What', 'is', 'the', 'stance', 'regarding', 'the', 'initiation', 'of', 'long', '-', 'term', 'opioid', 'therapy', 'for', 'chronic', 'pain', '?']","['strongly', 'recommend', 'against']",17,3
What is recommended when pharmacologic therapies are used?,What,75,non-opioids over opioids,Recommendations,1,1.0,"['What', 'is', 'recommended', 'when', 'pharmacologic', 'therapies', 'are', 'used', '?']","['non', '-', 'opioids', 'over', 'opioids']",9,5
What are recommended as alternatives to opioid therapy?,What,77,self-management strategies and other non-pharmacological treatments,Recommendations,1,1.0,"['What', 'are', 'recommended', 'as', 'alternatives', 'to', 'opioid', 'therapy', '?']","['self', '-', 'management', 'strategies', 'and', 'other', 'non', '-', 'pharmacological', 'treatments']",9,10
When is a short duration recommended?,When,78,If prescribing opioid therapy for patients with chronic pain,Recommendations,1,1.0,"['When', 'is', 'a', 'short', 'duration', 'recommended', '?']","['If', 'prescribing', 'opioid', 'therapy', 'for', 'patients', 'with', 'chronic', 'pain']",7,9
What does require reevaluation and discussion of risks and benefits with patients?,What,79,Consideration of opioid therapy beyond 90 days,Recommendations,1,1.0,"['What', 'does', 'require', 'reevaluation', 'and', 'discussion', 'of', 'risks', 'and', 'benefits', 'with', 'patients', '?']","['Consideration', 'of', 'opioid', 'therapy', 'beyond', '90', 'days']",13,7
When are non-opioids recommended over opioids?,When,80,When pharmacologic therapies are used,Recommendations,1,1.0,"['When', 'are', 'non', '-', 'opioids', 'recommended', 'over', 'opioids', '?']","['When', 'pharmacologic', 'therapies', 'are', 'used']",9,5
What is recommended if prescribing opioid therapy for patients with chronic pain?,What,81,a short duration,Recommendations,1,1.0,"['What', 'is', 'recommended', 'if', 'prescribing', 'opioid', 'therapy', 'for', 'patients', 'with', 'chronic', 'pain', '?']","['a', 'short', 'duration']",13,3
"When reducing 5% of morphine SR 90 mg Q8h = 270 MEDD, what dose should be taken on month six of the slowest opioid tapering?",When,84,60 mg SR Q8h,Specifications,1,1.0,"['When', 'reducing', '5', '%', 'of', 'morphine', 'SR', '90', 'mg', 'Q8h', '=', '270', 'MEDD', ',', 'what', 'dose', 'should', 'be', 'taken', 'on', 'month', 'six', 'of', 'the', 'slowest', 'opioid', 'tapering', '?']","['60', 'mg', 'SR', 'Q8h']",28,4
How much opioid to reduce in the slowest taper?,How,85,2 to 10% every 4 to 8 weeks with pauses in taper as needed,Specifications,0,0.7272727272727273,"['How', 'much', 'opioid', 'to', 'reduce', 'in', 'the', 'slowest', 'taper', '?']","['2', 'to', '10', '%', 'every', '4', 'to', '8', 'weeks', 'with', 'pauses', 'in', 'taper', 'as', 'needed']",10,15
How long does the slowest taper take?,How,86,over years,Specifications,1,1.0,"['How', 'long', 'does', 'the', 'slowest', 'taper', 'take', '?']","['over', 'years']",8,2
"When reducing 5% of morphine SR 90 mg Q8h = 270 MEDD, what dose should be taken on month eight of the slowest opioid tapering?",When,87,"45 mg SR qam, 45 mg noon, 60 mg qpm",Specifications,1,1.0,"['When', 'reducing', '5', '%', 'of', 'morphine', 'SR', '90', 'mg', 'Q8h', '=', '270', 'MEDD', ',', 'what', 'dose', 'should', 'be', 'taken', 'on', 'month', 'eight', 'of', 'the', 'slowest', 'opioid', 'tapering', '?']","['45', 'mg', 'SR', 'qam', ',', '45', 'mg', 'noon', ',', '60', 'mg', 'qpm']",28,12
How may pauses in the slowest opioid taper help the patient?,How,89,allow the patient time to acquire new skills for management of pain and emotional distress while allowing for neurobiological equilibration,Specifications,0,0.9444444444444444,"['How', 'may', 'pauses', 'in', 'the', 'slowest', 'opioid', 'taper', 'help', 'the', 'patient', '?']","['allow', 'the', 'patient', 'time', 'to', 'acquire', 'new', 'skills', 'for', 'management', 'of', 'pain', 'and', 'emotional', 'distress', 'while', 'allowing', 'for', 'neurobiological', 'equilibration']",12,20
"When reducing 5% of morphine SR 90 mg Q8h = 270 MEDD, what dose should be taken on month five of the slowest opioid tapering?",When,90,"60 mg SR qam, 60 mg noon, 75 mg qpm",Specifications,1,1.0,"['When', 'reducing', '5', '%', 'of', 'morphine', 'SR', '90', 'mg', 'Q8h', '=', '270', 'MEDD', ',', 'what', 'dose', 'should', 'be', 'taken', 'on', 'month', 'five', 'of', 'the', 'slowest', 'opioid', 'tapering', '?']","['60', 'mg', 'SR', 'qam', ',', '60', 'mg', 'noon', ',', '75', 'mg', 'qpm']",28,12
"When reducing 5% of morphine SR 90 mg Q8h = 270 MEDD, what dose should be taken on month two of the slowest opioid tapering?",When,91,"75 mg SR qam, 75 mg noon, 90 mg qpm",Specifications,1,1.0,"['When', 'reducing', '5', '%', 'of', 'morphine', 'SR', '90', 'mg', 'Q8h', '=', '270', 'MEDD', ',', 'what', 'dose', 'should', 'be', 'taken', 'on', 'month', 'two', 'of', 'the', 'slowest', 'opioid', 'tapering', '?']","['75', 'mg', 'SR', 'qam', ',', '75', 'mg', 'noon', ',', '90', 'mg', 'qpm']",28,12
What can allow the patient time to acquire new skills for management of pain and emotional distress while allowing for neurobiological equilibration?,What,93,Pauses in the taper,Specifications,1,1.0,"['What', 'can', 'allow', 'the', 'patient', 'time', 'to', 'acquire', 'new', 'skills', 'for', 'management', 'of', 'pain', 'and', 'emotional', 'distress', 'while', 'allowing', 'for', 'neurobiological', 'equilibration', '?']","['Pauses', 'in', 'the', 'taper']",23,4
"When reducing 5% of morphine SR 90 mg Q8h = 270 MEDD, what dose should be taken on month nine of the slowest opioid tapering?",When,94,45 mg SR Q8h,Specifications,1,1.0,"['When', 'reducing', '5', '%', 'of', 'morphine', 'SR', '90', 'mg', 'Q8h', '=', '270', 'MEDD', ',', 'what', 'dose', 'should', 'be', 'taken', 'on', 'month', 'nine', 'of', 'the', 'slowest', 'opioid', 'tapering', '?']","['45', 'mg', 'SR', 'Q8h']",28,4
"When reducing 5% of morphine SR 90 mg Q8h = 270 MEDD, what dose should be taken on month three of the slowest opioid tapering?",When,95,75 mg SR (60 mg+15 mg) Q8h,Specifications,1,1.0,"['When', 'reducing', '5', '%', 'of', 'morphine', 'SR', '90', 'mg', 'Q8h', '=', '270', 'MEDD', ',', 'what', 'dose', 'should', 'be', 'taken', 'on', 'month', 'three', 'of', 'the', 'slowest', 'opioid', 'tapering', '?']","['75', 'mg', 'SR', '(', '60', 'mg+15', 'mg', ')', 'Q8h']",28,9
"When reducing 5% of morphine SR 90 mg Q8h = 270 MEDD, what dose should be taken on month seven of the slowest opioid tapering?",When,96,"60 mg SR qam, 45 mg noon, 60 mg qpm",Specifications,1,1.0,"['When', 'reducing', '5', '%', 'of', 'morphine', 'SR', '90', 'mg', 'Q8h', '=', '270', 'MEDD', ',', 'what', 'dose', 'should', 'be', 'taken', 'on', 'month', 'seven', 'of', 'the', 'slowest', 'opioid', 'tapering', '?']","['60', 'mg', 'SR', 'qam', ',', '45', 'mg', 'noon', ',', '60', 'mg', 'qpm']",28,12
"When reducing 5% of morphine SR 90 mg Q8h = 270 MEDD, what dose should be taken on month four of the slowest opioid tapering?",When,98,"75 mg SR qam, 60 mg noon, 75 mg qpm",Specifications,1,1.0,"['When', 'reducing', '5', '%', 'of', 'morphine', 'SR', '90', 'mg', 'Q8h', '=', '270', 'MEDD', ',', 'what', 'dose', 'should', 'be', 'taken', 'on', 'month', 'four', 'of', 'the', 'slowest', 'opioid', 'tapering', '?']","['75', 'mg', 'SR', 'qam', ',', '60', 'mg', 'noon', ',', '75', 'mg', 'qpm']",28,12
Who is at a high risk of prescription opioid overdose?,Who,100,patients with co-occurring depression,Recommendations,1,1.0,"['Who', 'is', 'at', 'a', 'high', 'risk', 'of', 'prescription', 'opioid', 'overdose', '?']","['patients', 'with', 'co', '-', 'occurring', 'depression']",11,6
What does increase the risk for serious prescription opioid-related toxicity or overdose across opioid dosages in patients?,What,101,a history of or active SUD,Recommendations,1,1.0,"['What', 'does', 'increase', 'the', 'risk', 'for', 'serious', 'prescription', 'opioid', '-', 'related', 'toxicity', 'or', 'overdose', 'across', 'opioid', 'dosages', 'in', 'patients', '?']","['a', 'history', 'of', 'or', 'active', 'SUD']",20,6
What does increase the risk of fatal or non-fatal opioid overdose 2-10 fold across opioid dose ranges?,What,102,Concurrent  prescribing of sedative-hypnotics and benzodiazepines,Recommendations,1,1.0,"['What', 'does', 'increase', 'the', 'risk', 'of', 'fatal', 'or', 'non', '-', 'fatal', 'opioid', 'overdose', '2', '-', '10', 'fold', 'across', 'opioid', 'dose', 'ranges', '?']","['Concurrent', ' ', 'prescribing', 'of', 'sedative', '-', 'hypnotics', 'and', 'benzodiazepines']",22,9
"When reducing 16% of morphine SR 90 mg Q8h = 270 MEDD on month 1, what dose should be taken on month four of the slower opioid tapering?",When,103,30 mg SR Q8h,Specifications,1,1.0,"['When', 'reducing', '16', '%', 'of', 'morphine', 'SR', '90', 'mg', 'Q8h', '=', '270', 'MEDD', 'on', 'month', '1', ',', 'what', 'dose', 'should', 'be', 'taken', 'on', 'month', 'four', 'of', 'the', 'slower', 'opioid', 'tapering', '?']","['30', 'mg', 'SR', 'Q8h']",31,4
"When reducing 16% of morphine SR 90 mg Q8h = 270 MEDD on month 1, what dose should be taken on month two of the slower opioid tapering?",When,104,60 mg SR Q8h,Specifications,1,1.0,"['When', 'reducing', '16', '%', 'of', 'morphine', 'SR', '90', 'mg', 'Q8h', '=', '270', 'MEDD', 'on', 'month', '1', ',', 'what', 'dose', 'should', 'be', 'taken', 'on', 'month', 'two', 'of', 'the', 'slower', 'opioid', 'tapering', '?']","['60', 'mg', 'SR', 'Q8h']",31,4
Which one is the most common taper?,Which,105,Slower Taper,Specifications,1,1.0,"['Which', 'one', 'is', 'the', 'most', 'common', 'taper', '?']","['Slower', 'Taper']",8,2
"When reducing 16% of morphine SR 90 mg Q8h = 270 MEDD on month 1, what dose should be taken on month five of the slower opioid tapering?",When,106,15 mg SR Q8h,Specifications,1,1.0,"['When', 'reducing', '16', '%', 'of', 'morphine', 'SR', '90', 'mg', 'Q8h', '=', '270', 'MEDD', 'on', 'month', '1', ',', 'what', 'dose', 'should', 'be', 'taken', 'on', 'month', 'five', 'of', 'the', 'slower', 'opioid', 'tapering', '?']","['15', 'mg', 'SR', 'Q8h']",31,4
How much opioid to reduce in the slower taper?,How,107,5 to 20% every 4 weeks with pauses in taper as needed,Specifications,0,0.6666666666666666,"['How', 'much', 'opioid', 'to', 'reduce', 'in', 'the', 'slower', 'taper', '?']","['5', 'to', '20', '%', 'every', '4', 'weeks', 'with', 'pauses', 'in', 'taper', 'as', 'needed']",10,13
"When reducing 16% of morphine SR 90 mg Q8h = 270 MEDD on month 1, what dose should be taken on month three of the slower opioid tapering?",When,108,45 mg SR Q8h,Specifications,1,1.0,"['When', 'reducing', '16', '%', 'of', 'morphine', 'SR', '90', 'mg', 'Q8h', '=', '270', 'MEDD', 'on', 'month', '1', ',', 'what', 'dose', 'should', 'be', 'taken', 'on', 'month', 'three', 'of', 'the', 'slower', 'opioid', 'tapering', '?']","['45', 'mg', 'SR', 'Q8h']",31,4
How long does the slower taper take?,How,109,over months or years,Specifications,1,1.0,"['How', 'long', 'does', 'the', 'slower', 'taper', 'take', '?']","['over', 'months', 'or', 'years']",8,4
When to stop slower tapering?,When,110,after month 7,Specifications,1,1.0,"['When', 'to', 'stop', 'slower', 'tapering', '?']","['after', 'month', '7']",6,3
"When reducing 16% of morphine SR 90 mg Q8h = 270 MEDD on month 1, what dose should be taken on month seven of the slower opioid tapering?",When,112,15mg SR QHS,Specifications,1,1.0,"['When', 'reducing', '16', '%', 'of', 'morphine', 'SR', '90', 'mg', 'Q8h', '=', '270', 'MEDD', 'on', 'month', '1', ',', 'what', 'dose', 'should', 'be', 'taken', 'on', 'month', 'seven', 'of', 'the', 'slower', 'opioid', 'tapering', '?']","['15', 'mg', 'SR', 'QHS']",31,4
What may be considered after stopping faster tapering after month 7?,What,113,morphine IR 15 mg ½ tablet (7.5 mg) twice daily,Specifications,1,1.0,"['What', 'may', 'be', 'considered', 'after', 'stopping', 'faster', 'tapering', 'after', 'month', '7', '?']","['morphine', 'IR', '15', 'mg', '½', 'tablet', '(', '7.5', 'mg', ')', 'twice', 'daily']",12,12
"When reducing 16% of morphine SR 90 mg Q8h = 270 MEDD on month 1, what dose should be taken on month six of the slower opioid tapering?",When,114,15 mg SR Q12h,Specifications,1,1.0,"['When', 'reducing', '16', '%', 'of', 'morphine', 'SR', '90', 'mg', 'Q8h', '=', '270', 'MEDD', 'on', 'month', '1', ',', 'what', 'dose', 'should', 'be', 'taken', 'on', 'month', 'six', 'of', 'the', 'slower', 'opioid', 'tapering', '?']","['15', 'mg', 'SR', 'Q12h']",31,4
How can the use of opioids affect patients with impaired bowel motility?,How,115,can increase the risk of severe constipation/impaction or possible obstruction,Background,1,1.0,"['How', 'can', 'the', 'use', 'of', 'opioids', 'affect', 'patients', 'with', 'impaired', 'bowel', 'motility', '?']","['can', 'increase', 'the', 'risk', 'of', 'severe', 'constipation', '/', 'impaction', 'or', 'possible', 'obstruction']",13,12
What do opioids do to the bowel?,What,116,inhibit bowel peristalsis,Background,1,1.0,"['What', 'do', 'opioids', 'do', 'to', 'the', 'bowel', '?']","['inhibit', 'bowel', 'peristalsis']",8,3
What is the ratio of new users of injectable opioids who had previously used prescription oral opioid pain medication?,What,117,80%,Recommendations,0,0.6666666666666666,"['What', 'is', 'the', 'ratio', 'of', 'new', 'users', 'of', 'injectable', 'opioids', 'who', 'had', 'previously', 'used', 'prescription', 'oral', 'opioid', 'pain', 'medication', '?']","['80', '%']",20,2
What is an example of the threat to rural communities from non-prescription opioid use and the potential benefits of needle exchange programs for use as a risk mitigation strategy?,What,119,The 2015 outbreak of HIV/hepatitis in rural  Indiana and subsequent successful implementation of a needle exchange program,Recommendations,1,1.0,"['What', 'is', 'an', 'example', 'of', 'the', 'threat', 'to', 'rural', 'communities', 'from', 'non', '-', 'prescription', 'opioid', 'use', 'and', 'the', 'potential', 'benefits', 'of', 'needle', 'exchange', 'programs', 'for', 'use', 'as', 'a', 'risk', 'mitigation', 'strategy', '?']","['The', '2015', 'outbreak', 'of', 'HIV', '/', 'hepatitis', 'in', 'rural', ' ', 'Indiana', 'and', 'subsequent', 'successful', 'implementation', 'of', 'a', 'needle', 'exchange', 'program']",32,20
What accompanies the illicit use of injectable opioids?,What,120,an increased rate of human immunodeficiency virus (HIV) and hepatitis infection,Recommendations,1,1.0,"['What', 'accompanies', 'the', 'illicit', 'use', 'of', 'injectable', 'opioids', '?']","['an', 'increased', 'rate', 'of', 'human', 'immunodeficiency', 'virus', '(', 'HIV', ')', 'and', 'hepatitis', 'infection']",9,13
What has been an effective risk mitigation strategy for reducing high-risk behaviors and infectious disease transmission among injection drug users?,What,123,Community-based needle exchange programs,Recommendations,1,1.0,"['What', 'has', 'been', 'an', 'effective', 'risk', 'mitigation', 'strategy', 'for', 'reducing', 'high', '-', 'risk', 'behaviors', 'and', 'infectious', 'disease', 'transmission', 'among', 'injection', 'drug', 'users', '?']","['Community', '-', 'based', 'needle', 'exchange', 'programs']",23,6
What is an example of high-risk behaviors?,What,124,sharing needles,Recommendations,1,1.0,"['What', 'is', 'an', 'example', 'of', 'high', '-', 'risk', 'behaviors', '?']","['sharing', 'needles']",10,2
What should the clinicians do for patients who decline MAT for OUD?,What,125,"educating the patient regarding sterile injection techniques and community based needle exchange programs, if programs are available",Recommendations,0,0.9696969696969697,"['What', 'should', 'the', 'clinicians', 'do', 'for', 'patients', 'who', 'decline', 'MAT', 'for', 'OUD', '?']","['educating', 'the', 'patient', 'regarding', 'sterile', 'injection', 'techniques', 'and', 'community', 'based', 'needle', 'exchange', 'programs', ',', 'if', 'programs', 'are', 'available']",13,18
What is the first recommendation for patients who develop OUD and progress to intravenous drug use?,What,126,medication assisted treatment (MAT) for OUD,Recommendations,1,1.0,"['What', 'is', 'the', 'first', 'recommendation', 'for', 'patients', 'who', 'develop', 'OUD', 'and', 'progress', 'to', 'intravenous', 'drug', 'use', '?']","['medication', 'assisted', 'treatment', '(', 'MAT', ')', 'for', 'OUD']",17,8
What is accompanied by an increased rate of the human immunodeficiency virus (HIV) and hepatitis infection?,What,128,Illicit use of injectable opioids,Recommendations,1,1.0,"['What', 'is', 'accompanied', 'by', 'an', 'increased', 'rate', 'of', 'the', 'human', 'immunodeficiency', 'virus', '(', 'HIV', ')', 'and', 'hepatitis', 'infection', '?']","['Illicit', 'use', 'of', 'injectable', 'opioids']",19,5
What often far outweighs the potential benefits?,What,130,"the harms due to the potential for severe adverse events associated with opioids, particularly overdose and OUD",Recommendations,1,1.0,"['What', 'often', 'far', 'outweighs', 'the', 'potential', 'benefits', '?']","['the', 'harms', 'due', 'to', 'the', 'potential', 'for', 'severe', 'adverse', 'events', 'associated', 'with', 'opioids', ',', 'particularly', 'overdose', 'and', 'OUD']",8,18
What contributed to strong recommendations in multiple instances?,What,131,these factors,Recommendations,0,0.0,"['What', 'contributed', 'to', 'strong', 'recommendations', 'in', 'multiple', 'instances', '?']","['these', 'factors']",9,2
What were the goals of President’s National Drug Control strategy in 2010?,What,132,curtailing illicit drug consumption in America and improving the health and safety of the American people by reducing the consequences of drug abuse,Background,1,1.0,"['What', 'were', 'the', 'goals', 'of', 'President', '’s', 'National', 'Drug', 'Control', 'strategy', 'in', '2010', '?']","['curtailing', 'illicit', 'drug', 'consumption', 'in', 'America', 'and', 'improving', 'the', 'health', 'and', 'safety', 'of', 'the', 'American', 'people', 'by', 'reducing', 'the', 'consequences', 'of', 'drug', 'abuse']",14,23
What accompanied the 2015 National Drug Control strategy?,What,133,presidential memorandum on preventing prescription drug abuse and heroin use,Background,1,1.0,"['What', 'accompanied', 'the', '2015', 'National', 'Drug', 'Control', 'strategy', '?']","['presidential', 'memorandum', 'on', 'preventing', 'prescription', 'drug', 'abuse', 'and', 'heroin', 'use']",9,10
Which health issue has been identified as an epidemic?,Which,135,The increasing use of opioids,Background,1,1.0,"['Which', 'health', 'issue', 'has', 'been', 'identified', 'as', 'an', 'epidemic', '?']","['The', 'increasing', 'use', 'of', 'opioids']",10,5
What has accumulated growing attention from federal and local officials as well as other policymakers?,What,136,"The increasing use of opioids, as well as the accompanying rise in morbidity and mortality associated with opioid use",Background,1,1.0,"['What', 'has', 'accumulated', 'growing', 'attention', 'from', 'federal', 'and', 'local', 'officials', 'as', 'well', 'as', 'other', 'policymakers', '?']","['The', 'increasing', 'use', 'of', 'opioids', ',', 'as', 'well', 'as', 'the', 'accompanying', 'rise', 'in', 'morbidity', 'and', 'mortality', 'associated', 'with', 'opioid', 'use']",16,20
How did the 2015 National Drug Control strategy and an accompanying presidential memorandum encourage the improvement of health and safety using evidence-based methods regarding SUD treatments?,How,137,"by calling for change in a number of key areas including preventing drug use in communities, seeking early intervention opportunities, and integrating SUD treatment and supporting recovery",Background,1,1.0,"['How', 'did', 'the', '2015', 'National', 'Drug', 'Control', 'strategy', 'and', 'an', 'accompanying', 'presidential', 'memorandum', 'encourage', 'the', 'improvement', 'of', 'health', 'and', 'safety', 'using', 'evidence', '-', 'based', 'methods', 'regarding', 'SUD', 'treatments', '?']","['by', 'calling', 'for', 'change', 'in', 'a', 'number', 'of', 'key', 'areas', 'including', 'preventing', 'drug', 'use', 'in', 'communities', ',', 'seeking', 'early', 'intervention', 'opportunities', ',', 'and', 'integrating', 'SUD', 'treatment', 'and', 'supporting', 'recovery']",29,29
When was the 2015 National Drug Control strategy released?,When,138,October 2015,Background,1,1.0,"['When', 'was', 'the', '2015', 'National', 'Drug', 'Control', 'strategy', 'released', '?']","['October', '2015']",10,2
What is the stance regarding long-term opioid therapy for patients less than 30 years of age  secondary to higher risk of opioid use disorder and overdose?,What,139,recommend against,Recommendations,1,1.0,"['What', 'is', 'the', 'stance', 'regarding', 'long', '-', 'term', 'opioid', 'therapy', 'for', 'patients', 'less', 'than', '30', 'years', 'of', 'age', ' ', 'secondary', 'to', 'higher', 'risk', 'of', 'opioid', 'use', 'disorder', 'and', 'overdose', '?']","['recommend', 'against']",30,2
What is recommended for patients less than 30 years of age currently on long-term opioid therapy?,What,140,close monitoring and consideration for tapering when risks exceed benefits,Recommendations,1,1.0,"['What', 'is', 'recommended', 'for', 'patients', 'less', 'than', '30', 'years', 'of', 'age', 'currently', 'on', 'long', '-', 'term', 'opioid', 'therapy', '?']","['close', 'monitoring', 'and', 'consideration', 'for', 'tapering', 'when', 'risks', 'exceed', 'benefits']",19,10
"When reducing 33% of morphine SR 90 mg Q8h = 270 MEDD on day 1, what dose should be taken on day eight of the rapid opioid tapering?",When,141,15 mg SR QHS,Specifications,1,1.0,"['When', 'reducing', '33', '%', 'of', 'morphine', 'SR', '90', 'mg', 'Q8h', '=', '270', 'MEDD', 'on', 'day', '1', ',', 'what', 'dose', 'should', 'be', 'taken', 'on', 'day', 'eight', 'of', 'the', 'rapid', 'opioid', 'tapering', '?']","['15', 'mg', 'SR', 'QHS']",31,4
"When reducing 33% of morphine SR 90 mg Q8h = 270 MEDD on day 1, what dose should be taken on day seven of the rapid opioid tapering?",When,142,15 mg SR Q12h,Specifications,1,1.0,"['When', 'reducing', '33', '%', 'of', 'morphine', 'SR', '90', 'mg', 'Q8h', '=', '270', 'MEDD', 'on', 'day', '1', ',', 'what', 'dose', 'should', 'be', 'taken', 'on', 'day', 'seven', 'of', 'the', 'rapid', 'opioid', 'tapering', '?']","['15', 'mg', 'SR', 'Q12h']",31,4
When to take individualized decisions about which formulation to be tapered first?,When,143,If patients are prescribed both long-acting and short-acting opioids,Specifications,1,1.0,"['When', 'to', 'take', 'individualized', 'decisions', 'about', 'which', 'formulation', 'to', 'be', 'tapered', 'first', '?']","['If', 'patients', 'are', 'prescribed', 'both', 'long', '-', 'acting', 'and', 'short', '-', 'acting', 'opioids']",13,13
"When reducing 33% of morphine SR 90 mg Q8h = 270 MEDD on day 1, what dose should be taken on day ten of the rapid opioid tapering?",When,144,15 mg SR QHS,Specifications,0,0.5,"['When', 'reducing', '33', '%', 'of', 'morphine', 'SR', '90', 'mg', 'Q8h', '=', '270', 'MEDD', 'on', 'day', '1', ',', 'what', 'dose', 'should', 'be', 'taken', 'on', 'day', 'ten', 'of', 'the', 'rapid', 'opioid', 'tapering', '?']","['15', 'mg', 'SR', 'QHS']",31,4
"When reducing 33% of morphine SR 90 mg Q8h = 270 MEDD on day 1, what dose should be taken on day nine of the rapid opioid tapering?",When,145,15 mg SR QHS,Specifications,1,1.0,"['When', 'reducing', '33', '%', 'of', 'morphine', 'SR', '90', 'mg', 'Q8h', '=', '270', 'MEDD', 'on', 'day', '1', ',', 'what', 'dose', 'should', 'be', 'taken', 'on', 'day', 'nine', 'of', 'the', 'rapid', 'opioid', 'tapering', '?']","['15', 'mg', 'SR', 'QHS']",31,4
What may need to be considered during rapid tapers?,What,146,admitting the patient for inpatient care,Specifications,1,1.0,"['What', 'may', 'need', 'to', 'be', 'considered', 'during', 'rapid', 'tapers', '?']","['admitting', 'the', 'patient', 'for', 'inpatient', 'care']",10,6
"When reducing 33% of morphine SR 90 mg Q8h = 270 MEDD on day 1, what dose should be taken on day six of the rapid opioid tapering?",When,147,15 mg SR Q12h,Specifications,0,0.75,"['When', 'reducing', '33', '%', 'of', 'morphine', 'SR', '90', 'mg', 'Q8h', '=', '270', 'MEDD', 'on', 'day', '1', ',', 'what', 'dose', 'should', 'be', 'taken', 'on', 'day', 'six', 'of', 'the', 'rapid', 'opioid', 'tapering', '?']","['15', 'mg', 'SR', 'Q12h']",31,4
"When reducing 33% of morphine SR 90 mg Q8h = 270 MEDD on day 1, what dose should be taken on day three of the rapid opioid tapering?",When,149,30 mg SR (15 mg x 2) Q8h,Specifications,1,1.0,"['When', 'reducing', '33', '%', 'of', 'morphine', 'SR', '90', 'mg', 'Q8h', '=', '270', 'MEDD', 'on', 'day', '1', ',', 'what', 'dose', 'should', 'be', 'taken', 'on', 'day', 'three', 'of', 'the', 'rapid', 'opioid', 'tapering', '?']","['30', 'mg', 'SR', '(', '15', 'mg', 'x', '2', ')', 'Q8h']",31,10
Which taper can cause withdrawal effects?,Which,150,Rapid tapers,Specifications,1,1.0,"['Which', 'taper', 'can', 'cause', 'withdrawal', 'effects', '?']","['Rapid', 'tapers']",7,2
What can be caused by rapid taper?,What,151,withdrawal effects,Specifications,1,1.0,"['What', 'can', 'be', 'caused', 'by', 'rapid', 'taper', '?']","['withdrawal', 'effects']",8,2
When to stop rapid tapering?,When,152,after day 11,Specifications,1,1.0,"['When', 'to', 'stop', 'rapid', 'tapering', '?']","['after', 'day', '11']",6,3
"When reducing 33% of morphine SR 90 mg Q8h = 270 MEDD on day 1, what dose should be taken on day eleven of the rapid opioid tapering?",When,153,15 mg SR QHS,Specifications,1,1.0,"['When', 'reducing', '33', '%', 'of', 'morphine', 'SR', '90', 'mg', 'Q8h', '=', '270', 'MEDD', 'on', 'day', '1', ',', 'what', 'dose', 'should', 'be', 'taken', 'on', 'day', 'eleven', 'of', 'the', 'rapid', 'opioid', 'tapering', '?']","['15', 'mg', 'SR', 'QHS']",31,4
How much opioid to reduce in the rapid taper?,How,154,"by 20 to 50% of first dose if needed, then reduce by 10 to 20% every day",Specifications,0,0.9696969696969697,"['How', 'much', 'opioid', 'to', 'reduce', 'in', 'the', 'rapid', 'taper', '?']","['by', '20', 'to', '50', '%', 'of', 'first', 'dose', 'if', 'needed', ',', 'then', 'reduce', 'by', '10', 'to', '20', '%', 'every', 'day']",10,20
How to minimize withdrawal effects in patients caused by rapid tapers?,How,155,patients should be treated with adjunctive medications,Specifications,1,1.0,"['How', 'to', 'minimize', 'withdrawal', 'effects', 'in', 'patients', 'caused', 'by', 'rapid', 'tapers', '?']","['patients', 'should', 'be', 'treated', 'with', 'adjunctive', 'medications']",12,7
"When reducing 33% of morphine SR 90 mg Q8h = 270 MEDD on day 1, what dose should be taken on day five of the rapid opioid tapering?",When,157,15 mg SR Q12h,Specifications,1,1.0,"['When', 'reducing', '33', '%', 'of', 'morphine', 'SR', '90', 'mg', 'Q8h', '=', '270', 'MEDD', 'on', 'day', '1', ',', 'what', 'dose', 'should', 'be', 'taken', 'on', 'day', 'five', 'of', 'the', 'rapid', 'opioid', 'tapering', '?']","['15', 'mg', 'SR', 'Q12h']",31,4
"When reducing 33% of morphine SR 90 mg Q8h = 270 MEDD on day 1, what dose should be taken on day two of the rapid opioid tapering?",When,158,45 mg SR (15 mg x 3) Q8h,Specifications,1,1.0,"['When', 'reducing', '33', '%', 'of', 'morphine', 'SR', '90', 'mg', 'Q8h', '=', '270', 'MEDD', 'on', 'day', '1', ',', 'what', 'dose', 'should', 'be', 'taken', 'on', 'day', 'two', 'of', 'the', 'rapid', 'opioid', 'tapering', '?']","['45', 'mg', 'SR', '(', '15', 'mg', 'x', '3', ')', 'Q8h']",31,10
What may be considered after stopping rapid tapering after day 11?,What,159,morphine IR 15 mg ½ tablet (7.5 mg) twice daily,Specifications,1,1.0,"['What', 'may', 'be', 'considered', 'after', 'stopping', 'rapid', 'tapering', 'after', 'day', '11', '?']","['morphine', 'IR', '15', 'mg', '½', 'tablet', '(', '7.5', 'mg', ')', 'twice', 'daily']",12,12
"When reducing 33% of morphine SR 90 mg Q8h = 270 MEDD on day 1, what dose should be taken on day four of the rapid opioid tapering?",When,160,15 mg SR Q8h,Specifications,1,1.0,"['When', 'reducing', '33', '%', 'of', 'morphine', 'SR', '90', 'mg', 'Q8h', '=', '270', 'MEDD', 'on', 'day', '1', ',', 'what', 'dose', 'should', 'be', 'taken', 'on', 'day', 'four', 'of', 'the', 'rapid', 'opioid', 'tapering', '?']","['15', 'mg', 'SR', 'Q8h']",31,4
How long does the rapid taper take?,How,161,over days,Specifications,1,1.0,"['How', 'long', 'does', 'the', 'rapid', 'taper', 'take', '?']","['over', 'days']",8,2
When to administer Naloxone?,When,163,as a life saving measure following opioid overdose,Recommendations,0,0.6,"['When', 'to', 'administer', 'Naloxone', '?']","['as', 'a', 'life', 'saving', 'measure', 'following', 'opioid', 'overdose']",5,8
What has reduced opioid-related emergency department visits?,What,164,prescription of naloxone rescue and accompanying education,Recommendations,1,1.0,"['What', 'has', 'reduced', 'opioid', '-', 'related', 'emergency', 'department', 'visits', '?']","['prescription', 'of', 'naloxone', 'rescue', 'and', 'accompanying', 'education']",10,7
What is a life-saving measure following opioid overdose?,What,165,Naloxone administration,Recommendations,1,1.0,"['What', 'is', 'a', 'life', '-', 'saving', 'measure', 'following', 'opioid', 'overdose', '?']","['Naloxone', 'administration']",11,2
Who facilitates the distribution of naloxone for the reversal?,Who,168,the VA via Pharmacy Benefits Management,Recommendations,0,0.9090909090909091,"['Who', 'facilitates', 'the', 'distribution', 'of', 'naloxone', 'for', 'the', 'reversal', '?']","['the', 'VA', 'via', 'Pharmacy', 'Benefits', 'Management']",10,6
Who supports the distribution of naloxone for the reversal?,Who,169,"SAMHSA, the American Medical Association (AMA), and other medical societies",Recommendations,1,1.0,"['Who', 'supports', 'the', 'distribution', 'of', 'naloxone', 'for', 'the', 'reversal', '?']","['SAMHSA', ',', 'the', 'American', 'Medical', 'Association', '(', 'AMA', ')', ',', 'and', 'other', 'medical', 'societies']",10,14
What does the U.S. Department of Health and Human Services (HHS) National Pain Strategy  (March 2016) recommend?,What,171,a biopsychosocial approach to pain care that is multimodal and  interdisciplinary,Recommendations,1,1.0,"['What', 'does', 'the', 'U.S.', 'Department', 'of', 'Health', 'and', 'Human', 'Services', '(', 'HHS', ')', 'National', 'Pain', 'Strategy', ' ', '(', 'March', '2016', ')', 'recommend', '?']","['a', 'biopsychosocial', 'approach', 'to', 'pain', 'care', 'that', 'is', 'multimodal', 'and', ' ', 'interdisciplinary']",23,12
"What was the impact of the report on the state of pain research, treatment, and  education in the U.S. by the National Academy of Medicine in 2011?",What,172,The report called for a cultural transformation in the way pain is viewed and  treated.,Recommendations,1,1.0,"['What', 'was', 'the', 'impact', 'of', 'the', 'report', 'on', 'the', 'state', 'of', 'pain', 'research', ',', 'treatment', ',', 'and', ' ', 'education', 'in', 'the', 'U.S.', 'by', 'the', 'National', 'Academy', 'of', 'Medicine', 'in', '2011', '?']","['The', 'report', 'called', 'for', 'a', 'cultural', 'transformation', 'in', 'the', 'way', 'pain', 'is', 'viewed', 'and', ' ', 'treated', '.']",31,17
"Why did the National Academy of Medicine investigated and reported on the state of pain research, treatment, and  education in the U.S. in 2011?",Why,173,in response to the recognition of pain and its management as a public health problem,Recommendations,1,1.0,"['Why', 'did', 'the', 'National', 'Academy', 'of', 'Medicine', 'investigated', 'and', 'reported', 'on', 'the', 'state', 'of', 'pain', 'research', ',', 'treatment', ',', 'and', ' ', 'education', 'in', 'the', 'U.S.', 'in', '2011', '?']","['in', 'response', 'to', 'the', 'recognition', 'of', 'pain', 'and', 'its', 'management', 'as', 'a', 'public', 'health', 'problem']",28,15
Who does recommend a biopsychosocial approach to pain care that is multimodal and interdisciplinary?,Who,174,the U.S. Department of Health and Human Services (HHS) National Pain Strategy  (March 2016),Recommendations,0,0.9166666666666666,"['Who', 'does', 'recommend', 'a', 'biopsychosocial', 'approach', 'to', 'pain', 'care', 'that', 'is', 'multimodal', 'and', 'interdisciplinary', '?']","['the', 'U.S.', 'Department', 'of', 'Health', 'and', 'Human', 'Services', '(', 'HHS', ')', 'National', 'Pain', 'Strategy', ' ', '(', 'March', '2016', ')']",15,19
What are included in the underlying concepts of the biopsychosocial model of pain?,What,176,"pain perception and its effects on the patient’s function is mediated by multiple factors (e.g., mood, social  support, prior experience, biomechanical factors), not just biology alone",Recommendations,0,0.6842105263157895,"['What', 'are', 'included', 'in', 'the', 'underlying', 'concepts', 'of', 'the', 'biopsychosocial', 'model', 'of', 'pain', '?']","['pain', 'perception', 'and', 'its', 'effects', 'on', 'the', 'patient', '’s', 'function', 'is', 'mediated', 'by', 'multiple', 'factors', '(', 'e.g.', ',', 'mood', ',', 'social', ' ', 'support', ',', 'prior', 'experience', ',', 'biomechanical', 'factors', ')', ',', 'not', 'just', 'biology', 'alone']",14,35
What is recommended for patients currently on long-term opioid therapy with evidence of untreated substance use  disorder?,What,178,"close monitoring, including engagement in substance use disorder treatment, and discontinuation of opioid therapy for pain with appropriate tapering",Recommendations,1,1.0,"['What', 'is', 'recommended', 'for', 'patients', 'currently', 'on', 'long', '-', 'term', 'opioid', 'therapy', 'with', 'evidence', 'of', 'untreated', 'substance', 'use', ' ', 'disorder', '?']","['close', 'monitoring', ',', 'including', 'engagement', 'in', 'substance', 'use', 'disorder', 'treatment', ',', 'and', 'discontinuation', 'of', 'opioid', 'therapy', 'for', 'pain', 'with', 'appropriate', 'tapering']",21,21
What is the stance regarding long-term opioid therapy for pain in patients with untreated substance use disorder?,What,179,recommend against,Recommendations,1,1.0,"['What', 'is', 'the', 'stance', 'regarding', 'long', '-', 'term', 'opioid', 'therapy', 'for', 'pain', 'in', 'patients', 'with', 'untreated', 'substance', 'use', 'disorder', '?']","['recommend', 'against']",20,2
Which concerns need to be addressed at the time of opioid tapering?,Which,180,"concerns that may negatively impact taper (e.g., inability for adequate follow-up, inability to provide adequate treatment for co-occurring medical and mental health conditions and SUD)",Algorithm,0,0.3870967741935484,"['Which', 'concerns', 'need', 'to', 'be', 'addressed', 'at', 'the', 'time', 'of', 'opioid', 'tapering', '?']","['concerns', 'that', 'may', 'negatively', 'impact', 'taper', '(', 'e.g.', ',', 'inability', 'for', 'adequate', 'follow', '-', 'up', ',', 'inability', 'to', 'provide', 'adequate', 'treatment', 'for', 'co', '-', 'occurring', 'medical', 'and', 'mental', 'health', 'conditions', 'and', 'SUD', ')']",13,33
"When safety allows, what are the advantages of a gradual taper?",When,181,"a gradual taper rate (5-10% reduction every 4 weeks) allows time for neurobiological, psychological, and behavioral adaptations",Algorithm,0,0.6086956521739131,"['When', 'safety', 'allows', ',', 'what', 'are', 'the', 'advantages', 'of', 'a', 'gradual', 'taper', '?']","['a', 'gradual', 'taper', 'rate', '(', '5', '-', '10', '%', 'reduction', 'every', '4', 'weeks', ')', 'allows', 'time', 'for', 'neurobiological', ',', 'psychological', ',', 'and', 'behavioral', 'adaptations']",13,24
What is the rate of a gradual taper?,What,182,5-10% reduction every 4 weeks,Algorithm,1,1.0,"['What', 'is', 'the', 'rate', 'of', 'a', 'gradual', 'taper', '?']","['5', '-', '10', '%', 'reduction', 'every', '4', 'weeks']",9,8
What maybe included in interdisciplinary services?,What,183,"mental health, SUD, primary care, and specialty pain care",Algorithm,1,1.0,"['What', 'maybe', 'included', 'in', 'interdisciplinary', 'services', '?']","['mental', 'health', ',', 'SUD', ',', 'primary', 'care', ',', 'and', 'specialty', 'pain', 'care']",7,12
What does a gradual taper rate allow?,What,184,"time for neurobiological, psychological, and behavioral adaptations",Algorithm,1,1.0,"['What', 'does', 'a', 'gradual', 'taper', 'rate', 'allow', '?']","['time', 'for', 'neurobiological', ',', 'psychological', ',', 'and', 'behavioral', 'adaptations']",8,9
What to do when there are concerns regarding risks of tapering?,What,185,"consider interdisciplinary services that may include mental health, SUD, primary care, and specialty pain care",Algorithm,1,1.0,"['What', 'to', 'do', 'when', 'there', 'are', 'concerns', 'regarding', 'risks', 'of', 'tapering', '?']","['consider', 'interdisciplinary', 'services', 'that', 'may', 'include', 'mental', 'health', ',', 'SUD', ',', 'primary', 'care', ',', 'and', 'specialty', 'pain', 'care']",12,18
Which patient and treatment characteristics should be considered when determining tapering strategy?,Which,186,"opioid dose, duration of therapy, type of opioid formulation, psychiatric, medical and SUD comorbidities and other patient risk factors (e.g., non-adherence, high-risk medication-related behavior, strength of social support, and coping)",Algorithm,0,0.06451612903225806,"['Which', 'patient', 'and', 'treatment', 'characteristics', 'should', 'be', 'considered', 'when', 'determining', 'tapering', 'strategy', '?']","['opioid', 'dose', ',', 'duration', 'of', 'therapy', ',', 'type', 'of', 'opioid', 'formulation', ',', 'psychiatric', ',', 'medical', 'and', 'SUD', 'comorbidities', 'and', 'other', 'patient', 'risk', 'factors', '(', 'e.g.', ',', 'non', '-', 'adherence', ',', 'high', '-', 'risk', 'medication', '-', 'related', 'behavior', ',', 'strength', 'of', 'social', 'support', ',', 'and', 'coping', ')']",13,46
What are the risks associated with tapering?,What,187,"unmasked OUD, exacerbation of underlying mental health conditions",Algorithm,1,1.0,"['What', 'are', 'the', 'risks', 'associated', 'with', 'tapering', '?']","['unmasked', 'OUD', ',', 'exacerbation', 'of', 'underlying', 'mental', 'health', 'conditions']",8,9
What are some examples of concerns that may negatively impact taper?,What,188,"inability for adequate follow-up, inability to provide adequate treatment for co-occurring medical and mental health conditions and SUD",Algorithm,1,1.0,"['What', 'are', 'some', 'examples', 'of', 'concerns', 'that', 'may', 'negatively', 'impact', 'taper', '?']","['inability', 'for', 'adequate', 'follow', '-', 'up', ',', 'inability', 'to', 'provide', 'adequate', 'treatment', 'for', 'co', '-', 'occurring', 'medical', 'and', 'mental', 'health', 'conditions', 'and', 'SUD']",12,23
What does help mitigate the risk of suicide among patients on LOT?,What,192,intensification of monitoring,Recommendations,1,1.0,"['What', 'does', 'help', 'mitigate', 'the', 'risk', 'of', 'suicide', 'among', 'patients', 'on', 'LOT', '?']","['intensification', 'of', 'monitoring']",13,3
What were associated with decreased risk of suicide attempt?,What,194,patients on long-acting opioids within the facilities providing more follow-up after new prescriptions,Recommendations,0,0.4166666666666667,"['What', 'were', 'associated', 'with', 'decreased', 'risk', 'of', 'suicide', 'attempt', '?']","['patients', 'on', 'long', '-', 'acting', 'opioids', 'within', 'the', 'facilities', 'providing', 'more', 'follow', '-', 'up', 'after', 'new', 'prescriptions']",10,17
Which conditions significantly increase the risk of adverse outcomes from LOT?,Which,196,"Duration and dose of OT, Severe respiratory instability or sleep disordered breathing, Acute psychiatric instability or intermediate to high acute suicide risk, Mental health disorders, History of drug overdose, Under 30 years of age, Co-administration of a drug capable of inducing fatal drug-drug interactions, QTc interval >450 ms for using methadone, Evidence for or history of diversion of controlled substances, Intolerance, serious adverse effects, or a history of inadequate beneficial response to opioids, Impaired bowel motility unresponsive to therapy, Headache not responsive to other pain treatment modalities, Traumatic brain injury (TBI), True allergy to opioid agents",Background,0,0.021052631578947368,"['Which', 'conditions', 'significantly', 'increase', 'the', 'risk', 'of', 'adverse', 'outcomes', 'from', 'LOT', '?']","['Duration', 'and', 'dose', 'of', 'OT', ',', 'Severe', 'respiratory', 'instability', 'or', 'sleep', 'disordered', 'breathing', ',', 'Acute', 'psychiatric', 'instability', 'or', 'intermediate', 'to', 'high', 'acute', 'suicide', 'risk', ',', 'Mental', 'health', 'disorders', ',', 'History', 'of', 'drug', 'overdose', ',', 'Under', '30', 'years', 'of', 'age', ',', 'Co', '-', 'administration', 'of', 'a', 'drug', 'capable', 'of', 'inducing', 'fatal', 'drug', '-', 'drug', 'interactions', ',', 'QTc', 'interval', '>', '450', 'ms', 'for', 'using', 'methadone', ',', 'Evidence', 'for', 'or', 'history', 'of', 'diversion', 'of', 'controlled', 'substances', ',', 'Intolerance', ',', 'serious', 'adverse', 'effects', ',', 'or', 'a', 'history', 'of', 'inadequate', 'beneficial', 'response', 'to', 'opioids', ',', 'Impaired', 'bowel', 'motility', 'unresponsive', 'to', 'therapy', ',', 'Headache', 'not', 'responsive', 'to', 'other', 'pain', 'treatment', 'modalities', ',', 'Traumatic', 'brain', 'injury', '(', 'TBI', ')', ',', 'True', 'allergy', 'to', 'opioid', 'agents']",12,118
What to do after educating the patient?,What,197,"identify if there is presence of prescribed opioid dose>90 mg MEDD or combined sedating medication that increases risk of adverse events (e.g., benzodiazepine) or patient non-participation in a comprehensive pain care plan or other indications for tapering",Algorithm,0,0.05405405405405406,"['What', 'to', 'do', 'after', 'educating', 'the', 'patient', '?']","['identify', 'if', 'there', 'is', 'presence', 'of', 'prescribed', 'opioid', 'dose>90', 'mg', 'MEDD', 'or', 'combined', 'sedating', 'medication', 'that', 'increases', 'risk', 'of', 'adverse', 'events', '(', 'e.g.', ',', 'benzodiazepine', ')', 'or', 'patient', 'non', '-', 'participation', 'in', 'a', 'comprehensive', 'pain', 'care', 'plan', 'or', 'other', 'indications', 'for', 'tapering']",8,42
What to do if risks do not outweigh benefits of continuing OT?,What,198,"educate/re-educate on the following: non-opioid management, self-management to improve function and quality of life, realistic expectations and limitations of medical treatment options, preferred treatment methods being non-pharmacotherapy and non-opioid pharmacotherapy, new information on risks and lack of benefits of long-term OT",Algorithm,0,0.0,"['What', 'to', 'do', 'if', 'risks', 'do', 'not', 'outweigh', 'benefits', 'of', 'continuing', 'OT', '?']","['educate', '/', 're', '-', 'educate', 'on', 'the', 'following', ':', 'non', '-', 'opioid', 'management', ',', 'self', '-', 'management', 'to', 'improve', 'function', 'and', 'quality', 'of', 'life', ',', 'realistic', 'expectations', 'and', 'limitations', 'of', 'medical', 'treatment', 'options', ',', 'preferred', 'treatment', 'methods', 'being', 'non', '-', 'pharmacotherapy', 'and', 'non', '-', 'opioid', 'pharmacotherapy', ',', 'new', 'information', 'on', 'risks', 'and', 'lack', 'of', 'benefits', 'of', 'long', '-', 'term', 'OT']",13,60
What to do if the patient does not participate in a comprehensive pain care plan?,What,199,proceed to module C,Algorithm,1,1.0,"['What', 'to', 'do', 'if', 'the', 'patient', 'does', 'not', 'participate', 'in', 'a', 'comprehensive', 'pain', 'care', 'plan', '?']","['proceed', 'to', 'module', 'C']",16,4
What to do for patients currently on OT?,What,200,look for factors that would require immediate attention and possible discontinuation of OT due to unacceptable risk,Algorithm,1,1.0,"['What', 'to', 'do', 'for', 'patients', 'currently', 'on', 'OT', '?']","['look', 'for', 'factors', 'that', 'would', 'require', 'immediate', 'attention', 'and', 'possible', 'discontinuation', 'of', 'OT', 'due', 'to', 'unacceptable', 'risk']",9,17
What to do if there are no factors requiring immediate attention?,What,201,obtain a biopsychosocial assessment,Algorithm,1,1.0,"['What', 'to', 'do', 'if', 'there', 'are', 'no', 'factors', 'requiring', 'immediate', 'attention', '?']","['obtain', 'a', 'biopsychosocial', 'assessment']",12,4
What to do if prior medical records are not available for review?,What,202,address factors related to incomplete data prior to prescribing. Then review data and re-assess risks and benefits of continuing OT and consider strength and number of risk factors.,Algorithm,0,0.4864864864864865,"['What', 'to', 'do', 'if', 'prior', 'medical', 'records', 'are', 'not', 'available', 'for', 'review', '?']","['address', 'factors', 'related', 'to', 'incomplete', 'data', 'prior', 'to', 'prescribing', '.', 'Then', 'review', 'data', 'and', 're', '-', 'assess', 'risks', 'and', 'benefits', 'of', 'continuing', 'OT', 'and', 'consider', 'strength', 'and', 'number', 'of', 'risk', 'factors', '.']",13,32
What includes prior medical records?,What,203,"current prescriber, prior and current UDT, PDMP",Algorithm,1,1.0,"['What', 'includes', 'prior', 'medical', 'records', '?']","['current', 'prescriber', ',', 'prior', 'and', 'current', 'UDT', ',', 'PDMP']",6,9
What to do if the patient is prescribed opioid dose>90 mg MEDD?,What,204,proceed to module C,Algorithm,0,0.0,"['What', 'to', 'do', 'if', 'the', 'patient', 'is', 'prescribed', 'opioid', 'dose>90', 'mg', 'MEDD', '?']","['proceed', 'to', 'module', 'C']",13,4
What are non-opioid treatments for chronic pain?,What,205,physical and psychological treatments,Algorithm,1,1.0,"['What', 'are', 'non', '-', 'opioid', 'treatments', 'for', 'chronic', 'pain', '?']","['physical', 'and', 'psychological', 'treatments']",10,4
What to do if prior medical records are available for review?,What,206,review data and re-assess risks and benefits of continuing OT and consider strength and number of risk factors,Algorithm,1,1.0,"['What', 'to', 'do', 'if', 'prior', 'medical', 'records', 'are', 'available', 'for', 'review', '?']","['review', 'data', 'and', 're', '-', 'assess', 'risks', 'and', 'benefits', 'of', 'continuing', 'OT', 'and', 'consider', 'strength', 'and', 'number', 'of', 'risk', 'factors']",12,20
"What to do if there is presence of combined sedating medication that increases risk of adverse events (e.g., benzodiazepine)?",What,208,proceed to module C,Algorithm,1,1.0,"['What', 'to', 'do', 'if', 'there', 'is', 'presence', 'of', 'combined', 'sedating', 'medication', 'that', 'increases', 'risk', 'of', 'adverse', 'events', '(', 'e.g.', ',', 'benzodiazepine', ')', '?']","['proceed', 'to', 'module', 'C']",23,4
What to do if the patient is experiencing clear functional improvement with minimal risk?,What,209,"continue OT using the following approach: shortest duration, using lowest effective dose (recognizing that no dose is completely safe and overdose risk increases at doses > 20-50 mg MEDD), continual assessment of improvement in pain and functional status and adverse effects",Algorithm,0,0.05,"['What', 'to', 'do', 'if', 'the', 'patient', 'is', 'experiencing', 'clear', 'functional', 'improvement', 'with', 'minimal', 'risk', '?']","['continue', 'OT', 'using', 'the', 'following', 'approach', ':', 'shortest', 'duration', ',', 'using', 'lowest', 'effective', 'dose', '(', 'recognizing', 'that', 'no', 'dose', 'is', 'completely', 'safe', 'and', 'overdose', 'risk', 'increases', 'at', 'doses', '>', '20', '-', '50', 'mg', 'MEDD', ')', ',', 'continual', 'assessment', 'of', 'improvement', 'in', 'pain', 'and', 'functional', 'status', 'and', 'adverse', 'effects']",15,48
What to do if there is no presence of prescribed opioid dose>90 mg MEDD or combined sedating medication that increases risk of adverse events or patient non-participation in a comprehensive pain care plan or other indications for tapering? ,What,210,"reassess and optimize preferred non-opioid treatments for chronic pain (e.g., physical and psychological treatments) recognizing that the patient is willing to continue to engage in a comprehensive treatment plan including non-opioid treatments",Algorithm,0,0.0,"['What', 'to', 'do', 'if', 'there', 'is', 'no', 'presence', 'of', 'prescribed', 'opioid', 'dose>90', 'mg', 'MEDD', 'or', 'combined', 'sedating', 'medication', 'that', 'increases', 'risk', 'of', 'adverse', 'events', 'or', 'patient', 'non', '-', 'participation', 'in', 'a', 'comprehensive', 'pain', 'care', 'plan', 'or', 'other', 'indications', 'for', 'tapering', '?']","['reassess', 'and', 'optimize', 'preferred', 'non', '-', 'opioid', 'treatments', 'for', 'chronic', 'pain', '(', 'e.g.', ',', 'physical', 'and', 'psychological', 'treatments', ')', 'recognizing', 'that', 'the', 'patient', 'is', 'willing', 'to', 'continue', 'to', 'engage', 'in', 'a', 'comprehensive', 'treatment', 'plan', 'including', 'non', '-', 'opioid', 'treatments']",41,39
What to do if there are factors that would require immediate attention?,What,211,"admit/provide treatment to stabilize, including opioid tapering or SUD treatment as indicated",Algorithm,1,1.0,"['What', 'to', 'do', 'if', 'there', 'are', 'factors', 'that', 'would', 'require', 'immediate', 'attention', '?']","['admit', '/', 'provide', 'treatment', 'to', 'stabilize', ',', 'including', 'opioid', 'tapering', 'or', 'SUD', 'treatment', 'as', 'indicated']",13,15
What to do if risks outweigh benefits of continuing OT?,What,212,proceed to module C,Algorithm,1,1.0,"['What', 'to', 'do', 'if', 'risks', 'outweigh', 'benefits', 'of', 'continuing', 'OT', '?']","['proceed', 'to', 'module', 'C']",11,4
What is module D for?,What,213,patients currently on opioid therapy,Algorithm,1,1.0,"['What', 'is', 'module', 'D', 'for', '?']","['patients', 'currently', 'on', 'opioid', 'therapy']",6,5
What may be experienced by the patients with chronic pain?,What,214,"worsened quality of life, mental health, immune system function, physical function, sleep, employment  status, and impaired personal relationships",Background,1,1.0,"['What', 'may', 'be', 'experienced', 'by', 'the', 'patients', 'with', 'chronic', 'pain', '?']","['worsened', 'quality', 'of', 'life', ',', 'mental', 'health', ',', 'immune', 'system', 'function', ',', 'physical', 'function', ',', 'sleep', ',', 'employment', ' ', 'status', ',', 'and', 'impaired', 'personal', 'relationships']",11,25
What is reported more often by the patients with chronic pain than patients without chronic pain?,What,215,"psychological complaints (e.g.,  depression, anxiety, poor self-efficacy, poor general emotional functioning)",Background,1,1.0,"['What', 'is', 'reported', 'more', 'often', 'by', 'the', 'patients', 'with', 'chronic', 'pain', 'than', 'patients', 'without', 'chronic', 'pain', '?']","['psychological', 'complaints', '(', 'e.g.', ',', ' ', 'depression', ',', 'anxiety', ',', 'poor', 'self', '-', 'efficacy', ',', 'poor', 'general', 'emotional', 'functioning', ')']",17,20
What does a comprehensive pain assessment include?,What,216,a biopsychosocial interview and focused physical exam,Background,1,1.0,"['What', 'does', 'a', 'comprehensive', 'pain', 'assessment', 'include', '?']","['a', 'biopsychosocial', 'interview', 'and', 'focused', 'physical', 'exam']",8,7
Who report psychological complaints more often?,Who,217,Patients with chronic pain,Background,1,1.0,"['Who', 'report', 'psychological', 'complaints', 'more', 'often', '?']","['Patients', 'with', 'chronic', 'pain']",7,4
What are some examples of psychological complaints made by patients with chronic pain?,What,218,"depression, anxiety, poor self-efficacy, poor general emotional functioning",Background,1,1.0,"['What', 'are', 'some', 'examples', 'of', 'psychological', 'complaints', 'made', 'by', 'patients', 'with', 'chronic', 'pain', '?']","['depression', ',', 'anxiety', ',', 'poor', 'self', '-', 'efficacy', ',', 'poor', 'general', 'emotional', 'functioning']",14,13
What can be associated with pain severity and the presence of  psychiatric comorbidities?,What,219,"Worsening of some of these factors (e.g., quality of  life, change in employment status)",Background,1,1.0,"['What', 'can', 'be', 'associated', 'with', 'pain', 'severity', 'and', 'the', 'presence', 'of', ' ', 'psychiatric', 'comorbidities', '?']","['Worsening', 'of', 'some', 'of', 'these', 'factors', '(', 'e.g.', ',', 'quality', 'of', ' ', 'life', ',', 'change', 'in', 'employment', 'status', ')']",15,19
What are the elements of the biopsychosocial pain interview?,What,220,"a pain-related history, assessment of pertinent  medical and psychiatric comorbidities including personal and family history of SUD, functional status and  functional goals, coping strategies, and a variety of psychosocial factors such as the patient’s beliefs and  expectations about chronic pain and its treatment",Background,0,0.04878048780487806,"['What', 'are', 'the', 'elements', 'of', 'the', 'biopsychosocial', 'pain', 'interview', '?']","['a', 'pain', '-', 'related', 'history', ',', 'assessment', 'of', 'pertinent', ' ', 'medical', 'and', 'psychiatric', 'comorbidities', 'including', 'personal', 'and', 'family', 'history', 'of', 'SUD', ',', 'functional', 'status', 'and', ' ', 'functional', 'goals', ',', 'coping', 'strategies', ',', 'and', 'a', 'variety', 'of', 'psychosocial', 'factors', 'such', 'as', 'the', 'patient', '’s', 'beliefs', 'and', ' ', 'expectations', 'about', 'chronic', 'pain', 'and', 'its', 'treatment']",10,53
What are some examples of social and psychological consequences on account of chronic pain?,What,221,"decreased  ability to successfully maintain relationship and career roles and increased depression, fear, and anxiety as  a result of pain",Background,0,0.8823529411764706,"['What', 'are', 'some', 'examples', 'of', 'social', 'and', 'psychological', 'consequences', 'on', 'account', 'of', 'chronic', 'pain', '?']","['decreased', ' ', 'ability', 'to', 'successfully', 'maintain', 'relationship', 'and', 'career', 'roles', 'and', 'increased', 'depression', ',', 'fear', ',', 'and', 'anxiety', 'as', ' ', 'a', 'result', 'of', 'pain']",15,24
Where can the guidance on management of SUD be found?,Where,222,the VA/DoD SUD CPG,Recommendations,1,1.0,"['Where', 'can', 'the', 'guidance', 'on', 'management', 'of', 'SUD', 'be', 'found', '?']","['the', 'VA', '/', 'DoD', 'SUD', 'CPG']",11,6
When must special attention be given to ensure that the Veteran does not feel abandoned?,When,224,When a decision is made to taper,Specifications,1,1.0,"['When', 'must', 'special', 'attention', 'be', 'given', 'to', 'ensure', 'that', 'the', 'Veteran', 'does', 'not', 'feel', 'abandoned', '?']","['When', 'a', 'decision', 'is', 'made', 'to', 'taper']",16,7
What are Motivational Interviewing (MI) techniques used for?,What,225,to acknowledge the Veteran’s fears about tapering,Specifications,1,1.0,"['What', 'are', 'Motivational', 'Interviewing', '(', 'MI', ')', 'techniques', 'used', 'for', '?']","['to', 'acknowledge', 'the', 'Veteran', '’s', 'fears', 'about', 'tapering']",11,8
What is PHI?,What,226,Personal Health Inventory,Specifications,1,1.0,"['What', 'is', 'PHI', '?']","['Personal', 'Health', 'Inventory']",4,3
Who to include in the discussion?,Who,227,family members or other supporters,Specifications,1,1.0,"['Who', 'to', 'include', 'in', 'the', 'discussion', '?']","['family', 'members', 'or', 'other', 'supporters']",7,5
Which techniques to use to acknowledge the Veteran’s fears about tapering?,Which,228,Motivational Interviewing (MI),Specifications,1,1.0,"['Which', 'techniques', 'to', 'use', 'to', 'acknowledge', 'the', 'Veteran', '’s', 'fears', 'about', 'tapering', '?']","['Motivational', 'Interviewing', '(', 'MI', ')']",13,5
What should be done prior to any changes being made in opioid prescribing?,What,229,"a discussion should occur between the Veteran, family members/caregivers, and the provider either during a face-to-face appointment or on the telephone",Specifications,1,1.0,"['What', 'should', 'be', 'done', 'prior', 'to', 'any', 'changes', 'being', 'made', 'in', 'opioid', 'prescribing', '?']","['a', 'discussion', 'should', 'occur', 'between', 'the', 'Veteran', ',', 'family', 'members', '/', 'caregivers', ',', 'and', 'the', 'provider', 'either', 'during', 'a', 'face', '-', 'to', '-', 'face', 'appointment', 'or', 'on', 'the', 'telephone']",14,29
What strategies will help in the transition?,What,230,"discussion, asking about goals, educating the veteran",Specifications,1,1.0,"['What', 'strategies', 'will', 'help', 'in', 'the', 'transition', '?']","['discussion', ',', 'asking', 'about', 'goals', ',', 'educating', 'the', 'veteran']",8,9
What is included in the discussion?,What,232,"listening to the Veteran’s story, letting the Veteran know that you believe that their pain is real, using Motivational Interviewing (MI) techniques to acknowledge the Veteran’s fears about tapering",Specifications,0,0.0,"['What', 'is', 'included', 'in', 'the', 'discussion', '?']","['listening', 'to', 'the', 'Veteran', '’s', 'story', ',', 'letting', 'the', 'Veteran', 'know', 'that', 'you', 'believe', 'that', 'their', 'pain', 'is', 'real', ',', 'using', 'Motivational', 'Interviewing', '(', 'MI', ')', 'techniques', 'to', 'acknowledge', 'the', 'Veteran', '’s', 'fears', 'about', 'tapering']",7,35
What should not be the drawn-out life goals?,What,233,just being pain-free,Specifications,1,1.0,"['What', 'should', 'not', 'be', 'the', 'drawn', '-', 'out', 'life', 'goals', '?']","['just', 'being', 'pain', '-', 'free']",11,5
How to make sure that the veteran does not feel abandoned when a decision is made to taper?,How,234,special attention must be given to ensure that the Veteran does not feel abandoned,Specifications,0,0.5555555555555556,"['How', 'to', 'make', 'sure', 'that', 'the', 'veteran', 'does', 'not', 'feel', 'abandoned', 'when', 'a', 'decision', 'is', 'made', 'to', 'taper', '?']","['special', 'attention', 'must', 'be', 'given', 'to', 'ensure', 'that', 'the', 'Veteran', 'does', 'not', 'feel', 'abandoned']",19,14
What was the basis for the Clinical Practice Guideline for Management of Opioid Therapy for Chronic Pain published in 2010?,What,235,evidence reviewed through March 2009,Introduction,1,1.0,"['What', 'was', 'the', 'basis', 'for', 'the', 'Clinical', 'Practice', 'Guideline', 'for', 'Management', 'of', 'Opioid', 'Therapy', 'for', 'Chronic', 'Pain', 'published', 'in', '2010', '?']","['evidence', 'reviewed', 'through', 'March', '2009']",21,5
When was the Clinical Practice Guideline for Management of Opioid Therapy for Chronic Pain published?,When,237,2010,Introduction,1,1.0,"['When', 'was', 'the', 'Clinical', 'Practice', 'Guideline', 'for', 'Management', 'of', 'Opioid', 'Therapy', 'for', 'Chronic', 'Pain', 'published', '?']",['2010'],16,1
Who published the Clinical Practice Guideline for Management of Opioid Therapy for Chronic Pain (2010 OT CPG)?,Who,240,the VA and DoD,Introduction,1,1.0,"['Who', 'published', 'the', 'Clinical', 'Practice', 'Guideline', 'for', 'Management', 'of', 'Opioid', 'Therapy', 'for', 'Chronic', 'Pain', '(', '2010', 'OT', 'CPG', ')', '?']","['the', 'VA', 'and', 'DoD']",20,4
What does the National Drug Control Strategy advocate?,What,1,take back programs,Recommendations,0,0.6666666666666666,"['What', 'does', 'the', 'National', 'Drug', 'Control', 'Strategy', 'advocate', '?']","['take', 'back', 'programs']",9,3
What were the top five most common medications collected in a 2013 medication take back event in a Michigan community?,What,2,pain relievers,Recommendations,1,1.0,"['What', 'were', 'the', 'top', 'five', 'most', 'common', 'medications', 'collected', 'in', 'a', '2013', 'medication', 'take', 'back', 'event', 'in', 'a', 'Michigan', 'community', '?']","['pain', 'relievers']",21,2
Why has returning unused opioid medications been explored as a strategy to reduce the amount of opioids in  the community?,Why,3,it has been estimated that 70% of opioid prescriptions are left unused,Recommendations,0,0.9600000000000001,"['Why', 'has', 'returning', 'unused', 'opioid', 'medications', 'been', 'explored', 'as', 'a', 'strategy', 'to', 'reduce', 'the', 'amount', 'of', 'opioids', 'in', ' ', 'the', 'community', '?']","['it', 'has', 'been', 'estimated', 'that', '70', '%', 'of', 'opioid', 'prescriptions', 'are', 'left', 'unused']",22,13
Who does advocate take back programs as an effective tool?,Who,4,the National Drug Control Strategy,Recommendations,1,1.0,"['Who', 'does', 'advocate', 'take', 'back', 'programs', 'as', 'an', 'effective', 'tool', '?']","['the', 'National', 'Drug', 'Control', 'Strategy']",11,5
What has been explored as a strategy to reduce the amount of opioids in  the community?,What,5,Returning unused opioid medications,Recommendations,1,1.0,"['What', 'has', 'been', 'explored', 'as', 'a', 'strategy', 'to', 'reduce', 'the', 'amount', 'of', 'opioids', 'in', ' ', 'the', 'community', '?']","['Returning', 'unused', 'opioid', 'medications']",18,4
What is the ratio of opioid prescriptions that are left unused?,What,6,70%,Recommendations,1,1.0,"['What', 'is', 'the', 'ratio', 'of', 'opioid', 'prescriptions', 'that', 'are', 'left', 'unused', '?']","['70', '%']",12,2
What to consider for patients currently on long-term opioid therapy and benzodiazepines?,What,10,tapering one or both when risks exceed benefits and obtaining specialty consultation as appropriate,Recommendations,1,1.0,"['What', 'to', 'consider', 'for', 'patients', 'currently', 'on', 'long', '-', 'term', 'opioid', 'therapy', 'and', 'benzodiazepines', '?']","['tapering', 'one', 'or', 'both', 'when', 'risks', 'exceed', 'benefits', 'and', 'obtaining', 'specialty', 'consultation', 'as', 'appropriate']",15,14
What is the stance regarding the concurrent use of benzodiazepines and opioids?,What,11,recommend against,Recommendations,1,1.0,"['What', 'is', 'the', 'stance', 'regarding', 'the', 'concurrent', 'use', 'of', 'benzodiazepines', 'and', 'opioids', '?']","['recommend', 'against']",13,2
What should be approached with extreme caution and warrants specialty consultation?,What,12,The concomitant use of oral and transdermal opioids or oral and intrathecal pumps,Recommendations,1,1.0,"['What', 'should', 'be', 'approached', 'with', 'extreme', 'caution', 'and', 'warrants', 'specialty', 'consultation', '?']","['The', 'concomitant', 'use', 'of', 'oral', 'and', 'transdermal', 'opioids', 'or', 'oral', 'and', 'intrathecal', 'pumps']",12,13
What is recommended at least every 3 months?,What,13,evaluating benefits of continued opioid therapy and risk for opioid-related adverse events,Recommendations,1,1.0,"['What', 'is', 'recommended', 'at', 'least', 'every', '3', 'months', '?']","['evaluating', 'benefits', 'of', 'continued', 'opioid', 'therapy', 'and', 'risk', 'for', 'opioid', '-', 'related', 'adverse', 'events']",9,14
What risk is recommended to be evaluated at least every 3 months?,What,14,risk for opioid-related adverse events,Recommendations,1,1.0,"['What', 'risk', 'is', 'recommended', 'to', 'be', 'evaluated', 'at', 'least', 'every', '3', 'months', '?']","['risk', 'for', 'opioid', '-', 'related', 'adverse', 'events']",13,7
When is it recommended to evaluate benefits of continued opioid therapy and risk for opioid-related adverse events?,When,15,at least every three months,Recommendations,1,1.0,"['When', 'is', 'it', 'recommended', 'to', 'evaluate', 'benefits', 'of', 'continued', 'opioid', 'therapy', 'and', 'risk', 'for', 'opioid', '-', 'related', 'adverse', 'events', '?']","['at', 'least', 'every', 'three', 'months']",20,5
What kind of dose of opioids do not exist?,What,16,absolutely safe,Recommendations,1,1.0,"['What', 'kind', 'of', 'dose', 'of', 'opioids', 'do', 'not', 'exist', '?']","['absolutely', 'safe']",10,2
What benefits are recommended to be evaluated at least every 3 months?,What,18,benefits of continued opioid therapy,Recommendations,0,0.625,"['What', 'benefits', 'are', 'recommended', 'to', 'be', 'evaluated', 'at', 'least', 'every', '3', 'months', '?']","['benefits', 'of', 'continued', 'opioid', 'therapy']",13,5
What is recommended when considering initiating or continuing long-term opioid therapy?,What,20,assessing suicide risk and intervening when necessary,Recommendations,1,1.0,"['What', 'is', 'recommended', 'when', 'considering', 'initiating', 'or', 'continuing', 'long', '-', 'term', 'opioid', 'therapy', '?']","['assessing', 'suicide', 'risk', 'and', 'intervening', 'when', 'necessary']",14,7
When is assessing suicide risk and intervening recommended?,When,21,when considering initiating or continuing long-term opioid therapy,Recommendations,0,0.888888888888889,"['When', 'is', 'assessing', 'suicide', 'risk', 'and', 'intervening', 'recommended', '?']","['when', 'considering', 'initiating', 'or', 'continuing', 'long', '-', 'term', 'opioid', 'therapy']",9,10
What is the stance regarding the long-term opioid therapy for pain in patients with untreated substance use disorder?,What,22,recommend against,Recommendations,1,1.0,"['What', 'is', 'the', 'stance', 'regarding', 'the', 'long', '-', 'term', 'opioid', 'therapy', 'for', 'pain', 'in', 'patients', 'with', 'untreated', 'substance', 'use', 'disorder', '?']","['recommend', 'against']",21,2
What is recommended for patients currently on long-term opioid therapy with evidence of untreated substance use disorder?,What,23,"close monitoring, including engagement in substance use disorder treatment, and discontinuation of opioid therapy for pain with appropriate tapering",Recommendations,1,1.0,"['What', 'is', 'recommended', 'for', 'patients', 'currently', 'on', 'long', '-', 'term', 'opioid', 'therapy', 'with', 'evidence', 'of', 'untreated', 'substance', 'use', 'disorder', '?']","['close', 'monitoring', ',', 'including', 'engagement', 'in', 'substance', 'use', 'disorder', 'treatment', ',', 'and', 'discontinuation', 'of', 'opioid', 'therapy', 'for', 'pain', 'with', 'appropriate', 'tapering']",20,21
What is recommended for patients currently on long-term opioid therapy?,What,24,"ongoing risk mitigation strategies, assessment for opioid use disorder, and consideration for tapering when risks exceed benefits",Recommendations,1,1.0,"['What', 'is', 'recommended', 'for', 'patients', 'currently', 'on', 'long', '-', 'term', 'opioid', 'therapy', '?']","['ongoing', 'risk', 'mitigation', 'strategies', ',', 'assessment', 'for', 'opioid', 'use', 'disorder', ',', 'and', 'consideration', 'for', 'tapering', 'when', 'risks', 'exceed', 'benefits']",13,19
When may a consultation with an allergist be helpful?,When,25,When an opioid allergy is present and OT is being considered,Background,1,1.0,"['When', 'may', 'a', 'consultation', 'with', 'an', 'allergist', 'be', 'helpful', '?']","['When', 'an', 'opioid', 'allergy', 'is', 'present', 'and', 'OT', 'is', 'being', 'considered']",10,11
Why does Morphine frequently cause itching?,Why,26,Morphine causes a release of histamine,Background,0,0.7499999999999999,"['Why', 'does', 'Morphine', 'frequently', 'cause', 'itching', '?']","['Morphine', 'causes', 'a', 'release', 'of', 'histamine']",7,6
What to do when an opioid allergy is present and OT is being considered?,What,27,consultation with an allergist may be helpful,Background,1,1.0,"['What', 'to', 'do', 'when', 'an', 'opioid', 'allergy', 'is', 'present', 'and', 'OT', 'is', 'being', 'considered', '?']","['consultation', 'with', 'an', 'allergist', 'may', 'be', 'helpful']",15,7
What is an example of true allergy to opioid agents?,What,28,anaphylaxis,Background,1,1.0,"['What', 'is', 'an', 'example', 'of', 'true', 'allergy', 'to', 'opioid', 'agents', '?']",['anaphylaxis'],11,1
When to continue opioid therapy?,When,29,if there is clinically meaningful improvement in pain and function,Specifications,1,1.0,"['When', 'to', 'continue', 'opioid', 'therapy', '?']","['if', 'there', 'is', 'clinically', 'meaningful', 'improvement', 'in', 'pain', 'and', 'function']",6,10
What should be done before starting opioid therapy?,What,30,Establish treatment goals,Specifications,1,1.0,"['What', 'should', 'be', 'done', 'before', 'starting', 'opioid', 'therapy', '?']","['Establish', 'treatment', 'goals']",9,3
What is not first-line or routine therapy for chronic pain management?,What,31,Opioids,Specifications,1,1.0,"['What', 'is', 'not', 'first', '-', 'line', 'or', 'routine', 'therapy', 'for', 'chronic', 'pain', 'management', '?']",['Opioids'],14,1
What to discuss before starting the treatment?,What,32,"risks, benefits and responsibilities for managing therapy",Specifications,1,1.0,"['What', 'to', 'discuss', 'before', 'starting', 'the', 'treatment', '?']","['risks', ',', 'benefits', 'and', 'responsibilities', 'for', 'managing', 'therapy']",8,8
What should be done if an opioid thrapy is discontinued?,What,33,plan,Specifications,1,1.0,"['What', 'should', 'be', 'done', 'if', 'an', 'opioid', 'thrapy', 'is', 'discontinued', '?']",['plan'],11,1
What to discuss during the treatment?,What,34,"risks, benefits and responsibilities for managing therapy",Specifications,1,1.0,"['What', 'to', 'discuss', 'during', 'the', 'treatment', '?']","['risks', ',', 'benefits', 'and', 'responsibilities', 'for', 'managing', 'therapy']",7,8
Why is continuing LOT not recommended to “prevent suicide” in someone with chronic pain?,Why,35,an appropriate response if suicide risk is high or increases,Recommendations,0,0.9473684210526316,"['Why', 'is', 'continuing', 'LOT', 'not', 'recommended', 'to', '“', 'prevent', 'suicide', '”', 'in', 'someone', 'with', 'chronic', 'pain', '?']","['an', 'appropriate', 'response', 'if', 'suicide', 'risk', 'is', 'high', 'or', 'increases']",17,10
Who may threaten suicide when providers recommend discontinuation of opioids?,Who,36,"Some patients on LOT who suffer from chronic pain and co-occurring OUD, depression, and/or personality disorders",Recommendations,1,1.0,"['Who', 'may', 'threaten', 'suicide', 'when', 'providers', 'recommend', 'discontinuation', 'of', 'opioids', '?']","['Some', 'patients', 'on', 'LOT', 'who', 'suffer', 'from', 'chronic', 'pain', 'and', 'co', '-', 'occurring', 'OUD', ',', 'depression', ',', 'and/or', 'personality', 'disorders']",11,20
When is continuing LOT not recommended?,When,37,to “prevent suicide” in someone with chronic pain,Recommendations,0,0.0,"['When', 'is', 'continuing', 'LOT', 'not', 'recommended', '?']","['to', '“', 'prevent', 'suicide', '”', 'in', 'someone', 'with', 'chronic', 'pain']",7,10
What is not recommended as an appropriate response if suicide risk is high or increases?,What,38,continuing LOT to “prevent suicide” in someone with chronic pain,Recommendations,1,1.0,"['What', 'is', 'not', 'recommended', 'as', 'an', 'appropriate', 'response', 'if', 'suicide', 'risk', 'is', 'high', 'or', 'increases', '?']","['continuing', 'LOT', 'to', '“', 'prevent', 'suicide', '”', 'in', 'someone', 'with', 'chronic', 'pain']",16,12
What is essential to do when a patient becomes destabilized as a result of a medically appropriate decision to taper or cease LOT?,What,41,"involve behavioral health to assess, monitor, and treat",Recommendations,1,1.0,"['What', 'is', 'essential', 'to', 'do', 'when', 'a', 'patient', 'becomes', 'destabilized', 'as', 'a', 'result', 'of', 'a', 'medically', 'appropriate', 'decision', 'to', 'taper', 'or', 'cease', 'LOT', '?']","['involve', 'behavioral', 'health', 'to', 'assess', ',', 'monitor', ',', 'and', 'treat']",24,10
What is needed to identify strategies for safely managing patients at elevated risk of suicide who demand opioid medications or become further destabilized during tapering?,What,43,Further research,Recommendations,1,1.0,"['What', 'is', 'needed', 'to', 'identify', 'strategies', 'for', 'safely', 'managing', 'patients', 'at', 'elevated', 'risk', 'of', 'suicide', 'who', 'demand', 'opioid', 'medications', 'or', 'become', 'further', 'destabilized', 'during', 'tapering', '?']","['Further', 'research']",26,2
What needs to be better determined by researchers?,What,44,"the impact of systematic reductions in MEDD in terms of  pain relief, specific pain and medical conditions, overdose morbidity and mortality as well as potential  adverse outcomes (e.g., the incidence of associated OUD, infectious diseases related to intravenous drug  use disorder, and drug-related crime and diversion) and to determine whether/which conditions may be  appropriately treated with LOT",Recommendations,0,0.25396825396825395,"['What', 'needs', 'to', 'be', 'better', 'determined', 'by', 'researchers', '?']","['the', 'impact', 'of', 'systematic', 'reductions', 'in', 'MEDD', 'in', 'terms', 'of', ' ', 'pain', 'relief', ',', 'specific', 'pain', 'and', 'medical', 'conditions', ',', 'overdose', 'morbidity', 'and', 'mortality', 'as', 'well', 'as', 'potential', ' ', 'adverse', 'outcomes', '(', 'e.g.', ',', 'the', 'incidence', 'of', 'associated', 'OUD', ',', 'infectious', 'diseases', 'related', 'to', 'intravenous', 'drug', ' ', 'use', 'disorder', ',', 'and', 'drug', '-', 'related', 'crime', 'and', 'diversion', ')', 'and', 'to', 'determine', 'whether', '/', 'which', 'conditions', 'may', 'be', ' ', 'appropriately', 'treated', 'with', 'LOT']",9,72
What to do when Veteran feels supported and is adjusting to the dose reduction?,What,45,"continue the strategy of reducing to morphine SR 30 mg every 8 hours, follow up in 1 to 4 weeks to determine the next step in the taper",Specifications,1,1.0,"['What', 'to', 'do', 'when', 'Veteran', 'feels', 'supported', 'and', 'is', 'adjusting', 'to', 'the', 'dose', 'reduction', '?']","['continue', 'the', 'strategy', 'of', 'reducing', 'to', 'morphine', 'SR', '30', 'mg', 'every', '8', 'hours', ',', 'follow', 'up', 'in', '1', 'to', '4', 'weeks', 'to', 'determine', 'the', 'next', 'step', 'in', 'the', 'taper']",15,29
What to do when Veteran is safe?,What,46,remain at morphine SR 45 mg every 8 hours for 1 to 2 months then reassess,Specifications,1,1.0,"['What', 'to', 'do', 'when', 'Veteran', 'is', 'safe', '?']","['remain', 'at', 'morphine', 'SR', '45', 'mg', 'every', '8', 'hours', 'for', '1', 'to', '2', 'months', 'then', 'reassess']",8,16
What to do when Veteran is resisting further dose reductions?,What,47,explore the reason for the reluctance,Specifications,1,1.0,"['What', 'to', 'do', 'when', 'Veteran', 'is', 'resisting', 'further', 'dose', 'reductions', '?']","['explore', 'the', 'reason', 'for', 'the', 'reluctance']",11,6
What to do when Veteran strongly resists reduction?,What,48,request mental health support and consider the possibility of OUD,Specifications,1,1.0,"['What', 'to', 'do', 'when', 'Veteran', 'strongly', 'resists', 'reduction', '?']","['request', 'mental', 'health', 'support', 'and', 'consider', 'the', 'possibility', 'of', 'OUD']",9,10
What to do at each step in the taper?,What,50,"review the risk of the taper vs. the benefit of remaining at the current dose, and if necessary, adjust the speed of the taper according to the response of the Veteran",Specifications,0,0.6470588235294118,"['What', 'to', 'do', 'at', 'each', 'step', 'in', 'the', 'taper', '?']","['review', 'the', 'risk', 'of', 'the', 'taper', 'vs.', 'the', 'benefit', 'of', 'remaining', 'at', 'the', 'current', 'dose', ',', 'and', 'if', 'necessary', ',', 'adjust', 'the', 'speed', 'of', 'the', 'taper', 'according', 'to', 'the', 'response', 'of', 'the', 'Veteran']",10,33
What can be the reasons for the reluctance in further dose reductions?,What,51,"medical (increased pain), mental health (worsening depression, anxiety, etc.), and substance use disorder (SUD)/opioid use disorder (OUD)",Specifications,0,0.1111111111111111,"['What', 'can', 'be', 'the', 'reasons', 'for', 'the', 'reluctance', 'in', 'further', 'dose', 'reductions', '?']","['medical', '(', 'increased', 'pain', ')', ',', 'mental', 'health', '(', 'worsening', 'depression', ',', 'anxiety', ',', 'etc', '.', ')', ',', 'and', 'substance', 'use', 'disorder', '(', 'SUD)/opioid', 'use', 'disorder', '(', 'OUD', ')']",13,29
What to review at each step in the taper?,What,52,review the risk of the taper vs. the benefit of remaining at the current dose,Specifications,0,0.9523809523809523,"['What', 'to', 'review', 'at', 'each', 'step', 'in', 'the', 'taper', '?']","['review', 'the', 'risk', 'of', 'the', 'taper', 'vs.', 'the', 'benefit', 'of', 'remaining', 'at', 'the', 'current', 'dose']",10,15
How can a health care system use the CPG?,How,53,"to assure that its clinicians and patients have the resources available to compassionately, effectively, and safely evaluate and deliver LOT in a timely, culturally sensitive manner",Introduction,0,0.9787234042553191,"['How', 'can', 'a', 'health', 'care', 'system', 'use', 'the', 'CPG', '?']","['to', 'assure', 'that', 'its', 'clinicians', 'and', 'patients', 'have', 'the', 'resources', 'available', 'to', 'compassionately', ',', 'effectively', ',', 'and', 'safely', 'evaluate', 'and', 'deliver', 'LOT', 'in', 'a', 'timely', ',', 'culturally', 'sensitive', 'manner']",10,29
Who can use this guideline?,Who,54,general clinicians or specialists,Introduction,1,1.0,"['Who', 'can', 'use', 'this', 'guideline', '?']","['general', 'clinicians', 'or', 'specialists']",6,4
"When tapering is being considered, which section in the guideline can be used to assist in the development of a framework for guiding an individualized, informed discussion?",When,55,section on tapering and its accompanying appendix,Introduction,0,0.6,"['When', 'tapering', 'is', 'being', 'considered', ',', 'which', 'section', 'in', 'the', 'guideline', 'can', 'be', 'used', 'to', 'assist', 'in', 'the', 'development', 'of', 'a', 'framework', 'for', 'guiding', 'an', 'individualized', ',', 'informed', 'discussion', '?']","['section', 'on', 'tapering', 'and', 'its', 'accompanying', 'appendix']",30,7
What specific information can this guideline provide to guide a patient encounter?,What,56,looking up the dosing of a medication used less frequently or the meaning of the urine drug testing (UDT) result,Introduction,1,1.0,"['What', 'specific', 'information', 'can', 'this', 'guideline', 'provide', 'to', 'guide', 'a', 'patient', 'encounter', '?']","['looking', 'up', 'the', 'dosing', 'of', 'a', 'medication', 'used', 'less', 'frequently', 'or', 'the', 'meaning', 'of', 'the', 'urine', 'drug', 'testing', '(', 'UDT', ')', 'result']",13,22
How can it guide a patient encounter?,How,57,provide specific information,Introduction,0,0.0,"['How', 'can', 'it', 'guide', 'a', 'patient', 'encounter', '?']","['provide', 'specific', 'information']",8,3
How can patients examine the guideline?,How,58,to educate themselves and better understand their care,Introduction,1,1.0,"['How', 'can', 'patients', 'examine', 'the', 'guideline', '?']","['to', 'educate', 'themselves', 'and', 'better', 'understand', 'their', 'care']",7,8
When can this guideline be used?,When,59,to study and consider the latest information on opioid therapy (OT) and how and whether to incorporate that information or recommendations into their practice,Introduction,1,1.0,"['When', 'can', 'this', 'guideline', 'be', 'used', '?']","['to', 'study', 'and', 'consider', 'the', 'latest', 'information', 'on', 'opioid', 'therapy', '(', 'OT', ')', 'and', 'how', 'and', 'whether', 'to', 'incorporate', 'that', 'information', 'or', 'recommendations', 'into', 'their', 'practice']",7,26
What can be used to study and consider the latest information on opioid therapy (OT) by general clinicians or specialists?,What,60,This guideline,Introduction,1,1.0,"['What', 'can', 'be', 'used', 'to', 'study', 'and', 'consider', 'the', 'latest', 'information', 'on', 'opioid', 'therapy', '(', 'OT', ')', 'by', 'general', 'clinicians', 'or', 'specialists', '?']","['This', 'guideline']",23,2
What does implementing more extensive risk mitigation strategies entail?,What,61,an investment of resources,Recommendations,1,1.0,"['What', 'does', 'implementing', 'more', 'extensive', 'risk', 'mitigation', 'strategies', 'entail', '?']","['an', 'investment', 'of', 'resources']",10,4
Why may primary care providers require more time with patients?,Why,62,to allow for shared decision making and treatment planning,Recommendations,1,1.0,"['Why', 'may', 'primary', 'care', 'providers', 'require', 'more', 'time', 'with', 'patients', '?']","['to', 'allow', 'for', 'shared', 'decision', 'making', 'and', 'treatment', 'planning']",11,9
Who must follow VHA policy regarding education and signature informed consent when providing LOT for patients with non-cancer pain?,Who,63,VHA providers,Recommendations,1,1.0,"['Who', 'must', 'follow', 'VHA', 'policy', 'regarding', 'education', 'and', 'signature', 'informed', 'consent', 'when', 'providing', 'LOT', 'for', 'patients', 'with', 'non', '-', 'cancer', 'pain', '?']","['VHA', 'providers']",22,2
When must VHA providers follow VHA policy regarding education and signature informed consent?,When,64,when  providing LOT for patients with non-cancer pain,Recommendations,1,1.0,"['When', 'must', 'VHA', 'providers', 'follow', 'VHA', 'policy', 'regarding', 'education', 'and', 'signature', 'informed', 'consent', '?']","['when', ' ', 'providing', 'LOT', 'for', 'patients', 'with', 'non', '-', 'cancer', 'pain']",14,11
What must VHA providers follow when providing LOT for patients with non-cancer pain?,What,65,VHA policy regarding education and signature informed consent,Recommendations,1,1.0,"['What', 'must', 'VHA', 'providers', 'follow', 'when', 'providing', 'LOT', 'for', 'patients', 'with', 'non', '-', 'cancer', 'pain', '?']","['VHA', 'policy', 'regarding', 'education', 'and', 'signature', 'informed', 'consent']",16,8
What would happen if there were a more frequent follow-up of patients on LOT?,What,66,can affect access to care for all empaneled patients,Recommendations,1,1.0,"['What', 'would', 'happen', 'if', 'there', 'were', 'a', 'more', 'frequent', 'follow', '-', 'up', 'of', 'patients', 'on', 'LOT', '?']","['can', 'affect', 'access', 'to', 'care', 'for', 'all', 'empaneled', 'patients']",17,9
What should the clinicians do as part of the patient-centered care approach?,What,67,"review the patient’s history including previous treatment approaches, their results, and any other outcomes with the patient",Specifications,1,1.0,"['What', 'should', 'the', 'clinicians', 'do', 'as', 'part', 'of', 'the', 'patient', '-', 'centered', 'care', 'approach', '?']","['review', 'the', 'patient', '’s', 'history', 'including', 'previous', 'treatment', 'approaches', ',', 'their', 'results', ',', 'and', 'any', 'other', 'outcomes', 'with', 'the', 'patient']",15,20
What should the clinicians ask the patient?,What,68,about his or her willingness to accept a referral to an addiction or other behavioral health specialist when appropriate,Specifications,1,1.0,"['What', 'should', 'the', 'clinicians', 'ask', 'the', 'patient', '?']","['about', 'his', 'or', 'her', 'willingness', 'to', 'accept', 'a', 'referral', 'to', 'an', 'addiction', 'or', 'other', 'behavioral', 'health', 'specialist', 'when', 'appropriate']",8,19
Which patients may be at risk?,Which,69,"those with other risk factors for QTc prolongation, current or prior electrocardiograms (ECGs) with a prolonged QTc >450 ms, or a history of syncope",Background,0,0.9523809523809523,"['Which', 'patients', 'may', 'be', 'at', 'risk', '?']","['those', 'with', 'other', 'risk', 'factors', 'for', 'QTc', 'prolongation', ',', 'current', 'or', 'prior', 'electrocardiograms', '(', 'ECGs', ')', 'with', 'a', 'prolonged', 'QTc', '>', '450', 'ms', ',', 'or', 'a', 'history', 'of', 'syncope']",7,29
What is QTc interval?,What,70,the heart rate’s corrected time interval from the start of the Q wave to the end of the T wave,Background,1,1.0,"['What', 'is', 'QTc', 'interval', '?']","['the', 'heart', 'rate', '’s', 'corrected', 'time', 'interval', 'from', 'the', 'start', 'of', 'the', 'Q', 'wave', 'to', 'the', 'end', 'of', 'the', 'T', 'wave']",5,21
"Which opioid has unique pharmacodynamic properties that can prolong the QTc interval and precipitate torsades de pointes, a dangerous or fatal cardiac arrhythmia?",Which,71,methadone,Background,1,1.0,"['Which', 'opioid', 'has', 'unique', 'pharmacodynamic', 'properties', 'that', 'can', 'prolong', 'the', 'QTc', 'interval', 'and', 'precipitate', 'torsades', 'de', 'pointes', ',', 'a', 'dangerous', 'or', 'fatal', 'cardiac', 'arrhythmia', '?']",['methadone'],25,1
What unique properties does methadone have?,What,72,"unique pharmacodynamic properties that can prolong the QTc interval (the heart rate’s corrected time interval from the start of the Q wave to the end of the T wave) and precipitate torsades de pointes, a dangerous or fatal cardiac arrhythmia",Background,0,0.05882352941176471,"['What', 'unique', 'properties', 'does', 'methadone', 'have', '?']","['unique', 'pharmacodynamic', 'properties', 'that', 'can', 'prolong', 'the', 'QTc', 'interval', '(', 'the', 'heart', 'rate', '’s', 'corrected', 'time', 'interval', 'from', 'the', 'start', 'of', 'the', 'Q', 'wave', 'to', 'the', 'end', 'of', 'the', 'T', 'wave', ')', 'and', 'precipitate', 'torsades', 'de', 'pointes', ',', 'a', 'dangerous', 'or', 'fatal', 'cardiac', 'arrhythmia']",7,44
Why are ECGs highly advised before and after initiating methadone?,Why,73,"Patients who may be at risk include those with other risk factors for QTc prolongation, current or prior electrocardiograms (ECGs) with a prolonged QTc >450 ms, or a history of syncope.",Background,0,0.0,"['Why', 'are', 'ECGs', 'highly', 'advised', 'before', 'and', 'after', 'initiating', 'methadone', '?']","['Patients', 'who', 'may', 'be', 'at', 'risk', 'include', 'those', 'with', 'other', 'risk', 'factors', 'for', 'QTc', 'prolongation', ',', 'current', 'or', 'prior', 'electrocardiograms', '(', 'ECGs', ')', 'with', 'a', 'prolonged', 'QTc', '>', '450', 'ms', ',', 'or', 'a', 'history', 'of', 'syncope', '.']",11,37
Which one is a dangerous or fatal cardiac arrhythmia?,Which,74,torsades de pointes,Background,1,1.0,"['Which', 'one', 'is', 'a', 'dangerous', 'or', 'fatal', 'cardiac', 'arrhythmia', '?']","['torsades', 'de', 'pointes']",10,3
What is torsades de pointes?,What,75,a dangerous or fatal cardiac arrhythmia,Background,1,1.0,"['What', 'is', 'torsades', 'de', 'pointes', '?']","['a', 'dangerous', 'or', 'fatal', 'cardiac', 'arrhythmia']",6,6
What is the strength of this CPG?,What,76,"the multidisciplinary stakeholder involvement from its inception,  ensuring representation from the broad spectrum of clinicians engaged in the treatment and management  of patients with chronic pain on or being considered for LOT",Specifications,0,0.3043478260869565,"['What', 'is', 'the', 'strength', 'of', 'this', 'CPG', '?']","['the', 'multidisciplinary', 'stakeholder', 'involvement', 'from', 'its', 'inception', ',', ' ', 'ensuring', 'representation', 'from', 'the', 'broad', 'spectrum', 'of', 'clinicians', 'engaged', 'in', 'the', 'treatment', 'and', 'management', ' ', 'of', 'patients', 'with', 'chronic', 'pain', 'on', 'or', 'being', 'considered', 'for', 'LOT']",8,35
What does the 2017 version of the VA/DoD OT CPG provide?,What,77,practice  recommendations for the care of populations with chronic pain already on or being considered for LOT,Specifications,1,1.0,"['What', 'does', 'the', '2017', 'version', 'of', 'the', 'VA', '/', 'DoD', 'OT', 'CPG', 'provide', '?']","['practice', ' ', 'recommendations', 'for', 'the', 'care', 'of', 'populations', 'with', 'chronic', 'pain', 'already', 'on', 'or', 'being', 'considered', 'for', 'LOT']",14,18
What is the scope of this CPG?,What,78,to  focus on the use of opioids for chronic pain rather than being comprehensive about all treatment options,Specifications,0,0.9696969696969697,"['What', 'is', 'the', 'scope', 'of', 'this', 'CPG', '?']","['to', ' ', 'focus', 'on', 'the', 'use', 'of', 'opioids', 'for', 'chronic', 'pain', 'rather', 'than', 'being', 'comprehensive', 'about', 'all', 'treatment', 'options']",8,19
What can be difficult to distinguish from the underlying mechanism of illness?,What,79,Many different physical and psychological conditions have a pain component,Background,1,1.0,"['What', 'can', 'be', 'difficult', 'to', 'distinguish', 'from', 'the', 'underlying', 'mechanism', 'of', 'illness', '?']","['Many', 'different', 'physical', 'and', 'psychological', 'conditions', 'have', 'a', 'pain', 'component']",13,10
Who may have different needs or respond to treatment differently than individuals with chronic pain alone?,Who,80,Individuals with conditions that result in or co-occur with chronic pain,Background,1,1.0,"['Who', 'may', 'have', 'different', 'needs', 'or', 'respond', 'to', 'treatment', 'differently', 'than', 'individuals', 'with', 'chronic', 'pain', 'alone', '?']","['Individuals', 'with', 'conditions', 'that', 'result', 'in', 'or', 'co', '-', 'occur', 'with', 'chronic', 'pain']",17,13
What should be arranged for patients with OUD?,What,82,MAT (Medication-Assisted Treatment),Specifications,0,0.5,"['What', 'should', 'be', 'arranged', 'for', 'patients', 'with', 'OUD', '?']","['MAT', '(', 'Medication', '-', 'Assisted', 'Treatment', ')']",9,7
How often the prescription drug monitoring program data need to be reviewed?,How,83,at least every 3 months,Specifications,1,1.0,"['How', 'often', 'the', 'prescription', 'drug', 'monitoring', 'program', 'data', 'need', 'to', 'be', 'reviewed', '?']","['at', 'least', 'every', '3', 'months']",13,5
What should not be prescribed concurrently when possible?,What,84,opioid and benzodiazepines,Specifications,1,1.0,"['What', 'should', 'not', 'be', 'prescribed', 'concurrently', 'when', 'possible', '?']","['opioid', 'and', 'benzodiazepines']",9,3
How often the urine drug testing needs to be performed?,How,85,at least annually,Specifications,1,1.0,"['How', 'often', 'the', 'urine', 'drug', 'testing', 'needs', 'to', 'be', 'performed', '?']","['at', 'least', 'annually']",11,3
Who should be offered medication-assisted treatment?,Who,86,patients with OUD (Opioid Use Disorder),Specifications,1,1.0,"['Who', 'should', 'be', 'offered', 'medication', '-', 'assisted', 'treatment', '?']","['patients', 'with', 'OUD', '(', 'Opioid', 'Use', 'Disorder', ')']",9,8
What should be offered for patients with OUD?,What,87,MAT (Medication-Assisted Treatment),Specifications,1,1.0,"['What', 'should', 'be', 'offered', 'for', 'patients', 'with', 'OUD', '?']","['MAT', '(', 'Medication', '-', 'Assisted', 'Treatment', ')']",9,7
How often the PDMP data need to be reviewed?,How,88,at least every 3 months,Specifications,1,1.0,"['How', 'often', 'the', 'PDMP', 'data', 'need', 'to', 'be', 'reviewed', '?']","['at', 'least', 'every', '3', 'months']",10,5
What should be offered for patients with opioid use disorder?,What,89,MAT (Medication-Assisted Treatment),Specifications,0,0.5,"['What', 'should', 'be', 'offered', 'for', 'patients', 'with', 'opioid', 'use', 'disorder', '?']","['MAT', '(', 'Medication', '-', 'Assisted', 'Treatment', ')']",11,7
Who should be offered MAT?,Who,90,patients with OUD (Opioid Use Disorder),Specifications,1,1.0,"['Who', 'should', 'be', 'offered', 'MAT', '?']","['patients', 'with', 'OUD', '(', 'Opioid', 'Use', 'Disorder', ')']",6,8
How often the UDT needs to be performed?,How,91,at least annually,Specifications,1,1.0,"['How', 'often', 'the', 'UDT', 'needs', 'to', 'be', 'performed', '?']","['at', 'least', 'annually']",9,3
"What does carry a significant risk for OUD, overdose, and death, especially among patients with untreated  SUD?",What,93,Opioids,Recommendations,1,1.0,"['What', 'does', 'carry', 'a', 'significant', 'risk', 'for', 'OUD', ',', 'overdose', ',', 'and', 'death', ',', 'especially', 'among', 'patients', 'with', 'untreated', ' ', 'SUD', '?']",['Opioids'],22,1
What is suggested to be used when opioids are used for acute pain?,What,96,multimodal pain care including non-opioid medications as indicated,Recommendations,0,0.888888888888889,"['What', 'is', 'suggested', 'to', 'be', 'used', 'when', 'opioids', 'are', 'used', 'for', 'acute', 'pain', '?']","['multimodal', 'pain', 'care', 'including', 'non', '-', 'opioid', 'medications', 'as', 'indicated']",14,10
When is it suggested to use multimodal pain care including non-opioid medications as indicated?,When,98,when opioids are used for acute pain,Recommendations,1,1.0,"['When', 'is', 'it', 'suggested', 'to', 'use', 'multimodal', 'pain', 'care', 'including', 'non', '-', 'opioid', 'medications', 'as', 'indicated', '?']","['when', 'opioids', 'are', 'used', 'for', 'acute', 'pain']",17,7
What should be offered to patients?,What,99,education about opioid risks and alternatives to opioid therapy,Recommendations,0,0.9473684210526316,"['What', 'should', 'be', 'offered', 'to', 'patients', '?']","['education', 'about', 'opioid', 'risks', 'and', 'alternatives', 'to', 'opioid', 'therapy']",7,9
What is recommended if take-home opioids are prescribed?,What,101,immediate-release opioids are used at the lowest effective dose with opioid therapy reassessment no later than 3-5 days to determine if adjustments or continuing opioid therapy is indicated,Recommendations,0,0.07142857142857142,"['What', 'is', 'recommended', 'if', 'take', '-', 'home', 'opioids', 'are', 'prescribed', '?']","['immediate', '-', 'release', 'opioids', 'are', 'used', 'at', 'the', 'lowest', 'effective', 'dose', 'with', 'opioid', 'therapy', 'reassessment', 'no', 'later', 'than', '3', '-', '5', 'days', 'to', 'determine', 'if', 'adjustments', 'or', 'continuing', 'opioid', 'therapy', 'is', 'indicated']",11,32
What is recommended for mild-to-moderate acute pain?,What,102,alternatives to opioids,Recommendations,1,1.0,"['What', 'is', 'recommended', 'for', 'mild', '-', 'to', '-', 'moderate', 'acute', 'pain', '?']","['alternatives', 'to', 'opioids']",12,3
What does VA/DoD Suicide CPG refer to?,What,105,VA/DoD Clinical Practice Guideline for the Assessment and Management of Patients at Risk for Suicide,Algorithm,1,1.0,"['What', 'does', 'VA', '/', 'DoD', 'Suicide', 'CPG', 'refer', 'to', '?']","['VA', '/', 'DoD', 'Clinical', 'Practice', 'Guideline', 'for', 'the', 'Assessment', 'and', 'Management', 'of', 'Patients', 'at', 'Risk', 'for', 'Suicide']",10,17
What are psychological factors?,What,106,"beliefs, expectations, fears",Algorithm,1,1.0,"['What', 'are', 'psychological', 'factors', '?']","['beliefs', ',', 'expectations', ',', 'fears']",5,5
What does PDMP mean?,What,107,Prescription Drug Monitoring Program,Algorithm,1,1.0,"['What', 'does', 'PDMP', 'mean', '?']","['Prescription', 'Drug', 'Monitoring', 'Program']",5,4
What is LOT?,What,108,long-term opioid therapy,Algorithm,1,1.0,"['What', 'is', 'LOT', '?']","['long', '-', 'term', 'opioid', 'therapy']",4,5
What to assess for patients already on OT?,What,109,psychological factors related to continuing vs. tapering OT,Algorithm,1,1.0,"['What', 'to', 'assess', 'for', 'patients', 'already', 'on', 'OT', '?']","['psychological', 'factors', 'related', 'to', 'continuing', 'vs.', 'tapering', 'OT']",9,8
What does pain assessment include?,What,110,"history, physical exam, comorbidities, previous treatment and medications, duration of symptoms, onset and triggers",Algorithm,1,1.0,"['What', 'does', 'pain', 'assessment', 'include', '?']","['history', ',', 'physical', 'exam', ',', 'comorbidities', ',', 'previous', 'treatment', 'and', 'medications', ',', 'duration', 'of', 'symptoms', ',', 'onset', 'and', 'triggers']",6,19
What are some examples of absolute contraindications to initiating opioid therapy for chronic pain?,What,111,"true life-threatening allergy to opioids, active SUD, elevated suicide risk, concomitant use of benzodiazepines",Algorithm,1,1.0,"['What', 'are', 'some', 'examples', 'of', 'absolute', 'contraindications', 'to', 'initiating', 'opioid', 'therapy', 'for', 'chronic', 'pain', '?']","['true', 'life', '-', 'threatening', 'allergy', 'to', 'opioids', ',', 'active', 'SUD', ',', 'elevated', 'suicide', 'risk', ',', 'concomitant', 'use', 'of', 'benzodiazepines']",15,19
What are the components of biopsychosocial assessment?,What,112,"pain assessment, patient functional goals, impact of pain on family, work, life, review of previous diagnostic studies, additional consultations and referrals, coexisting illness and treatments and effect on pain, significant psychological, social, or behavioral factors that may affect treatment, family history of chronic pain, collateral of family involvement, patient beliefs/knowledge of the cause of their pain and their treatment preferences along with the perceived efficacy of various treatment options",Algorithm,0,0.029411764705882353,"['What', 'are', 'the', 'components', 'of', 'biopsychosocial', 'assessment', '?']","['pain', 'assessment', ',', 'patient', 'functional', 'goals', ',', 'impact', 'of', 'pain', 'on', 'family', ',', 'work', ',', 'life', ',', 'review', 'of', 'previous', 'diagnostic', 'studies', ',', 'additional', 'consultations', 'and', 'referrals', ',', 'coexisting', 'illness', 'and', 'treatments', 'and', 'effect', 'on', 'pain', ',', 'significant', 'psychological', ',', 'social', ',', 'or', 'behavioral', 'factors', 'that', 'may', 'affect', 'treatment', ',', 'family', 'history', 'of', 'chronic', 'pain', ',', 'collateral', 'of', 'family', 'involvement', ',', 'patient', 'beliefs', '/', 'knowledge', 'of', 'the', 'cause', 'of', 'their', 'pain', 'and', 'their', 'treatment', 'preferences', 'along', 'with', 'the', 'perceived', 'efficacy', 'of', 'various', 'treatment', 'options']",8,84
What does it mean by SUD?,What,113,substance use disorder,Algorithm,1,1.0,"['What', 'does', 'it', 'mean', 'by', 'SUD', '?']","['substance', 'use', 'disorder']",7,3
What is OT?,What,114,opioid therapy,Algorithm,1,1.0,"['What', 'is', 'OT', '?']","['opioid', 'therapy']",4,2
What does UDT refer to?,What,115,urine drug test,Algorithm,1,1.0,"['What', 'does', 'UDT', 'refer', 'to', '?']","['urine', 'drug', 'test']",6,3
What is SAMHSA?,What,116,Substance Abuse and Mental Health Services  Administration,Background,1,1.0,"['What', 'is', 'SAMHSA', '?']","['Substance', 'Abuse', 'and', 'Mental', 'Health', 'Services', ' ', 'Administration']",4,8
What does the OSI requirements include?,What,117,"specific  indicators (e.g., the number of unique pharmacy patients dispensed an opioid, the unique patients on LOT who have received UDT)",Background,1,1.0,"['What', 'does', 'the', 'OSI', 'requirements', 'include', '?']","['specific', ' ', 'indicators', '(', 'e.g.', ',', 'the', 'number', 'of', 'unique', 'pharmacy', 'patients', 'dispensed', 'an', 'opioid', ',', 'the', 'unique', 'patients', 'on', 'LOT', 'who', 'have', 'received', 'UDT', ')']",7,26
When did VA deploy the Opioid Safety Initiative requirements to all Veterans Integrated Service Networks?,When,118,August 2013,Background,1,1.0,"['When', 'did', 'VA', 'deploy', 'the', 'Opioid', 'Safety', 'Initiative', 'requirements', 'to', 'all', 'Veterans', 'Integrated', 'Service', 'Networks', '?']","['August', '2013']",16,2
What does the OSI use to identify providers whose prescribing practices do not  reflect best evidence so that patient care can be improved?,What,119,Veterans Health Administration (VHA’s) electronic health record,Background,1,1.0,"['What', 'does', 'the', 'OSI', 'use', 'to', 'identify', 'providers', 'whose', 'prescribing', 'practices', 'do', 'not', ' ', 'reflect', 'best', 'evidence', 'so', 'that', 'patient', 'care', 'can', 'be', 'improved', '?']","['Veterans', 'Health', 'Administration', '(', 'VHA', '’s', ')', 'electronic', 'health', 'record']",25,10
Why does the OSI use Veterans Health Administration (VHA’s) electronic health record?,Why,120,to identify patients who may be  high-risk for adverse outcomes with use of opioids and providers whose prescribing practices do not  reflect best evidence so that patient care can be improved,Background,0,0.0625,"['Why', 'does', 'the', 'OSI', 'use', 'Veterans', 'Health', 'Administration', '(', 'VHA', '’s', ')', 'electronic', 'health', 'record', '?']","['to', 'identify', 'patients', 'who', 'may', 'be', ' ', 'high', '-', 'risk', 'for', 'adverse', 'outcomes', 'with', 'use', 'of', 'opioids', 'and', 'providers', 'whose', 'prescribing', 'practices', 'do', 'not', ' ', 'reflect', 'best', 'evidence', 'so', 'that', 'patient', 'care', 'can', 'be', 'improved']",16,35
What was launched by the VA as part of the OSI?,What,121,the Opioid Overdose Education and  Naloxone Distribution (OEND) program,Background,1,1.0,"['What', 'was', 'launched', 'by', 'the', 'VA', 'as', 'part', 'of', 'the', 'OSI', '?']","['the', 'Opioid', 'Overdose', 'Education', 'and', ' ', 'Naloxone', 'Distribution', '(', 'OEND', ')', 'program']",12,12
What was the aim of the Opioid Safety Initiative?,What,122,"ensuring opioids are used in a safe, effective, and judicious manner.",Background,1,1.0,"['What', 'was', 'the', 'aim', 'of', 'the', 'Opioid', 'Safety', 'Initiative', '?']","['ensuring', 'opioids', 'are', 'used', 'in', 'a', 'safe', ',', 'effective', ',', 'and', 'judicious', 'manner', '.']",10,14
What are the components of the OEND program?,What,123,"education and training  regarding the following topics: opioid overdose prevention, recognition, and rescue response; risk  mitigation strategies; and issuing naloxone kits, which can be used as an antidote to opioid  overdose",Background,0,0.06666666666666667,"['What', 'are', 'the', 'components', 'of', 'the', 'OEND', 'program', '?']","['education', 'and', 'training', ' ', 'regarding', 'the', 'following', 'topics', ':', 'opioid', 'overdose', 'prevention', ',', 'recognition', ',', 'and', 'rescue', 'response', ';', 'risk', ' ', 'mitigation', 'strategies', ';', 'and', 'issuing', 'naloxone', 'kits', ',', 'which', 'can', 'be', 'used', 'as', 'an', 'antidote', 'to', 'opioid', ' ', 'overdose']",9,40
What was the purpose of the OEND program?,What,124,implemented as a risk mitigation strategy aimed at  reducing deaths from opioid overdose,Background,0,0.2222222222222222,"['What', 'was', 'the', 'purpose', 'of', 'the', 'OEND', 'program', '?']","['implemented', 'as', 'a', 'risk', 'mitigation', 'strategy', 'aimed', 'at', ' ', 'reducing', 'deaths', 'from', 'opioid', 'overdose']",9,14
What does the OSI use to identify patients who may be  high-risk for adverse outcomes with use of opioids?,What,125,Veterans Health Administration (VHA’s) electronic health record,Background,1,1.0,"['What', 'does', 'the', 'OSI', 'use', 'to', 'identify', 'patients', 'who', 'may', 'be', ' ', 'high', '-', 'risk', 'for', 'adverse', 'outcomes', 'with', 'use', 'of', 'opioids', '?']","['Veterans', 'Health', 'Administration', '(', 'VHA', '’s', ')', 'electronic', 'health', 'record']",23,10
Which government agencies launched initiatives to improve the study and treatment of pain and  adverse events associated with opioid analgesics?,Which,126,"VA, DoD, and Substance Abuse and Mental Health Services  Administration (SAMHSA)",Background,1,1.0,"['Which', 'government', 'agencies', 'launched', 'initiatives', 'to', 'improve', 'the', 'study', 'and', 'treatment', 'of', 'pain', 'and', ' ', 'adverse', 'events', 'associated', 'with', 'opioid', 'analgesics', '?']","['VA', ',', 'DoD', ',', 'and', 'Substance', 'Abuse', 'and', 'Mental', 'Health', 'Services', ' ', 'Administration', '(', 'SAMHSA', ')']",22,16
What is VISNs?,What,127,Veterans Integrated Service Networks,Background,1,1.0,"['What', 'is', 'VISNs', '?']","['Veterans', 'Integrated', 'Service', 'Networks']",4,4
What is OSI?,What,128,Opioid Safety Initiative,Background,1,1.0,"['What', 'is', 'OSI', '?']","['Opioid', 'Safety', 'Initiative']",4,3
What is recommended upon initiation of long-term opioid therapy?,What,130,implementing risk mitigation strategies,Recommendations,1,1.0,"['What', 'is', 'recommended', 'upon', 'initiation', 'of', 'long', '-', 'term', 'opioid', 'therapy', '?']","['implementing', 'risk', 'mitigation', 'strategies']",12,4
What should be commensurate with risk factors?,What,131,The strategies and their frequency,Recommendations,1,1.0,"['What', 'should', 'be', 'commensurate', 'with', 'risk', 'factors', '?']","['The', 'strategies', 'and', 'their', 'frequency']",8,5
How to implement the risk mitigation strategies upon initiation of long-term opioid therapy?,How,132,starting with an informed consent conversation covering the risks and benefits of opioid therapy as well as alternative therapies,Recommendations,1,1.0,"['How', 'to', 'implement', 'the', 'risk', 'mitigation', 'strategies', 'upon', 'initiation', 'of', 'long', '-', 'term', 'opioid', 'therapy', '?']","['starting', 'with', 'an', 'informed', 'consent', 'conversation', 'covering', 'the', 'risks', 'and', 'benefits', 'of', 'opioid', 'therapy', 'as', 'well', 'as', 'alternative', 'therapies']",16,19
What are included in the strategies and their frequency?,What,133,"ongoing, random urine drug testing (including appropriate confirmatory testing), checking state prescription drug monitoring programs, monitoring for overdose potential and suicidality, providing overdose education, prescribing of naloxone rescue and accompanying education",Recommendations,0,0.0625,"['What', 'are', 'included', 'in', 'the', 'strategies', 'and', 'their', 'frequency', '?']","['ongoing', ',', 'random', 'urine', 'drug', 'testing', '(', 'including', 'appropriate', 'confirmatory', 'testing', ')', ',', 'checking', 'state', 'prescription', 'drug', 'monitoring', 'programs', ',', 'monitoring', 'for', 'overdose', 'potential', 'and', 'suicidality', ',', 'providing', 'overdose', 'education', ',', 'prescribing', 'of', 'naloxone', 'rescue', 'and', 'accompanying', 'education']",10,38
Which opioid risk mitigation strategies should be incorporateed into opioid prescribing for acute pain?,Which,134,"patient education, use of non-opioid adjunctive therapy, and  structured reassessment of opioid risks and benefits for all on acute OT. Also, consider checking the PDMP and performing a UDT.  ",Recommendations,0,0.851063829787234,"['Which', 'opioid', 'risk', 'mitigation', 'strategies', 'should', 'be', 'incorporateed', 'into', 'opioid', 'prescribing', 'for', 'acute', 'pain', '?']","['patient', 'education', ',', 'use', 'of', 'non', '-', 'opioid', 'adjunctive', 'therapy', ',', 'and', ' ', 'structured', 'reassessment', 'of', 'opioid', 'risks', 'and', 'benefits', 'for', 'all', 'on', 'acute', 'OT', '.', 'Also', ',', 'consider', 'checking', 'the', 'PDMP', 'and', 'performing', 'a', 'UDT', '.', ' ']",15,38
How did OT increasingly become a mainstay for cancer and end-of-life pain?,How,135,As the hospice and palliative care  movement began defining end-of-life care in the U.S. during the 1980s and emphasizing the importance of  pain relief,Background,0,0.7499999999999999,"['How', 'did', 'OT', 'increasingly', 'become', 'a', 'mainstay', 'for', 'cancer', 'and', 'end', '-', 'of', '-', 'life', 'pain', '?']","['As', 'the', 'hospice', 'and', 'palliative', 'care', ' ', 'movement', 'began', 'defining', 'end', '-', 'of', '-', 'life', 'care', 'in', 'the', 'U.S.', 'during', 'the', '1980s', 'and', 'emphasizing', 'the', 'importance', 'of', ' ', 'pain', 'relief']",17,30
Which efforts led to an unprecedented increase in opioid prescribing for chronic non-terminal pain?,Which,136,Efforts to destigmatize the use of prescription opioids for chronic non-terminal pain,Background,1,1.0,"['Which', 'efforts', 'led', 'to', 'an', 'unprecedented', 'increase', 'in', 'opioid', 'prescribing', 'for', 'chronic', 'non', '-', 'terminal', 'pain', '?']","['Efforts', 'to', 'destigmatize', 'the', 'use', 'of', 'prescription', 'opioids', 'for', 'chronic', 'non', '-', 'terminal', 'pain']",17,14
When did chronic pain management became synonymous with LOT?,When,137,in the 1990s and the first decade of the 2000s,Background,0,0.923076923076923,"['When', 'did', 'chronic', 'pain', 'management', 'became', 'synonymous', 'with', 'LOT', '?']","['in', 'the', '1990s', 'and', 'the', 'first', 'decade', 'of', 'the', '2000s']",10,10
Which became synonymous with LOT in the 1990s and the first decade of the 2000s?,Which,138,Chronic pain management,Background,1,1.0,"['Which', 'became', 'synonymous', 'with', 'LOT', 'in', 'the', '1990s', 'and', 'the', 'first', 'decade', 'of', 'the', '2000s', '?']","['Chronic', 'pain', 'management']",16,3
How was OT used prior to 1980s?,How,139,"rarely used outside of severe acute injury or post-surgical pain, primarily due to concern for tolerance, physical dependence, and addiction",Background,1,1.0,"['How', 'was', 'OT', 'used', 'prior', 'to', '1980s', '?']","['rarely', 'used', 'outside', 'of', 'severe', 'acute', 'injury', 'or', 'post', '-', 'surgical', 'pain', ',', 'primarily', 'due', 'to', 'concern', 'for', 'tolerance', ',', 'physical', 'dependence', ',', 'and', 'addiction']",8,25
What was the state of long-term safety or efficacy data when OT for chronic non-terminal pain became a mainstay of therapy?,What,140,absence,Background,1,1.0,"['What', 'was', 'the', 'state', 'of', 'long', '-', 'term', 'safety', 'or', 'efficacy', 'data', 'when', 'OT', 'for', 'chronic', 'non', '-', 'terminal', 'pain', 'became', 'a', 'mainstay', 'of', 'therapy', '?']",['absence'],26,1
How did a more cautious approach to OT for chronic non-terminal pain emerge?,How,141,as observational and epidemiologic data of harm from LOT accumulated,Background,1,1.0,"['How', 'did', 'a', 'more', 'cautious', 'approach', 'to', 'OT', 'for', 'chronic', 'non', '-', 'terminal', 'pain', 'emerge', '?']","['as', 'observational', 'and', 'epidemiologic', 'data', 'of', 'harm', 'from', 'LOT', 'accumulated']",16,10
Name the concerning factors regarding the use of OT prior to 1980s.,What,142,"tolerance, physical dependence, and addiction",Background,0,0.8333333333333333,"['Name', 'the', 'concerning', 'factors', 'regarding', 'the', 'use', 'of', 'OT', 'prior', 'to', '1980s', '.']","['tolerance', ',', 'physical', 'dependence', ',', 'and', 'addiction']",13,7
What happened concurrently with the transformation in pain care?,What,143,A paradigm shift in the use of OT for chronic non-terminal pain,Background,1,1.0,"['What', 'happened', 'concurrently', 'with', 'the', 'transformation', 'in', 'pain', 'care', '?']","['A', 'paradigm', 'shift', 'in', 'the', 'use', 'of', 'OT', 'for', 'chronic', 'non', '-', 'terminal', 'pain']",10,14
When did a more cautious approach to OT for chronic non-terminal pain emerge?,When,144,in the decade of the 2010s,Background,0,0.8571428571428571,"['When', 'did', 'a', 'more', 'cautious', 'approach', 'to', 'OT', 'for', 'chronic', 'non', '-', 'terminal', 'pain', 'emerge', '?']","['in', 'the', 'decade', 'of', 'the', '2010s']",16,6
What are the signs of/risk factors for infection?,What,146,"fever, recent skin or urinary infection, immunosuppression, IV drug use",Specifications,1,1.0,"['What', 'are', 'the', 'signs', 'of', '/', 'risk', 'factors', 'for', 'infection', '?']","['fever', ',', 'recent', 'skin', 'or', 'urinary', 'infection', ',', 'immunosuppression', ',', 'IV', 'drug', 'use']",11,13
What to do if a patient is taking more than their prescribed dosage of opioids?,What,147,"before deciding to change therapy, look for “red flags”. The red flags are progressive numbness or weakness, progressive changes in bowel or bladder function, unexplained weight loss, history of internal malignancy that has not been re-staged, signs of/risk factors for infection.",Specifications,0,0.18181818181818182,"['What', 'to', 'do', 'if', 'a', 'patient', 'is', 'taking', 'more', 'than', 'their', 'prescribed', 'dosage', 'of', 'opioids', '?']","['before', 'deciding', 'to', 'change', 'therapy', ',', 'look', 'for', '“', 'red', 'flags', '”', '.', 'The', 'red', 'flags', 'are', 'progressive', 'numbness', 'or', 'weakness', ',', 'progressive', 'changes', 'in', 'bowel', 'or', 'bladder', 'function', ',', 'unexplained', 'weight', 'loss', ',', 'history', 'of', 'internal', 'malignancy', 'that', 'has', 'not', 'been', 're', '-', 'staged', ',', 'signs', 'of', '/', 'risk', 'factors', 'for', 'infection', '.']",16,54
What is needed when there are progressive changes in bowel or bladder function?,What,148,An urgent evaluation,Specifications,1,1.0,"['What', 'is', 'needed', 'when', 'there', 'are', 'progressive', 'changes', 'in', 'bowel', 'or', 'bladder', 'function', '?']","['An', 'urgent', 'evaluation']",14,3
What is needed when there is progressive numbness or weakness?,What,149,An urgent evaluation,Specifications,1,1.0,"['What', 'is', 'needed', 'when', 'there', 'is', 'progressive', 'numbness', 'or', 'weakness', '?']","['An', 'urgent', 'evaluation']",11,3
What is needed when there is a history of internal malignancy that has not been re-staged?,What,150,An urgent evaluation,Specifications,1,1.0,"['What', 'is', 'needed', 'when', 'there', 'is', 'a', 'history', 'of', 'internal', 'malignancy', 'that', 'has', 'not', 'been', 're', '-', 'staged', '?']","['An', 'urgent', 'evaluation']",19,3
What to monitor for when considering an opioid taper?,What,151,conditions that may warrant evaluation,Specifications,0,0.5,"['What', 'to', 'monitor', 'for', 'when', 'considering', 'an', 'opioid', 'taper', '?']","['conditions', 'that', 'may', 'warrant', 'evaluation']",10,5
What is needed when there are signs of/risk factors for infection?,What,152,An urgent evaluation,Specifications,1,1.0,"['What', 'is', 'needed', 'when', 'there', 'are', 'signs', 'of', '/', 'risk', 'factors', 'for', 'infection', '?']","['An', 'urgent', 'evaluation']",14,3
What warrants an urgent evaluation during opioid therapy?,What,153,"when there is progressive numbness or weakness, progressive changes in bowel or bladder function, unexplained weight loss, a history of internal malignancy that has not been re-staged, signs of/risk factors for infection such as fever, recent skin or urinary infection, immunosuppression, IV drug use",Specifications,0,0.04545454545454545,"['What', 'warrants', 'an', 'urgent', 'evaluation', 'during', 'opioid', 'therapy', '?']","['when', 'there', 'is', 'progressive', 'numbness', 'or', 'weakness', ',', 'progressive', 'changes', 'in', 'bowel', 'or', 'bladder', 'function', ',', 'unexplained', 'weight', 'loss', ',', 'a', 'history', 'of', 'internal', 'malignancy', 'that', 'has', 'not', 'been', 're', '-', 'staged', ',', 'signs', 'of', '/', 'risk', 'factors', 'for', 'infection', 'such', 'as', 'fever', ',', 'recent', 'skin', 'or', 'urinary', 'infection', ',', 'immunosuppression', ',', 'IV', 'drug', 'use']",9,55
What is needed when there is unexplained weight loss?,What,154,An urgent evaluation,Specifications,1,1.0,"['What', 'is', 'needed', 'when', 'there', 'is', 'unexplained', 'weight', 'loss', '?']","['An', 'urgent', 'evaluation']",10,3
What to do if a patient is showing signs of aberrant behavior?,What,155,"before deciding to change therapy, look for “red flags”. The red flags are progressive numbness or weakness, progressive changes in bowel or bladder function, unexplained weight loss, history of internal malignancy that has not been re-staged, signs of/risk factors for infection.",Specifications,0,0.18181818181818182,"['What', 'to', 'do', 'if', 'a', 'patient', 'is', 'showing', 'signs', 'of', 'aberrant', 'behavior', '?']","['before', 'deciding', 'to', 'change', 'therapy', ',', 'look', 'for', '“', 'red', 'flags', '”', '.', 'The', 'red', 'flags', 'are', 'progressive', 'numbness', 'or', 'weakness', ',', 'progressive', 'changes', 'in', 'bowel', 'or', 'bladder', 'function', ',', 'unexplained', 'weight', 'loss', ',', 'history', 'of', 'internal', 'malignancy', 'that', 'has', 'not', 'been', 're', '-', 'staged', ',', 'signs', 'of', '/', 'risk', 'factors', 'for', 'infection', '.']",13,54
What are the red flags in a patient who is taking more than their prescribed dose or showing signs of aberrant behavior?,What,156,"progressive numbness or weakness, progressive changes in bowel or bladder function, unexplained weight loss, history of internal malignancy that has not been re-staged, signs of/risk factors for infection",Specifications,0,0.0689655172413793,"['What', 'are', 'the', 'red', 'flags', 'in', 'a', 'patient', 'who', 'is', 'taking', 'more', 'than', 'their', 'prescribed', 'dose', 'or', 'showing', 'signs', 'of', 'aberrant', 'behavior', '?']","['progressive', 'numbness', 'or', 'weakness', ',', 'progressive', 'changes', 'in', 'bowel', 'or', 'bladder', 'function', ',', 'unexplained', 'weight', 'loss', ',', 'history', 'of', 'internal', 'malignancy', 'that', 'has', 'not', 'been', 're', '-', 'staged', ',', 'signs', 'of', '/', 'risk', 'factors', 'for', 'infection']",23,36
What is the stance regarding the concurrent use of benzodiazepines and opioids?,What,157,recommend against,Recommendations,1,1.0,"['What', 'is', 'the', 'stance', 'regarding', 'the', 'concurrent', 'use', 'of', 'benzodiazepines', 'and', 'opioids', '?']","['recommend', 'against']",13,2
What is the stance regarding long-term opioid therapy for patients less than 30 years of age secondary to higher risk of opioid use disorder and overdose?,What,158,recommend against,Recommendations,1,1.0,"['What', 'is', 'the', 'stance', 'regarding', 'long', '-', 'term', 'opioid', 'therapy', 'for', 'patients', 'less', 'than', '30', 'years', 'of', 'age', 'secondary', 'to', 'higher', 'risk', 'of', 'opioid', 'use', 'disorder', 'and', 'overdose', '?']","['recommend', 'against']",29,2
What to consider for patients currently on long-term opioid therapy and benzodiazepines?,What,159,consider tapering one or both when risks exceed benefits and obtaining specialty consultation as appropriate,Recommendations,0,0.9655172413793104,"['What', 'to', 'consider', 'for', 'patients', 'currently', 'on', 'long', '-', 'term', 'opioid', 'therapy', 'and', 'benzodiazepines', '?']","['consider', 'tapering', 'one', 'or', 'both', 'when', 'risks', 'exceed', 'benefits', 'and', 'obtaining', 'specialty', 'consultation', 'as', 'appropriate']",15,15
What to recommend for patients less than 30 years of age currently on long-term opioid therapy?,What,160,close monitoring and consideration for tapering when risks exceed benefits,Recommendations,1,1.0,"['What', 'to', 'recommend', 'for', 'patients', 'less', 'than', '30', 'years', 'of', 'age', 'currently', 'on', 'long', '-', 'term', 'opioid', 'therapy', '?']","['close', 'monitoring', 'and', 'consideration', 'for', 'tapering', 'when', 'risks', 'exceed', 'benefits']",19,10
"What is needed to ascertain whether said formulations differ across clinical outcomes such as pain, function,  and adverse events?  ",What,161,Future research,Recommendations,1,1.0,"['What', 'is', 'needed', 'to', 'ascertain', 'whether', 'said', 'formulations', 'differ', 'across', 'clinical', 'outcomes', 'such', 'as', 'pain', ',', 'function', ',', ' ', 'and', 'adverse', 'events', '?', ' ']","['Future', 'research']",24,2
What is needed to ascertain whether abuse deterrent formulations actually reduce OUD when used for chronic pain? ,What,162,Future research,Recommendations,1,1.0,"['What', 'is', 'needed', 'to', 'ascertain', 'whether', 'abuse', 'deterrent', 'formulations', 'actually', 'reduce', 'OUD', 'when', 'used', 'for', 'chronic', 'pain', '?']","['Future', 'research']",18,2
What to do with the increment of opioid dosage and risk?,What,163,more frequent monitoring for adverse events including opioid use disorder and overdose,Recommendations,1,1.0,"['What', 'to', 'do', 'with', 'the', 'increment', 'of', 'opioid', 'dosage', 'and', 'risk', '?']","['more', 'frequent', 'monitoring', 'for', 'adverse', 'events', 'including', 'opioid', 'use', 'disorder', 'and', 'overdose']",12,12
What is the recommended dose of opioids?,What,167,the lowest dose of opioids as indicated by patient-specific risks and benefits,Recommendations,0,0.16666666666666669,"['What', 'is', 'the', 'recommended', 'dose', 'of', 'opioids', '?']","['the', 'lowest', 'dose', 'of', 'opioids', 'as', 'indicated', 'by', 'patient', '-', 'specific', 'risks', 'and', 'benefits']",8,14
What opioid dose is not recommended for treating chronic pain?,What,168,over 90 mg morphine equivalent daily dose,Recommendations,1,1.0,"['What', 'opioid', 'dose', 'is', 'not', 'recommended', 'for', 'treating', 'chronic', 'pain', '?']","['over', '90', 'mg', 'morphine', 'equivalent', 'daily', 'dose']",11,7
What is recommended for patients who are currently prescribed doses over 90 mg morphine equivalent daily dose?,What,169,evaluate for tapering to reduced dose or to discontinuation,Recommendations,1,1.0,"['What', 'is', 'recommended', 'for', 'patients', 'who', 'are', 'currently', 'prescribed', 'doses', 'over', '90', 'mg', 'morphine', 'equivalent', 'daily', 'dose', '?']","['evaluate', 'for', 'tapering', 'to', 'reduced', 'dose', 'or', 'to', 'discontinuation']",18,9
What is required by the interpretation of a UDT and confirmatory results?,What,171,education and knowledge of the local procedures and clinical  scenario,Recommendations,1,1.0,"['What', 'is', 'required', 'by', 'the', 'interpretation', 'of', 'a', 'UDT', 'and', 'confirmatory', 'results', '?']","['education', 'and', 'knowledge', 'of', 'the', 'local', 'procedures', 'and', 'clinical', ' ', 'scenario']",13,11
What can identify active SUD or possible diversion?,What,172,UDT results,Recommendations,1,1.0,"['What', 'can', 'identify', 'active', 'SUD', 'or', 'possible', 'diversion', '?']","['UDT', 'results']",9,2
What is critical due to the false positive and negative rates associated with UDTs?,What,173,"Availability of accurate and timely confirmatory testing (e.g., gas chromatography-mass spectrometry  [GCMS])",Recommendations,1,1.0,"['What', 'is', 'critical', 'due', 'to', 'the', 'false', 'positive', 'and', 'negative', 'rates', 'associated', 'with', 'UDTs', '?']","['Availability', 'of', 'accurate', 'and', 'timely', 'confirmatory', 'testing', '(', 'e.g.', ',', 'gas', 'chromatography', '-', 'mass', 'spectrometry', ' ', '[', 'GCMS', ']', ')']",15,20
When should clinicians obtain UDT?,When,174,prior to initiating or continuing LOT and periodically thereafter,Recommendations,1,1.0,"['When', 'should', 'clinicians', 'obtain', 'UDT', '?']","['prior', 'to', 'initiating', 'or', 'continuing', 'LOT', 'and', 'periodically', 'thereafter']",6,9
What should be done when a patient is referred for  SUD treatment or is engaged in on-going treatment?,What,175,close communication between the  SUD and pain management providers,Recommendations,0,0.8421052631578948,"['What', 'should', 'be', 'done', 'when', 'a', 'patient', 'is', 'referred', 'for', ' ', 'SUD', 'treatment', 'or', 'is', 'engaged', 'in', 'on', '-', 'going', 'treatment', '?']","['close', 'communication', 'between', 'the', ' ', 'SUD', 'and', 'pain', 'management', 'providers']",22,10
What is the format of the ideal approach to communicate between the  SUD and pain management providers when a patient is referred for  SUD treatment or is engaged in ongoing treatment?,What,176,interdisciplinary,Recommendations,1,1.0,"['What', 'is', 'the', 'format', 'of', 'the', 'ideal', 'approach', 'to', 'communicate', 'between', 'the', ' ', 'SUD', 'and', 'pain', 'management', 'providers', 'when', 'a', 'patient', 'is', 'referred', 'for', ' ', 'SUD', 'treatment', 'or', 'is', 'engaged', 'in', 'ongoing', 'treatment', '?']",['interdisciplinary'],34,1
What does require education and knowledge of the local procedures and clinical  scenario?,What,177,Interpretation of a  UDT and confirmatory results,Recommendations,1,1.0,"['What', 'does', 'require', 'education', 'and', 'knowledge', 'of', 'the', 'local', 'procedures', 'and', 'clinical', ' ', 'scenario', '?']","['Interpretation', 'of', 'a', ' ', 'UDT', 'and', 'confirmatory', 'results']",15,8
Why is UDT and confirmatory testing used as an additional method of examining for patient substance misuse and adherence to the  prescribed regimen?,Why,178,As substance misuse in patients on LOT is more than 30% in some series,Recommendations,1,1.0,"['Why', 'is', 'UDT', 'and', 'confirmatory', 'testing', 'used', 'as', 'an', 'additional', 'method', 'of', 'examining', 'for', 'patient', 'substance', 'misuse', 'and', 'adherence', 'to', 'the', ' ', 'prescribed', 'regimen', '?']","['As', 'substance', 'misuse', 'in', 'patients', 'on', 'LOT', 'is', 'more', 'than', '30', '%', 'in', 'some', 'series']",25,15
What should clinicians obtain prior to initiating or continuing LOT and periodically thereafter?,What,179,UDT,Recommendations,1,1.0,"['What', 'should', 'clinicians', 'obtain', 'prior', 'to', 'initiating', 'or', 'continuing', 'LOT', 'and', 'periodically', 'thereafter', '?']",['UDT'],14,1
What do UDTs do when used appropriately?,What,180,"help to address safety, fairness, and trust with OT",Recommendations,1,1.0,"['What', 'do', 'UDTs', 'do', 'when', 'used', 'appropriately', '?']","['help', 'to', 'address', 'safety', ',', 'fairness', ',', 'and', 'trust', 'with', 'OT']",8,11
What can UDT results do?,What,181,help identify active SUD or possible diversion,Recommendations,0,0.8235294117647058,"['What', 'can', 'UDT', 'results', 'do', '?']","['help', 'identify', 'active', 'SUD', 'or', 'possible', 'diversion']",6,7
What is the relationship between opioid dosage and risks of opioid overdose?,What,184,progressively higher doses of prescribed opioids result in correspondingly higher risks of opioid overdose,Recommendations,0,0.12903225806451615,"['What', 'is', 'the', 'relationship', 'between', 'opioid', 'dosage', 'and', 'risks', 'of', 'opioid', 'overdose', '?']","['progressively', 'higher', 'doses', 'of', 'prescribed', 'opioids', 'result', 'in', 'correspondingly', 'higher', 'risks', 'of', 'opioid', 'overdose']",13,14
Which factors increase the risk of opioid overdose?,Which,185,"certain concomitant demographic factors, co-occurring medical or psychiatric conditions,  or interacting medications or substances",Recommendations,0,0.9655172413793104,"['Which', 'factors', 'increase', 'the', 'risk', 'of', 'opioid', 'overdose', '?']","['certain', 'concomitant', 'demographic', 'factors', ',', 'co', '-', 'occurring', 'medical', 'or', 'psychiatric', 'conditions', ',', ' ', 'or', 'interacting', 'medications', 'or', 'substances']",9,19
Which step should be taken to address the problem of opioid-related overdose epidemic?,Which,186,Achieving an improved understanding of the factors contributing to prescription opioid-related overdose,Recommendations,1,1.0,"['Which', 'step', 'should', 'be', 'taken', 'to', 'address', 'the', 'problem', 'of', 'opioid', '-', 'related', 'overdose', 'epidemic', '?']","['Achieving', 'an', 'improved', 'understanding', 'of', 'the', 'factors', 'contributing', 'to', 'prescription', 'opioid', '-', 'related', 'overdose']",16,14
What increases the risk of overdose and overdose death?,What,187,concurrent use of benzodiazepines with prescription opioids,Recommendations,1,1.0,"['What', 'increases', 'the', 'risk', 'of', 'overdose', 'and', 'overdose', 'death', '?']","['concurrent', 'use', 'of', 'benzodiazepines', 'with', 'prescription', 'opioids']",10,7
Who has the highest adjusted odds ratio (AOR) for drug  overdose?,Who,188,individuals on LOT for chronic pain (without anxiety or PTSD) who also received  concurrent long-term benzodiazepine therapy,Recommendations,1,1.0,"['Who', 'has', 'the', 'highest', 'adjusted', 'odds', 'ratio', '(', 'AOR', ')', 'for', 'drug', ' ', 'overdose', '?']","['individuals', 'on', 'LOT', 'for', 'chronic', 'pain', '(', 'without', 'anxiety', 'or', 'PTSD', ')', 'who', 'also', 'received', ' ', 'concurrent', 'long', '-', 'term', 'benzodiazepine', 'therapy']",15,22
What is the effect of concurrent use of benzodiazepines with prescription opioids?,What,190,increases the risk of  overdose and overdose death,Recommendations,1,1.0,"['What', 'is', 'the', 'effect', 'of', 'concurrent', 'use', 'of', 'benzodiazepines', 'with', 'prescription', 'opioids', '?']","['increases', 'the', 'risk', 'of', ' ', 'overdose', 'and', 'overdose', 'death']",13,9
What is the relationship between harms and benefits for the concurrent use of benzodiazepines and LOT?,What,191,Harms may outweigh benefits,Recommendations,1,1.0,"['What', 'is', 'the', 'relationship', 'between', 'harms', 'and', 'benefits', 'for', 'the', 'concurrent', 'use', 'of', 'benzodiazepines', 'and', 'LOT', '?']","['Harms', 'may', 'outweigh', 'benefits']",17,4
Who were at an increased risk of death from drug overdose?,Who,192,Veterans receiving both opioids and  benzodiazepines,Recommendations,1,1.0,"['Who', 'were', 'at', 'an', 'increased', 'risk', 'of', 'death', 'from', 'drug', 'overdose', '?']","['Veterans', 'receiving', 'both', 'opioids', 'and', ' ', 'benzodiazepines']",12,7
What was highest for individuals on LOT for chronic pain (without anxiety or PTSD) who also received  concurrent long-term benzodiazepine therapy?,What,193,the adjusted odds ratio (AOR) for drug  overdose,Recommendations,1,1.0,"['What', 'was', 'highest', 'for', 'individuals', 'on', 'LOT', 'for', 'chronic', 'pain', '(', 'without', 'anxiety', 'or', 'PTSD', ')', 'who', 'also', 'received', ' ', 'concurrent', 'long', '-', 'term', 'benzodiazepine', 'therapy', '?']","['the', 'adjusted', 'odds', 'ratio', '(', 'AOR', ')', 'for', 'drug', ' ', 'overdose']",27,11
When do the risks for opioid use disorder start?,When,194,at any dose,Recommendations,0,0.5,"['When', 'do', 'the', 'risks', 'for', 'opioid', 'use', 'disorder', 'start', '?']","['at', 'any', 'dose']",10,3
What does significantly increase at a range of 20- 50 mg morphine equivalent daily dose?,What,195,Risks for overdose and death,Recommendations,1,1.0,"['What', 'does', 'significantly', 'increase', 'at', 'a', 'range', 'of', '20-', '50', 'mg', 'morphine', 'equivalent', 'daily', 'dose', '?']","['Risks', 'for', 'overdose', 'and', 'death']",16,5
How do the risks for opioid use disorder increase?,How,197,in a dose dependent manner,Recommendations,1,1.0,"['How', 'do', 'the', 'risks', 'for', 'opioid', 'use', 'disorder', 'increase', '?']","['in', 'a', 'dose', 'dependent', 'manner']",10,5
What is recommended as opioid dosage and risk increase?,What,198,more frequent monitoring for adverse events including opioid use disorder and overdose,Recommendations,1,1.0,"['What', 'is', 'recommended', 'as', 'opioid', 'dosage', 'and', 'risk', 'increase', '?']","['more', 'frequent', 'monitoring', 'for', 'adverse', 'events', 'including', 'opioid', 'use', 'disorder', 'and', 'overdose']",10,12
When is it recommended more frequent monitoring for adverse events?,When,199,As opioid dosage and risk increase,Recommendations,1,1.0,"['When', 'is', 'it', 'recommended', 'more', 'frequent', 'monitoring', 'for', 'adverse', 'events', '?']","['As', 'opioid', 'dosage', 'and', 'risk', 'increase']",11,6
Where does OT have a limited role?,Where,200,"primarily in the treatment of severe acute pain, post-operative pain, and end-of-life pain",Background,1,1.0,"['Where', 'does', 'OT', 'have', 'a', 'limited', 'role', '?']","['primarily', 'in', 'the', 'treatment', 'of', 'severe', 'acute', 'pain', ',', 'post', '-', 'operative', 'pain', ',', 'and', 'end', '-', 'of', '-', 'life', 'pain']",8,21
What was coupled with the newly cautious approach to LOT?,What,201,the evidence of both the safety and efficacy for non-pharmacologic and non-opioid pharmacologic pain therapies,Background,1,1.0,"['What', 'was', 'coupled', 'with', 'the', 'newly', 'cautious', 'approach', 'to', 'LOT', '?']","['the', 'evidence', 'of', 'both', 'the', 'safety', 'and', 'efficacy', 'for', 'non', '-', 'pharmacologic', 'and', 'non', '-', 'opioid', 'pharmacologic', 'pain', 'therapies']",11,19
How is pain recognized by the biopsychosocial model of pain?,How,202,as a complex multidimensional experience that requires multimodal and integrated care approaches,Background,0,0.9565217391304348,"['How', 'is', 'pain', 'recognized', 'by', 'the', 'biopsychosocial', 'model', 'of', 'pain', '?']","['as', 'a', 'complex', 'multidimensional', 'experience', 'that', 'requires', 'multimodal', 'and', 'integrated', 'care', 'approaches']",11,12
What warranted a cautious approach to LOT prioritizing safety?,What,203,The accumulation of evidence of harms and the absence of evidence of long-term benefits,Background,1,1.0,"['What', 'warranted', 'a', 'cautious', 'approach', 'to', 'LOT', 'prioritizing', 'safety', '?']","['The', 'accumulation', 'of', 'evidence', 'of', 'harms', 'and', 'the', 'absence', 'of', 'evidence', 'of', 'long', '-', 'term', 'benefits']",10,16
"What is the role of OT in the treatment of severe acute pain, post-operative pain, and end-of-life pain?",What,204,limited,Background,1,1.0,"['What', 'is', 'the', 'role', 'of', 'OT', 'in', 'the', 'treatment', 'of', 'severe', 'acute', 'pain', ',', 'post', '-', 'operative', 'pain', ',', 'and', 'end', '-', 'of', '-', 'life', 'pain', '?']",['limited'],27,1
What are the preferred treatments for chronic non-terminal pain?,What,205,non-pharmacologic treatments and non-opioid medications,Background,1,1.0,"['What', 'are', 'the', 'preferred', 'treatments', 'for', 'chronic', 'non', '-', 'terminal', 'pain', '?']","['non', '-', 'pharmacologic', 'treatments', 'and', 'non', '-', 'opioid', 'medications']",12,9
Who is responsible for evaluating the appropriateness of applying the guidelines?,Who,206,Every healthcare professional making use of these guidelines,Introduction,1,1.0,"['Who', 'is', 'responsible', 'for', 'evaluating', 'the', 'appropriateness', 'of', 'applying', 'the', 'guidelines', '?']","['Every', 'healthcare', 'professional', 'making', 'use', 'of', 'these', 'guidelines']",12,8
When will the variations in practice inevitably and appropriately occur?,When,207,"when clinicians take into account the needs of individual patients, available resources, and limitations unique to an institution or type of practice",Introduction,1,1.0,"['When', 'will', 'the', 'variations', 'in', 'practice', 'inevitably', 'and', 'appropriately', 'occur', '?']","['when', 'clinicians', 'take', 'into', 'account', 'the', 'needs', 'of', 'individual', 'patients', ',', 'available', 'resources', ',', 'and', 'limitations', 'unique', 'to', 'an', 'institution', 'or', 'type', 'of', 'practice']",11,24
Which mental health comorbidities can worsen with opioid therapy?,Which,209,"PTSD, depression, anxiety",Specifications,1,1.0,"['Which', 'mental', 'health', 'comorbidities', 'can', 'worsen', 'with', 'opioid', 'therapy', '?']","['PTSD', ',', 'depression', ',', 'anxiety']",10,5
What includes personal history of SUD?,What,211,"alcohol use disorder (AUD), opioid use disorder (OUD), and/or a use disorder involving other substances",Specifications,1,1.0,"['What', 'includes', 'personal', 'history', 'of', 'SUD', '?']","['alcohol', 'use', 'disorder', '(', 'AUD', ')', ',', 'opioid', 'use', 'disorder', '(', 'OUD', ')', ',', 'and/or', 'a', 'use', 'disorder', 'involving', 'other', 'substances']",7,21
Which medical comorbidities can increase risk during opioid therapy?,Which,212,"lung disease, sleep apnea, liver disease, renal disease, fall risk, advanced age",Specifications,1,1.0,"['Which', 'medical', 'comorbidities', 'can', 'increase', 'risk', 'during', 'opioid', 'therapy', '?']","['lung', 'disease', ',', 'sleep', 'apnea', ',', 'liver', 'disease', ',', 'renal', 'disease', ',', 'fall', 'risk', ',', 'advanced', 'age']",10,17
"What is an example of medication that can increase risk during opioid therapy, if used concomitantly?",What,213,benzodiazepines,Specifications,1,1.0,"['What', 'is', 'an', 'example', 'of', 'medication', 'that', 'can', 'increase', 'risk', 'during', 'opioid', 'therapy', ',', 'if', 'used', 'concomitantly', '?']",['benzodiazepines'],18,1
What to do when there is concomitant use of medications that increase risk?,What,214,Consider tapering opioids,Specifications,1,1.0,"['What', 'to', 'do', 'when', 'there', 'is', 'concomitant', 'use', 'of', 'medications', 'that', 'increase', 'risk', '?']","['Consider', 'tapering', 'opioids']",14,3
Which can help reduce withdrawal symptoms?,Which,215,Gabapentin,Specifications,1,1.0,"['Which', 'can', 'help', 'reduce', 'withdrawal', 'symptoms', '?']",['Gabapentin'],7,1
What is the first-line treatment option for autonomic symptoms?,What,217,clonidine 0.1 to 0.2 mg oral every 6 to 8 hours,Specifications,0,0.16666666666666669,"['What', 'is', 'the', 'first', '-', 'line', 'treatment', 'option', 'for', 'autonomic', 'symptoms', '?']","['clonidine', '0.1', 'to', '0.2', 'mg', 'oral', 'every', '6', 'to', '8', 'hours']",12,11
What are the alternative treatment options for autonomic symptoms?,What,218,"Baclofen, Gabapentin, Tizanidine",Specifications,1,1.0,"['What', 'are', 'the', 'alternative', 'treatment', 'options', 'for', 'autonomic', 'symptoms', '?']","['Baclofen', ',', 'Gabapentin', ',', 'Tizanidine']",10,5
What is the recommended dose if blood pressure <90/60 mmHg while administering clonidine for autonomic symptoms?,What,219,0.1 mg oral,Specifications,0,0.5714285714285715,"['What', 'is', 'the', 'recommended', 'dose', 'if', 'blood', 'pressure', '<', '90/60', 'mmHg', 'while', 'administering', 'clonidine', 'for', 'autonomic', 'symptoms', '?']","['0.1', 'mg', 'oral']",18,3
When to hold dose if administering clonidine for autonomic symptoms?,When,220,if blood pressure <90/60 mmHg (0.1 to 0.2 mg 2 to 4 times daily is commonly used in the outpatient setting),Specifications,0,0.4,"['When', 'to', 'hold', 'dose', 'if', 'administering', 'clonidine', 'for', 'autonomic', 'symptoms', '?']","['if', 'blood', 'pressure', '<', '90/60', 'mmHg', '(', '0.1', 'to', '0.2', 'mg', '2', 'to', '4', 'times', 'daily', 'is', 'commonly', 'used', 'in', 'the', 'outpatient', 'setting', ')']",11,24
What is the alternative treatment option for autonomic symptoms using Baclofen?,What,221,5 mg 3 times daily; may increase to 40 mg total daily dose; re-evaluate in 3 to 7 days; average duration 15 days; may continue after acute withdrawal to help decrease cravings; should be tapered when it is discontinued,Specifications,0,0.5,"['What', 'is', 'the', 'alternative', 'treatment', 'option', 'for', 'autonomic', 'symptoms', 'using', 'Baclofen', '?']","['5', 'mg', '3', 'times', 'daily', ';', 'may', 'increase', 'to', '40', 'mg', 'total', 'daily', 'dose', ';', 're', '-', 'evaluate', 'in', '3', 'to', '7', 'days', ';', 'average', 'duration', '15', 'days', ';', 'may', 'continue', 'after', 'acute', 'withdrawal', 'to', 'help', 'decrease', 'cravings', ';', 'should', 'be', 'tapered', 'when', 'it', 'is', 'discontinued']",12,46
"Which can help reduce withdrawal symptoms and help with pain, anxiety, and sleep?",Which,222,Gabapentin,Specifications,1,1.0,"['Which', 'can', 'help', 'reduce', 'withdrawal', 'symptoms', 'and', 'help', 'with', 'pain', ',', 'anxiety', ',', 'and', 'sleep', '?']",['Gabapentin'],16,1
"Which can help with pain, anxiety, and sleep?",Which,223,Gabapentin,Specifications,1,1.0,"['Which', 'can', 'help', 'with', 'pain', ',', 'anxiety', ',', 'and', 'sleep', '?']",['Gabapentin'],11,1
What to consider to reduce withdrawal symptoms during the taper?,What,224,use of adjuvant medications,Specifications,1,1.0,"['What', 'to', 'consider', 'to', 'reduce', 'withdrawal', 'symptoms', 'during', 'the', 'taper', '?']","['use', 'of', 'adjuvant', 'medications']",11,4
What is the alternative treatment option for autonomic symptoms using Gabapentin?,What,225,start at 100 to 300 mg and titrate to 1800 to 2100 mg divided in 2 to 3 daily doses; adjust dose if renal impairment,Specifications,1,1.0,"['What', 'is', 'the', 'alternative', 'treatment', 'option', 'for', 'autonomic', 'symptoms', 'using', 'Gabapentin', '?']","['start', 'at', '100', 'to', '300', 'mg', 'and', 'titrate', 'to', '1800', 'to', '2100', 'mg', 'divided', 'in', '2', 'to', '3', 'daily', 'doses', ';', 'adjust', 'dose', 'if', 'renal', 'impairment']",12,26
What do autonomic symptoms include?,What,226,"sweating, tachycardia, myoclonus",Specifications,1,1.0,"['What', 'do', 'autonomic', 'symptoms', 'include', '?']","['sweating', ',', 'tachycardia', ',', 'myoclonus']",6,5
What is the alternative treatment option for autonomic symptoms using Tizanidine?,What,227,"4 mg three times daily, can increase to 8 mg three times daily",Specifications,1,1.0,"['What', 'is', 'the', 'alternative', 'treatment', 'option', 'for', 'autonomic', 'symptoms', 'using', 'Tizanidine', '?']","['4', 'mg', 'three', 'times', 'daily', ',', 'can', 'increase', 'to', '8', 'mg', 'three', 'times', 'daily']",12,14
How many discharges in the emergency department included prescriptions for opioids?,How,0,at least 17%,Background,0,0.5,"['How', 'many', 'discharges', 'in', 'the', 'emergency', 'department', 'included', 'prescriptions', 'for', 'opioids', '?']","['at', 'least', '17', '%']",12,4
Who is sponsoring the training and related management support?,Who,5,Defense Centers of  Excellence for Psychological Health and Traumatic Brain Injury,Background,1,1.0,"['Who', 'is', 'sponsoring', 'the', 'training', 'and', 'related', 'management', 'support', '?']","['Defense', 'Centers', 'of', ' ', 'Excellence', 'for', 'Psychological', 'Health', 'and', 'Traumatic', 'Brain', 'Injury']",10,12
Which training program was launched according to the mandate by the presidential memorandum of October 2015?,Which,6,DoD Opioid Prescriber Safety  Training Program,Background,1,1.0,"['Which', 'training', 'program', 'was', 'launched', 'according', 'to', 'the', 'mandate', 'by', 'the', 'presidential', 'memorandum', 'of', 'October', '2015', '?']","['DoD', 'Opioid', 'Prescriber', 'Safety', ' ', 'Training', 'Program']",17,7
What was mandated by the presidential memorandum of October 2015?,What,7,"executive departments and agencies shall, to the extent permitted by law, provide training on the appropriate and effective prescribing of opioid medications to all employees who are health care professionals and who prescribe controlled substances as part of their federal responsibilities and duties",Background,0,0.047619047619047616,"['What', 'was', 'mandated', 'by', 'the', 'presidential', 'memorandum', 'of', 'October', '2015', '?']","['executive', 'departments', 'and', 'agencies', 'shall', ',', 'to', 'the', 'extent', 'permitted', 'by', 'law', ',', 'provide', 'training', 'on', 'the', 'appropriate', 'and', 'effective', 'prescribing', 'of', 'opioid', 'medications', 'to', 'all', 'employees', 'who', 'are', 'health', 'care', 'professionals', 'and', 'who', 'prescribe', 'controlled', 'substances', 'as', 'part', 'of', 'their', 'federal', 'responsibilities', 'and', 'duties']",11,45
What does the DoD Opioid Prescriber Safety  Training Program include?,What,8,"modules on pain management and opioid prescribing safety, the recent Centers for Disease Control and Prevention (CDC) guideline, and the identification of substance misuse and referral to specialized services",Background,0,0.07142857142857142,"['What', 'does', 'the', 'DoD', 'Opioid', 'Prescriber', 'Safety', ' ', 'Training', 'Program', 'include', '?']","['modules', 'on', 'pain', 'management', 'and', 'opioid', 'prescribing', 'safety', ',', 'the', 'recent', 'Centers', 'for', 'Disease', 'Control', 'and', 'Prevention', '(', 'CDC', ')', 'guideline', ',', 'and', 'the', 'identification', 'of', 'substance', 'misuse', 'and', 'referral', 'to', 'specialized', 'services']",12,33
Who mandated training on the appropriate and effective prescribing of opioid medications to all employees who prescribe controlled substances as part of their federal responsibilities and duties?,Who,9,The presidential memorandum of October 2015,Background,1,1.0,"['Who', 'mandated', 'training', 'on', 'the', 'appropriate', 'and', 'effective', 'prescribing', 'of', 'opioid', 'medications', 'to', 'all', 'employees', 'who', 'prescribe', 'controlled', 'substances', 'as', 'part', 'of', 'their', 'federal', 'responsibilities', 'and', 'duties', '?']","['The', 'presidential', 'memorandum', 'of', 'October', '2015']",28,6
Where can the DoD Opioid Prescriber Safety  Training Program be found?,Where,10,http://opstp.cds.pesgce.com/hub.php,Background,1,1.0,"['Where', 'can', 'the', 'DoD', 'Opioid', 'Prescriber', 'Safety', ' ', 'Training', 'Program', 'be', 'found', '?']",['http://opstp.cds.pesgce.com/hub.php'],13,1
Who mandated training on the appropriate and effective prescribing of opioid medications to all employees who are health care professionals?,Who,11,The presidential memorandum of October 2015,Background,1,1.0,"['Who', 'mandated', 'training', 'on', 'the', 'appropriate', 'and', 'effective', 'prescribing', 'of', 'opioid', 'medications', 'to', 'all', 'employees', 'who', 'are', 'health', 'care', 'professionals', '?']","['The', 'presidential', 'memorandum', 'of', 'October', '2015']",21,6
What do prolonged symptoms include?,What,12,"irritability, fatigue, bradycardia, decreased body temperature, craving, insomnia",Specifications,1,1.0,"['What', 'do', 'prolonged', 'symptoms', 'include', '?']","['irritability', ',', 'fatigue', ',', 'bradycardia', ',', 'decreased', 'body', 'temperature', ',', 'craving', ',', 'insomnia']",6,13
What do late symptoms include?,What,13,"runny nose, tearing eyes, rapid breathing, yawning, tremor, diffuse muscle spasms/aches, piloerection, nausea, vomiting, and diarrhea, abdominal pain, fever, chills, increased white blood cells if sudden withdrawal",Specifications,0,0.25806451612903225,"['What', 'do', 'late', 'symptoms', 'include', '?']","['runny', 'nose', ',', 'tearing', 'eyes', ',', 'rapid', 'breathing', ',', 'yawning', ',', 'tremor', ',', 'diffuse', 'muscle', 'spasms', '/', 'aches', ',', 'piloerection', ',', 'nausea', ',', 'vomiting', ',', 'and', 'diarrhea', ',', 'abdominal', 'pain', ',', 'fever', ',', 'chills', ',', 'increased', 'white', 'blood', 'cells', 'if', 'sudden', 'withdrawal']",6,42
How long does it take for prolonged withdrawal symptoms to appear?,How,14,weeks to months,Specifications,1,1.0,"['How', 'long', 'does', 'it', 'take', 'for', 'prolonged', 'withdrawal', 'symptoms', 'to', 'appear', '?']","['weeks', 'to', 'months']",12,3
How long does it take for early withdrawal symptoms to appear?,How,15,hours to days,Specifications,1,1.0,"['How', 'long', 'does', 'it', 'take', 'for', 'early', 'withdrawal', 'symptoms', 'to', 'appear', '?']","['hours', 'to', 'days']",12,3
What do early symptoms include?,What,16,"anxiety/restlessness, rapid short respirations, runny nose, tearing eyes, sweating, insomnia, and dilated reactive pupils",Specifications,1,1.0,"['What', 'do', 'early', 'symptoms', 'include', '?']","['anxiety', '/', 'restlessness', ',', 'rapid', 'short', 'respirations', ',', 'runny', 'nose', ',', 'tearing', 'eyes', ',', 'sweating', ',', 'insomnia', ',', 'and', 'dilated', 'reactive', 'pupils']",6,22
When we may not see withdrawal symptoms?,When,17,with a gradual taper,Specifications,1,1.0,"['When', 'we', 'may', 'not', 'see', 'withdrawal', 'symptoms', '?']","['with', 'a', 'gradual', 'taper']",8,4
What can be utilized to assist with managing the withdrawal symptoms?,What,18,Short-term oral medications,Specifications,1,1.0,"['What', 'can', 'be', 'utilized', 'to', 'assist', 'with', 'managing', 'the', 'withdrawal', 'symptoms', '?']","['Short', '-', 'term', 'oral', 'medications']",12,5
Which withdrawal symptoms in patients with chronic pain may improve over time?,Which,19,"fatigue, mental functioning, pain, and well-being",Specifications,1,1.0,"['Which', 'withdrawal', 'symptoms', 'in', 'patients', 'with', 'chronic', 'pain', 'may', 'improve', 'over', 'time', '?']","['fatigue', ',', 'mental', 'functioning', ',', 'pain', ',', 'and', 'well', '-', 'being']",13,11
How long does it take to resolve early symptoms?,How,20,"5 to 10 days following opioid dose reduction/cessation but may take longer depending on the half-life of the opioid (e.g., methadone)",Specifications,0,0.34782608695652173,"['How', 'long', 'does', 'it', 'take', 'to', 'resolve', 'early', 'symptoms', '?']","['5', 'to', '10', 'days', 'following', 'opioid', 'dose', 'reduction', '/', 'cessation', 'but', 'may', 'take', 'longer', 'depending', 'on', 'the', 'half', '-', 'life', 'of', 'the', 'opioid', '(', 'e.g.', ',', 'methadone', ')']",10,28
How long does it take for late withdrawal symptoms to appear?,How,21,days to weeks,Specifications,1,1.0,"['How', 'long', 'does', 'it', 'take', 'for', 'late', 'withdrawal', 'symptoms', 'to', 'appear', '?']","['days', 'to', 'weeks']",12,3
What not to use to treat withdrawal symptoms?,What,22,an opioid or benzodiazepine,Specifications,1,1.0,"['What', 'not', 'to', 'use', 'to', 'treat', 'withdrawal', 'symptoms', '?']","['an', 'opioid', 'or', 'benzodiazepine']",9,4
Which symptoms of withdrawal may take longer?,Which,23,"dysphoria, insomnia",Specifications,0,0.5714285714285715,"['Which', 'symptoms', 'of', 'withdrawal', 'may', 'take', 'longer', '?']","['dysphoria', ',', 'insomnia']",8,3
What to do if an SUD is identified?,What,24,find out if the patient is willing to engage in SUD therapy,Algorithm,1,1.0,"['What', 'to', 'do', 'if', 'an', 'SUD', 'is', 'identified', '?']","['find', 'out', 'if', 'the', 'patient', 'is', 'willing', 'to', 'engage', 'in', 'SUD', 'therapy']",9,12
What to do if the patient is not willing to engage in SUD therapy?,What,25,"address safety and misuse, assess for withdrawal symptoms and offer expedited taper, immediate discontinuation or detox as indicated, continue to monitor for SUD and mental health comorbidities and offer treatment as indicated (see VA/DoD SUD CPG and Academic Detailing Tapering Document), exit algorithm and manage with non-opioid modalities",Algorithm,0,0.5882352941176471,"['What', 'to', 'do', 'if', 'the', 'patient', 'is', 'not', 'willing', 'to', 'engage', 'in', 'SUD', 'therapy', '?']","['address', 'safety', 'and', 'misuse', ',', 'assess', 'for', 'withdrawal', 'symptoms', 'and', 'offer', 'expedited', 'taper', ',', 'immediate', 'discontinuation', 'or', 'detox', 'as', 'indicated', ',', 'continue', 'to', 'monitor', 'for', 'SUD', 'and', 'mental', 'health', 'comorbidities', 'and', 'offer', 'treatment', 'as', 'indicated', '(', 'see', 'VA', '/', 'DoD', 'SUD', 'CPG', 'and', 'Academic', 'Detailing', 'Tapering', 'Document', ')', ',', 'exit', 'algorithm', 'and', 'manage', 'with', 'non', '-', 'opioid', 'modalities']",15,58
What to do if there is no concern for diversion?,What,26,follow-up 1 week to 1 month after each change in dosage and after discontinuation considering patient and treatment characteristics,Algorithm,1,1.0,"['What', 'to', 'do', 'if', 'there', 'is', 'no', 'concern', 'for', 'diversion', '?']","['follow', '-', 'up', '1', 'week', 'to', '1', 'month', 'after', 'each', 'change', 'in', 'dosage', 'and', 'after', 'discontinuation', 'considering', 'patient', 'and', 'treatment', 'characteristics']",11,21
What is Module C about?,What,27,tapering or discontinuation of opioid therapy,Algorithm,0,0.923076923076923,"['What', 'is', 'Module', 'C', 'about', '?']","['tapering', 'or', 'discontinuation', 'of', 'opioid', 'therapy']",6,6
What to consider for patients who are actively engaged in skills training?,What,28,reduced rate of taper or pause in taper,Algorithm,1,1.0,"['What', 'to', 'consider', 'for', 'patients', 'who', 'are', 'actively', 'engaged', 'in', 'skills', 'training', '?']","['reduced', 'rate', 'of', 'taper', 'or', 'pause', 'in', 'taper']",13,8
What to do if there is no high risk or dangerous behavior?,What,29,"develop an individualized tapering treatment plan (including pace of tapering, setting of care) based on patient and treatment characteristics",Algorithm,1,1.0,"['What', 'to', 'do', 'if', 'there', 'is', 'no', 'high', 'risk', 'or', 'dangerous', 'behavior', '?']","['develop', 'an', 'individualized', 'tapering', 'treatment', 'plan', '(', 'including', 'pace', 'of', 'tapering', ',', 'setting', 'of', 'care', ')', 'based', 'on', 'patient', 'and', 'treatment', 'characteristics']",13,22
What are some examples of high-risk or dangerous behavior?,What,30,"overdose event, accidents, and threatening provider",Algorithm,1,1.0,"['What', 'are', 'some', 'examples', 'of', 'high', '-', 'risk', 'or', 'dangerous', 'behavior', '?']","['overdose', 'event', ',', 'accidents', ',', 'and', 'threatening', 'provider']",12,8
What to do if an SUD is not identified?,What,31,"identify the followings: use of opioids to modulate emotions (i.e., “chemical coping”), untreated or undertreated psychiatric disorder",Algorithm,0,0.09523809523809523,"['What', 'to', 'do', 'if', 'an', 'SUD', 'is', 'not', 'identified', '?']","['identify', 'the', 'followings', ':', 'use', 'of', 'opioids', 'to', 'modulate', 'emotions', '(', 'i.e.', ',', '“', 'chemical', 'coping', '”', ')', ',', 'untreated', 'or', 'undertreated', 'psychiatric', 'disorder']",10,24
What to consider at each interaction with patient during the follow-ups?,What,32,"educate on self-management and risks of OT, optimize whole person approach to pain care, optimize treatment of co-occurring mental health conditions, optimize non-opioid pain treatment modalities, reassess for OUD and readiness for OUD treatment as indicated",Algorithm,0,0.05405405405405406,"['What', 'to', 'consider', 'at', 'each', 'interaction', 'with', 'patient', 'during', 'the', 'follow', '-', 'ups', '?']","['educate', 'on', 'self', '-', 'management', 'and', 'risks', 'of', 'OT', ',', 'optimize', 'whole', 'person', 'approach', 'to', 'pain', 'care', ',', 'optimize', 'treatment', 'of', 'co', '-', 'occurring', 'mental', 'health', 'conditions', ',', 'optimize', 'non', '-', 'opioid', 'pain', 'treatment', 'modalities', ',', 'reassess', 'for', 'OUD', 'and', 'readiness', 'for', 'OUD', 'treatment', 'as', 'indicated']",14,46
What to do if there is high risk or dangerous behavior?,What,33,"address safety and misuse, assess for withdrawal symptoms and offer expedited taper, immediate discontinuation or detox as indicated, continue to monitor for SUD and mental health comorbidities and offer treatment as indicated (see VA/DoD SUD CPG and Academic Detailing Tapering Document), exit algorithm and manage with non-opioid modalities",Algorithm,0,0.10344827586206896,"['What', 'to', 'do', 'if', 'there', 'is', 'high', 'risk', 'or', 'dangerous', 'behavior', '?']","['address', 'safety', 'and', 'misuse', ',', 'assess', 'for', 'withdrawal', 'symptoms', 'and', 'offer', 'expedited', 'taper', ',', 'immediate', 'discontinuation', 'or', 'detox', 'as', 'indicated', ',', 'continue', 'to', 'monitor', 'for', 'SUD', 'and', 'mental', 'health', 'comorbidities', 'and', 'offer', 'treatment', 'as', 'indicated', '(', 'see', 'VA', '/', 'DoD', 'SUD', 'CPG', 'and', 'Academic', 'Detailing', 'Tapering', 'Document', ')', ',', 'exit', 'algorithm', 'and', 'manage', 'with', 'non', '-', 'opioid', 'modalities']",12,58
What to do if there is high risk or dangerous behaviors?,What,34,repeat comprehensive biopsychosocial assessment and see if an SUD is identified,Algorithm,1,1.0,"['What', 'to', 'do', 'if', 'there', 'is', 'high', 'risk', 'or', 'dangerous', 'behaviors', '?']","['repeat', 'comprehensive', 'biopsychosocial', 'assessment', 'and', 'see', 'if', 'an', 'SUD', 'is', 'identified']",12,11
What to do if there is use of opioids to modulate emotions or an untreated or undertreated psychiatric disorder?,What,35,"engage the patient in appropriate behavioral and/or psychiatric treatment, ideally in an interdisciplinary setting, consider reduced rate of taper or pause in taper for patients actively engaged in skills training",Algorithm,0,0.0689655172413793,"['What', 'to', 'do', 'if', 'there', 'is', 'use', 'of', 'opioids', 'to', 'modulate', 'emotions', 'or', 'an', 'untreated', 'or', 'undertreated', 'psychiatric', 'disorder', '?']","['engage', 'the', 'patient', 'in', 'appropriate', 'behavioral', 'and/or', 'psychiatric', 'treatment', ',', 'ideally', 'in', 'an', 'interdisciplinary', 'setting', ',', 'consider', 'reduced', 'rate', 'of', 'taper', 'or', 'pause', 'in', 'taper', 'for', 'patients', 'actively', 'engaged', 'in', 'skills', 'training']",20,32
When to follow-up after each change in dosage?,When,36,1 week to 1 month,Algorithm,1,1.0,"['When', 'to', 'follow', '-', 'up', 'after', 'each', 'change', 'in', 'dosage', '?']","['1', 'week', 'to', '1', 'month']",11,5
What to use for more frequent follow-up?,What,37,the expanded care team,Algorithm,0,0.4,"['What', 'to', 'use', 'for', 'more', 'frequent', 'follow', '-', 'up', '?']","['the', 'expanded', 'care', 'team']",10,4
What to do if patient is fearful or anxious about taper and ability to function on lower dose or without opioids?,What,38,"provide additional education about whole person pain care and LOT and reassurance that the patient will not be abandoned, consider more frequent follow-up using the expanded care team (registered nurse, clinical pharmacist, health coach, mental health provider), consider reduced rate of taper or pause in taper for patients actively engaged in skills training, reassess for OUD throughout the taper",Algorithm,0,0.4864864864864865,"['What', 'to', 'do', 'if', 'patient', 'is', 'fearful', 'or', 'anxious', 'about', 'taper', 'and', 'ability', 'to', 'function', 'on', 'lower', 'dose', 'or', 'without', 'opioids', '?']","['provide', 'additional', 'education', 'about', 'whole', 'person', 'pain', 'care', 'and', 'LOT', 'and', 'reassurance', 'that', 'the', 'patient', 'will', 'not', 'be', 'abandoned', ',', 'consider', 'more', 'frequent', 'follow', '-', 'up', 'using', 'the', 'expanded', 'care', 'team', '(', 'registered', 'nurse', ',', 'clinical', 'pharmacist', ',', 'health', 'coach', ',', 'mental', 'health', 'provider', ')', ',', 'consider', 'reduced', 'rate', 'of', 'taper', 'or', 'pause', 'in', 'taper', 'for', 'patients', 'actively', 'engaged', 'in', 'skills', 'training', ',', 'reassess', 'for', 'OUD', 'throughout', 'the', 'taper']",22,69
What to do if there is no evidence of diversion?,What,39,"look for high-risk or dangerous behavior (e.g., overdose event, accidents, and threatening provider)",Algorithm,1,1.0,"['What', 'to', 'do', 'if', 'there', 'is', 'no', 'evidence', 'of', 'diversion', '?']","['look', 'for', 'high', '-', 'risk', 'or', 'dangerous', 'behavior', '(', 'e.g.', ',', 'overdose', 'event', ',', 'accidents', ',', 'and', 'threatening', 'provider', ')']",11,20
What to do if an SUD is not identified and there is use of opioids to modulate emotions or an untreated or undertreated psychiatric disorder?,What,40,"engage the patient in appropriate behavioral and/or psychiatric treatment, ideally in an interdisciplinary setting, consider reduced rate of taper or pause in taper for patients actively engaged in skills training",Algorithm,0,0.0689655172413793,"['What', 'to', 'do', 'if', 'an', 'SUD', 'is', 'not', 'identified', 'and', 'there', 'is', 'use', 'of', 'opioids', 'to', 'modulate', 'emotions', 'or', 'an', 'untreated', 'or', 'undertreated', 'psychiatric', 'disorder', '?']","['engage', 'the', 'patient', 'in', 'appropriate', 'behavioral', 'and/or', 'psychiatric', 'treatment', ',', 'ideally', 'in', 'an', 'interdisciplinary', 'setting', ',', 'consider', 'reduced', 'rate', 'of', 'taper', 'or', 'pause', 'in', 'taper', 'for', 'patients', 'actively', 'engaged', 'in', 'skills', 'training']",26,32
What to do if the patient resists taper?,What,41,repeat comprehensive biopsychosocial assessment and see if an SUD is identified,Algorithm,1,1.0,"['What', 'to', 'do', 'if', 'the', 'patient', 'resists', 'taper', '?']","['repeat', 'comprehensive', 'biopsychosocial', 'assessment', 'and', 'see', 'if', 'an', 'SUD', 'is', 'identified']",9,11
When to follow-up after discontinuation?,When,42,1 week to 1 month,Algorithm,1,1.0,"['When', 'to', 'follow', '-', 'up', 'after', 'discontinuation', '?']","['1', 'week', 'to', '1', 'month']",8,5
What to do if there is evidence of diversion?,What,43,immediately discontinue opioid therapy,Algorithm,1,1.0,"['What', 'to', 'do', 'if', 'there', 'is', 'evidence', 'of', 'diversion', '?']","['immediately', 'discontinue', 'opioid', 'therapy']",10,4
What includes expanded care team?,What,44,"registered nurse, clinical pharmacist, health coach, mental health provider",Algorithm,1,1.0,"['What', 'includes', 'expanded', 'care', 'team', '?']","['registered', 'nurse', ',', 'clinical', 'pharmacist', ',', 'health', 'coach', ',', 'mental', 'health', 'provider']",6,12
What to do immediately after discontinuing OT?,What,45,"address safety and misuse, assess for withdrawal symptoms and offer expedited taper, immediate discontinuation or detox as indicated, continue to monitor for SUD and mental health comorbidities and offer treatment as indicated (see VA/DoD SUD CPG and Academic Detailing Tapering Document), exit algorithm and manage with non-opioid modalities",Algorithm,0,0.5882352941176471,"['What', 'to', 'do', 'immediately', 'after', 'discontinuing', 'OT', '?']","['address', 'safety', 'and', 'misuse', ',', 'assess', 'for', 'withdrawal', 'symptoms', 'and', 'offer', 'expedited', 'taper', ',', 'immediate', 'discontinuation', 'or', 'detox', 'as', 'indicated', ',', 'continue', 'to', 'monitor', 'for', 'SUD', 'and', 'mental', 'health', 'comorbidities', 'and', 'offer', 'treatment', 'as', 'indicated', '(', 'see', 'VA', '/', 'DoD', 'SUD', 'CPG', 'and', 'Academic', 'Detailing', 'Tapering', 'Document', ')', ',', 'exit', 'algorithm', 'and', 'manage', 'with', 'non', '-', 'opioid', 'modalities']",8,58
What to do if there is an indication to taper to reduced dose or taper to discontinuation?,What,46,repeat comprehensive biopsychosocial assessment. Then see if the patient demonstrates signs or symptoms of SUD.,Algorithm,1,1.0,"['What', 'to', 'do', 'if', 'there', 'is', 'an', 'indication', 'to', 'taper', 'to', 'reduced', 'dose', 'or', 'taper', 'to', 'discontinuation', '?']","['repeat', 'comprehensive', 'biopsychosocial', 'assessment', '.', 'Then', 'see', 'if', 'the', 'patient', 'demonstrates', 'signs', 'or', 'symptoms', 'of', 'SUD', '.']",18,17
What is chemical coping?,What,47,use of opioids to modulate emotions,Algorithm,1,1.0,"['What', 'is', 'chemical', 'coping', '?']","['use', 'of', 'opioids', 'to', 'modulate', 'emotions']",5,6
What to do if there is a concern for diversion?,What,48,immediately discontinue opioid therapy,Algorithm,1,1.0,"['What', 'to', 'do', 'if', 'there', 'is', 'a', 'concern', 'for', 'diversion', '?']","['immediately', 'discontinue', 'opioid', 'therapy']",11,4
What to do if the patient is willing to engage in SUD therapy?,What,49,"access specialized SUD care with monitoring and follow-up appropriate for the patient’s needs (e.g., MAT, treatment for comorbidities), see VA/DoD SUD CPG, exit algorithms and manage with non-opioid modalities",Algorithm,0,0.05714285714285715,"['What', 'to', 'do', 'if', 'the', 'patient', 'is', 'willing', 'to', 'engage', 'in', 'SUD', 'therapy', '?']","['access', 'specialized', 'SUD', 'care', 'with', 'monitoring', 'and', 'follow', '-', 'up', 'appropriate', 'for', 'the', 'patient', '’s', 'needs', '(', 'e.g.', ',', 'MAT', ',', 'treatment', 'for', 'comorbidities', ')', ',', 'see', 'VA', '/', 'DoD', 'SUD', 'CPG', ',', 'exit', 'algorithms', 'and', 'manage', 'with', 'non', '-', 'opioid', 'modalities']",14,42
What to consider while deciding when to follow up with a patient after each change in dosage or after discontinuation?,What,50,patient and treatment characteristics,Algorithm,1,1.0,"['What', 'to', 'consider', 'while', 'deciding', 'when', 'to', 'follow', 'up', 'with', 'a', 'patient', 'after', 'each', 'change', 'in', 'dosage', 'or', 'after', 'discontinuation', '?']","['patient', 'and', 'treatment', 'characteristics']",21,4
What to do if the patient does not demonstrate signs or symptoms of SUD?,What,51,look for evidence of diversion,Algorithm,1,1.0,"['What', 'to', 'do', 'if', 'the', 'patient', 'does', 'not', 'demonstrate', 'signs', 'or', 'symptoms', 'of', 'SUD', '?']","['look', 'for', 'evidence', 'of', 'diversion']",15,5
What to do if the patient demonstrates signs or symptoms of SUD?,What,52,see whether the patient is willing to engage in SUD therapy,Algorithm,1,1.0,"['What', 'to', 'do', 'if', 'the', 'patient', 'demonstrates', 'signs', 'or', 'symptoms', 'of', 'SUD', '?']","['see', 'whether', 'the', 'patient', 'is', 'willing', 'to', 'engage', 'in', 'SUD', 'therapy']",13,11
What to do if there is an increase in patient distress?,What,53,repeat comprehensive biopsychosocial assessment and see if an SUD is identified,Algorithm,1,1.0,"['What', 'to', 'do', 'if', 'there', 'is', 'an', 'increase', 'in', 'patient', 'distress', '?']","['repeat', 'comprehensive', 'biopsychosocial', 'assessment', 'and', 'see', 'if', 'an', 'SUD', 'is', 'identified']",12,11
What is recommended if take-home opioids are prescribed?,What,54,immediate-release opioids are used at the lowest effective dose with opioid therapy reassessment no later than 3-5 days to determine if  adjustments or continuing opioid therapy is indicated,Recommendations,0,0.0,"['What', 'is', 'recommended', 'if', 'take', '-', 'home', 'opioids', 'are', 'prescribed', '?']","['immediate', '-', 'release', 'opioids', 'are', 'used', 'at', 'the', 'lowest', 'effective', 'dose', 'with', 'opioid', 'therapy', 'reassessment', 'no', 'later', 'than', '3', '-', '5', 'days', 'to', 'determine', 'if', ' ', 'adjustments', 'or', 'continuing', 'opioid', 'therapy', 'is', 'indicated']",11,33
What is sugested when opioids are used for acute pain?,What,55,use of multimodal pain care including non-opioid medications as indicated,Recommendations,0,0.888888888888889,"['What', 'is', 'sugested', 'when', 'opioids', 'are', 'used', 'for', 'acute', 'pain', '?']","['use', 'of', 'multimodal', 'pain', 'care', 'including', 'non', '-', 'opioid', 'medications', 'as', 'indicated']",11,12
What should be offered to patients?,What,56,Patient education about opioid risks and alternatives to opioid therapy,Recommendations,0,0.9473684210526316,"['What', 'should', 'be', 'offered', 'to', 'patients', '?']","['Patient', 'education', 'about', 'opioid', 'risks', 'and', 'alternatives', 'to', 'opioid', 'therapy']",7,10
What is recommended for mild-to-moderate acute pain?,What,57,alternatives to opioids,Recommendations,1,1.0,"['What', 'is', 'recommended', 'for', 'mild', '-', 'to', '-', 'moderate', 'acute', 'pain', '?']","['alternatives', 'to', 'opioids']",12,3
Who were significantly less likely than 20-44 year olds to have non-detection of a prescribed opioid (indicating possible diversion)?,Who,60,Patients in the 45-64 and ≥65 age groups,Recommendations,1,1.0,"['Who', 'were', 'significantly', 'less', 'likely', 'than', '20', '-', '44', 'year', 'olds', 'to', 'have', 'non', '-', 'detection', 'of', 'a', 'prescribed', 'opioid', '(', 'indicating', 'possible', 'diversion', ')', '?']","['Patients', 'in', 'the', '45', '-', '64', 'and', '≥65', 'age', 'groups']",26,10
Who are at a higher risk of opioid misuse?,Who,63,Younger patients,Recommendations,1,1.0,"['Who', 'are', 'at', 'a', 'higher', 'risk', 'of', 'opioid', 'misuse', '?']","['Younger', 'patients']",10,2
Who were significantly less likely to have an aberrant UDT in comparison to patients in the 20-44 age  group?,Who,64,patients in the 45-64 year age group,Recommendations,1,1.0,"['Who', 'were', 'significantly', 'less', 'likely', 'to', 'have', 'an', 'aberrant', 'UDT', 'in', 'comparison', 'to', 'patients', 'in', 'the', '20', '-', '44', 'age', ' ', 'group', '?']","['patients', 'in', 'the', '45', '-', '64', 'year', 'age', 'group']",23,9
What are significantly less likely in patients in the 45-64 and ≥65 age groups than 20-44 year olds?,What,65,to  have non-detection of a prescribed opioid as well (indicating possible diversion),Recommendations,0,0.9,"['What', 'are', 'significantly', 'less', 'likely', 'in', 'patients', 'in', 'the', '45', '-', '64', 'and', '≥65', 'age', 'groups', 'than', '20', '-', '44', 'year', 'olds', '?']","['to', ' ', 'have', 'non', '-', 'detection', 'of', 'a', 'prescribed', 'opioid', 'as', 'well', '(', 'indicating', 'possible', 'diversion', ')']",23,17
What is the relationship between patient values and preferences?,What,66,There may be some variation,Recommendations,1,1.0,"['What', 'is', 'the', 'relationship', 'between', 'patient', 'values', 'and', 'preferences', '?']","['There', 'may', 'be', 'some', 'variation']",10,5
How many people died between 1999 and 2015 from overdoses related to prescription opioids?,How,68,"more than 183,000",Background,1,1.0,"['How', 'many', 'people', 'died', 'between', '1999', 'and', '2015', 'from', 'overdoses', 'related', 'to', 'prescription', 'opioids', '?']","['more', 'than', '183,000']",15,3
What is one of the most disabling chronic medical conditions in the U.S.?,What,69,Chronic pain,Background,1,1.0,"['What', 'is', 'one', 'of', 'the', 'most', 'disabling', 'chronic', 'medical', 'conditions', 'in', 'the', 'U.S.', '?']","['Chronic', 'pain']",14,2
What is one of the most costly chronic medical conditions in the U.S.?,What,70,Chronic pain,Background,1,1.0,"['What', 'is', 'one', 'of', 'the', 'most', 'costly', 'chronic', 'medical', 'conditions', 'in', 'the', 'U.S.', '?']","['Chronic', 'pain']",14,2
What is one of the most common chronic medical conditions in the U.S.?,What,71,Chronic pain,Background,1,1.0,"['What', 'is', 'one', 'of', 'the', 'most', 'common', 'chronic', 'medical', 'conditions', 'in', 'the', 'U.S.', '?']","['Chronic', 'pain']",14,2
How much has the absolute number of deaths associated with the use of opioids increased from 2013 to 2014?,How,73,14%,Background,1,1.0,"['How', 'much', 'has', 'the', 'absolute', 'number', 'of', 'deaths', 'associated', 'with', 'the', 'use', 'of', 'opioids', 'increased', 'from', '2013', 'to', '2014', '?']","['14', '%']",20,2
"What were the changes in the sales of prescription opioids in the U.S. from 1999 and 2014, according to CDC?",What,74,quadrupled,Background,1,1.0,"['What', 'were', 'the', 'changes', 'in', 'the', 'sales', 'of', 'prescription', 'opioids', 'in', 'the', 'U.S.', 'from', '1999', 'and', '2014', ',', 'according', 'to', 'CDC', '?']",['quadrupled'],22,1
How much has the absolute number of deaths associated with the use of opioids increased since 2000?,How,75,four-fold,Background,1,1.0,"['How', 'much', 'has', 'the', 'absolute', 'number', 'of', 'deaths', 'associated', 'with', 'the', 'use', 'of', 'opioids', 'increased', 'since', '2000', '?']","['four', '-', 'fold']",18,3
What is the ratio of patients with non-cancer pain or pain-related diagnoses who receive opioid prescriptions in office-based settings?,What,76,Approximately one in five,Background,0,0.8571428571428571,"['What', 'is', 'the', 'ratio', 'of', 'patients', 'with', 'non', '-', 'cancer', 'pain', 'or', 'pain', '-', 'related', 'diagnoses', 'who', 'receive', 'opioid', 'prescriptions', 'in', 'office', '-', 'based', 'settings', '?']","['Approximately', 'one', 'in', 'five']",26,4
How many adults in the U.S. experience chronic pain?,How,78,approximately 100 million,Background,0,0.8,"['How', 'many', 'adults', 'in', 'the', 'U.S.', 'experience', 'chronic', 'pain', '?']","['approximately', '100', 'million']",10,3
Why is frequent follow-up needed?,Why,79,"in order to increase the impact of risk mitigation strategies and enhance the delivery of comprehensive, biopsychosocial pain care",Recommendations,1,1.0,"['Why', 'is', 'frequent', 'follow', '-', 'up', 'needed', '?']","['in', 'order', 'to', 'increase', 'the', 'impact', 'of', 'risk', 'mitigation', 'strategies', 'and', 'enhance', 'the', 'delivery', 'of', 'comprehensive', ',', 'biopsychosocial', 'pain', 'care']",8,20
What to do after initiating OT?,What,80,frequent visits contribute to the appropriate use and adjustment of the planned therapy,Recommendations,1,1.0,"['What', 'to', 'do', 'after', 'initiating', 'OT', '?']","['frequent', 'visits', 'contribute', 'to', 'the', 'appropriate', 'use', 'and', 'adjustment', 'of', 'the', 'planned', 'therapy']",7,13
How to decide the frequency of follow-up visits?,How,81,based on risk stratification,Recommendations,0,0.5714285714285715,"['How', 'to', 'decide', 'the', 'frequency', 'of', 'follow', '-', 'up', 'visits', '?']","['based', 'on', 'risk', 'stratification']",11,4
Why follow up at least every three months or more frequently?,Why,82,due to the balance of benefits and harms,Recommendations,0,0.0,"['Why', 'follow', 'up', 'at', 'least', 'every', 'three', 'months', 'or', 'more', 'frequently', '?']","['due', 'to', 'the', 'balance', 'of', 'benefits', 'and', 'harms']",12,8
When to follow up?,When,83,at least every three months or more frequently,Recommendations,1,1.0,"['When', 'to', 'follow', 'up', '?']","['at', 'least', 'every', 'three', 'months', 'or', 'more', 'frequently']",5,8
What to do before initiating OT?,What,84,an individualized assessment of potential opioid-related harms relative to realistic treatment goals must be completed,Recommendations,1,1.0,"['What', 'to', 'do', 'before', 'initiating', 'OT', '?']","['an', 'individualized', 'assessment', 'of', 'potential', 'opioid', '-', 'related', 'harms', 'relative', 'to', 'realistic', 'treatment', 'goals', 'must', 'be', 'completed']",7,17
How frequently should the harms versus benefits be re-evaluated according to the CDC guideline?,How,85,"within one to four weeks of starting OT or at any dose change, and at least every three months or more frequently if needed",Recommendations,1,1.0,"['How', 'frequently', 'should', 'the', 'harms', 'versus', 'benefits', 'be', 're', '-', 'evaluated', 'according', 'to', 'the', 'CDC', 'guideline', '?']","['within', 'one', 'to', 'four', 'weeks', 'of', 'starting', 'OT', 'or', 'at', 'any', 'dose', 'change', ',', 'and', 'at', 'least', 'every', 'three', 'months', 'or', 'more', 'frequently', 'if', 'needed']",17,25
What was associated with depressed mood?,What,86,high dose chronic opioid therapy for pain,Background,1,1.0,"['What', 'was', 'associated', 'with', 'depressed', 'mood', '?']","['high', 'dose', 'chronic', 'opioid', 'therapy', 'for', 'pain']",7,7
What was significantly associated with suicide attempts for the chronic use of short-acting and long-acting opioids?,What,87,a  diagnosis of a mood disorder,Background,1,1.0,"['What', 'was', 'significantly', 'associated', 'with', 'suicide', 'attempts', 'for', 'the', 'chronic', 'use', 'of', 'short', '-', 'acting', 'and', 'long', '-', 'acting', 'opioids', '?']","['a', ' ', 'diagnosis', 'of', 'a', 'mood', 'disorder']",21,7
Where can more information on suicidality be found?,Where,88,the VA/DoD Suicide CPG,Background,0,0.4444444444444444,"['Where', 'can', 'more', 'information', 'on', 'suicidality', 'be', 'found', '?']","['the', 'VA', '/', 'DoD', 'Suicide', 'CPG']",9,6
Where can more information on bipolar disorder be found?,Where,90,the  VA/DoD Clinical Practice Guideline for Management of Bipolar Disorder in Adults (VA/DoD BD  CPG),Background,1,1.0,"['Where', 'can', 'more', 'information', 'on', 'bipolar', 'disorder', 'be', 'found', '?']","['the', ' ', 'VA', '/', 'DoD', 'Clinical', 'Practice', 'Guideline', 'for', 'Management', 'of', 'Bipolar', 'Disorder', 'in', 'Adults', '(', 'VA', '/', 'DoD', 'BD', ' ', 'CPG', ')']",10,23
What are the odds of suicidal ideation within the past 12 months in those with bipolar disorder compared to those with no bipolar disorder?,What,91,2.9 times,Background,1,1.0,"['What', 'are', 'the', 'odds', 'of', 'suicidal', 'ideation', 'within', 'the', 'past', '12', 'months', 'in', 'those', 'with', 'bipolar', 'disorder', 'compared', 'to', 'those', 'with', 'no', 'bipolar', 'disorder', '?']","['2.9', 'times']",25,2
What does preclude the safe use of self-administered LOT?,What,92,"Intermediate to high acute suicide risk, severe depression, unstable bipolar disorder, or unstable psychotic disorder",Background,0,0.7499999999999999,"['What', 'does', 'preclude', 'the', 'safe', 'use', 'of', 'self', '-', 'administered', 'LOT', '?']","['Intermediate', 'to', 'high', 'acute', 'suicide', 'risk', ',', 'severe', 'depression', ',', 'unstable', 'bipolar', 'disorder', ',', 'or', 'unstable', 'psychotic', 'disorder']",12,18
What are the odds of a lifetime suicide attempt in those with bipolar disorder compared to those with no bipolar disorder?,What,93,3.2  times,Background,1,1.0,"['What', 'are', 'the', 'odds', 'of', 'a', 'lifetime', 'suicide', 'attempt', 'in', 'those', 'with', 'bipolar', 'disorder', 'compared', 'to', 'those', 'with', 'no', 'bipolar', 'disorder', '?']","['3.2', ' ', 'times']",22,3
"Which treatment for chronic pain may have benefits in treating depression, PTSD, and in reducing suicide risk?",Which,94,"Treatment for chronic pain with movement, exercise, and cognitive-behavioral therapy for pain",Background,1,1.0,"['Which', 'treatment', 'for', 'chronic', 'pain', 'may', 'have', 'benefits', 'in', 'treating', 'depression', ',', 'PTSD', ',', 'and', 'in', 'reducing', 'suicide', 'risk', '?']","['Treatment', 'for', 'chronic', 'pain', 'with', 'movement', ',', 'exercise', ',', 'and', 'cognitive', '-', 'behavioral', 'therapy', 'for', 'pain']",20,16
When was a recommendation to update the 2010 OT CPG initiated?,When,95,in 2015,Introduction,0,0.6666666666666666,"['When', 'was', 'a', 'recommendation', 'to', 'update', 'the', '2010', 'OT', 'CPG', 'initiated', '?']","['in', '2015']",12,2
What is the updated CPG intended for?,What,96,"to assist healthcare providers in all aspects of patient care, including, but not limited to, diagnosis, treatment, and follow-up",Introduction,0,0.972972972972973,"['What', 'is', 'the', 'updated', 'CPG', 'intended', 'for', '?']","['to', 'assist', 'healthcare', 'providers', 'in', 'all', 'aspects', 'of', 'patient', 'care', ',', 'including', ',', 'but', 'not', 'limited', 'to', ',', 'diagnosis', ',', 'treatment', ',', 'and', 'follow', '-', 'up']",8,26
What does the updated CPG include?,What,97,"objective, evidence-based information on the management of chronic pain",Introduction,1,1.0,"['What', 'does', 'the', 'updated', 'CPG', 'include', '?']","['objective', ',', 'evidence', '-', 'based', 'information', 'on', 'the', 'management', 'of', 'chronic', 'pain']",7,12
"How much to take from days 1 to 10, when using morphine SR 15 mg tablets?",How,98,"4 tablets = 60 mg in the morning, 3 tablets = 45 mg in the afternoon, 4 tablets = 60 mg in the evening",Specifications,1,1.0,"['How', 'much', 'to', 'take', 'from', 'days', '1', 'to', '10', ',', 'when', 'using', 'morphine', 'SR', '15', 'mg', 'tablets', '?']","['4', 'tablets', '=', '60', 'mg', 'in', 'the', 'morning', ',', '3', 'tablets', '=', '45', 'mg', 'in', 'the', 'afternoon', ',', '4', 'tablets', '=', '60', 'mg', 'in', 'the', 'evening']",18,26
"How much to take from days 11 to 20, when using morphine SR 15 mg tablets?",How,100,"3 tablets = 45 mg in the morning, 3 tablets = 45 mg in the afternoon, 4 tablets = 60 mg in the evening",Specifications,1,1.0,"['How', 'much', 'to', 'take', 'from', 'days', '11', 'to', '20', ',', 'when', 'using', 'morphine', 'SR', '15', 'mg', 'tablets', '?']","['3', 'tablets', '=', '45', 'mg', 'in', 'the', 'morning', ',', '3', 'tablets', '=', '45', 'mg', 'in', 'the', 'afternoon', ',', '4', 'tablets', '=', '60', 'mg', 'in', 'the', 'evening']",18,26
"How much to take from days 21 to 30, when using morphine SR 15 mg tablets?",How,101,"3 tablets = 45 mg in the morning, 3 tablets = 45 mg in the afternoon, 3 tablets = 45 mg in the evening",Specifications,1,1.0,"['How', 'much', 'to', 'take', 'from', 'days', '21', 'to', '30', ',', 'when', 'using', 'morphine', 'SR', '15', 'mg', 'tablets', '?']","['3', 'tablets', '=', '45', 'mg', 'in', 'the', 'morning', ',', '3', 'tablets', '=', '45', 'mg', 'in', 'the', 'afternoon', ',', '3', 'tablets', '=', '45', 'mg', 'in', 'the', 'evening']",18,26
What dosage indicates high risk of adverse events?,What,102,doses of 90 MEDD (Morphine equivalent daily dose) and higher,Specifications,1,1.0,"['What', 'dosage', 'indicates', 'high', 'risk', 'of', 'adverse', 'events', '?']","['doses', 'of', '90', 'MEDD', '(', 'Morphine', 'equivalent', 'daily', 'dose', ')', 'and', 'higher']",9,12
What to do when there is an overdose event involving opioids?,What,103,Re-evaluate the risks and benefits of continuing opioid therapy,Specifications,0,0.0,"['What', 'to', 'do', 'when', 'there', 'is', 'an', 'overdose', 'event', 'involving', 'opioids', '?']","['Re', '-', 'evaluate', 'the', 'risks', 'and', 'benefits', 'of', 'continuing', 'opioid', 'therapy']",12,11
What to do when there are concerns related to an increased risk of SUD?,What,104,Re-evaluate the risks and benefits of continuing opioid therapy,Specifications,1,1.0,"['What', 'to', 'do', 'when', 'there', 'are', 'concerns', 'related', 'to', 'an', 'increased', 'risk', 'of', 'SUD', '?']","['Re', '-', 'evaluate', 'the', 'risks', 'and', 'benefits', 'of', 'continuing', 'opioid', 'therapy']",15,11
What to do when there are severe unmanageable adverse effects?,What,105,Re-evaluate the risks and benefits of continuing opioid therapy,Specifications,1,1.0,"['What', 'to', 'do', 'when', 'there', 'are', 'severe', 'unmanageable', 'adverse', 'effects', '?']","['Re', '-', 'evaluate', 'the', 'risks', 'and', 'benefits', 'of', 'continuing', 'opioid', 'therapy']",11,11
What to do when there is no pain reduction?,What,106,Re-evaluate the risks and benefits of continuing opioid therapy,Specifications,1,1.0,"['What', 'to', 'do', 'when', 'there', 'is', 'no', 'pain', 'reduction', '?']","['Re', '-', 'evaluate', 'the', 'risks', 'and', 'benefits', 'of', 'continuing', 'opioid', 'therapy']",10,11
What are some examples of severe unmanageable adverse effects?,What,107,"drowsiness, constipation, and cognitive impairment",Specifications,1,1.0,"['What', 'are', 'some', 'examples', 'of', 'severe', 'unmanageable', 'adverse', 'effects', '?']","['drowsiness', ',', 'constipation', ',', 'and', 'cognitive', 'impairment']",10,7
Which factors can raise concerns related to an increased risk of substance use disorder?,Which,108,"behaviors, age < 30, family history, personal history of SUD",Specifications,1,1.0,"['Which', 'factors', 'can', 'raise', 'concerns', 'related', 'to', 'an', 'increased', 'risk', 'of', 'substance', 'use', 'disorder', '?']","['behaviors', ',', 'age', '<', '30', ',', 'family', 'history', ',', 'personal', 'history', 'of', 'SUD']",15,13
Which behaviors can be characterized as unsafe?,Which,109,"early refills, lost/stolen prescription, buying or borrowing opioids, failure to obtain or aberrant UDT",Specifications,1,1.0,"['Which', 'behaviors', 'can', 'be', 'characterized', 'as', 'unsafe', '?']","['early', 'refills', ',', 'lost', '/', 'stolen', 'prescription', ',', 'buying', 'or', 'borrowing', 'opioids', ',', 'failure', 'to', 'obtain', 'or', 'aberrant', 'UDT']",8,19
What are examples of non-adherence to the treatment plan or unsafe behaviors?,What,110,"early refills, lost/stolen prescription, buying or borrowing opioids, failure to obtain or aberrant UDT",Specifications,1,1.0,"['What', 'are', 'examples', 'of', 'non', '-', 'adherence', 'to', 'the', 'treatment', 'plan', 'or', 'unsafe', 'behaviors', '?']","['early', 'refills', ',', 'lost', '/', 'stolen', 'prescription', ',', 'buying', 'or', 'borrowing', 'opioids', ',', 'failure', 'to', 'obtain', 'or', 'aberrant', 'UDT']",15,19
What to do when there is no improvement in function?,What,111,Re-evaluate the risks and benefits of continuing opioid therapy,Specifications,1,1.0,"['What', 'to', 'do', 'when', 'there', 'is', 'no', 'improvement', 'in', 'function', '?']","['Re', '-', 'evaluate', 'the', 'risks', 'and', 'benefits', 'of', 'continuing', 'opioid', 'therapy']",11,11
What to do when patient requests to discontinue therapy?,What,112,Re-evaluate the risks and benefits of continuing opioid therapy,Specifications,0,0.6153846153846153,"['What', 'to', 'do', 'when', 'patient', 'requests', 'to', 'discontinue', 'therapy', '?']","['Re', '-', 'evaluate', 'the', 'risks', 'and', 'benefits', 'of', 'continuing', 'opioid', 'therapy']",10,11
How much dosage indicates high risk of adverse events?,How,113,doses of 90 MEDD (Morphine equivalent daily dose) and higher,Specifications,1,1.0,"['How', 'much', 'dosage', 'indicates', 'high', 'risk', 'of', 'adverse', 'events', '?']","['doses', 'of', '90', 'MEDD', '(', 'Morphine', 'equivalent', 'daily', 'dose', ')', 'and', 'higher']",10,12
What to do when there is non-adherence to the treatment plan or unsafe behaviors?,What,114,Re-evaluate the risks and benefits of continuing opioid therapy,Specifications,1,1.0,"['What', 'to', 'do', 'when', 'there', 'is', 'non', '-', 'adherence', 'to', 'the', 'treatment', 'plan', 'or', 'unsafe', 'behaviors', '?']","['Re', '-', 'evaluate', 'the', 'risks', 'and', 'benefits', 'of', 'continuing', 'opioid', 'therapy']",17,11
What does it mean by severe unmanageable adverse effects?,What,115,"drowsiness, constipation, and cognitive impairment",Specifications,1,1.0,"['What', 'does', 'it', 'mean', 'by', 'severe', 'unmanageable', 'adverse', 'effects', '?']","['drowsiness', ',', 'constipation', ',', 'and', 'cognitive', 'impairment']",10,7
What to do when dosage indicates high risk of adverse events?,What,116,Re-evaluate the risks and benefits of continuing opioid therapy,Specifications,0,0.22222222222222224,"['What', 'to', 'do', 'when', 'dosage', 'indicates', 'high', 'risk', 'of', 'adverse', 'events', '?']","['Re', '-', 'evaluate', 'the', 'risks', 'and', 'benefits', 'of', 'continuing', 'opioid', 'therapy']",12,11
What to do when there are concerns related to an increased risk of substance use disorder?,What,117,Re-evaluate the risks and benefits of continuing opioid therapy,Specifications,1,1.0,"['What', 'to', 'do', 'when', 'there', 'are', 'concerns', 'related', 'to', 'an', 'increased', 'risk', 'of', 'substance', 'use', 'disorder', '?']","['Re', '-', 'evaluate', 'the', 'risks', 'and', 'benefits', 'of', 'continuing', 'opioid', 'therapy']",17,11
When to re-evaluate the risks and benefits of continuing opioid therapy?,When,118,"no pain reduction, no improvement in function or patient requests to discontinue therapy, severe unmanageable adverse effects, dosage indicates high risk of adverse events, concerns related to an increased risk of SUD (Substance use disorder) (e.g., behaviors, age < 30, family history, personal history of SUD), an overdose event involving opioids, non-adherence to the treatment plan or unsafe behaviors",Specifications,0,0.0,"['When', 'to', 're', '-', 'evaluate', 'the', 'risks', 'and', 'benefits', 'of', 'continuing', 'opioid', 'therapy', '?']","['no', 'pain', 'reduction', ',', 'no', 'improvement', 'in', 'function', 'or', 'patient', 'requests', 'to', 'discontinue', 'therapy', ',', 'severe', 'unmanageable', 'adverse', 'effects', ',', 'dosage', 'indicates', 'high', 'risk', 'of', 'adverse', 'events', ',', 'concerns', 'related', 'to', 'an', 'increased', 'risk', 'of', 'SUD', '(', 'Substance', 'use', 'disorder', ')', '(', 'e.g.', ',', 'behaviors', ',', 'age', '<', '30', ',', 'family', 'history', ',', 'personal', 'history', 'of', 'SUD', ')', ',', 'an', 'overdose', 'event', 'involving', 'opioids', ',', 'non', '-', 'adherence', 'to', 'the', 'treatment', 'plan', 'or', 'unsafe', 'behaviors']",14,75
What to do when patients are displaying other aberrant behaviors during the taper?,What,119,providing follow-up in a clinic visit may be more optimal than a telephone visit,Specifications,1,1.0,"['What', 'to', 'do', 'when', 'patients', 'are', 'displaying', 'other', 'aberrant', 'behaviors', 'during', 'the', 'taper', '?']","['providing', 'follow', '-', 'up', 'in', 'a', 'clinic', 'visit', 'may', 'be', 'more', 'optimal', 'than', 'a', 'telephone', 'visit']",14,16
Where to follow up with the Veteran during the slower taper?,Where,121,in the clinic and/or over telephone,Specifications,0,0.0,"['Where', 'to', 'follow', 'up', 'with', 'the', 'Veteran', 'during', 'the', 'slower', 'taper', '?']","['in', 'the', 'clinic', 'and/or', 'over', 'telephone']",12,6
What to do if there are issues with the Veteran obtaining outside prescriptions during the taper?,What,122,providing follow-up in a clinic visit may be more optimal than a telephone visit,Specifications,1,1.0,"['What', 'to', 'do', 'if', 'there', 'are', 'issues', 'with', 'the', 'Veteran', 'obtaining', 'outside', 'prescriptions', 'during', 'the', 'taper', '?']","['providing', 'follow', '-', 'up', 'in', 'a', 'clinic', 'visit', 'may', 'be', 'more', 'optimal', 'than', 'a', 'telephone', 'visit']",17,16
When to follow up with the Veteran during the rapid taper?,When,123,daily before each dose reduction or if available offer inpatient admission,Specifications,0,0.5000000000000001,"['When', 'to', 'follow', 'up', 'with', 'the', 'Veteran', 'during', 'the', 'rapid', 'taper', '?']","['daily', 'before', 'each', 'dose', 'reduction', 'or', 'if', 'available', 'offer', 'inpatient', 'admission']",12,11
Where to follow up with the Veteran during the slowest taper?,Where,125,in the clinic and/or over telephone,Specifications,0,0.0,"['Where', 'to', 'follow', 'up', 'with', 'the', 'Veteran', 'during', 'the', 'slowest', 'taper', '?']","['in', 'the', 'clinic', 'and/or', 'over', 'telephone']",12,6
Where to follow up with the Veteran during the faster taper?,Where,126,in the clinic and/or over telephone,Specifications,0,0.0,"['Where', 'to', 'follow', 'up', 'with', 'the', 'Veteran', 'during', 'the', 'faster', 'taper', '?']","['in', 'the', 'clinic', 'and/or', 'over', 'telephone']",12,6
Who may require a clinic visit over telephone follow-up?,Who,127,A Veteran with high risk due to a medical condition,Specifications,1,1.0,"['Who', 'may', 'require', 'a', 'clinic', 'visit', 'over', 'telephone', 'follow', '-', 'up', '?']","['A', 'Veteran', 'with', 'high', 'risk', 'due', 'to', 'a', 'medical', 'condition']",12,10
Who will need to determine whether a telephone or in-clinic appointment is appropriate based on the risk category of the Veteran?,Who,128,Providers,Specifications,1,1.0,"['Who', 'will', 'need', 'to', 'determine', 'whether', 'a', 'telephone', 'or', 'in', '-', 'clinic', 'appointment', 'is', 'appropriate', 'based', 'on', 'the', 'risk', 'category', 'of', 'the', 'Veteran', '?']",['Providers'],24,1
Who may need to be included in the follow-up plan?,Who,129,Mental health practitioners,Specifications,1,1.0,"['Who', 'may', 'need', 'to', 'be', 'included', 'in', 'the', 'follow', '-', 'up', 'plan', '?']","['Mental', 'health', 'practitioners']",13,3
When to follow up with the Veteran during the faster taper?,When,130,weekly before each dose reduction,Specifications,1,1.0,"['When', 'to', 'follow', 'up', 'with', 'the', 'Veteran', 'during', 'the', 'faster', 'taper', '?']","['weekly', 'before', 'each', 'dose', 'reduction']",12,5
When to follow up with the Veteran during the slower taper?,When,131,1 to 4 weeks after starting taper then monthly before each reduction,Specifications,1,1.0,"['When', 'to', 'follow', 'up', 'with', 'the', 'Veteran', 'during', 'the', 'slower', 'taper', '?']","['1', 'to', '4', 'weeks', 'after', 'starting', 'taper', 'then', 'monthly', 'before', 'each', 'reduction']",12,12
What is recommended to be a team function?,What,132,Follow-up for tapering,Specifications,1,1.0,"['What', 'is', 'recommended', 'to', 'be', 'a', 'team', 'function', '?']","['Follow', '-', 'up', 'for', 'tapering']",9,5
Who may have decompensation during the taper?,Who,133,A Veteran with high risk due to a medical condition,Specifications,1,1.0,"['Who', 'may', 'have', 'decompensation', 'during', 'the', 'taper', '?']","['A', 'Veteran', 'with', 'high', 'risk', 'due', 'to', 'a', 'medical', 'condition']",8,10
Where to follow up with the Veteran during the rapid taper?,Where,135,"in the hospital, clinic or over telephone",Specifications,0,0.0,"['Where', 'to', 'follow', 'up', 'with', 'the', 'Veteran', 'during', 'the', 'rapid', 'taper', '?']","['in', 'the', 'hospital', ',', 'clinic', 'or', 'over', 'telephone']",12,8
When to follow up with the Veteran during the slowest taper?,When,137,1 to 4 weeks after starting taper then monthly before each reduction,Specifications,1,1.0,"['When', 'to', 'follow', 'up', 'with', 'the', 'Veteran', 'during', 'the', 'slowest', 'taper', '?']","['1', 'to', '4', 'weeks', 'after', 'starting', 'taper', 'then', 'monthly', 'before', 'each', 'reduction']",12,12
Which tapers may be required in certain instances like drug diversion?,Which,138,More rapid tapers,Specifications,1,1.0,"['Which', 'tapers', 'may', 'be', 'required', 'in', 'certain', 'instances', 'like', 'drug', 'diversion', '?']","['More', 'rapid', 'tapers']",12,3
How long does it take to lose tolerance?,How,139,as little as a week,Specifications,1,1.0,"['How', 'long', 'does', 'it', 'take', 'to', 'lose', 'tolerance', '?']","['as', 'little', 'as', 'a', 'week']",9,5
Which tapers may be required in certain instances like illegal activities?,Which,140,More rapid tapers,Specifications,1,1.0,"['Which', 'tapers', 'may', 'be', 'required', 'in', 'certain', 'instances', 'like', 'illegal', 'activities', '?']","['More', 'rapid', 'tapers']",12,3
Which tapers may be required in certain instances like situations where the risks of continuing the opioid outweigh the risks of a rapid taper?,Which,142,More rapid tapers,Specifications,1,1.0,"['Which', 'tapers', 'may', 'be', 'required', 'in', 'certain', 'instances', 'like', 'situations', 'where', 'the', 'risks', 'of', 'continuing', 'the', 'opioid', 'outweigh', 'the', 'risks', 'of', 'a', 'rapid', 'taper', '?']","['More', 'rapid', 'tapers']",25,3
What to provide to patients at increased risk of overdose?,What,144,opioid overdose education,Specifications,0,0.6666666666666666,"['What', 'to', 'provide', 'to', 'patients', 'at', 'increased', 'risk', 'of', 'overdose', '?']","['opioid', 'overdose', 'education']",11,3
How long does it take to complete slower tapers?,How,146,several months to years,Specifications,0,0.6153846153846153,"['How', 'long', 'does', 'it', 'take', 'to', 'complete', 'slower', 'tapers', '?']","['several', 'months', 'to', 'years']",10,4
Which tapers are often the most tolerable?,Which,147,"Slower, more gradual tapers",Specifications,1,1.0,"['Which', 'tapers', 'are', 'often', 'the', 'most', 'tolerable', '?']","['Slower', ',', 'more', 'gradual', 'tapers']",8,5
"Which tapers may be required in certain instances like drug diversion, illegal activities, or situations where the risks of continuing the opioid outweigh the risks of a rapid taper?",Which,149,More rapid tapers,Specifications,1,1.0,"['Which', 'tapers', 'may', 'be', 'required', 'in', 'certain', 'instances', 'like', 'drug', 'diversion', ',', 'illegal', 'activities', ',', 'or', 'situations', 'where', 'the', 'risks', 'of', 'continuing', 'the', 'opioid', 'outweigh', 'the', 'risks', 'of', 'a', 'rapid', 'taper', '?']","['More', 'rapid', 'tapers']",32,3
Whom to provide opioid overdose education?,Who,150,patients at increased risk of overdose,Specifications,1,1.0,"['Whom', 'to', 'provide', 'opioid', 'overdose', 'education', '?']","['patients', 'at', 'increased', 'risk', 'of', 'overdose']",7,6
Which tapers can be completed over several months to years?,Which,151,"Slower, more gradual tapers",Specifications,1,1.0,"['Which', 'tapers', 'can', 'be', 'completed', 'over', 'several', 'months', 'to', 'years', '?']","['Slower', ',', 'more', 'gradual', 'tapers']",11,5
"When formulating an opioid taper plan, what can be the initial goal?",When,153,dose reduction or complete discontinuation,Specifications,1,1.0,"['When', 'formulating', 'an', 'opioid', 'taper', 'plan', ',', 'what', 'can', 'be', 'the', 'initial', 'goal', '?']","['dose', 'reduction', 'or', 'complete', 'discontinuation']",14,5
What to prescribe to patients at increased risk of overdose?,What,154,naloxone,Specifications,1,1.0,"['What', 'to', 'prescribe', 'to', 'patients', 'at', 'increased', 'risk', 'of', 'overdose', '?']",['naloxone'],11,1
What to document in the Veteran’s medical record?,What,156,the rationale for the opioid taper and the opioid taper schedule,Specifications,1,1.0,"['What', 'to', 'document', 'in', 'the', 'Veteran', '’s', 'medical', 'record', '?']","['the', 'rationale', 'for', 'the', 'opioid', 'taper', 'and', 'the', 'opioid', 'taper', 'schedule']",10,11
Whom to prescribe naloxone?,Who,157,patients at increased risk of overdose,Specifications,1,1.0,"['Whom', 'to', 'prescribe', 'naloxone', '?']","['patients', 'at', 'increased', 'risk', 'of', 'overdose']",5,6
"When the risks of continuing the opioid outweigh the risks of a rapid taper, which tapers may be required?",When,158,More rapid tapers,Specifications,1,1.0,"['When', 'the', 'risks', 'of', 'continuing', 'the', 'opioid', 'outweigh', 'the', 'risks', 'of', 'a', 'rapid', 'taper', ',', 'which', 'tapers', 'may', 'be', 'required', '?']","['More', 'rapid', 'tapers']",21,3
What kind of treatments can be beneficial for reducing pain intensity and disability  when compared to usual care in the treatment of chronic pain condition?,What,159,"Exercise treatments, including yoga",Recommendations,1,1.0,"['What', 'kind', 'of', 'treatments', 'can', 'be', 'beneficial', 'for', 'reducing', 'pain', 'intensity', 'and', 'disability', ' ', 'when', 'compared', 'to', 'usual', 'care', 'in', 'the', 'treatment', 'of', 'chronic', 'pain', 'condition', '?']","['Exercise', 'treatments', ',', 'including', 'yoga']",27,5
What kind of intervention has been  shown to be more effective than usual care in improving pain and disability?,What,160,"multidisciplinary biopsychosocial rehabilitation (described as a combination of a physical  intervention such as graded exercise and a psychological, social, or occupational intervention)",Recommendations,0,0.2727272727272727,"['What', 'kind', 'of', 'intervention', 'has', 'been', ' ', 'shown', 'to', 'be', 'more', 'effective', 'than', 'usual', 'care', 'in', 'improving', 'pain', 'and', 'disability', '?']","['multidisciplinary', 'biopsychosocial', 'rehabilitation', '(', 'described', 'as', 'a', 'combination', 'of', 'a', 'physical', ' ', 'intervention', 'such', 'as', 'graded', 'exercise', 'and', 'a', 'psychological', ',', 'social', ',', 'or', 'occupational', 'intervention', ')']",21,27
Which treatments should be offered to all patients with chronic pain including those currently receiving LOT?,Which,161,exercise and psychological therapies,Recommendations,0,0.25,"['Which', 'treatments', 'should', 'be', 'offered', 'to', 'all', 'patients', 'with', 'chronic', 'pain', 'including', 'those', 'currently', 'receiving', 'LOT', '?']","['exercise', 'and', 'psychological', 'therapies']",17,4
How to choose between psychological and physical therapies as a first-try?,How,162,the choice of which to try first should be individualized based on patient  assessment and a shared decision making process,Recommendations,0,0.7142857142857143,"['How', 'to', 'choose', 'between', 'psychological', 'and', 'physical', 'therapies', 'as', 'a', 'first', '-', 'try', '?']","['the', 'choice', 'of', 'which', 'to', 'try', 'first', 'should', 'be', 'individualized', 'based', 'on', 'patient', ' ', 'assessment', 'and', 'a', 'shared', 'decision', 'making', 'process']",14,21
What have been found to be effective for pain reduction in multiple pain conditions?,What,163,"Psychological therapies (e.g., cognitive behavioral interventions such as Cognitive Behavioral Therapy  [CBT], biofeedback)",Recommendations,1,1.0,"['What', 'have', 'been', 'found', 'to', 'be', 'effective', 'for', 'pain', 'reduction', 'in', 'multiple', 'pain', 'conditions', '?']","['Psychological', 'therapies', '(', 'e.g.', ',', 'cognitive', 'behavioral', 'interventions', 'such', 'as', 'Cognitive', 'Behavioral', 'Therapy', ' ', '[', 'CBT', ']', ',', 'biofeedback', ')']",15,20
What evidence is there to recommend psychological over physical therapies or vice versa?,What,164,insufficient,Recommendations,1,1.0,"['What', 'evidence', 'is', 'there', 'to', 'recommend', 'psychological', 'over', 'physical', 'therapies', 'or', 'vice', 'versa', '?']",['insufficient'],14,1
What are some examples of psychological therapies?,What,165,"cognitive behavioral interventions such as Cognitive Behavioral Therapy  [CBT], biofeedback",Recommendations,1,1.0,"['What', 'are', 'some', 'examples', 'of', 'psychological', 'therapies', '?']","['cognitive', 'behavioral', 'interventions', 'such', 'as', 'Cognitive', 'Behavioral', 'Therapy', ' ', '[', 'CBT', ']', ',', 'biofeedback']",8,14
What do psychological therapies help?,What,166,effective for pain reduction in multiple pain conditions,Recommendations,0,0.8571428571428571,"['What', 'do', 'psychological', 'therapies', 'help', '?']","['effective', 'for', 'pain', 'reduction', 'in', 'multiple', 'pain', 'conditions']",6,8
Why exercise and psychological therapies are preferred over LOT?,Why,167,In light of the low harms associated with exercise and psychological therapies when compared with LOT,Recommendations,1,1.0,"['Why', 'exercise', 'and', 'psychological', 'therapies', 'are', 'preferred', 'over', 'LOT', '?']","['In', 'light', 'of', 'the', 'low', 'harms', 'associated', 'with', 'exercise', 'and', 'psychological', 'therapies', 'when', 'compared', 'with', 'LOT']",10,16
Which treatments are preferred over LOT?,Which,168,exercise and psychological therapies,Recommendations,1,1.0,"['Which', 'treatments', 'are', 'preferred', 'over', 'LOT', '?']","['exercise', 'and', 'psychological', 'therapies']",7,4
Why exercise and psychological therapies should be offered to all patients with chronic pain including  those currently receiving LOT?,Why,169,In light of the low harms associated with exercise and psychological therapies when compared with LOT,Recommendations,1,1.0,"['Why', 'exercise', 'and', 'psychological', 'therapies', 'should', 'be', 'offered', 'to', 'all', 'patients', 'with', 'chronic', 'pain', 'including', ' ', 'those', 'currently', 'receiving', 'LOT', '?']","['In', 'light', 'of', 'the', 'low', 'harms', 'associated', 'with', 'exercise', 'and', 'psychological', 'therapies', 'when', 'compared', 'with', 'LOT']",21,16
How do exercise and  psychological therapies help reduce pain intensity and disability?,How,170,"Exercise and  psychological therapies may each exert their influence through multiple mechanisms including but not  limited to the reduction in fear-avoidance, reduction in catastrophizing, and/or enhancing mood.",Recommendations,0,0.9166666666666666,"['How', 'do', 'exercise', 'and', ' ', 'psychological', 'therapies', 'help', 'reduce', 'pain', 'intensity', 'and', 'disability', '?']","['Exercise', 'and', ' ', 'psychological', 'therapies', 'may', 'each', 'exert', 'their', 'influence', 'through', 'multiple', 'mechanisms', 'including', 'but', 'not', ' ', 'limited', 'to', 'the', 'reduction', 'in', 'fear', '-', 'avoidance', ',', 'reduction', 'in', 'catastrophizing', ',', 'and/or', 'enhancing', 'mood', '.']",14,34
What is multidisciplinary biopsychosocial rehabilitation?,What,171,"described as a combination of a physical  intervention such as graded exercise and a psychological, social, or occupational intervention",Recommendations,0,0.9333333333333333,"['What', 'is', 'multidisciplinary', 'biopsychosocial', 'rehabilitation', '?']","['described', 'as', 'a', 'combination', 'of', 'a', 'physical', ' ', 'intervention', 'such', 'as', 'graded', 'exercise', 'and', 'a', 'psychological', ',', 'social', ',', 'or', 'occupational', 'intervention']",6,22
Which interventions are safe and have not been shown to increase morbidity or mortality?,Which,172,"multidisciplinary biopsychosocial rehabilitation (described as a combination of a physical  intervention such as graded exercise and a psychological, social, or occupational intervention)",Recommendations,0,0.2727272727272727,"['Which', 'interventions', 'are', 'safe', 'and', 'have', 'not', 'been', 'shown', 'to', 'increase', 'morbidity', 'or', 'mortality', '?']","['multidisciplinary', 'biopsychosocial', 'rehabilitation', '(', 'described', 'as', 'a', 'combination', 'of', 'a', 'physical', ' ', 'intervention', 'such', 'as', 'graded', 'exercise', 'and', 'a', 'psychological', ',', 'social', ',', 'or', 'occupational', 'intervention', ')']",15,27
Who are recommended to be offered medication assisted treatment? ,Who,174,patients with chronic pain and opioid use disorder,Recommendations,1,1.0,"['Who', 'are', 'recommended', 'to', 'be', 'offered', 'medication', 'assisted', 'treatment', '?']","['patients', 'with', 'chronic', 'pain', 'and', 'opioid', 'use', 'disorder']",10,8
"What kind of care is recommended that addresses pain, substance use disorders, and/or mental health problems for patients presenting with high risk and/or aberrant behavior?",What,175,interdisciplinary,Recommendations,1,1.0,"['What', 'kind', 'of', 'care', 'is', 'recommended', 'that', 'addresses', 'pain', ',', 'substance', 'use', 'disorders', ',', 'and/or', 'mental', 'health', 'problems', 'for', 'patients', 'presenting', 'with', 'high', 'risk', 'and/or', 'aberrant', 'behavior', '?']",['interdisciplinary'],28,1
Where can we find information on the Management of Substance Use Disorders?,Where,176,VA/DoD Clinical Practice Guideline,Recommendations,1,1.0,"['Where', 'can', 'we', 'find', 'information', 'on', 'the', 'Management', 'of', 'Substance', 'Use', 'Disorders', '?']","['VA', '/', 'DoD', 'Clinical', 'Practice', 'Guideline']",13,6
What does interdisciplinary care do?,What,177,"addresses pain, substance use disorders, and/or mental health problems for patients presenting with high risk and/or aberrant behavior",Recommendations,1,1.0,"['What', 'does', 'interdisciplinary', 'care', 'do', '?']","['addresses', 'pain', ',', 'substance', 'use', 'disorders', ',', 'and/or', 'mental', 'health', 'problems', 'for', 'patients', 'presenting', 'with', 'high', 'risk', 'and/or', 'aberrant', 'behavior']",6,20
What treatment is recommended to offer for opioid use disorder to patients with chronic pain and opioid use disorder?,What,178,medication assisted treatment,Recommendations,1,1.0,"['What', 'treatment', 'is', 'recommended', 'to', 'offer', 'for', 'opioid', 'use', 'disorder', 'to', 'patients', 'with', 'chronic', 'pain', 'and', 'opioid', 'use', 'disorder', '?']","['medication', 'assisted', 'treatment']",20,3
How much did the rate of heroin overdose deaths increase between 2000 and 2013?,How,179,nearly four-fold,Background,1,1.0,"['How', 'much', 'did', 'the', 'rate', 'of', 'heroin', 'overdose', 'deaths', 'increase', 'between', '2000', 'and', '2013', '?']","['nearly', 'four', '-', 'fold']",15,4
What called attention to the need for a paradigm shift in pain and its treatment protocols?,What,180,"increase in the use of opioids, as well as associated morbidity, mortality, and other adverse outcomes",Background,0,0.967741935483871,"['What', 'called', 'attention', 'to', 'the', 'need', 'for', 'a', 'paradigm', 'shift', 'in', 'pain', 'and', 'its', 'treatment', 'protocols', '?']","['increase', 'in', 'the', 'use', 'of', 'opioids', ',', 'as', 'well', 'as', 'associated', 'morbidity', ',', 'mortality', ',', 'and', 'other', 'adverse', 'outcomes']",17,19
Where can further information on SUD treatment be found?,Where,181,the VA/DoD Clinical Practice Guideline for the Management of Substance Use Disorders (VA/DoD SUD CPG),Background,0,0.962962962962963,"['Where', 'can', 'further', 'information', 'on', 'SUD', 'treatment', 'be', 'found', '?']","['the', 'VA', '/', 'DoD', 'Clinical', 'Practice', 'Guideline', 'for', 'the', 'Management', 'of', 'Substance', 'Use', 'Disorders', '(', 'VA', '/', 'DoD', 'SUD', 'CPG', ')']",10,21
What was the first opioid used by most of the people entering SUD treatment for heroin use in the 2000s?,What,182,prescription opioids,Background,1,1.0,"['What', 'was', 'the', 'first', 'opioid', 'used', 'by', 'most', 'of', 'the', 'people', 'entering', 'SUD', 'treatment', 'for', 'heroin', 'use', 'in', 'the', '2000s', '?']","['prescription', 'opioids']",21,2
What percentage of people entering SUD treatment for heroin use started using heroin as their first opioid in the 1960s?,What,183,80%,Background,1,1.0,"['What', 'percentage', 'of', 'people', 'entering', 'SUD', 'treatment', 'for', 'heroin', 'use', 'started', 'using', 'heroin', 'as', 'their', 'first', 'opioid', 'in', 'the', '1960s', '?']","['80', '%']",21,2
What percentage of people entering SUD treatment for heroin use started using prescription opioids as their first opioid in the 2000s?,What,184,75%,Background,1,1.0,"['What', 'percentage', 'of', 'people', 'entering', 'SUD', 'treatment', 'for', 'heroin', 'use', 'started', 'using', 'prescription', 'opioids', 'as', 'their', 'first', 'opioid', 'in', 'the', '2000s', '?']","['75', '%']",22,2
What was the first opioid used by most of the people entering SUD treatment for heroin use in the 1960s?,What,185,heroin,Background,1,1.0,"['What', 'was', 'the', 'first', 'opioid', 'used', 'by', 'most', 'of', 'the', 'people', 'entering', 'SUD', 'treatment', 'for', 'heroin', 'use', 'in', 'the', '1960s', '?']",['heroin'],21,1
What is VA/DoD SUD CPG?,What,186,VA/DoD Clinical Practice Guideline for the Management of Substance Use Disorders,Background,0,0.9473684210526316,"['What', 'is', 'VA', '/', 'DoD', 'SUD', 'CPG', '?']","['VA', '/', 'DoD', 'Clinical', 'Practice', 'Guideline', 'for', 'the', 'Management', 'of', 'Substance', 'Use', 'Disorders']",8,13
What should be exhausted before consideration of LOT?,What,189,all avenues for obtaining these treatments (e.g. Internet based CBT) and all appropriate non opioid medications,Recommendations,1,1.0,"['What', 'should', 'be', 'exhausted', 'before', 'consideration', 'of', 'LOT', '?']","['all', 'avenues', 'for', 'obtaining', 'these', 'treatments', '(', 'e.g.', 'Internet', 'based', 'CBT', ')', 'and', 'all', 'appropriate', 'non', 'opioid', 'medications']",9,18
"What are the treatment options for anxiety, dysphoria, lacrimation, and rhinorrhea?",What,190,"hydroxyzine 25 to 50 mg three times a day as needed, diphenhydramine 25 mg every 6 hours as needed",Specifications,1,1.0,"['What', 'are', 'the', 'treatment', 'options', 'for', 'anxiety', ',', 'dysphoria', ',', 'lacrimation', ',', 'and', 'rhinorrhea', '?']","['hydroxyzine', '25', 'to', '50', 'mg', 'three', 'times', 'a', 'day', 'as', 'needed', ',', 'diphenhydramine', '25', 'mg', 'every', '6', 'hours', 'as', 'needed']",15,20
What is the treatment option for sleep disturbance?,What,191,Trazodone 25 to 300 mg orally at bedtime,Specifications,1,1.0,"['What', 'is', 'the', 'treatment', 'option', 'for', 'sleep', 'disturbance', '?']","['Trazodone', '25', 'to', '300', 'mg', 'orally', 'at', 'bedtime']",9,8
When to avoid diphenhydramine?,When,192,for Veterans older than 65 years,Specifications,1,1.0,"['When', 'to', 'avoid', 'diphenhydramine', '?']","['for', 'Veterans', 'older', 'than', '65', 'years']",5,6
What are the treatment options for myalgias?,What,194,"NSAIDs (e.g., naproxen 375 to 500 mg twice daily or ibuprofen 400 to 600 mg four times daily), acetaminophen 650 mg every 6 hours as needed, topical medications like menthol/methylsalicylate cream, lidocaine cream/ointment",Specifications,0,0.05882352941176471,"['What', 'are', 'the', 'treatment', 'options', 'for', 'myalgias', '?']","['NSAIDs', '(', 'e.g.', ',', 'naproxen', '375', 'to', '500', 'mg', 'twice', 'daily', 'or', 'ibuprofen', '400', 'to', '600', 'mg', 'four', 'times', 'daily', ')', ',', 'acetaminophen', '650', 'mg', 'every', '6', 'hours', 'as', 'needed', ',', 'topical', 'medications', 'like', 'menthol', '/', 'methylsalicylate', 'cream', ',', 'lidocaine', 'cream', '/', 'ointment']",8,43
"When reducing 16% of morphine SR 90 mg Q8h = 270 MEDD on week 1, what dose should be taken on week three of the faster opioid tapering?",When,195,45 mg SR (15 mg x 3) Q8h,Specifications,1,1.0,"['When', 'reducing', '16', '%', 'of', 'morphine', 'SR', '90', 'mg', 'Q8h', '=', '270', 'MEDD', 'on', 'week', '1', ',', 'what', 'dose', 'should', 'be', 'taken', 'on', 'week', 'three', 'of', 'the', 'faster', 'opioid', 'tapering', '?']","['45', 'mg', 'SR', '(', '15', 'mg', 'x', '3', ')', 'Q8h']",31,10
"When reducing 16% of morphine SR 90 mg Q8h = 270 MEDD on week 1, what dose should be taken on week seven of the faster opioid tapering?",When,196,15 mg SR QHS x 7 days,Specifications,1,1.0,"['When', 'reducing', '16', '%', 'of', 'morphine', 'SR', '90', 'mg', 'Q8h', '=', '270', 'MEDD', 'on', 'week', '1', ',', 'what', 'dose', 'should', 'be', 'taken', 'on', 'week', 'seven', 'of', 'the', 'faster', 'opioid', 'tapering', '?']","['15', 'mg', 'SR', 'QHS', 'x', '7', 'days']",31,7
When to stop faster tapering?,When,197,after week 7,Specifications,1,1.0,"['When', 'to', 'stop', 'faster', 'tapering', '?']","['after', 'week', '7']",6,3
"When reducing 16% of morphine SR 90 mg Q8h = 270 MEDD on week 1, what dose should be taken on week five of the faster opioid tapering?",When,198,15 mg SR Q8h,Specifications,1,1.0,"['When', 'reducing', '16', '%', 'of', 'morphine', 'SR', '90', 'mg', 'Q8h', '=', '270', 'MEDD', 'on', 'week', '1', ',', 'what', 'dose', 'should', 'be', 'taken', 'on', 'week', 'five', 'of', 'the', 'faster', 'opioid', 'tapering', '?']","['15', 'mg', 'SR', 'Q8h']",31,4
What may be considered after stopping faster tapering after week 7?,What,199,morphine IR 15 mg ½ tablet (7.5 mg) twice daily,Specifications,1,1.0,"['What', 'may', 'be', 'considered', 'after', 'stopping', 'faster', 'tapering', 'after', 'week', '7', '?']","['morphine', 'IR', '15', 'mg', '½', 'tablet', '(', '7.5', 'mg', ')', 'twice', 'daily']",12,12
"When reducing 16% of morphine SR 90 mg Q8h = 270 MEDD on week 1, what dose should be taken on week four of the faster opioid tapering?",When,200,30 mg SR (15 mg x 2) Q8h,Specifications,1,1.0,"['When', 'reducing', '16', '%', 'of', 'morphine', 'SR', '90', 'mg', 'Q8h', '=', '270', 'MEDD', 'on', 'week', '1', ',', 'what', 'dose', 'should', 'be', 'taken', 'on', 'week', 'four', 'of', 'the', 'faster', 'opioid', 'tapering', '?']","['30', 'mg', 'SR', '(', '15', 'mg', 'x', '2', ')', 'Q8h']",31,10
How much opioid to reduce in the faster taper?,How,201,10 to 20% every week,Specifications,1,1.0,"['How', 'much', 'opioid', 'to', 'reduce', 'in', 'the', 'faster', 'taper', '?']","['10', 'to', '20', '%', 'every', 'week']",10,6
How long does the faster taper take?,How,202,over weeks,Specifications,1,1.0,"['How', 'long', 'does', 'the', 'faster', 'taper', 'take', '?']","['over', 'weeks']",8,2
"When reducing 16% of morphine SR 90 mg Q8h = 270 MEDD on week 1, what dose should be taken on week two of the faster opioid tapering?",When,203,60 mg SR (15 mg x 4) Q8h,Specifications,1,1.0,"['When', 'reducing', '16', '%', 'of', 'morphine', 'SR', '90', 'mg', 'Q8h', '=', '270', 'MEDD', 'on', 'week', '1', ',', 'what', 'dose', 'should', 'be', 'taken', 'on', 'week', 'two', 'of', 'the', 'faster', 'opioid', 'tapering', '?']","['60', 'mg', 'SR', '(', '15', 'mg', 'x', '4', ')', 'Q8h']",31,10
"When reducing 16% of morphine SR 90 mg Q8h = 270 MEDD on week 1, what dose should be taken on week six of the faster opioid tapering?",When,205,15 mg SR Q12h,Specifications,1,1.0,"['When', 'reducing', '16', '%', 'of', 'morphine', 'SR', '90', 'mg', 'Q8h', '=', '270', 'MEDD', 'on', 'week', '1', ',', 'what', 'dose', 'should', 'be', 'taken', 'on', 'week', 'six', 'of', 'the', 'faster', 'opioid', 'tapering', '?']","['15', 'mg', 'SR', 'Q12h']",31,4
What was increasing at an alarming rate until recently?,What,206,the treatment of chronic pain with opioids,Background,1,1.0,"['What', 'was', 'increasing', 'at', 'an', 'alarming', 'rate', 'until', 'recently', '?']","['the', 'treatment', 'of', 'chronic', 'pain', 'with', 'opioids']",10,7
What is a national public health problem as outlined in the 2011 study by the National Academy of Medicine?,What,207,Chronic pain,Background,1,1.0,"['What', 'is', 'a', 'national', 'public', 'health', 'problem', 'as', 'outlined', 'in', 'the', '2011', 'study', 'by', 'the', 'National', 'Academy', 'of', 'Medicine', '?']","['Chronic', 'pain']",20,2
What was the National Academy of Medicine formerly known as?,What,208,the Institute of Medicine [IOM],Background,1,1.0,"['What', 'was', 'the', 'National', 'Academy', 'of', 'Medicine', 'formerly', 'known', 'as', '?']","['the', 'Institute', 'of', 'Medicine', '[', 'IOM', ']']",11,7
How many Americans suffer from some form of chronic pain?,How,209,At least 100 million,Background,1,1.0,"['How', 'many', 'Americans', 'suffer', 'from', 'some', 'form', 'of', 'chronic', 'pain', '?']","['At', 'least', '100', 'million']",11,4
What was accompanying the increase in prescriptions of opioid medications?,What,210,an epidemic of opioid-related adverse events,Background,1,1.0,"['What', 'was', 'accompanying', 'the', 'increase', 'in', 'prescriptions', 'of', 'opioid', 'medications', '?']","['an', 'epidemic', 'of', 'opioid', '-', 'related', 'adverse', 'events']",11,8
What is required when considering opioid therapy beyond 90 days?,What,211,re-evaluation and discussion with patient of risks and benefits,Recommendations,1,1.0,"['What', 'is', 'required', 'when', 'considering', 'opioid', 'therapy', 'beyond', '90', 'days', '?']","['re', '-', 'evaluation', 'and', 'discussion', 'with', 'patient', 'of', 'risks', 'and', 'benefits']",11,11
What timeframe is recommended if prescribing opioid therapy for patients with chronic pain?,What,214,a short duration,Recommendations,1,1.0,"['What', 'timeframe', 'is', 'recommended', 'if', 'prescribing', 'opioid', 'therapy', 'for', 'patients', 'with', 'chronic', 'pain', '?']","['a', 'short', 'duration']",14,3
What is recommended for patients currently on long-term opioid therapy?,What,215,"ongoing risk mitigation strategies (see Recommendations 7-9), assessment for opioid use disorder, and consideration for tapering when risks exceed benefits (see Recommendation 14)",Recommendations,0,0.9302325581395349,"['What', 'is', 'recommended', 'for', 'patients', 'currently', 'on', 'long', '-', 'term', 'opioid', 'therapy', '?']","['ongoing', 'risk', 'mitigation', 'strategies', '(', 'see', 'Recommendations', '7', '-', '9', ')', ',', 'assessment', 'for', 'opioid', 'use', 'disorder', ',', 'and', 'consideration', 'for', 'tapering', 'when', 'risks', 'exceed', 'benefits', '(', 'see', 'Recommendation', '14', ')']",13,31
What does require re-evaluation and discussion with patient of risks and benefits?,What,218,Consideration of opioid therapy beyond 90 days,Recommendations,1,1.0,"['What', 'does', 'require', 're', '-', 'evaluation', 'and', 'discussion', 'with', 'patient', 'of', 'risks', 'and', 'benefits', '?']","['Consideration', 'of', 'opioid', 'therapy', 'beyond', '90', 'days']",15,7
Where can the OSI toolkit materials be found? ,Where,219,https://www.va.gov/PAINMANAGEMENT/Opioid_Safety_Initiative_Toolkit.asp,Background,1,1.0,"['Where', 'can', 'the', 'OSI', 'toolkit', 'materials', 'be', 'found', '?']",['https://www.va.gov/PAINMANAGEMENT/Opioid_Safety_Initiative_Toolkit.asp'],9,1
What is the aim of the patient guide?,What,220,providing information to patients as well as their providers regarding the safe use  of opioids,Background,1,1.0,"['What', 'is', 'the', 'aim', 'of', 'the', 'patient', 'guide', '?']","['providing', 'information', 'to', 'patients', 'as', 'well', 'as', 'their', 'providers', 'regarding', 'the', 'safe', 'use', ' ', 'of', 'opioids']",9,16
Why did VHA issue a policy requiring  standardized education and signature informed consent for all patients receiving LOT for non-cancer  pain? ,Why,221,To further promote safety and patient centered care,Background,1,1.0,"['Why', 'did', 'VHA', 'issue', 'a', 'policy', 'requiring', ' ', 'standardized', 'education', 'and', 'signature', 'informed', 'consent', 'for', 'all', 'patients', 'receiving', 'LOT', 'for', 'non', '-', 'cancer', ' ', 'pain', '?']","['To', 'further', 'promote', 'safety', 'and', 'patient', 'centered', 'care']",26,8
Who issued a policy requiring  standardized education and signature informed consent for all patients receiving LOT for non-cancer  pain? ,Who,222,the VHA,Background,1,1.0,"['Who', 'issued', 'a', 'policy', 'requiring', ' ', 'standardized', 'education', 'and', 'signature', 'informed', 'consent', 'for', 'all', 'patients', 'receiving', 'LOT', 'for', 'non', '-', 'cancer', ' ', 'pain', '?']","['the', 'VHA']",24,2
Name two initiatives that are aimed at improving the safe use of opioids? ,What,223,OSI Toolkit and the patient  guide “Taking Opioids Responsibly for Your Safety and the Safety of Others: Patient Information Guide on  Long-term Opioid Therapy for Chronic Pain”,Background,0,0.0,"['Name', 'two', 'initiatives', 'that', 'are', 'aimed', 'at', 'improving', 'the', 'safe', 'use', 'of', 'opioids', '?']","['OSI', 'Toolkit', 'and', 'the', 'patient', ' ', 'guide', '“', 'Taking', 'Opioids', 'Responsibly', 'for', 'Your', 'Safety', 'and', 'the', 'Safety', 'of', 'Others', ':', 'Patient', 'Information', 'Guide', 'on', ' ', 'Long', '-', 'term', 'Opioid', 'Therapy', 'for', 'Chronic', 'Pain', '”']",14,34
What was the purpose of the OSI toolkit?,What,224,provide clinicians with  materials to inform clinical decision-making regarding opioid therapy and safe opioid prescribing,Background,1,1.0,"['What', 'was', 'the', 'purpose', 'of', 'the', 'OSI', 'toolkit', '?']","['provide', 'clinicians', 'with', ' ', 'materials', 'to', 'inform', 'clinical', 'decision', '-', 'making', 'regarding', 'opioid', 'therapy', 'and', 'safe', 'opioid', 'prescribing']",9,18
When did VHA issue a policy requiring  standardized education and signature informed consent for all patients receiving LOT for non-cancer  pain? ,When,225,in 2014,Background,0,0.6666666666666666,"['When', 'did', 'VHA', 'issue', 'a', 'policy', 'requiring', ' ', 'standardized', 'education', 'and', 'signature', 'informed', 'consent', 'for', 'all', 'patients', 'receiving', 'LOT', 'for', 'non', '-', 'cancer', ' ', 'pain', '?']","['in', '2014']",26,2
What are the requirements in the policy issued by the VHA to further promote safety and patient centered care?,What,226,standardized education and signature informed consent for all patients receiving LOT for non-cancer  pain,Background,1,1.0,"['What', 'are', 'the', 'requirements', 'in', 'the', 'policy', 'issued', 'by', 'the', 'VHA', 'to', 'further', 'promote', 'safety', 'and', 'patient', 'centered', 'care', '?']","['standardized', 'education', 'and', 'signature', 'informed', 'consent', 'for', 'all', 'patients', 'receiving', 'LOT', 'for', 'non', '-', 'cancer', ' ', 'pain']",20,17
Where can more information be found on the patient guide?,Where,227,http://www.healthquality.va.gov/guidelines/Pain/cot/OpiodTheraphyforChronicPainPatientTool20May20 13print.pdf,Background,0,0.0,"['Where', 'can', 'more', 'information', 'be', 'found', 'on', 'the', 'patient', 'guide', '?']","['http://www.healthquality.va.gov/guidelines/Pain/cot/OpiodTheraphyforChronicPainPatientTool20May20', '13print.pdf']",11,2
What is a red flag in the presence of which providers should proceed with utmost caution when considering LOT for these patients?,What,228,A history of overdose,Background,1,1.0,"['What', 'is', 'a', 'red', 'flag', 'in', 'the', 'presence', 'of', 'which', 'providers', 'should', 'proceed', 'with', 'utmost', 'caution', 'when', 'considering', 'LOT', 'for', 'these', 'patients', '?']","['A', 'history', 'of', 'overdose']",23,4
What has been associated with worsening depressive symptoms?,What,232,LOT,Background,1,1.0,"['What', 'has', 'been', 'associated', 'with', 'worsening', 'depressive', 'symptoms', '?']",['LOT'],9,1
What can be signalled by frequent requests for early refills required to control pain?,What,233,an emerging SUD as well as  diversion,Background,1,1.0,"['What', 'can', 'be', 'signalled', 'by', 'frequent', 'requests', 'for', 'early', 'refills', 'required', 'to', 'control', 'pain', '?']","['an', 'emerging', 'SUD', 'as', 'well', 'as', ' ', 'diversion']",15,8
What can be signalled by frequent requests for atypically large quantities required to control pain?,What,234,an emerging SUD as well as  diversion,Background,1,1.0,"['What', 'can', 'be', 'signalled', 'by', 'frequent', 'requests', 'for', 'atypically', 'large', 'quantities', 'required', 'to', 'control', 'pain', '?']","['an', 'emerging', 'SUD', 'as', 'well', 'as', ' ', 'diversion']",16,8
Where can more information be found on PTSD?,Where,236,VA/DoD PTSD CPG,Background,1,1.0,"['Where', 'can', 'more', 'information', 'be', 'found', 'on', 'PTSD', '?']","['VA', '/', 'DoD', 'PTSD', 'CPG']",9,5
What can signal an emerging SUD as well as  diversion?,What,237,Frequent requests for early refills or atypically large quantities required to control pain,Background,1,1.0,"['What', 'can', 'signal', 'an', 'emerging', 'SUD', 'as', 'well', 'as', ' ', 'diversion', '?']","['Frequent', 'requests', 'for', 'early', 'refills', 'or', 'atypically', 'large', 'quantities', 'required', 'to', 'control', 'pain']",12,13
What should be commensurate with risk factors?,What,239,The strategies and their frequency,Recommendations,1,1.0,"['What', 'should', 'be', 'commensurate', 'with', 'risk', 'factors', '?']","['The', 'strategies', 'and', 'their', 'frequency']",8,5
What is recommended upon initiation of long-term opioid  therapy?,What,240,implementing risk mitigation strategies,Recommendations,1,1.0,"['What', 'is', 'recommended', 'upon', 'initiation', 'of', 'long', '-', 'term', 'opioid', ' ', 'therapy', '?']","['implementing', 'risk', 'mitigation', 'strategies']",13,4
How to implement risk mitigation strategies upon initiation of long-term opioid  therapy?,How,241,starting with an informed consent conversation covering the risks and benefits of opioid  therapy as well as alternative therapies,Recommendations,1,1.0,"['How', 'to', 'implement', 'risk', 'mitigation', 'strategies', 'upon', 'initiation', 'of', 'long', '-', 'term', 'opioid', ' ', 'therapy', '?']","['starting', 'with', 'an', 'informed', 'consent', 'conversation', 'covering', 'the', 'risks', 'and', 'benefits', 'of', 'opioid', ' ', 'therapy', 'as', 'well', 'as', 'alternative', 'therapies']",16,20
What should be included in the risk mitigation strategies and their frequency?,What,242,"Ongoing, random urine drug testing (including appropriate confirmatory testing), Checking state prescription drug monitoring programs, Monitoring for overdose potential and suicidality, Providing overdose education, Prescribing of naloxone rescue and accompanying education",Recommendations,0,0.0,"['What', 'should', 'be', 'included', 'in', 'the', 'risk', 'mitigation', 'strategies', 'and', 'their', 'frequency', '?']","['Ongoing', ',', 'random', 'urine', 'drug', 'testing', '(', 'including', 'appropriate', 'confirmatory', 'testing', ')', ',', 'Checking', 'state', 'prescription', 'drug', 'monitoring', 'programs', ',', 'Monitoring', 'for', 'overdose', 'potential', 'and', 'suicidality', ',', 'Providing', 'overdose', 'education', ',', 'Prescribing', 'of', 'naloxone', 'rescue', 'and', 'accompanying', 'education']",13,38
Why should particular caution be used when considering initiating benzodiazepines for Veterans with PTSD who have co-occurring chronic pain?,Why,243,Due to the  difficulty of tapering or discontinuing benzodiazepines,Recommendations,1,1.0,"['Why', 'should', 'particular', 'caution', 'be', 'used', 'when', 'considering', 'initiating', 'benzodiazepines', 'for', 'Veterans', 'with', 'PTSD', 'who', 'have', 'co', '-', 'occurring', 'chronic', 'pain', '?']","['Due', 'to', 'the', ' ', 'difficulty', 'of', 'tapering', 'or', 'discontinuing', 'benzodiazepines']",22,10
Why should abrupt discontinuation of benzodiazepines be avoided?,Why,244,as it can lead to serious adverse  effects including seizures and death,Recommendations,0,0.9565217391304348,"['Why', 'should', 'abrupt', 'discontinuation', 'of', 'benzodiazepines', 'be', 'avoided', '?']","['as', 'it', 'can', 'lead', 'to', 'serious', 'adverse', ' ', 'effects', 'including', 'seizures', 'and', 'death']",9,13
Why can benzodiazepines be challenging to discontinue once initiated?,Why,245,"due to symptoms related to benzodiazepine dependence, exacerbations of PTSD, and/or anxiety",Recommendations,1,1.0,"['Why', 'can', 'benzodiazepines', 'be', 'challenging', 'to', 'discontinue', 'once', 'initiated', '?']","['due', 'to', 'symptoms', 'related', 'to', 'benzodiazepine', 'dependence', ',', 'exacerbations', 'of', 'PTSD', ',', 'and/or', 'anxiety']",10,14
What should be weighed heavily in the risk-benefit evaluation for tapering versus continuing one or both agents?,What,247,Concurrent benzodiazepine and LOT use,Recommendations,0,0.5555555555555556,"['What', 'should', 'be', 'weighed', 'heavily', 'in', 'the', 'risk', '-', 'benefit', 'evaluation', 'for', 'tapering', 'versus', 'continuing', 'one', 'or', 'both', 'agents', '?']","['Concurrent', 'benzodiazepine', 'and', 'LOT', 'use']",20,5
What is the stance regarding the use of benzodiazepines for the prevention of PTSD?,What,248,recommends against,Recommendations,1,1.0,"['What', 'is', 'the', 'stance', 'regarding', 'the', 'use', 'of', 'benzodiazepines', 'for', 'the', 'prevention', 'of', 'PTSD', '?']","['recommends', 'against']",15,2
What kind of risk is associated with concurrent benzodiazepine and LOT use?,What,249,unintentional overdose death,Recommendations,0,0.6,"['What', 'kind', 'of', 'risk', 'is', 'associated', 'with', 'concurrent', 'benzodiazepine', 'and', 'LOT', 'use', '?']","['unintentional', 'overdose', 'death']",13,3
What does caution against the use of benzodiazepines in treatment of PTSD?,What,250,The VA/DoD PTSD  CPG,Recommendations,0,0.4,"['What', 'does', 'caution', 'against', 'the', 'use', 'of', 'benzodiazepines', 'in', 'treatment', 'of', 'PTSD', '?']","['The', 'VA', '/', 'DoD', 'PTSD', ' ', 'CPG']",13,7
What is considered a contraindication to initiation of OT?,What,251,Concomitant use of benzodiazepines,Recommendations,1,1.0,"['What', 'is', 'considered', 'a', 'contraindication', 'to', 'initiation', 'of', 'OT', '?']","['Concomitant', 'use', 'of', 'benzodiazepines']",10,4
What is a serious risk factor for unintentional overdose death?,What,252,Concurrent benzodiazepine and LOT use,Recommendations,1,1.0,"['What', 'is', 'a', 'serious', 'risk', 'factor', 'for', 'unintentional', 'overdose', 'death', '?']","['Concurrent', 'benzodiazepine', 'and', 'LOT', 'use']",11,5
What should be performed with caution and within a team environment when possible?,What,253,Tapering benzodiazepines,Recommendations,1,1.0,"['What', 'should', 'be', 'performed', 'with', 'caution', 'and', 'within', 'a', 'team', 'environment', 'when', 'possible', '?']","['Tapering', 'benzodiazepines']",14,2
How to perform tapering of benzodiazepines?,How,254,with caution and  within a team environment when possible (see Recommendation 26 in the VA/DoD SUD CPG),Recommendations,0,0.6956521739130436,"['How', 'to', 'perform', 'tapering', 'of', 'benzodiazepines', '?']","['with', 'caution', 'and', ' ', 'within', 'a', 'team', 'environment', 'when', 'possible', '(', 'see', 'Recommendation', '26', 'in', 'the', 'VA', '/', 'DoD', 'SUD', 'CPG', ')']",7,22
What kind of discontinuation of benzodiazepines should be avoided?,What,256,abrupt,Recommendations,1,1.0,"['What', 'kind', 'of', 'discontinuation', 'of', 'benzodiazepines', 'should', 'be', 'avoided', '?']",['abrupt'],10,1
What may gradual benzodiazepine taper result in?,What,257,exacerbation of severe PTSD symptoms,Recommendations,1,1.0,"['What', 'may', 'gradual', 'benzodiazepine', 'taper', 'result', 'in', '?']","['exacerbation', 'of', 'severe', 'PTSD', 'symptoms']",8,5
What are associated with a higher incidence of PTSD symptoms?,What,259,Benzodiazepines to treat acute anxiety symptoms after trauma,Recommendations,1,1.0,"['What', 'are', 'associated', 'with', 'a', 'higher', 'incidence', 'of', 'PTSD', 'symptoms', '?']","['Benzodiazepines', 'to', 'treat', 'acute', 'anxiety', 'symptoms', 'after', 'trauma']",11,8
What does recommend against benzodiazepines for the prevention of PTSD?,What,261,The VA/DoD PTSD  CPG,Recommendations,1,1.0,"['What', 'does', 'recommend', 'against', 'benzodiazepines', 'for', 'the', 'prevention', 'of', 'PTSD', '?']","['The', 'VA', '/', 'DoD', 'PTSD', ' ', 'CPG']",11,7
What is the effect of benzodiazepines in patients with PTSD?,What,262,"Although  anxiety may initially improve with benzodiazepines, the improvement is short-lived and may result in  tolerance to increasing doses and eventual failure of the treatment.",Recommendations,1,1.0,"['What', 'is', 'the', 'effect', 'of', 'benzodiazepines', 'in', 'patients', 'with', 'PTSD', '?']","['Although', ' ', 'anxiety', 'may', 'initially', 'improve', 'with', 'benzodiazepines', ',', 'the', 'improvement', 'is', 'short', '-', 'lived', 'and', 'may', 'result', 'in', ' ', 'tolerance', 'to', 'increasing', 'doses', 'and', 'eventual', 'failure', 'of', 'the', 'treatment', '.']",11,31
What should be avoided?,What,263,abrupt discontinuation of benzodiazepines,Recommendations,1,1.0,"['What', 'should', 'be', 'avoided', '?']","['abrupt', 'discontinuation', 'of', 'benzodiazepines']",5,4
"What can be challenging to discontinue due to symptoms related to benzodiazepine dependence, exacerbations of PTSD, and/or anxiety?",What,264,benzodiazepines,Recommendations,1,1.0,"['What', 'can', 'be', 'challenging', 'to', 'discontinue', 'due', 'to', 'symptoms', 'related', 'to', 'benzodiazepine', 'dependence', ',', 'exacerbations', 'of', 'PTSD', ',', 'and/or', 'anxiety', '?']",['benzodiazepines'],21,1
What kind of approach should be used to discuss options for OUD treatment?,What,265,shared decision-making,Specifications,0,0.8,"['What', 'kind', 'of', 'approach', 'should', 'be', 'used', 'to', 'discuss', 'options', 'for', 'OUD', 'treatment', '?']","['shared', 'decision', '-', 'making']",14,4
What are some examples of opioid agonist medications?,What,266,buprenorphine/naloxone (Suboxone) or methadone,Specifications,1,1.0,"['What', 'are', 'some', 'examples', 'of', 'opioid', 'agonist', 'medications', '?']","['buprenorphine', '/', 'naloxone', '(', 'Suboxone', ')', 'or', 'methadone']",9,8
What does opioid agonist treatment involve?,What,267,taking opioid agonist medications such as buprenorphine/naloxone (Suboxone) or methadone,Specifications,1,1.0,"['What', 'does', 'opioid', 'agonist', 'treatment', 'involve', '?']","['taking', 'opioid', 'agonist', 'medications', 'such', 'as', 'buprenorphine', '/', 'naloxone', '(', 'Suboxone', ')', 'or', 'methadone']",7,14
Name a sleep disorder.,What,268,Sleep apnea,Specifications,1,1.0,"['Name', 'a', 'sleep', 'disorder', '.']","['Sleep', 'apnea']",5,2
How to provide methadone for OUD therapy?,How,269,through a federally regulated opioid treatment program for OUD therapy,Specifications,0,0.8,"['How', 'to', 'provide', 'methadone', 'for', 'OUD', 'therapy', '?']","['through', 'a', 'federally', 'regulated', 'opioid', 'treatment', 'program', 'for', 'OUD', 'therapy']",8,10
What can cause moral injury?,What,270,"betrayal, disproportionate violence, incidents involving civilians, within-rank violence",Specifications,0,0.5925925925925926,"['What', 'can', 'cause', 'moral', 'injury', '?']","['betrayal', ',', 'disproportionate', 'violence', ',', 'incidents', 'involving', 'civilians', ',', 'within', '-', 'rank', 'violence']",6,13
What is the alternative OUD treatment?,What,271,extended-release (ER) injectable naltrexone (Vivitrol),Specifications,1,1.0,"['What', 'is', 'the', 'alternative', 'OUD', 'treatment', '?']","['extended', '-', 'release', '(', 'ER', ')', 'injectable', 'naltrexone', '(', 'Vivitrol', ')']",7,11
What is the first-line treatment for OUD?,What,272,Medication-Assisted Therapy (MAT),Specifications,1,1.0,"['What', 'is', 'the', 'first', '-', 'line', 'treatment', 'for', 'OUD', '?']","['Medication', '-', 'Assisted', 'Therapy', '(', 'MAT', ')']",10,7
What is the preferred OUD treatment?,What,273,Opioid Agonist Therapy (OAT),Specifications,1,1.0,"['What', 'is', 'the', 'preferred', 'OUD', 'treatment', '?']","['Opioid', 'Agonist', 'Therapy', '(', 'OAT', ')']",7,6
How to treat a moral injury?,How,274,via psychologists or chaplains,Specifications,1,1.0,"['How', 'to', 'treat', 'a', 'moral', 'injury', '?']","['via', 'psychologists', 'or', 'chaplains']",7,4
Name the treatment settings in which MAT can be provided.,What,275,"residential SUD treatment, intensive outpatient SUD treatment, regular SUD specialty care clinic, primary care or general mental health clinic, or federally regulated opioid treatment program",Specifications,1,1.0,"['Name', 'the', 'treatment', 'settings', 'in', 'which', 'MAT', 'can', 'be', 'provided', '.']","['residential', 'SUD', 'treatment', ',', 'intensive', 'outpatient', 'SUD', 'treatment', ',', 'regular', 'SUD', 'specialty', 'care', 'clinic', ',', 'primary', 'care', 'or', 'general', 'mental', 'health', 'clinic', ',', 'or', 'federally', 'regulated', 'opioid', 'treatment', 'program']",11,29
What is moral injury?,What,276,"an act of transgression that leads to serious inner conflict typically brought on by betrayal, disproportionate violence, incidents involving civilians, within-rank violence",Specifications,0,0.9500000000000001,"['What', 'is', 'moral', 'injury', '?']","['an', 'act', 'of', 'transgression', 'that', 'leads', 'to', 'serious', 'inner', 'conflict', 'typically', 'brought', 'on', 'by', 'betrayal', ',', 'disproportionate', 'violence', ',', 'incidents', 'involving', 'civilians', ',', 'within', '-', 'rank', 'violence']",5,27
What kind of increase has there been in the absolute number of deaths associated with the use of opioids since 2000?,What,278,a four-fold increase,Background,0,0.6666666666666666,"['What', 'kind', 'of', 'increase', 'has', 'there', 'been', 'in', 'the', 'absolute', 'number', 'of', 'deaths', 'associated', 'with', 'the', 'use', 'of', 'opioids', 'since', '2000', '?']","['a', 'four', '-', 'fold', 'increase']",22,5
What was the statistics of the events related to OUD or prescription drug overdose in 2014?,What,279,"1.9 million Americans were affected by an OUD related to non-medical  use of prescription pain relievers, and in the same year, 18,893 individuals died as a result of a  prescription drug overdose",Background,0,0.4864864864864865,"['What', 'was', 'the', 'statistics', 'of', 'the', 'events', 'related', 'to', 'OUD', 'or', 'prescription', 'drug', 'overdose', 'in', '2014', '?']","['1.9', 'million', 'Americans', 'were', 'affected', 'by', 'an', 'OUD', 'related', 'to', 'non', '-', 'medical', ' ', 'use', 'of', 'prescription', 'pain', 'relievers', ',', 'and', 'in', 'the', 'same', 'year', ',', '18,893', 'individuals', 'died', 'as', 'a', 'result', 'of', 'a', ' ', 'prescription', 'drug', 'overdose']",17,38
What was the leading cause of injury-related death in the U.S. in 2009?,What,280,drug overdose,Background,1,1.0,"['What', 'was', 'the', 'leading', 'cause', 'of', 'injury', '-', 'related', 'death', 'in', 'the', 'U.S.', 'in', '2009', '?']","['drug', 'overdose']",16,2
What is CNCP?,What,281,chronic non-cancer pain,Background,1,1.0,"['What', 'is', 'CNCP', '?']","['chronic', 'non', '-', 'cancer', 'pain']",4,5
How many Americans were affected by an OUD related to non-medical  use of prescription pain relievers in 2014?,How,282,1.9 million,Background,1,1.0,"['How', 'many', 'Americans', 'were', 'affected', 'by', 'an', 'OUD', 'related', 'to', 'non', '-', 'medical', ' ', 'use', 'of', 'prescription', 'pain', 'relievers', 'in', '2014', '?']","['1.9', 'million']",22,2
How many Americans died as a result of a  prescription drug overdose in 2014?,How,284,"18,893",Background,1,1.0,"['How', 'many', 'Americans', 'died', 'as', 'a', 'result', 'of', 'a', ' ', 'prescription', 'drug', 'overdose', 'in', '2014', '?']","['18,893']",16,1
What kind of increase has there been in the absolute number of deaths associated with the use of opioids between 2013 and 2014 alone?,What,285,14% increase,Background,0,0.6666666666666666,"['What', 'kind', 'of', 'increase', 'has', 'there', 'been', 'in', 'the', 'absolute', 'number', 'of', 'deaths', 'associated', 'with', 'the', 'use', 'of', 'opioids', 'between', '2013', 'and', '2014', 'alone', '?']","['14', '%', 'increase']",25,3
What was the outcome of the survey of patients prescribed opioids for chronic non-cancer pain and their family members?,What,287,"34% of patients reported that they thought they were “addicted” or “dependent” on opioid pain medication, 34% said that they used the medication for “fun” or to “get high,” while 22% used the medication to relieve day-to-day stress",Background,0,0.6153846153846153,"['What', 'was', 'the', 'outcome', 'of', 'the', 'survey', 'of', 'patients', 'prescribed', 'opioids', 'for', 'chronic', 'non', '-', 'cancer', 'pain', 'and', 'their', 'family', 'members', '?']","['34', '%', 'of', 'patients', 'reported', 'that', 'they', 'thought', 'they', 'were', '“', 'addicted', '”', 'or', '“', 'dependent', '”', 'on', 'opioid', 'pain', 'medication', ',', '34', '%', 'said', 'that', 'they', 'used', 'the', 'medication', 'for', '“', 'fun', '”', 'or', 'to', '“', 'get', 'high', ',', '”', 'while', '22', '%', 'used', 'the', 'medication', 'to', 'relieve', 'day', '-', 'to', '-', 'day', 'stress']",22,55
What is not static?,What,289,Suicide risk,Recommendations,1,1.0,"['What', 'is', 'not', 'static', '?']","['Suicide', 'risk']",5,2
"Why is ongoing assessment of suicide risk important whether one is initiating, maintaining,  or terminating LOT?",Why,290,"Suicide risk is not static, and many factors influence an individual’s risk of suicide at any given point in time, as noted in the VA/DoD  Suicide CPG.",Recommendations,0,0.2,"['Why', 'is', 'ongoing', 'assessment', 'of', 'suicide', 'risk', 'important', 'whether', 'one', 'is', 'initiating', ',', 'maintaining', ',', ' ', 'or', 'terminating', 'LOT', '?']","['Suicide', 'risk', 'is', 'not', 'static', ',', 'and', 'many', 'factors', 'influence', 'an', 'individual', '’s', 'risk', 'of', 'suicide', 'at', 'any', 'given', 'point', 'in', 'time', ',', 'as', 'noted', 'in', 'the', 'VA', '/', 'DoD', ' ', 'Suicide', 'CPG', '.']",20,34
What influence an individual’s risk of suicide at any given point in time?,What,291,many factors,Recommendations,1,1.0,"['What', 'influence', 'an', 'individual', '’s', 'risk', 'of', 'suicide', 'at', 'any', 'given', 'point', 'in', 'time', '?']","['many', 'factors']",15,2
Which represent an independent risk factor for suicide?,Which,292,certain chronic pain conditions,Recommendations,1,1.0,"['Which', 'represent', 'an', 'independent', 'risk', 'factor', 'for', 'suicide', '?']","['certain', 'chronic', 'pain', 'conditions']",9,4
What is associated with prescribed opioid dose?,What,294,suicide risk among Veterans receiving OT for CNCP,Recommendations,1,1.0,"['What', 'is', 'associated', 'with', 'prescribed', 'opioid', 'dose', '?']","['suicide', 'risk', 'among', 'Veterans', 'receiving', 'OT', 'for', 'CNCP']",8,8
What is represented by chronic pain conditions?,What,295,an independent risk factor for suicide,Recommendations,1,1.0,"['What', 'is', 'represented', 'by', 'chronic', 'pain', 'conditions', '?']","['an', 'independent', 'risk', 'factor', 'for', 'suicide']",8,6
When is it important to assess suicide risk?,When,296,"whether one is initiating, maintaining,  or terminating LOT",Recommendations,1,1.0,"['When', 'is', 'it', 'important', 'to', 'assess', 'suicide', 'risk', '?']","['whether', 'one', 'is', 'initiating', ',', 'maintaining', ',', ' ', 'or', 'terminating', 'LOT']",9,11
What is associated with suicide risk among Veterans receiving OT for CNCP?,What,298,prescribed opioid dose,Recommendations,1,1.0,"['What', 'is', 'associated', 'with', 'suicide', 'risk', 'among', 'Veterans', 'receiving', 'OT', 'for', 'CNCP', '?']","['prescribed', 'opioid', 'dose']",13,3
What is influenced by many factors?,What,299,an individual’s risk of suicide at any given point in time,Recommendations,0,0.9473684210526316,"['What', 'is', 'influenced', 'by', 'many', 'factors', '?']","['an', 'individual', '’s', 'risk', 'of', 'suicide', 'at', 'any', 'given', 'point', 'in', 'time']",7,12
What are some examples of comprehensive pain care plan?,What,300,"non-opioid treatments, self-management strategies",Algorithm,1,1.0,"['What', 'are', 'some', 'examples', 'of', 'comprehensive', 'pain', 'care', 'plan', '?']","['non', '-', 'opioid', 'treatments', ',', 'self', '-', 'management', 'strategies']",10,9
What to do if there are no indications to discontinue or taper?,What,302,reassess in 1-3 months or more frequently as determined by patient risk factors,Algorithm,1,1.0,"['What', 'to', 'do', 'if', 'there', 'are', 'no', 'indications', 'to', 'discontinue', 'or', 'taper', '?']","['reassess', 'in', '1', '-', '3', 'months', 'or', 'more', 'frequently', 'as', 'determined', 'by', 'patient', 'risk', 'factors']",13,15
What to do if a patient is not medically or psychiatrically unstable?,What,303,see if there is a clinically meaningful improvement in function in the absence of significant risk factors,Algorithm,1,1.0,"['What', 'to', 'do', 'if', 'a', 'patient', 'is', 'not', 'medically', 'or', 'psychiatrically', 'unstable', '?']","['see', 'if', 'there', 'is', 'a', 'clinically', 'meaningful', 'improvement', 'in', 'function', 'in', 'the', 'absence', 'of', 'significant', 'risk', 'factors']",13,17
What to do if there are indications to discontinue or taper?,What,304,taper to reduced dose or taper to discontinuation,Algorithm,1,1.0,"['What', 'to', 'do', 'if', 'there', 'are', 'indications', 'to', 'discontinue', 'or', 'taper', '?']","['taper', 'to', 'reduced', 'dose', 'or', 'taper', 'to', 'discontinuation']",12,8
Who should not be prescribed long-acting opioids?,Who,305,opioid-naive individuals,Algorithm,1,1.0,"['Who', 'should', 'not', 'be', 'prescribed', 'long', '-', 'acting', 'opioids', '?']","['opioid', '-', 'naive', 'individuals']",10,4
What to review and optimize during a follow-up?,What,306,comprehensive pain care plan,Algorithm,1,1.0,"['What', 'to', 'review', 'and', 'optimize', 'during', 'a', 'follow', '-', 'up', '?']","['comprehensive', 'pain', 'care', 'plan']",11,4
Which approach to follow when initiating OT?,Which,307,"short duration (e.g., 1 week initial prescription; no more than 3 months total), use the lowest effective dose recognizing that no dose is completely safe, long-acting opioids should not be prescribed for opioid-naive individuals, consider alternatives to methadone and transdermal fentanyl, assessment of improvement in pain and functional status and adverse effects, offer overdose education and naloxone distribution (OEND)",Algorithm,0,0.6024096385542169,"['Which', 'approach', 'to', 'follow', 'when', 'initiating', 'OT', '?']","['short', 'duration', '(', 'e.g.', ',', '1', 'week', 'initial', 'prescription', ';', 'no', 'more', 'than', '3', 'months', 'total', ')', ',', 'use', 'the', 'lowest', 'effective', 'dose', 'recognizing', 'that', 'no', 'dose', 'is', 'completely', 'safe', ',', 'long', '-', 'acting', 'opioids', 'should', 'not', 'be', 'prescribed', 'for', 'opioid', '-', 'naive', 'individuals', ',', 'consider', 'alternatives', 'to', 'methadone', 'and', 'transdermal', 'fentanyl', ',', 'assessment', 'of', 'improvement', 'in', 'pain', 'and', 'functional', 'status', 'and', 'adverse', 'effects', ',', 'offer', 'overdose', 'education', 'and', 'naloxone', 'distribution', '(', 'OEND', ')']",8,74
What is module B about?,What,308,treatment with opioid therapy,Algorithm,1,1.0,"['What', 'is', 'module', 'B', 'about', '?']","['treatment', 'with', 'opioid', 'therapy']",6,4
What to do if a patient is medically or psychiatrically unstable?,What,310,admit/provide medical and psychiatric treatment to stabilize as indicated,Algorithm,1,1.0,"['What', 'to', 'do', 'if', 'a', 'patient', 'is', 'medically', 'or', 'psychiatrically', 'unstable', '?']","['admit', '/', 'provide', 'medical', 'and', 'psychiatric', 'treatment', 'to', 'stabilize', 'as', 'indicated']",12,11
Who are provided opioid therapy treatment?,Who,311,the candidate for trial of OT with consent (in conjunction with a comprehensive pain care plan),Algorithm,0,0.6666666666666666,"['Who', 'are', 'provided', 'opioid', 'therapy', 'treatment', '?']","['the', 'candidate', 'for', 'trial', 'of', 'OT', 'with', 'consent', '(', 'in', 'conjunction', 'with', 'a', 'comprehensive', 'pain', 'care', 'plan', ')']",7,18
What can happen with a strategy of escalating dose during OT?,What,312,A strategy of escalating dose to achieve benefit increases risk and has not been shown to improve function.,Algorithm,0,0.8666666666666666,"['What', 'can', 'happen', 'with', 'a', 'strategy', 'of', 'escalating', 'dose', 'during', 'OT', '?']","['A', 'strategy', 'of', 'escalating', 'dose', 'to', 'achieve', 'benefit', 'increases', 'risk', 'and', 'has', 'not', 'been', 'shown', 'to', 'improve', 'function', '.']",12,19
What to do if there is no clinically meaningful improvement in function in the absence of significant risk factors?,What,313,"taper to discontinuation (consult Module C if needed), exit algorithm and manage with non-opioid modalities",Algorithm,1,1.0,"['What', 'to', 'do', 'if', 'there', 'is', 'no', 'clinically', 'meaningful', 'improvement', 'in', 'function', 'in', 'the', 'absence', 'of', 'significant', 'risk', 'factors', '?']","['taper', 'to', 'discontinuation', '(', 'consult', 'Module', 'C', 'if', 'needed', ')', ',', 'exit', 'algorithm', 'and', 'manage', 'with', 'non', '-', 'opioid', 'modalities']",20,20
What to assess during a follow-up with a patient?,What,314,"function, risks, and benefits of OT, progress toward functional treatment goals, adverse effects, adherence to treatment plan, complications or co-occurring conditions (e.g., medical, mental health, and/or SUD)",Algorithm,0,0.07142857142857142,"['What', 'to', 'assess', 'during', 'a', 'follow', '-', 'up', 'with', 'a', 'patient', '?']","['function', ',', 'risks', ',', 'and', 'benefits', 'of', 'OT', ',', 'progress', 'toward', 'functional', 'treatment', 'goals', ',', 'adverse', 'effects', ',', 'adherence', 'to', 'treatment', 'plan', ',', 'complications', 'or', 'co', '-', 'occurring', 'conditions', '(', 'e.g.', ',', 'medical', ',', 'mental', 'health', ',', 'and/or', 'SUD', ')']",12,40
What to do during a follow-up with a patient?,What,315,"assess function, risks, and benefits of OT, progress toward functional treatment goals, adverse effects, adherence to treatment plan, complications or co-occurring conditions (e.g., medical, mental health, and/or SUD); complete risk mitigation strategies; review and optimize comprehensive pain care plan",Algorithm,0,0.05,"['What', 'to', 'do', 'during', 'a', 'follow', '-', 'up', 'with', 'a', 'patient', '?']","['assess', 'function', ',', 'risks', ',', 'and', 'benefits', 'of', 'OT', ',', 'progress', 'toward', 'functional', 'treatment', 'goals', ',', 'adverse', 'effects', ',', 'adherence', 'to', 'treatment', 'plan', ',', 'complications', 'or', 'co', '-', 'occurring', 'conditions', '(', 'e.g.', ',', 'medical', ',', 'mental', 'health', ',', 'and/or', 'SUD', ')', ';', 'complete', 'risk', 'mitigation', 'strategies', ';', 'review', 'and', 'optimize', 'comprehensive', 'pain', 'care', 'plan']",12,54
What to do if the factors that increase risks of OT are present?,What,316,"consider one or more of the following: shortening prescribing interval, intensifying risk mitigation strategies, increasing intensity of monitoring, referring to interdisciplinary care and consulting with or referring to specialty care",Algorithm,0,0.8846153846153846,"['What', 'to', 'do', 'if', 'the', 'factors', 'that', 'increase', 'risks', 'of', 'OT', 'are', 'present', '?']","['consider', 'one', 'or', 'more', 'of', 'the', 'following', ':', 'shortening', 'prescribing', 'interval', ',', 'intensifying', 'risk', 'mitigation', 'strategies', ',', 'increasing', 'intensity', 'of', 'monitoring', ',', 'referring', 'to', 'interdisciplinary', 'care', 'and', 'consulting', 'with', 'or', 'referring', 'to', 'specialty', 'care']",14,34
How much dose escalation has not been shown to improve function and increase risk?,How,318,above 20-50 mg MEDD,Algorithm,1,1.0,"['How', 'much', 'dose', 'escalation', 'has', 'not', 'been', 'shown', 'to', 'improve', 'function', 'and', 'increase', 'risk', '?']","['above', '20', '-', '50', 'mg', 'MEDD']",15,6
Which factors can increase the risks of OT?,Which,319,"non-adherence, co-occurring conditions, behaviors suggesting OUD, indications for referral",Algorithm,1,1.0,"['Which', 'factors', 'can', 'increase', 'the', 'risks', 'of', 'OT', '?']","['non', '-', 'adherence', ',', 'co', '-', 'occurring', 'conditions', ',', 'behaviors', 'suggesting', 'OUD', ',', 'indications', 'for', 'referral']",9,16
What should be the duration and dosage when initiatiing opioid thrapy? ,What,320,"short duration (e.g., 1 week initial prescription; no more than 3 months total), use the lowest effective dose recognizing that no dose is completely safe",Algorithm,0,0.5882352941176471,"['What', 'should', 'be', 'the', 'duration', 'and', 'dosage', 'when', 'initiatiing', 'opioid', 'thrapy', '?']","['short', 'duration', '(', 'e.g.', ',', '1', 'week', 'initial', 'prescription', ';', 'no', 'more', 'than', '3', 'months', 'total', ')', ',', 'use', 'the', 'lowest', 'effective', 'dose', 'recognizing', 'that', 'no', 'dose', 'is', 'completely', 'safe']",12,30
What to do if the factors that increase risks of OT are not present?,What,321,see if there are indications to discontinue or taper,Algorithm,1,1.0,"['What', 'to', 'do', 'if', 'the', 'factors', 'that', 'increase', 'risks', 'of', 'OT', 'are', 'not', 'present', '?']","['see', 'if', 'there', 'are', 'indications', 'to', 'discontinue', 'or', 'taper']",15,9
What to do if there is a clinically meaningful improvement in function in the absence of significant risk factors?,What,322,"review and optimize comprehensive pain care plan (e.g., non-opioid treatments, self-management strategies)",Algorithm,1,1.0,"['What', 'to', 'do', 'if', 'there', 'is', 'a', 'clinically', 'meaningful', 'improvement', 'in', 'function', 'in', 'the', 'absence', 'of', 'significant', 'risk', 'factors', '?']","['review', 'and', 'optimize', 'comprehensive', 'pain', 'care', 'plan', '(', 'e.g.', ',', 'non', '-', 'opioid', 'treatments', ',', 'self', '-', 'management', 'strategies', ')']",20,20
What are the treatment options for diarrhea?,What,323,"loperamide 4 mg orally initially, then 2 mg with each loose stool, not to exceed 16 mg daily; bismuth subsalicylate 524 mg every 0.5 to 1 hour orally, not to exceed 4192 mg/day",Specifications,0,0.7058823529411764,"['What', 'are', 'the', 'treatment', 'options', 'for', 'diarrhea', '?']","['loperamide', '4', 'mg', 'orally', 'initially', ',', 'then', '2', 'mg', 'with', 'each', 'loose', 'stool', ',', 'not', 'to', 'exceed', '16', 'mg', 'daily', ';', 'bismuth', 'subsalicylate', '524', 'mg', 'every', '0.5', 'to', '1', 'hour', 'orally', ',', 'not', 'to', 'exceed', '4192', 'mg', '/', 'day']",8,39
What is the treatment option for abdominal cramping?,What,324,dicyclomine 20 mg every 6 to 8 hours as needed,Specifications,1,1.0,"['What', 'is', 'the', 'treatment', 'option', 'for', 'abdominal', 'cramping', '?']","['dicyclomine', '20', 'mg', 'every', '6', 'to', '8', 'hours', 'as', 'needed']",9,10
What are the treatment options for nausea?,What,325,"prochlorperazine 5 to 10 mg every 4 hours as needed, promethazine 25 mg orally or rectally every 6 hours as needed, ondansetron 4 mg every 6 hours as needed",Specifications,0,0.5128205128205129,"['What', 'are', 'the', 'treatment', 'options', 'for', 'nausea', '?']","['prochlorperazine', '5', 'to', '10', 'mg', 'every', '4', 'hours', 'as', 'needed', ',', 'promethazine', '25', 'mg', 'orally', 'or', 'rectally', 'every', '6', 'hours', 'as', 'needed', ',', 'ondansetron', '4', 'mg', 'every', '6', 'hours', 'as', 'needed']",8,31
What does this guideline not cover?,What,326,the variety of ever-changing state regulations that may be pertinent,Introduction,1,1.0,"['What', 'does', 'this', 'guideline', 'not', 'cover', '?']","['the', 'variety', 'of', 'ever', '-', 'changing', 'state', 'regulations', 'that', 'may', 'be', 'pertinent']",7,12
Who must make the ultimate judgement regarding a particular clinical procedure or treatment course?,Who,327,the individual clinician,Introduction,0,0.2222222222222222,"['Who', 'must', 'make', 'the', 'ultimate', 'judgement', 'regarding', 'a', 'particular', 'clinical', 'procedure', 'or', 'treatment', 'course', '?']","['the', 'individual', 'clinician']",15,3
How are the standards of care determined?,How,330,on the basis of all clinical data available for an individual case and are subject to change as scientific knowledge and technology advances and patterns evolve,Introduction,1,1.0,"['How', 'are', 'the', 'standards', 'of', 'care', 'determined', '?']","['on', 'the', 'basis', 'of', 'all', 'clinical', 'data', 'available', 'for', 'an', 'individual', 'case', 'and', 'are', 'subject', 'to', 'change', 'as', 'scientific', 'knowledge', 'and', 'technology', 'advances', 'and', 'patterns', 'evolve']",8,26
Which groups had the highest prevalence of opioid use?,Which,337,"women and young adults (i.e., 18-34 years old)",Background,1,1.0,"['Which', 'groups', 'had', 'the', 'highest', 'prevalence', 'of', 'opioid', 'use', '?']","['women', 'and', 'young', 'adults', '(', 'i.e.', ',', '18', '-', '34', 'years', 'old', ')']",10,13
What was the increment of the prevalence of opioid prescriptions among Veterans from fiscal years 2004 to 2012?,What,338,"from  18.9% to 33.4%, an increase of 76.7%",Background,0,0.25,"['What', 'was', 'the', 'increment', 'of', 'the', 'prevalence', 'of', 'opioid', 'prescriptions', 'among', 'Veterans', 'from', 'fiscal', 'years', '2004', 'to', '2012', '?']","['from', ' ', '18.9', '%', 'to', '33.4', '%', ',', 'an', 'increase', 'of', '76.7', '%']",19,13
Who did carry 11 times the odds of OUD and overdose compared to patients ≥65 years old?,Who,344,patients 18-30 years old,Recommendations,1,1.0,"['Who', 'did', 'carry', '11', 'times', 'the', 'odds', 'of', 'OUD', 'and', 'overdose', 'compared', 'to', 'patients', '≥65', 'years', 'old', '?']","['patients', '18', '-', '30', 'years', 'old']",18,6
Who had roughly half the risk of developing OUD or overdose compared to subjects 18-29 years old?,Who,346,patients 30-39  years old,Recommendations,1,1.0,"['Who', 'had', 'roughly', 'half', 'the', 'risk', 'of', 'developing', 'OUD', 'or', 'overdose', 'compared', 'to', 'subjects', '18', '-', '29', 'years', 'old', '?']","['patients', '30', '-', '39', ' ', 'years', 'old']",20,7
Who did carry 5 times the odds of OUD and overdose compared to patients ≥65 years old?,Who,347,Patients 31-40 years,Recommendations,0,0.8571428571428571,"['Who', 'did', 'carry', '5', 'times', 'the', 'odds', 'of', 'OUD', 'and', 'overdose', 'compared', 'to', 'patients', '≥65', 'years', 'old', '?']","['Patients', '31', '-', '40', 'years']",18,5
What was the amount of risk of developing OUD or overdose in patients 30-39  years old compared to subjects 18-29 years old?,What,348,roughly half,Recommendations,0,0.6666666666666666,"['What', 'was', 'the', 'amount', 'of', 'risk', 'of', 'developing', 'OUD', 'or', 'overdose', 'in', 'patients', '30', '-', '39', ' ', 'years', 'old', 'compared', 'to', 'subjects', '18', '-', '29', 'years', 'old', '?']","['roughly', 'half']",28,2
What was the amount of risk of developing OUD or overdose in patients ≥70 years old compared to subjects 18-29 years old?,What,349,far less risk (nearly 1/17),Recommendations,1,1.0,"['What', 'was', 'the', 'amount', 'of', 'risk', 'of', 'developing', 'OUD', 'or', 'overdose', 'in', 'patients', '≥70', 'years', 'old', 'compared', 'to', 'subjects', '18', '-', '29', 'years', 'old', '?']","['far', 'less', 'risk', '(', 'nearly', '1/17', ')']",25,7
Who had far less risk of developing OUD or overdose compared to subjects 18-29 years old?,Who,352,patients ≥70 years old,Recommendations,1,1.0,"['Who', 'had', 'far', 'less', 'risk', 'of', 'developing', 'OUD', 'or', 'overdose', 'compared', 'to', 'subjects', '18', '-', '29', 'years', 'old', '?']","['patients', '≥70', 'years', 'old']",19,4
Who have an added great risk for OUD and overdose?,Who,354,younger patients using opioids,Recommendations,1,1.0,"['Who', 'have', 'an', 'added', 'great', 'risk', 'for', 'OUD', 'and', 'overdose', '?']","['younger', 'patients', 'using', 'opioids']",11,4
What should all patients in the healthcare system be offered?,What,356,access to evidence-based interventions appropriate to that  patient,Specifications,1,1.0,"['What', 'should', 'all', 'patients', 'in', 'the', 'healthcare', 'system', 'be', 'offered', '?']","['access', 'to', 'evidence', '-', 'based', 'interventions', 'appropriate', 'to', 'that', ' ', 'patient']",11,11
What can be used to convey openness to discuss any future concerns?,What,357,Improved patient-clinician communication through  patient-centered care,Specifications,1,1.0,"['What', 'can', 'be', 'used', 'to', 'convey', 'openness', 'to', 'discuss', 'any', 'future', 'concerns', '?']","['Improved', 'patient', '-', 'clinician', 'communication', 'through', ' ', 'patient', '-', 'centered', 'care']",13,11
What does VA/DoD CPGs encourage clinicians to do?,What,358,"to use a patient-centered care approach that is tailored to the patient’s  capabilities, needs, goals, prior treatment experience, and preferences",Specifications,0,0.9714285714285714,"['What', 'does', 'VA', '/', 'DoD', 'CPGs', 'encourage', 'clinicians', 'to', 'do', '?']","['to', 'use', 'a', 'patient', '-', 'centered', 'care', 'approach', 'that', 'is', 'tailored', 'to', 'the', 'patient', '’s', ' ', 'capabilities', ',', 'needs', ',', 'goals', ',', 'prior', 'treatment', 'experience', ',', 'and', 'preferences']",11,28
What is the purpose of patient-centered care?,What,359,"decrease patient anxiety, increase trust in  clinicians,[77] and improve treatment adherence",Specifications,0,0.9565217391304348,"['What', 'is', 'the', 'purpose', 'of', 'patient', '-', 'centered', 'care', '?']","['decrease', 'patient', 'anxiety', ',', 'increase', 'trust', 'in', ' ', 'clinicians,[77', ']', 'and', 'improve', 'treatment', 'adherence']",10,14
What is Module A about?,What,360,determination of appropriateness for opioid therapy,Algorithm,1,1.0,"['What', 'is', 'Module', 'A', 'about', '?']","['determination', 'of', 'appropriateness', 'for', 'opioid', 'therapy']",6,6
"When the patient is willing to engage in a comprehensive pain care plan, what to educate the patient and family about?",When,361,"treatment options, including education on known risks and unknown long-term benefits of OT, risks of SUD and overdose, need for risk mitigation strategies, naloxone rescue",Algorithm,0,0.2380952380952381,"['When', 'the', 'patient', 'is', 'willing', 'to', 'engage', 'in', 'a', 'comprehensive', 'pain', 'care', 'plan', ',', 'what', 'to', 'educate', 'the', 'patient', 'and', 'family', 'about', '?']","['treatment', 'options', ',', 'including', 'education', 'on', 'known', 'risks', 'and', 'unknown', 'long', '-', 'term', 'benefits', 'of', 'OT', ',', 'risks', 'of', 'SUD', 'and', 'overdose', ',', 'need', 'for', 'risk', 'mitigation', 'strategies', ',', 'naloxone', 'rescue']",23,31
How to determine whether patient risks outweigh benefits?,How,363,by considering strength and number of risk factors and patient preference,Algorithm,1,1.0,"['How', 'to', 'determine', 'whether', 'patient', 'risks', 'outweigh', 'benefits', '?']","['by', 'considering', 'strength', 'and', 'number', 'of', 'risk', 'factors', 'and', 'patient', 'preference']",9,11
What to implement and optimize for patients who are in chronic pain and have not been on daily OT for pain for more than 3 months?,What,364,non-opioid treatments for chronic pain,Algorithm,0,0.5555555555555556,"['What', 'to', 'implement', 'and', 'optimize', 'for', 'patients', 'who', 'are', 'in', 'chronic', 'pain', 'and', 'have', 'not', 'been', 'on', 'daily', 'OT', 'for', 'pain', 'for', 'more', 'than', '3', 'months', '?']","['non', '-', 'opioid', 'treatments', 'for', 'chronic', 'pain']",27,7
What to do if adding OT to comprehensive pain therapy is indicated at this time?,What,365,see if the patient is prepared to accept responsibilities and the provider is prepared to implement risk mitigation strategies,Algorithm,1,1.0,"['What', 'to', 'do', 'if', 'adding', 'OT', 'to', 'comprehensive', 'pain', 'therapy', 'is', 'indicated', 'at', 'this', 'time', '?']","['see', 'if', 'the', 'patient', 'is', 'prepared', 'to', 'accept', 'responsibilities', 'and', 'the', 'provider', 'is', 'prepared', 'to', 'implement', 'risk', 'mitigation', 'strategies']",16,19
What to do if the treatments are not effective in managing pain and optimizing function?,What,366,complete opioid risk assessment and see if patient risks outweigh benefits by considering strength and number of risk factors and patient preference,Algorithm,1,1.0,"['What', 'to', 'do', 'if', 'the', 'treatments', 'are', 'not', 'effective', 'in', 'managing', 'pain', 'and', 'optimizing', 'function', '?']","['complete', 'opioid', 'risk', 'assessment', 'and', 'see', 'if', 'patient', 'risks', 'outweigh', 'benefits', 'by', 'considering', 'strength', 'and', 'number', 'of', 'risk', 'factors', 'and', 'patient', 'preference']",16,22
What to do if a patient is with chronic pain and has been on daily OT for pain for more than 3 months?,What,367,proceed to module D,Algorithm,1,1.0,"['What', 'to', 'do', 'if', 'a', 'patient', 'is', 'with', 'chronic', 'pain', 'and', 'has', 'been', 'on', 'daily', 'OT', 'for', 'pain', 'for', 'more', 'than', '3', 'months', '?']","['proceed', 'to', 'module', 'D']",24,4
What to do if the patient is not willing to engage in a comprehensive pain care plan?,What,368,exit algorithm; manage with non-opioid modalities,Algorithm,1,1.0,"['What', 'to', 'do', 'if', 'the', 'patient', 'is', 'not', 'willing', 'to', 'engage', 'in', 'a', 'comprehensive', 'pain', 'care', 'plan', '?']","['exit', 'algorithm', ';', 'manage', 'with', 'non', '-', 'opioid', 'modalities']",18,9
What to do if referral/consultation for evaluation and treatment is not indicated?,What,369,see if the patient is willing to engage in a comprehensive pain care plan,Algorithm,1,1.0,"['What', 'to', 'do', 'if', 'referral', '/', 'consultation', 'for', 'evaluation', 'and', 'treatment', 'is', 'not', 'indicated', '?']","['see', 'if', 'the', 'patient', 'is', 'willing', 'to', 'engage', 'in', 'a', 'comprehensive', 'pain', 'care', 'plan']",15,14
What to do if patient risk outweighs benefits?,What,370,"see whether referral/consultation for evaluation and treatment is indicated (e.g., mental health, SUD, more intensive interdisciplinary care)",Algorithm,1,1.0,"['What', 'to', 'do', 'if', 'patient', 'risk', 'outweighs', 'benefits', '?']","['see', 'whether', 'referral', '/', 'consultation', 'for', 'evaluation', 'and', 'treatment', 'is', 'indicated', '(', 'e.g.', ',', 'mental', 'health', ',', 'SUD', ',', 'more', 'intensive', 'interdisciplinary', 'care', ')']",9,24
What to do if the patient is willing to engage in a comprehensive pain care plan?,What,371,"educate the patient and family about treatment options, including education on known risks and unknown long-term benefits of OT, risks of SUD and overdose, need for risk mitigation strategies, naloxone rescue. Then see if adding OT to comprehensive pain therapy is indicated at this time.",Algorithm,0,0.044444444444444446,"['What', 'to', 'do', 'if', 'the', 'patient', 'is', 'willing', 'to', 'engage', 'in', 'a', 'comprehensive', 'pain', 'care', 'plan', '?']","['educate', 'the', 'patient', 'and', 'family', 'about', 'treatment', 'options', ',', 'including', 'education', 'on', 'known', 'risks', 'and', 'unknown', 'long', '-', 'term', 'benefits', 'of', 'OT', ',', 'risks', 'of', 'SUD', 'and', 'overdose', ',', 'need', 'for', 'risk', 'mitigation', 'strategies', ',', 'naloxone', 'rescue', '.', 'Then', 'see', 'if', 'adding', 'OT', 'to', 'comprehensive', 'pain', 'therapy', 'is', 'indicated', 'at', 'this', 'time', '.']",17,53
What to do if the treatments are effective in managing pain and optimizing function?,What,372,exit algorithm; manage with non-opioid modalities,Algorithm,1,1.0,"['What', 'to', 'do', 'if', 'the', 'treatments', 'are', 'effective', 'in', 'managing', 'pain', 'and', 'optimizing', 'function', '?']","['exit', 'algorithm', ';', 'manage', 'with', 'non', '-', 'opioid', 'modalities']",15,9
What to do if the patient is not prepared to accept responsibilities or the provider is not prepared to implement risk mitigation strategies?,What,373,exit algorithm; manage with non-opioid modalities,Algorithm,0,0.07692307692307691,"['What', 'to', 'do', 'if', 'the', 'patient', 'is', 'not', 'prepared', 'to', 'accept', 'responsibilities', 'or', 'the', 'provider', 'is', 'not', 'prepared', 'to', 'implement', 'risk', 'mitigation', 'strategies', '?']","['exit', 'algorithm', ';', 'manage', 'with', 'non', '-', 'opioid', 'modalities']",24,9
What to do if referral/consultation for evaluation and treatment is indicated?,What,374,"refer/consult with appropriate interdisciplinary treatments. Then after referral/consultation with appropriate interdisciplinary treatments, see if the patient is willing to engage in a comprehensive pain care plan.",Algorithm,0,0.3448275862068966,"['What', 'to', 'do', 'if', 'referral', '/', 'consultation', 'for', 'evaluation', 'and', 'treatment', 'is', 'indicated', '?']","['refer', '/', 'consult', 'with', 'appropriate', 'interdisciplinary', 'treatments', '.', 'Then', 'after', 'referral', '/', 'consultation', 'with', 'appropriate', 'interdisciplinary', 'treatments', ',', 'see', 'if', 'the', 'patient', 'is', 'willing', 'to', 'engage', 'in', 'a', 'comprehensive', 'pain', 'care', 'plan', '.']",14,33
What to do if a patient is with chronic pain and has not been on daily OT for pain for more than 3 months?,What,375,"obtain biopsychosocial assessment. Then educate or re-educate on non-opioid management, self-management to improve function and quality of life, realistic expectations and limitations of medical treatment. Then implement and optimize non-opioid treatments for chronic pain (e.g., physical, psychological, and complementary and integrative treatments).",Algorithm,0,0.13333333333333333,"['What', 'to', 'do', 'if', 'a', 'patient', 'is', 'with', 'chronic', 'pain', 'and', 'has', 'not', 'been', 'on', 'daily', 'OT', 'for', 'pain', 'for', 'more', 'than', '3', 'months', '?']","['obtain', 'biopsychosocial', 'assessment', '.', 'Then', 'educate', 'or', 're', '-', 'educate', 'on', 'non', '-', 'opioid', 'management', ',', 'self', '-', 'management', 'to', 'improve', 'function', 'and', 'quality', 'of', 'life', ',', 'realistic', 'expectations', 'and', 'limitations', 'of', 'medical', 'treatment', '.', 'Then', 'implement', 'and', 'optimize', 'non', '-', 'opioid', 'treatments', 'for', 'chronic', 'pain', '(', 'e.g.', ',', 'physical', ',', 'psychological', ',', 'and', 'complementary', 'and', 'integrative', 'treatments', ')', '.']",25,60
What to do if adding OT to comprehensive pain therapy is not indicated at this time?,What,376,exit algorithm; manage with non-opioid modalities,Algorithm,1,1.0,"['What', 'to', 'do', 'if', 'adding', 'OT', 'to', 'comprehensive', 'pain', 'therapy', 'is', 'not', 'indicated', 'at', 'this', 'time', '?']","['exit', 'algorithm', ';', 'manage', 'with', 'non', '-', 'opioid', 'modalities']",17,9
What therapies are preferred for chronic pain?,What,377,Non-pharmacologic and non-opioid pharmacologic,Algorithm,0,0.888888888888889,"['What', 'therapies', 'are', 'preferred', 'for', 'chronic', 'pain', '?']","['Non', '-', 'pharmacologic', 'and', 'non', '-', 'opioid', 'pharmacologic']",8,8
What to do if the patient is prepared to accept responsibilities?,What,378,"discuss and complete written informed consent with patient and family, determine and document treatment plan, and proceed to module B",Algorithm,1,1.0,"['What', 'to', 'do', 'if', 'the', 'patient', 'is', 'prepared', 'to', 'accept', 'responsibilities', '?']","['discuss', 'and', 'complete', 'written', 'informed', 'consent', 'with', 'patient', 'and', 'family', ',', 'determine', 'and', 'document', 'treatment', 'plan', ',', 'and', 'proceed', 'to', 'module', 'B']",12,22
Which topics are covered in the CDC Guideline for Prescribing Opioids for Chronic Pain?,Which,379,"initiation and continuation of OT, management of  OT, and risk assessment and use of risk mitigation strategies",Background,1,1.0,"['Which', 'topics', 'are', 'covered', 'in', 'the', 'CDC', 'Guideline', 'for', 'Prescribing', 'Opioids', 'for', 'Chronic', 'Pain', '?']","['initiation', 'and', 'continuation', 'of', 'OT', ',', 'management', 'of', ' ', 'OT', ',', 'and', 'risk', 'assessment', 'and', 'use', 'of', 'risk', 'mitigation', 'strategies']",15,20
When did the CDC released its Guideline for Prescribing Opioids for Chronic Pain? ,When,380,"March 15, 2016",Background,1,1.0,"['When', 'did', 'the', 'CDC', 'released', 'its', 'Guideline', 'for', 'Prescribing', 'Opioids', 'for', 'Chronic', 'Pain', '?']","['March', '15', ',', '2016']",14,4
Which system is used by the CDC guideline to assign a  grade for the strength for each recommendation? ,Which,381,GRADE system,Background,0,0.6666666666666666,"['Which', 'system', 'is', 'used', 'by', 'the', 'CDC', 'guideline', 'to', 'assign', 'a', ' ', 'grade', 'for', 'the', 'strength', 'for', 'each', 'recommendation', '?']","['GRADE', 'system']",20,2
Who are the targeted individuals for the CDC Guideline for Prescribing Opioids for Chronic Pain?,Who,382,primary care physicians,Background,1,1.0,"['Who', 'are', 'the', 'targeted', 'individuals', 'for', 'the', 'CDC', 'Guideline', 'for', 'Prescribing', 'Opioids', 'for', 'Chronic', 'Pain', '?']","['primary', 'care', 'physicians']",16,3
What does the GRADE system include?,What,383,"assessment of the quality of the evidence and consideration of the balance of desirable and undesirable outcomes, patient values and preferences,  and other considerations (e.g., resource use, equity) during recommendation development",Background,0,0.0689655172413793,"['What', 'does', 'the', 'GRADE', 'system', 'include', '?']","['assessment', 'of', 'the', 'quality', 'of', 'the', 'evidence', 'and', 'consideration', 'of', 'the', 'balance', 'of', 'desirable', 'and', 'undesirable', 'outcomes', ',', 'patient', 'values', 'and', 'preferences', ',', ' ', 'and', 'other', 'considerations', '(', 'e.g.', ',', 'resource', 'use', ',', 'equity', ')', 'during', 'recommendation', 'development']",7,38
What is the aim of the CDC Guideline for Prescribing Opioids for Chronic Pain?,What,384,"assist primary care providers in offering safe and effective treatment for patients with chronic pain in the outpatient setting (not including active cancer treatment, palliative care, or end-of-life care). It is also aimed at improving communication between providers and patients and decreasing adverse outcomes associated with LOT.",Background,0,0.0,"['What', 'is', 'the', 'aim', 'of', 'the', 'CDC', 'Guideline', 'for', 'Prescribing', 'Opioids', 'for', 'Chronic', 'Pain', '?']","['assist', 'primary', 'care', 'providers', 'in', 'offering', 'safe', 'and', 'effective', 'treatment', 'for', 'patients', 'with', 'chronic', 'pain', 'in', 'the', 'outpatient', 'setting', '(', 'not', 'including', 'active', 'cancer', 'treatment', ',', 'palliative', 'care', ',', 'or', 'end', '-', 'of', '-', 'life', 'care', ')', '.', 'It', 'is', 'also', 'aimed', 'at', 'improving', 'communication', 'between', 'providers', 'and', 'patients', 'and', 'decreasing', 'adverse', 'outcomes', 'associated', 'with', 'LOT', '.']",15,57
The use of the algorithm format as a way to represent patient management was chosen based on what?,What,27,the understanding that such a format may promote more efficient diagnostic and therapeutic decision making and has the potential to change patterns of resource use,Algorithm,1,1.0,"['The', 'use', 'of', 'the', 'algorithm', 'format', 'as', 'a', 'way', 'to', 'represent', 'patient', 'management', 'was', 'chosen', 'based', 'on', 'what', '?']","['the', 'understanding', 'that', 'such', 'a', 'format', 'may', 'promote', 'more', 'efficient', 'diagnostic', 'and', 'therapeutic', 'decision', 'making', 'and', 'has', 'the', 'potential', 'to', 'change', 'patterns', 'of', 'resource', 'use']",19,25
The CPG follows an algorithm that is designed to do what?,What,31,facilitate understanding of the clinical pathway and decision making process used in management of LOT,Algorithm,1,1.0,"['The', 'CPG', 'follows', 'an', 'algorithm', 'that', 'is', 'designed', 'to', 'do', 'what', '?']","['facilitate', 'understanding', 'of', 'the', 'clinical', 'pathway', 'and', 'decision', 'making', 'process', 'used', 'in', 'management', 'of', 'LOT']",12,15
Some patients with SUD may disagree with what?,What,33,the recommendation to use non-opioid modalities in lieu of  LOT to treat their pain,Recommendations,1,1.0,"['Some', 'patients', 'with', 'SUD', 'may', 'disagree', 'with', 'what', '?']","['the', 'recommendation', 'to', 'use', 'non', '-', 'opioid', 'modalities', 'in', 'lieu', 'of', ' ', 'LOT', 'to', 'treat', 'their', 'pain']",9,17
At what dosage there is a significant risk?,What,34,a daily dosage range of 20 to <50 mg MEDD,Recommendations,1,1.0,"['At', 'what', 'dosage', 'there', 'is', 'a', 'significant', 'risk', '?']","['a', 'daily', 'dosage', 'range', 'of', '20', 'to', '<', '50', 'mg', 'MEDD']",9,11
At what dosage does the risk increase even further?,What,36,a range of 50 to <100 mg MEDD compared to risk at <20 mg MEDD,Recommendations,0,0.6666666666666666,"['At', 'what', 'dosage', 'does', 'the', 'risk', 'increase', 'even', 'further', '?']","['a', 'range', 'of', '50', 'to', '<', '100', 'mg', 'MEDD', 'compared', 'to', 'risk', 'at', '<', '20', 'mg', 'MEDD']",10,17
All patients who take opioids chronically are at risk for what?,What,60,OUD and overdose,Recommendations,1,1.0,"['All', 'patients', 'who', 'take', 'opioids', 'chronically', 'are', 'at', 'risk', 'for', 'what', '?']","['OUD', 'and', 'overdose']",12,3
"In addition to non-pharmacological therapies, what should be tried and optimized before consideration of opioid medications?",What,69,appropriate mechanism and condition specific non-opioid pharmacologic agents,Recommendations,1,1.0,"['In', 'addition', 'to', 'non', '-', 'pharmacological', 'therapies', ',', 'what', 'should', 'be', 'tried', 'and', 'optimized', 'before', 'consideration', 'of', 'opioid', 'medications', '?']","['appropriate', 'mechanism', 'and', 'condition', 'specific', 'non', '-', 'opioid', 'pharmacologic', 'agents']",20,10
The presence of a lifetime history of SUD for patients with CNCP was associated with what?,What,83,28 times increased  odds of therapeutic opioid addiction compared to patients with CNCP without a lifetime history of SUD,Recommendations,0,0.6153846153846153,"['The', 'presence', 'of', 'a', 'lifetime', 'history', 'of', 'SUD', 'for', 'patients', 'with', 'CNCP', 'was', 'associated', 'with', 'what', '?']","['28', 'times', 'increased', ' ', 'odds', 'of', 'therapeutic', 'opioid', 'addiction', 'compared', 'to', 'patients', 'with', 'CNCP', 'without', 'a', 'lifetime', 'history', 'of', 'SUD']",17,20
This CPG is based on what?,What,0,evidence available by December 2016,Specifications,1,1.0,"['This', 'CPG', 'is', 'based', 'on', 'what', '?']","['evidence', 'available', 'by', 'December', '2016']",7,5
To what the prevalence of OUD in patients with CNCP is related?,What,39,duration of opioid use as well as dose,Recommendations,1,1.0,"['To', 'what', 'the', 'prevalence', 'of', 'OUD', 'in', 'patients', 'with', 'CNCP', 'is', 'related', '?']","['duration', 'of', 'opioid', 'use', 'as', 'well', 'as', 'dose']",13,8
The combination of zolpidem and opioids increases what?,What,52,the AOR of  overdose,Recommendations,1,1.0,"['The', 'combination', 'of', 'zolpidem', 'and', 'opioids', 'increases', 'what', '?']","['the', 'AOR', 'of', ' ', 'overdose']",9,5
"In addition to benzodiazepines, what to do with caution?",What,53,the addition of other psychoactive medications to LOT,Recommendations,1,1.0,"['In', 'addition', 'to', 'benzodiazepines', ',', 'what', 'to', 'do', 'with', 'caution', '?']","['the', 'addition', 'of', 'other', 'psychoactive', 'medications', 'to', 'LOT']",11,8
On what kind of evidence should the providers who suspect diversion base treatment plans?,What,62,objective,Background,1,1.0,"['On', 'what', 'kind', 'of', 'evidence', 'should', 'the', 'providers', 'who', 'suspect', 'diversion', 'base', 'treatment', 'plans', '?']",['objective'],15,1
"Given the recognized risks of opioid therapy, what should include a robust,  signature informed consent process?",What,84,an optimal approach to care,Recommendations,1,1.0,"['Given', 'the', 'recognized', 'risks', 'of', 'opioid', 'therapy', ',', 'what', 'should', 'include', 'a', 'robust', ',', ' ', 'signature', 'informed', 'consent', 'process', '?']","['an', 'optimal', 'approach', 'to', 'care']",20,5
"Given the recognized risks of opioid therapy, what should be included in an optimal approach to care?",What,85,"a robust,  signature informed consent process that is patient-centered and provides patients with information about  known benefits and harms of OT and treatment alternatives",Recommendations,1,1.0,"['Given', 'the', 'recognized', 'risks', 'of', 'opioid', 'therapy', ',', 'what', 'should', 'be', 'included', 'in', 'an', 'optimal', 'approach', 'to', 'care', '?']","['a', 'robust', ',', ' ', 'signature', 'informed', 'consent', 'process', 'that', 'is', 'patient', '-', 'centered', 'and', 'provides', 'patients', 'with', 'information', 'about', ' ', 'known', 'benefits', 'and', 'harms', 'of', 'OT', 'and', 'treatment', 'alternatives']",19,29
Continuing to prescribe the opioid without providing OUD treatment may increase the risk of what?,What,106,overdose and other adverse events,Specifications,1,1.0,"['Continuing', 'to', 'prescribe', 'the', 'opioid', 'without', 'providing', 'OUD', 'treatment', 'may', 'increase', 'the', 'risk', 'of', 'what', '?']","['overdose', 'and', 'other', 'adverse', 'events']",16,5
Tapering the opioid analgesic without providing OUD treatment may increase the risk of what?,What,110,overdose and other adverse events,Specifications,1,1.0,"['Tapering', 'the', 'opioid', 'analgesic', 'without', 'providing', 'OUD', 'treatment', 'may', 'increase', 'the', 'risk', 'of', 'what', '?']","['overdose', 'and', 'other', 'adverse', 'events']",15,5
Patients receiving opioid analgesics who do not meet DSM-5 criteria for OUD may benefit from what?,What,121,an  alternative management strategy: close follow-up and CBT,Recommendations,1,1.0,"['Patients', 'receiving', 'opioid', 'analgesics', 'who', 'do', 'not', 'meet', 'DSM-5', 'criteria', 'for', 'OUD', 'may', 'benefit', 'from', 'what', '?']","['an', ' ', 'alternative', 'management', 'strategy', ':', 'close', 'follow', '-', 'up', 'and', 'CBT']",17,12
"Being developed by a panel of multidisciplinary experts, what does the guideline do?",What,123,provides a clear explanation of the logical relationships between various care options and health outcomes while rating both the quality of the evidence and the strength of the recommendation,Introduction,0,0.9787234042553191,"['Being', 'developed', 'by', 'a', 'panel', 'of', 'multidisciplinary', 'experts', ',', 'what', 'does', 'the', 'guideline', 'do', '?']","['provides', 'a', 'clear', 'explanation', 'of', 'the', 'logical', 'relationships', 'between', 'various', 'care', 'options', 'and', 'health', 'outcomes', 'while', 'rating', 'both', 'the', 'quality', 'of', 'the', 'evidence', 'and', 'the', 'strength', 'of', 'the', 'recommendation']",15,29
LOT is an ineffective treatment modality for patients with what kind of headaches?,What,12,"migraine headaches (with or without aura), tension-type headaches,  occipital neuralgia, or myofascial pain",Background,1,1.0,"['LOT', 'is', 'an', 'ineffective', 'treatment', 'modality', 'for', 'patients', 'with', 'what', 'kind', 'of', 'headaches', '?']","['migraine', 'headaches', '(', 'with', 'or', 'without', 'aura', ')', ',', 'tension', '-', 'type', 'headaches', ',', ' ', 'occipital', 'neuralgia', ',', 'or', 'myofascial', 'pain']",14,21
"According to CDC, what needs to be checked at least quarterly?",What,47,the state database system,Recommendations,1,1.0,"['According', 'to', 'CDC', ',', 'what', 'needs', 'to', 'be', 'checked', 'at', 'least', 'quarterly', '?']","['the', 'state', 'database', 'system']",13,4
For what purpose state database queries are used throughout the country?,What,49,detection of multi-sourcing of controlled substances,Recommendations,1,1.0,"['For', 'what', 'purpose', 'state', 'database', 'queries', 'are', 'used', 'throughout', 'the', 'country', '?']","['detection', 'of', 'multi', '-', 'sourcing', 'of', 'controlled', 'substances']",12,8
It is recommended to individualize opioid tapering based on what?,What,55,risk assessment and patient needs and characteristics,Recommendations,1,1.0,"['It', 'is', 'recommended', 'to', 'individualize', 'opioid', 'tapering', 'based', 'on', 'what', '?']","['risk', 'assessment', 'and', 'patient', 'needs', 'and', 'characteristics']",11,7
Consideration of opioid therapy beyond 90 days requires what?,What,76,reevaluation and discussion with patient of risks and benefits,Recommendations,1,1.0,"['Consideration', 'of', 'opioid', 'therapy', 'beyond', '90', 'days', 'requires', 'what', '?']","['reevaluation', 'and', 'discussion', 'with', 'patient', 'of', 'risks', 'and', 'benefits']",10,9
Self-management strategies are recommended as alternatives to what?,What,82,opioid therapy,Recommendations,1,1.0,"['Self', '-', 'management', 'strategies', 'are', 'recommended', 'as', 'alternatives', 'to', 'what', '?']","['opioid', 'therapy']",11,2
5% opioid reduction of morphine SR 90 mg Q8h = 270 MEDD during the first month in the slowest taper consists of what?,What,88,"90 mg SR qam, 75 mg for noon, 90 mg qpm",Specifications,1,1.0,"['5', '%', 'opioid', 'reduction', 'of', 'morphine', 'SR', '90', 'mg', 'Q8h', '=', '270', 'MEDD', 'during', 'the', 'first', 'month', 'in', 'the', 'slowest', 'taper', 'consists', 'of', 'what', '?']","['90', 'mg', 'SR', 'qam', ',', '75', 'mg', 'for', 'noon', ',', '90', 'mg', 'qpm']",25,13
Clinicians should continue the slowest taper based on what?,What,97,Veteran response,Specifications,1,1.0,"['Clinicians', 'should', 'continue', 'the', 'slowest', 'taper', 'based', 'on', 'what', '?']","['Veteran', 'response']",10,2
"Following an elevated baseline adjusted risk ratio (ARR) of 3.96, what were the odds of overdose in depressed patients taking 1-19 mg, 20 to <50 mg, 50 to <100 mg, and ≥100 mg MEDD?",What,99,"4.75, 5.47, 6.44, and 7.06, compared to those taking an opioid at the same dosage level without a diagnosis of depression",Recommendations,0,0.10526315789473684,"['Following', 'an', 'elevated', 'baseline', 'adjusted', 'risk', 'ratio', '(', 'ARR', ')', 'of', '3.96', ',', 'what', 'were', 'the', 'odds', 'of', 'overdose', 'in', 'depressed', 'patients', 'taking', '1', '-', '19', 'mg', ',', '20', 'to', '<', '50', 'mg', ',', '50', 'to', '<', '100', 'mg', ',', 'and', '≥100', 'mg', 'MEDD', '?']","['4.75', ',', '5.47', ',', '6.44', ',', 'and', '7.06', ',', 'compared', 'to', 'those', 'taking', 'an', 'opioid', 'at', 'the', 'same', 'dosage', 'level', 'without', 'a', 'diagnosis', 'of', 'depression']",45,25
During the first month in the slower taper what does consist of 16% reduction of morphine SR 90 mg Q8h = 270 MEDD?,What,111,75 mg (60 mg+15 mg)SR Q8h,Specifications,1,1.0,"['During', 'the', 'first', 'month', 'in', 'the', 'slower', 'taper', 'what', 'does', 'consist', 'of', '16', '%', 'reduction', 'of', 'morphine', 'SR', '90', 'mg', 'Q8h', '=', '270', 'MEDD', '?']","['75', 'mg', '(', '60', 'mg+15', 'mg)SR', 'Q8h']",25,7
The 2015 outbreak of HIV/hepatitis in rural Indiana and subsequent successful implementation of a needle exchange program is an example of what?,What,118,the threat to rural communities from non-prescription opioid use and the potential benefits of needle exchange programs for use as a risk mitigation strategy,Recommendations,1,1.0,"['The', '2015', 'outbreak', 'of', 'HIV', '/', 'hepatitis', 'in', 'rural', 'Indiana', 'and', 'subsequent', 'successful', 'implementation', 'of', 'a', 'needle', 'exchange', 'program', 'is', 'an', 'example', 'of', 'what', '?']","['the', 'threat', 'to', 'rural', 'communities', 'from', 'non', '-', 'prescription', 'opioid', 'use', 'and', 'the', 'potential', 'benefits', 'of', 'needle', 'exchange', 'programs', 'for', 'use', 'as', 'a', 'risk', 'mitigation', 'strategy']",25,26
Community-based needle exchange programs have been shown to do what?,What,122,"be an effective risk mitigation strategy for reducing high-risk behaviors (e.g., sharing needles) and infectious disease transmission among injection drug users",Recommendations,0,0.9743589743589743,"['Community', '-', 'based', 'needle', 'exchange', 'programs', 'have', 'been', 'shown', 'to', 'do', 'what', '?']","['be', 'an', 'effective', 'risk', 'mitigation', 'strategy', 'for', 'reducing', 'high', '-', 'risk', 'behaviors', '(', 'e.g.', ',', 'sharing', 'needles', ')', 'and', 'infectious', 'disease', 'transmission', 'among', 'injection', 'drug', 'users']",13,26
"Given the relevance of all four domains in grading recommendations, what did the Work Group encounter?",What,129,"multiple instances in which confidence in the quality of the evidence was low or very low, while there was marked imbalance of benefits and harms, as well as certain other important considerations arising from the domains of values and preferences and/or other implications",Recommendations,0,0.04878048780487806,"['Given', 'the', 'relevance', 'of', 'all', 'four', 'domains', 'in', 'grading', 'recommendations', ',', 'what', 'did', 'the', 'Work', 'Group', 'encounter', '?']","['multiple', 'instances', 'in', 'which', 'confidence', 'in', 'the', 'quality', 'of', 'the', 'evidence', 'was', 'low', 'or', 'very', 'low', ',', 'while', 'there', 'was', 'marked', 'imbalance', 'of', 'benefits', 'and', 'harms', ',', 'as', 'well', 'as', 'certain', 'other', 'important', 'considerations', 'arising', 'from', 'the', 'domains', 'of', 'values', 'and', 'preferences', 'and/or', 'other', 'implications']",18,45
"In 2010, what was the focus of National Drug Control Strategy?",What,134,The increasing use of opioids,Background,0,0.08333333333333334,"['In', '2010', ',', 'what', 'was', 'the', 'focus', 'of', 'National', 'Drug', 'Control', 'Strategy', '?']","['The', 'increasing', 'use', 'of', 'opioids']",13,5
During the first day in the rapid taper what does consist of 33% reduction of morphine SR 90 mg Q8h = 270 MEDD?,What,148,60 mg SR (15 mg x 4) Q8h,Specifications,1,1.0,"['During', 'the', 'first', 'day', 'in', 'the', 'rapid', 'taper', 'what', 'does', 'consist', 'of', '33', '%', 'reduction', 'of', 'morphine', 'SR', '90', 'mg', 'Q8h', '=', '270', 'MEDD', '?']","['60', 'mg', 'SR', '(', '15', 'mg', 'x', '4', ')', 'Q8h']",25,10
"If patients are prescribed both long-acting and short-acting opioids, the decision about which formulation to be tapered first should be individualized based on what?",What,156,"medical history, mental health diagnoses, and patient preference",Specifications,1,1.0,"['If', 'patients', 'are', 'prescribed', 'both', 'long', '-', 'acting', 'and', 'short', '-', 'acting', 'opioids', ',', 'the', 'decision', 'about', 'which', 'formulation', 'to', 'be', 'tapered', 'first', 'should', 'be', 'individualized', 'based', 'on', 'what', '?']","['medical', 'history', ',', 'mental', 'health', 'diagnoses', ',', 'and', 'patient', 'preference']",30,10
"In response to the recognition of pain and its management as a public health problem in 2011, what was investigated and reported by the National Academy of Medicine?",What,170,"the state of pain research, treatment, and  education in the U.S.",Recommendations,1,1.0,"['In', 'response', 'to', 'the', 'recognition', 'of', 'pain', 'and', 'its', 'management', 'as', 'a', 'public', 'health', 'problem', 'in', '2011', ',', 'what', 'was', 'investigated', 'and', 'reported', 'by', 'the', 'National', 'Academy', 'of', 'Medicine', '?']","['the', 'state', 'of', 'pain', 'research', ',', 'treatment', ',', 'and', ' ', 'education', 'in', 'the', 'U.S.']",30,14
Patients on long-acting opioids within the facilities providing more follow-up after new prescriptions  were associated with what?,What,189,decreased risk of suicide attempt,Recommendations,1,1.0,"['Patients', 'on', 'long', '-', 'acting', 'opioids', 'within', 'the', 'facilities', 'providing', 'more', 'follow', '-', 'up', 'after', 'new', 'prescriptions', ' ', 'were', 'associated', 'with', 'what', '?']","['decreased', 'risk', 'of', 'suicide', 'attempt']",23,5
Intensification of monitoring helps with what?,What,190,mitigate the risk of suicide among patients on LOT,Recommendations,1,1.0,"['Intensification', 'of', 'monitoring', 'helps', 'with', 'what', '?']","['mitigate', 'the', 'risk', 'of', 'suicide', 'among', 'patients', 'on', 'LOT']",7,9
Follow-up with patients frequently based on what?,What,207,patient risk factors,Algorithm,1,1.0,"['Follow', '-', 'up', 'with', 'patients', 'frequently', 'based', 'on', 'what', '?']","['patient', 'risk', 'factors']",10,3
"A discussion should occur between the Veteran, family members/caregivers, and the provider prior to what?",What,223,any changes being made in opioid prescribing,Specifications,1,1.0,"['A', 'discussion', 'should', 'occur', 'between', 'the', 'Veteran', ',', 'family', 'members', '/', 'caregivers', ',', 'and', 'the', 'provider', 'prior', 'to', 'what', '?']","['any', 'changes', 'being', 'made', 'in', 'opioid', 'prescribing']",20,7
"Since the release of the Clinical Practice Guideline, what has been growingly recognized?",What,239,"an epidemic of opioid misuse and opioid use disorder (OUD) in America, including among America’s Veterans",Introduction,1,1.0,"['Since', 'the', 'release', 'of', 'the', 'Clinical', 'Practice', 'Guideline', ',', 'what', 'has', 'been', 'growingly', 'recognized', '?']","['an', 'epidemic', 'of', 'opioid', 'misuse', 'and', 'opioid', 'use', 'disorder', '(', 'OUD', ')', 'in', 'America', ',', 'including', 'among', 'America', '’s', 'Veterans']",15,20
The National Drug Control Strategy advocates take back programs as what?,What,7,an effective tool,Recommendations,1,1.0,"['The', 'National', 'Drug', 'Control', 'Strategy', 'advocates', 'take', 'back', 'programs', 'as', 'what', '?']","['an', 'effective', 'tool']",12,3
Returning unused opioid medications has been explored as a strategy for what?,What,8,to reduce the amount of opioids in  the community,Recommendations,0,0.923076923076923,"['Returning', 'unused', 'opioid', 'medications', 'has', 'been', 'explored', 'as', 'a', 'strategy', 'for', 'what', '?']","['to', 'reduce', 'the', 'amount', 'of', 'opioids', 'in', ' ', 'the', 'community']",13,10
"If prescribing opioids, what is the recommended dose?",What,17,lowest dose of opioids as indicated by patient-specific risks and benefits,Recommendations,1,1.0,"['If', 'prescribing', 'opioids', ',', 'what', 'is', 'the', 'recommended', 'dose', '?']","['lowest', 'dose', 'of', 'opioids', 'as', 'indicated', 'by', 'patient', '-', 'specific', 'risks', 'and', 'benefits']",10,13
"Some patients on LOT who suffer from chronic pain and co-occurring OUD, depression, and/or personality disorders may do what?",What,40,threaten suicide when providers recommend discontinuation of opioid,Recommendations,0,0.875,"['Some', 'patients', 'on', 'LOT', 'who', 'suffer', 'from', 'chronic', 'pain', 'and', 'co', '-', 'occurring', 'OUD', ',', 'depression', ',', 'and/or', 'personality', 'disorders', 'may', 'do', 'what', '?']","['threaten', 'suicide', 'when', 'providers', 'recommend', 'discontinuation', 'of', 'opioid']",24,8
Further research is needed for what?,What,42,to identify strategies for safely managing patients at elevated risk of suicide who demand opioid medications or become further destabilized during tapering,Recommendations,0,0.9767441860465117,"['Further', 'research', 'is', 'needed', 'for', 'what', '?']","['to', 'identify', 'strategies', 'for', 'safely', 'managing', 'patients', 'at', 'elevated', 'risk', 'of', 'suicide', 'who', 'demand', 'opioid', 'medications', 'or', 'become', 'further', 'destabilized', 'during', 'tapering']",7,22
The veteran undergoing slow tapering should be involved in what?,What,49,skills training and/or have a comprehensive pain care plan,Specifications,1,1.0,"['The', 'veteran', 'undergoing', 'slow', 'tapering', 'should', 'be', 'involved', 'in', 'what', '?']","['skills', 'training', 'and/or', 'have', 'a', 'comprehensive', 'pain', 'care', 'plan']",11,9
"For patients at risk for overdose, what should be done?",What,81,"Offer risk mitigation strategies, including naloxone",Specifications,1,1.0,"['For', 'patients', 'at', 'risk', 'for', 'overdose', ',', 'what', 'should', 'be', 'done', '?']","['Offer', 'risk', 'mitigation', 'strategies', ',', 'including', 'naloxone']",12,7
Opioids carry a significant risk for what?,What,95,"OUD, overdose, and death, especially among patients with untreated  SUD",Recommendations,0,0.5714285714285715,"['Opioids', 'carry', 'a', 'significant', 'risk', 'for', 'what', '?']","['OUD', ',', 'overdose', ',', 'and', 'death', ',', 'especially', 'among', 'patients', 'with', 'untreated', ' ', 'SUD']",8,14
"If take-home opioids are prescribed, what is the recommended dose of immediate-release opioids?",What,100,lowest effective,Recommendations,0,0.16666666666666669,"['If', 'take', '-', 'home', 'opioids', 'are', 'prescribed', ',', 'what', 'is', 'the', 'recommended', 'dose', 'of', 'immediate', '-', 'release', 'opioids', '?']","['lowest', 'effective']",19,2
Alternatives to opioids are recommended for what?,What,103,mild-to-moderate acute pain,Recommendations,1,1.0,"['Alternatives', 'to', 'opioids', 'are', 'recommended', 'for', 'what', '?']","['mild', '-', 'to', '-', 'moderate', 'acute', 'pain']",8,7
At what dose do risks for opioid use disorder begin?,What,164,any,Recommendations,1,1.0,"['At', 'what', 'dose', 'do', 'risks', 'for', 'opioid', 'use', 'disorder', 'begin', '?']",['any'],11,1
At what dose do risks for opioid use disorder increase?,What,165,in a dose-dependent manner,Recommendations,0,0.0,"['At', 'what', 'dose', 'do', 'risks', 'for', 'opioid', 'use', 'disorder', 'increase', '?']","['in', 'a', 'dose', '-', 'dependent', 'manner']",11,6
At what dose do the risks for overdose and death increase?,What,166,a range of 20-50 mg morphine equivalent daily dose,Recommendations,1,1.0,"['At', 'what', 'dose', 'do', 'the', 'risks', 'for', 'overdose', 'and', 'death', 'increase', '?']","['a', 'range', 'of', '20', '-', '50', 'mg', 'morphine', 'equivalent', 'daily', 'dose']",12,11
"Availability of accurate and timely confirmatory testing (e.g., gas chromatography-mass spectrometry  [GCMS]) is critical due to what?",What,182,the false positive and negative rates associated with UDTs,Recommendations,1,1.0,"['Availability', 'of', 'accurate', 'and', 'timely', 'confirmatory', 'testing', '(', 'e.g.', ',', 'gas', 'chromatography', '-', 'mass', 'spectrometry', ' ', '[', 'GCMS', ']', ')', 'is', 'critical', 'due', 'to', 'what', '?']","['the', 'false', 'positive', 'and', 'negative', 'rates', 'associated', 'with', 'UDTs']",26,9
Veterans receiving both opioids and benzodiazepines were at an increased risk of what?,What,189,death from drug overdose,Recommendations,1,1.0,"['Veterans', 'receiving', 'both', 'opioids', 'and', 'benzodiazepines', 'were', 'at', 'an', 'increased', 'risk', 'of', 'what', '?']","['death', 'from', 'drug', 'overdose']",14,4
At what range of dose the risks for overdose and death significantly increase?,What,196,20- 50 mg morphine equivalent daily dose,Recommendations,1,1.0,"['At', 'what', 'range', 'of', 'dose', 'the', 'risks', 'for', 'overdose', 'and', 'death', 'significantly', 'increase', '?']","['20-', '50', 'mg', 'morphine', 'equivalent', 'daily', 'dose']",14,7
Every healthcare professional making use of these guidelines is responsible for what?,What,208,evaluating the appropriateness of applying them in the setting of any particular clinical situation,Introduction,1,1.0,"['Every', 'healthcare', 'professional', 'making', 'use', 'of', 'these', 'guidelines', 'is', 'responsible', 'for', 'what', '?']","['evaluating', 'the', 'appropriateness', 'of', 'applying', 'them', 'in', 'the', 'setting', 'of', 'any', 'particular', 'clinical', 'situation']",13,14
"Prior to any changes in therapy, what should be discussed with the Veteran?",What,210,"the risks of continued use, along with possible benefits",Specifications,1,1.0,"['Prior', 'to', 'any', 'changes', 'in', 'therapy', ',', 'what', 'should', 'be', 'discussed', 'with', 'the', 'Veteran', '?']","['the', 'risks', 'of', 'continued', 'use', ',', 'along', 'with', 'possible', 'benefits']",15,10
Gabapentin can help reduce what?,What,216,"withdrawal symptoms and help with pain, anxiety, and sleep",Specifications,0,0.3636363636363636,"['Gabapentin', 'can', 'help', 'reduce', 'what', '?']","['withdrawal', 'symptoms', 'and', 'help', 'with', 'pain', ',', 'anxiety', ',', 'and', 'sleep']",6,11
"From 2000 through 2010, what was the increment of the proportion of pain visits during which opioid was prescribed?",What,2,from 11.3% to 19.6%,Background,0,0.8571428571428571,"['From', '2000', 'through', '2010', ',', 'what', 'was', 'the', 'increment', 'of', 'the', 'proportion', 'of', 'pain', 'visits', 'during', 'which', 'opioid', 'was', 'prescribed', '?']","['from', '11.3', '%', 'to', '19.6', '%']",21,6
"From 2000 through 2010, what was the increment of the proportion of pain visits during which non-opioid pharmacologic therapies were prescribed?",What,4,from 26% to 29%,Background,0,0.5,"['From', '2000', 'through', '2010', ',', 'what', 'was', 'the', 'increment', 'of', 'the', 'proportion', 'of', 'pain', 'visits', 'during', 'which', 'non', '-', 'opioid', 'pharmacologic', 'therapies', 'were', 'prescribed', '?']","['from', '26', '%', 'to', '29', '%']",25,6
"In comparison to patients in the 20-44 age  group, patients in the 45-64 year age group were significantly less likely to have what?",What,58,"an aberrant UDT (detection of a non-prescribed opioid, non-prescribed  benzodiazepine, illicit drug, or tetrahydrocannabinol [THC])",Recommendations,0,0.2666666666666667,"['In', 'comparison', 'to', 'patients', 'in', 'the', '20', '-', '44', 'age', ' ', 'group', ',', 'patients', 'in', 'the', '45', '-', '64', 'year', 'age', 'group', 'were', 'significantly', 'less', 'likely', 'to', 'have', 'what', '?']","['an', 'aberrant', 'UDT', '(', 'detection', 'of', 'a', 'non', '-', 'prescribed', 'opioid', ',', 'non', '-', 'prescribed', ' ', 'benzodiazepine', ',', 'illicit', 'drug', ',', 'or', 'tetrahydrocannabinol', '[', 'THC', ']', ')']",30,27
Younger patients are at a higher risk of what?,What,61,opioid misuse (as suggested by a UDT indicating high-risk  medication-related behavior),Recommendations,1,1.0,"['Younger', 'patients', 'are', 'at', 'a', 'higher', 'risk', 'of', 'what', '?']","['opioid', 'misuse', '(', 'as', 'suggested', 'by', 'a', 'UDT', 'indicating', 'high', '-', 'risk', ' ', 'medication', '-', 'related', 'behavior', ')']",10,18
There may be some variation in what?,What,67,patient values and preferences,Recommendations,1,1.0,"['There', 'may', 'be', 'some', 'variation', 'in', 'what', '?']","['patient', 'values', 'and', 'preferences']",8,4
On what to follow-up with the Veteran?,What,120,"patient function, pain intensity, sleep, physical activity, personal goals, and stress level",Specifications,1,1.0,"['On', 'what', 'to', 'follow', '-', 'up', 'with', 'the', 'Veteran', '?']","['patient', 'function', ',', 'pain', 'intensity', ',', 'sleep', ',', 'physical', 'activity', ',', 'personal', 'goals', ',', 'and', 'stress', 'level']",10,17
Follow-up for tapering is recommended to be what?,What,134,a team function with various team members taking on roles in which they have demonstrated specific competencies,Specifications,1,1.0,"['Follow', '-', 'up', 'for', 'tapering', 'is', 'recommended', 'to', 'be', 'what', '?']","['a', 'team', 'function', 'with', 'various', 'team', 'members', 'taking', 'on', 'roles', 'in', 'which', 'they', 'have', 'demonstrated', 'specific', 'competencies']",11,17
"If the patients under opioid taper pna resume their original dose, they are at risk of what?",What,143,an overdose,Specifications,1,1.0,"['If', 'the', 'patients', 'under', 'opioid', 'taper', 'pna', 'resume', 'their', 'original', 'dose', ',', 'they', 'are', 'at', 'risk', 'of', 'what', '?']","['an', 'overdose']",19,2
"If the initial goal is determined to be a dose reduction, what may indicate that complete discontinuation is more suitable?",What,145,subsequent regular reassessment,Specifications,1,1.0,"['If', 'the', 'initial', 'goal', 'is', 'determined', 'to', 'be', 'a', 'dose', 'reduction', ',', 'what', 'may', 'indicate', 'that', 'complete', 'discontinuation', 'is', 'more', 'suitable', '?']","['subsequent', 'regular', 'reassessment']",22,3
"Slower, more gradual tapers can be completed over several months to years based on what?",What,152,the opioid dose,Specifications,1,1.0,"['Slower', ',', 'more', 'gradual', 'tapers', 'can', 'be', 'completed', 'over', 'several', 'months', 'to', 'years', 'based', 'on', 'what', '?']","['the', 'opioid', 'dose']",17,3
Medication assisted treatment is recommended for what?,What,173,opioid use disorder,Recommendations,0,0.4,"['Medication', 'assisted', 'treatment', 'is', 'recommended', 'for', 'what', '?']","['opioid', 'use', 'disorder']",8,3
"Between 2000 and 2013, what increased along with the increment of prescription opioid use?",What,187,the rate of heroin overdose deaths,Background,1,1.0,"['Between', '2000', 'and', '2013', ',', 'what', 'increased', 'along', 'with', 'the', 'increment', 'of', 'prescription', 'opioid', 'use', '?']","['the', 'rate', 'of', 'heroin', 'overdose', 'deaths']",16,6
During the first week in the faster taper what does consist of 16% reduction of morphine SR 90 mg Q8h = 270 MEDD?,What,204,75 mg SR Q8h,Specifications,1,1.0,"['During', 'the', 'first', 'week', 'in', 'the', 'faster', 'taper', 'what', 'does', 'consist', 'of', '16', '%', 'reduction', 'of', 'morphine', 'SR', '90', 'mg', 'Q8h', '=', '270', 'MEDD', '?']","['75', 'mg', 'SR', 'Q8h']",25,4
"Among patients  being treated by the VHA system that received opioids, a history of depression was  significantly associated with what?",What,229,opioid-related toxicity/overdose,Background,0,0.4,"['Among', 'patients', ' ', 'being', 'treated', 'by', 'the', 'VHA', 'system', 'that', 'received', 'opioids', ',', 'a', 'history', 'of', 'depression', 'was', ' ', 'significantly', 'associated', 'with', 'what', '?']","['opioid', '-', 'related', 'toxicity', '/', 'overdose']",24,6
"Among patients on OT, what was significantly higher among patients with a history of PTSD as compared to patients with other (or no) mental  health diagnoses?",What,230,a prevalence of self inflicted injuries,Background,1,1.0,"['Among', 'patients', 'on', 'OT', ',', 'what', 'was', 'significantly', 'higher', 'among', 'patients', 'with', 'a', 'history', 'of', 'PTSD', 'as', 'compared', 'to', 'patients', 'with', 'other', '(', 'or', 'no', ')', 'mental', ' ', 'health', 'diagnoses', '?']","['a', 'prevalence', 'of', 'self', 'inflicted', 'injuries']",31,6
"Among patients  being treated by the VHA system that received opioids, what was significantly associated with opioid-related toxicity/overdose compared to no history of  depression?",What,231,a history of depression,Background,1,1.0,"['Among', 'patients', ' ', 'being', 'treated', 'by', 'the', 'VHA', 'system', 'that', 'received', 'opioids', ',', 'what', 'was', 'significantly', 'associated', 'with', 'opioid', '-', 'related', 'toxicity', '/', 'overdose', 'compared', 'to', 'no', 'history', 'of', ' ', 'depression', '?']","['a', 'history', 'of', 'depression']",32,4
LOT has been associated with what kinds of symptoms?,What,238,worsening depressive symptoms,Background,0,0.8,"['LOT', 'has', 'been', 'associated', 'with', 'what', 'kinds', 'of', 'symptoms', '?']","['worsening', 'depressive', 'symptoms']",10,3
"Due to the difficulty of tapering or discontinuing benzodiazepines, what should be done when considering initiating benzodiazepines for Veterans with PTSD who have co-occurring chronic pain?",What,246,particular caution should be used,Recommendations,0,0.5714285714285715,"['Due', 'to', 'the', 'difficulty', 'of', 'tapering', 'or', 'discontinuing', 'benzodiazepines', ',', 'what', 'should', 'be', 'done', 'when', 'considering', 'initiating', 'benzodiazepines', 'for', 'Veterans', 'with', 'PTSD', 'who', 'have', 'co', '-', 'occurring', 'chronic', 'pain', '?']","['particular', 'caution', 'should', 'be', 'used']",30,5
Exacerbation of severe PTSD symptoms may result from what?,What,255,gradual benzodiazepine taper,Recommendations,0,0.8571428571428571,"['Exacerbation', 'of', 'severe', 'PTSD', 'symptoms', 'may', 'result', 'from', 'what', '?']","['gradual', 'benzodiazepine', 'taper']",10,3
Benzodiazepines to treat acute anxiety symptoms after trauma are associated with what?,What,260,a  higher incidence of PTSD symptoms,Recommendations,1,1.0,"['Benzodiazepines', 'to', 'treat', 'acute', 'anxiety', 'symptoms', 'after', 'trauma', 'are', 'associated', 'with', 'what', '?']","['a', ' ', 'higher', 'incidence', 'of', 'PTSD', 'symptoms']",13,7
"From 1999 to 2008, what is increasing in parallel with the increment of opioid prescribing?",What,288,"morbidity, mortality, opioid-related  overdose death rates, and substance use disorders (SUD) treatment admissions",Background,1,1.0,"['From', '1999', 'to', '2008', ',', 'what', 'is', 'increasing', 'in', 'parallel', 'with', 'the', 'increment', 'of', 'opioid', 'prescribing', '?']","['morbidity', ',', 'mortality', ',', 'opioid', '-', 'related', ' ', 'overdose', 'death', 'rates', ',', 'and', 'substance', 'use', 'disorders', '(', 'SUD', ')', 'treatment', 'admissions']",17,21
The use of a CPG must always be considered as what?,What,328,"a recommendation, within the context of a provider’s clinical judgment and patient values and preferences, in the care for an individual patient.",Introduction,1,1.0,"['The', 'use', 'of', 'a', 'CPG', 'must', 'always', 'be', 'considered', 'as', 'what', '?']","['a', 'recommendation', ',', 'within', 'the', 'context', 'of', 'a', 'provider', '’s', 'clinical', 'judgment', 'and', 'patient', 'values', 'and', 'preferences', ',', 'in', 'the', 'care', 'for', 'an', 'individual', 'patient', '.']",12,26
The ultimate judgement regarding a particular clinical procedure or treatment course must be made in light of what?,What,329,"the patient’s clinical presentation, patient preferences, and the available diagnostic and treatment options",Introduction,1,1.0,"['The', 'ultimate', 'judgement', 'regarding', 'a', 'particular', 'clinical', 'procedure', 'or', 'treatment', 'course', 'must', 'be', 'made', 'in', 'light', 'of', 'what', '?']","['the', 'patient', '’s', 'clinical', 'presentation', ',', 'patient', 'preferences', ',', 'and', 'the', 'available', 'diagnostic', 'and', 'treatment', 'options']",19,16
"In Operation Enduring Freedom/Operation Iraqi Freedom (OEF/OIF) Veterans, chronic pain was associated with what?",What,331,"poorer physical function, independent of comorbid mental health concerns",Background,0,0.5,"['In', 'Operation', 'Enduring', 'Freedom', '/', 'Operation', 'Iraqi', 'Freedom', '(', 'OEF', '/', 'OIF', ')', 'Veterans', ',', 'chronic', 'pain', 'was', 'associated', 'with', 'what', '?']","['poorer', 'physical', 'function', ',', 'independent', 'of', 'comorbid', 'mental', 'health', 'concerns']",22,10
Should you prescribe the highest or lowest effective dose when starting therapy?,When,72,lowest,Specifications,1,1.0,"['Should', 'you', 'prescribe', 'the', 'highest', 'or', 'lowest', 'effective', 'dose', 'when', 'starting', 'therapy', '?']",['lowest'],13,1
"Since when has there been growing recognition of an opioid misuse epidemic, including among America’s Veterans?",When,236,the release of that guideline,Introduction,1,1.0,"['Since', 'when', 'has', 'there', 'been', 'growing', 'recognition', 'of', 'an', 'opioid', 'misuse', 'epidemic', ',', 'including', 'among', 'America', '’s', 'Veterans', '?']","['the', 'release', 'of', 'that', 'guideline']",19,5
"Since when has there been growing recognition of opioid use disorder in America, including among America’s Veterans?",When,238,the release of that guideline,Introduction,1,1.0,"['Since', 'when', 'has', 'there', 'been', 'growing', 'recognition', 'of', 'opioid', 'use', 'disorder', 'in', 'America', ',', 'including', 'among', 'America', '’s', 'Veterans', '?']","['the', 'release', 'of', 'that', 'guideline']",20,5
For whom to consider tapering one or both benzodiazepines and opioids when risks exceed benefits and obtaining specialty consultation as appropriate?,When,9,patients currently on long-term opioid therapy and benzodiazepines,Recommendations,1,1.0,"['For', 'whom', 'to', 'consider', 'tapering', 'one', 'or', 'both', 'benzodiazepines', 'and', 'opioids', 'when', 'risks', 'exceed', 'benefits', 'and', 'obtaining', 'specialty', 'consultation', 'as', 'appropriate', '?']","['patients', 'currently', 'on', 'long', '-', 'term', 'opioid', 'therapy', 'and', 'benzodiazepines']",22,10
"If take-home opioids are prescribed, when is the opioid therapy reassessment recommended?",When,104,no later than 3-5 days,Recommendations,0,0.5,"['If', 'take', '-', 'home', 'opioids', 'are', 'prescribed', ',', 'when', 'is', 'the', 'opioid', 'therapy', 'reassessment', 'recommended', '?']","['no', 'later', 'than', '3', '-', '5', 'days']",16,7
"Since when has there been a significant increment of opioid-related morbidity, mortality, overdose death, and SUD treatment admissions?",When,72,the late 1990s and early 2000s,Background,1,1.0,"['Since', 'when', 'has', 'there', 'been', 'a', 'significant', 'increment', 'of', 'opioid', '-', 'related', 'morbidity', ',', 'mortality', ',', 'overdose', 'death', ',', 'and', 'SUD', 'treatment', 'admissions', '?']","['the', 'late', '1990s', 'and', 'early', '2000s']",24,6
Since when has there been a significant increment of opioid prescriptions during pain visits?,When,77,the late 1990s and early 2000s,Background,1,1.0,"['Since', 'when', 'has', 'there', 'been', 'a', 'significant', 'increment', 'of', 'opioid', 'prescriptions', 'during', 'pain', 'visits', '?']","['the', 'late', '1990s', 'and', 'early', '2000s']",15,6
For whom consideration for tapering when risks exceed benefits is recommended?,When,212,patients currently on long-term opioid therapy,Recommendations,1,1.0,"['For', 'whom', 'consideration', 'for', 'tapering', 'when', 'risks', 'exceed', 'benefits', 'is', 'recommended', '?']","['patients', 'currently', 'on', 'long', '-', 'term', 'opioid', 'therapy']",12,8
"For whom ongoing risk mitigation strategies, assessment for opioid use disorder, and consideration for tapering when risks exceed benefits are recommended?",When,213,patients currently on long-term opioid therapy,Recommendations,1,1.0,"['For', 'whom', 'ongoing', 'risk', 'mitigation', 'strategies', ',', 'assessment', 'for', 'opioid', 'use', 'disorder', ',', 'and', 'consideration', 'for', 'tapering', 'when', 'risks', 'exceed', 'benefits', 'are', 'recommended', '?']","['patients', 'currently', 'on', 'long', '-', 'term', 'opioid', 'therapy']",24,8
For whom particular caution should be used when considering initiating benzodiazepines due to the difficulty of tapering or discontinuing benzodiazepines?,When,258,Veterans with PTSD who have co-occurring chronic pain,Recommendations,1,1.0,"['For', 'whom', 'particular', 'caution', 'should', 'be', 'used', 'when', 'considering', 'initiating', 'benzodiazepines', 'due', 'to', 'the', 'difficulty', 'of', 'tapering', 'or', 'discontinuing', 'benzodiazepines', '?']","['Veterans', 'with', 'PTSD', 'who', 'have', 'co', '-', 'occurring', 'chronic', 'pain']",21,10
For whom is his CPG is intended?,Who,79,"adults, including Veterans as well as deployed and  non-deployed Active Duty Service Members, their beneficiaries, and retirees and their beneficiaries, with  chronic pain who are receiving care from the VA or DoD healthcare delivery systems",Specifications,0,0.05714285714285715,"['For', 'whom', 'is', 'his', 'CPG', 'is', 'intended', '?']","['adults', ',', 'including', 'Veterans', 'as', 'well', 'as', 'deployed', 'and', ' ', 'non', '-', 'deployed', 'Active', 'Duty', 'Service', 'Members', ',', 'their', 'beneficiaries', ',', 'and', 'retirees', 'and', 'their', 'beneficiaries', ',', 'with', ' ', 'chronic', 'pain', 'who', 'are', 'receiving', 'care', 'from', 'the', 'VA', 'or', 'DoD', 'healthcare', 'delivery', 'systems']",8,43
For whom to evaluate for tapering to reduced dose or to discontinuation?,Who,16,patients who are currently prescribed doses over 90 mg morphine equivalent daily dose,Recommendations,1,1.0,"['For', 'whom', 'to', 'evaluate', 'for', 'tapering', 'to', 'reduced', 'dose', 'or', 'to', 'discontinuation', '?']","['patients', 'who', 'are', 'currently', 'prescribed', 'doses', 'over', '90', 'mg', 'morphine', 'equivalent', 'daily', 'dose']",13,13
"In patients receiving LOT, who are 50% more likely to escalate to high-dose opioids and twice as likely to  experience an opioid-related death?",Who,41,men,Recommendations,1,1.0,"['In', 'patients', 'receiving', 'LOT', ',', 'who', 'are', '50', '%', 'more', 'likely', 'to', 'escalate', 'to', 'high', '-', 'dose', 'opioids', 'and', 'twice', 'as', 'likely', 'to', ' ', 'experience', 'an', 'opioid', '-', 'related', 'death', '?']",['men'],31,1
For whom should the slowest taper be considered?,Who,83,patients taking high doses of long-acting opioids for many years,Specifications,1,1.0,"['For', 'whom', 'should', 'the', 'slowest', 'taper', 'be', 'considered', '?']","['patients', 'taking', 'high', 'doses', 'of', 'long', '-', 'acting', 'opioids', 'for', 'many', 'years']",9,12
"For whom should clinicians consider educating the patient regarding sterile injection techniques and community-based needle exchange programs, if programs are available?",Who,121,patients who decline MAT for OUD,Recommendations,1,1.0,"['For', 'whom', 'should', 'clinicians', 'consider', 'educating', 'the', 'patient', 'regarding', 'sterile', 'injection', 'techniques', 'and', 'community', '-', 'based', 'needle', 'exchange', 'programs', ',', 'if', 'programs', 'are', 'available', '?']","['patients', 'who', 'decline', 'MAT', 'for', 'OUD']",25,6
"In response to the recognition of pain and its management as a public health problem in 2011, who investigated and reported on the state of pain research, treatment, and  education in the U.S.?",Who,175,the  National Academy of Medicine,Recommendations,1,1.0,"['In', 'response', 'to', 'the', 'recognition', 'of', 'pain', 'and', 'its', 'management', 'as', 'a', 'public', 'health', 'problem', 'in', '2011', ',', 'who', 'investigated', 'and', 'reported', 'on', 'the', 'state', 'of', 'pain', 'research', ',', 'treatment', ',', 'and', ' ', 'education', 'in', 'the', 'U.S.', '?']","['the', ' ', 'National', 'Academy', 'of', 'Medicine']",38,6
"Prior to any changes being made in opioid prescribing, a discussion should occur between whom?",Who,231,"the Veteran, family members/caregivers, and the provider",Specifications,1,1.0,"['Prior', 'to', 'any', 'changes', 'being', 'made', 'in', 'opioid', 'prescribing', ',', 'a', 'discussion', 'should', 'occur', 'between', 'whom', '?']","['the', 'Veteran', ',', 'family', 'members', '/', 'caregivers', ',', 'and', 'the', 'provider']",17,11
"In which cases it is essential to involve behavioral health to assess, monitor, and treat a patient who becomes destabilized as a result of a medically appropriate decision to taper or cease LOT?",Who,39,"However,  continuing LOT to “prevent suicide” in someone with chronic pain is not recommended as an appropriate response if suicide risk is high or increases.",Recommendations,0,0.9787234042553191,"['In', 'which', 'cases', 'it', 'is', 'essential', 'to', 'involve', 'behavioral', 'health', 'to', 'assess', ',', 'monitor', ',', 'and', 'treat', 'a', 'patient', 'who', 'becomes', 'destabilized', 'as', 'a', 'result', 'of', 'a', 'medically', 'appropriate', 'decision', 'to', 'taper', 'or', 'cease', 'LOT', '?']","['However', ',', ' ', 'continuing', 'LOT', 'to', '“', 'prevent', 'suicide', '”', 'in', 'someone', 'with', 'chronic', 'pain', 'is', 'not', 'recommended', 'as', 'an', 'appropriate', 'response', 'if', 'suicide', 'risk', 'is', 'high', 'or', 'increases', '.']",36,30
For whom is this guideline intended?,Who,145,"VA and  DoD healthcare practitioners including physicians, nurse practitioners, physician assistants, physical and  occupational therapists, psychologists, social workers, nurses, clinical pharmacists, chaplains, addiction  counselors, and others involved in the care of Service Members and their beneficiaries, retirees and their  beneficiaries, or Veterans on or being considered for LOT",Specifications,0,0.1923076923076923,"['For', 'whom', 'is', 'this', 'guideline', 'intended', '?']","['VA', 'and', ' ', 'DoD', 'healthcare', 'practitioners', 'including', 'physicians', ',', 'nurse', 'practitioners', ',', 'physician', 'assistants', ',', 'physical', 'and', ' ', 'occupational', 'therapists', ',', 'psychologists', ',', 'social', 'workers', ',', 'nurses', ',', 'clinical', 'pharmacists', ',', 'chaplains', ',', 'addiction', ' ', 'counselors', ',', 'and', 'others', 'involved', 'in', 'the', 'care', 'of', 'Service', 'Members', 'and', 'their', 'beneficiaries', ',', 'retirees', 'and', 'their', ' ', 'beneficiaries', ',', 'or', 'Veterans', 'on', 'or', 'being', 'considered', 'for', 'LOT']",7,64
Patients in the 45-64 and ≥65 age groups were significantly less likely than whom to  have non-detection of a prescribed opioid (indicating possible diversion)?,Who,59,20-44 year olds,Recommendations,1,1.0,"['Patients', 'in', 'the', '45', '-', '64', 'and', '≥65', 'age', 'groups', 'were', 'significantly', 'less', 'likely', 'than', 'whom', 'to', ' ', 'have', 'non', '-', 'detection', 'of', 'a', 'prescribed', 'opioid', '(', 'indicating', 'possible', 'diversion', ')', '?']","['20', '-', '44', 'year', 'olds']",32,5
"Patients in the 45-64 year age group were significantly less likely to have an aberrant UDT (detection of a non-prescribed opioid, non-prescribed  benzodiazepine, illicit drug, or tetrahydrocannabinol [THC]) in comparison to whom?",Who,62,patients in the 20-44 age  group,Recommendations,1,1.0,"['Patients', 'in', 'the', '45', '-', '64', 'year', 'age', 'group', 'were', 'significantly', 'less', 'likely', 'to', 'have', 'an', 'aberrant', 'UDT', '(', 'detection', 'of', 'a', 'non', '-', 'prescribed', 'opioid', ',', 'non', '-', 'prescribed', ' ', 'benzodiazepine', ',', 'illicit', 'drug', ',', 'or', 'tetrahydrocannabinol', '[', 'THC', ']', ')', 'in', 'comparison', 'to', 'whom', '?']","['patients', 'in', 'the', '20', '-', '44', 'age', ' ', 'group']",47,9
"In a study of patients on opioids, who had 2.9 times the odds of suicidal ideation within the past 12 months as well as 3.2  times the odds of a lifetime suicide attempt compared to those with no bipolar disorder?",Who,89,those with bipolar disorder,Background,1,1.0,"['In', 'a', 'study', 'of', 'patients', 'on', 'opioids', ',', 'who', 'had', '2.9', 'times', 'the', 'odds', 'of', 'suicidal', 'ideation', 'within', 'the', 'past', '12', 'months', 'as', 'well', 'as', '3.2', ' ', 'times', 'the', 'odds', 'of', 'a', 'lifetime', 'suicide', 'attempt', 'compared', 'to', 'those', 'with', 'no', 'bipolar', 'disorder', '?']","['those', 'with', 'bipolar', 'disorder']",43,4
With whom to follow up during opioid taper?,Who,136,PACT Team,Specifications,1,1.0,"['With', 'whom', 'to', 'follow', 'up', 'during', 'opioid', 'taper', '?']","['PACT', 'Team']",9,2
For whom assessment for opioid use disorder is recommended?,Who,216,patients currently on long-term opioid therapy,Recommendations,1,1.0,"['For', 'whom', 'assessment', 'for', 'opioid', 'use', 'disorder', 'is', 'recommended', '?']","['patients', 'currently', 'on', 'long', '-', 'term', 'opioid', 'therapy']",10,8
For whom ongoing risk mitigation strategies are recommended?,Who,217,patients currently on long-term opioid therapy,Recommendations,1,1.0,"['For', 'whom', 'ongoing', 'risk', 'mitigation', 'strategies', 'are', 'recommended', '?']","['patients', 'currently', 'on', 'long', '-', 'term', 'opioid', 'therapy']",9,8
"Depending on age, marital status, race, and living conditions, who were more likely to continue using opioids?",Who,333,"those who were aged 50-65 years,  were married, were of a race other than African American, and who lived in a rural setting",Background,1,1.0,"['Depending', 'on', 'age', ',', 'marital', 'status', ',', 'race', ',', 'and', 'living', 'conditions', ',', 'who', 'were', 'more', 'likely', 'to', 'continue', 'using', 'opioids', '?']","['those', 'who', 'were', 'aged', '50', '-', '65', 'years', ',', ' ', 'were', 'married', ',', 'were', 'of', 'a', 'race', 'other', 'than', 'African', 'American', ',', 'and', 'who', 'lived', 'in', 'a', 'rural', 'setting']",22,29
"In a sample of non-treatment-seeking members of the military who were interviewed within three months of returning from Afghanistan, how many reported chronic pain?",Who,334,44%,Background,1,1.0,"['In', 'a', 'sample', 'of', 'non', '-', 'treatment', '-', 'seeking', 'members', 'of', 'the', 'military', 'who', 'were', 'interviewed', 'within', 'three', 'months', 'of', 'returning', 'from', 'Afghanistan', ',', 'how', 'many', 'reported', 'chronic', 'pain', '?']","['44', '%']",30,2
"Among the Veterans, who were more likely to continue their opioid use?",Who,335,Veterans on higher doses of opioids,Background,1,1.0,"['Among', 'the', 'Veterans', ',', 'who', 'were', 'more', 'likely', 'to', 'continue', 'their', 'opioid', 'use', '?']","['Veterans', 'on', 'higher', 'doses', 'of', 'opioids']",14,6
"In a study of civilian patients who had been on opioids for at least 90 days, how many remained on opioids through the 4.8 year follow-up period?",Who,336,approximately 65%,Background,1,1.0,"['In', 'a', 'study', 'of', 'civilian', 'patients', 'who', 'had', 'been', 'on', 'opioids', 'for', 'at', 'least', '90', 'days', ',', 'how', 'many', 'remained', 'on', 'opioids', 'through', 'the', '4.8', 'year', 'follow', '-', 'up', 'period', '?']","['approximately', '65', '%']",31,3
"In a study of Veterans with chronic pain who had been on opioids for at least 90 days, how many continued to use opioids after completion of the 3.5 year follow-up period?",Who,339,nearly 80%,Background,1,1.0,"['In', 'a', 'study', 'of', 'Veterans', 'with', 'chronic', 'pain', 'who', 'had', 'been', 'on', 'opioids', 'for', 'at', 'least', '90', 'days', ',', 'how', 'many', 'continued', 'to', 'use', 'opioids', 'after', 'completion', 'of', 'the', '3.5', 'year', 'follow', '-', 'up', 'period', '?']","['nearly', '80', '%']",36,3
"Among the Veterans, who were less likely to continue their opioid use?",Who,340,those with mental health diagnoses,Background,1,1.0,"['Among', 'the', 'Veterans', ',', 'who', 'were', 'less', 'likely', 'to', 'continue', 'their', 'opioid', 'use', '?']","['those', 'with', 'mental', 'health', 'diagnoses']",14,5
"In a sample of non-treatment-seeking members of the military who were interviewed within three months of returning from Afghanistan, how many reported using opioids?",Who,341,15%,Background,1,1.0,"['In', 'a', 'sample', 'of', 'non', '-', 'treatment', '-', 'seeking', 'members', 'of', 'the', 'military', 'who', 'were', 'interviewed', 'within', 'three', 'months', 'of', 'returning', 'from', 'Afghanistan', ',', 'how', 'many', 'reported', 'using', 'opioids', '?']","['15', '%']",30,2
"In a study of Veterans with chronic pain who had been on opioids for at least 90 days, how many continued to use opioids one year later?",Who,342,over 90%,Background,1,1.0,"['In', 'a', 'study', 'of', 'Veterans', 'with', 'chronic', 'pain', 'who', 'had', 'been', 'on', 'opioids', 'for', 'at', 'least', '90', 'days', ',', 'how', 'many', 'continued', 'to', 'use', 'opioids', 'one', 'year', 'later', '?']","['over', '90', '%']",29,3
"Compared to whom, patients 18-30 years old carried 11 times the odds of OUD  and overdose?",Who,343,patients ≥65 years old,Recommendations,1,1.0,"['Compared', 'to', 'whom', ',', 'patients', '18', '-', '30', 'years', 'old', 'carried', '11', 'times', 'the', 'odds', 'of', 'OUD', ' ', 'and', 'overdose', '?']","['patients', '≥65', 'years', 'old']",21,4
"Compared to whom, patients ≥70 years old had far less risk of developing OUD or overdose?",Who,350,subjects 18-29 years old,Recommendations,1,1.0,"['Compared', 'to', 'whom', ',', 'patients', '≥70', 'years', 'old', 'had', 'far', 'less', 'risk', 'of', 'developing', 'OUD', 'or', 'overdose', '?']","['subjects', '18', '-', '29', 'years', 'old']",18,6
"Compared to whom, patients 31-40 years old carried 5 times the odds of OUD and overdose?",Who,351,those  ≥65 years old,Recommendations,1,1.0,"['Compared', 'to', 'whom', ',', 'patients', '31', '-', '40', 'years', 'old', 'carried', '5', 'times', 'the', 'odds', 'of', 'OUD', 'and', 'overdose', '?']","['those', ' ', '≥65', 'years', 'old']",20,5
"Compared to whom, patients 30-39  years old had roughly half the risk of developing OUD or overdose?",Who,355,subjects 18-29 years old,Recommendations,1,1.0,"['Compared', 'to', 'whom', ',', 'patients', '30', '-', '39', ' ', 'years', 'old', 'had', 'roughly', 'half', 'the', 'risk', 'of', 'developing', 'OUD', 'or', 'overdose', '?']","['subjects', '18', '-', '29', 'years', 'old']",22,6
"For patients who are in chronic pain and have not been on daily OT for pain for more than 3 months, which topics to consider for educating or re-educating them?",Who,362,"non-opioid management, self-management to improve function and quality of life, realistic expectations and limitations of medical treatment",Algorithm,1,1.0,"['For', 'patients', 'who', 'are', 'in', 'chronic', 'pain', 'and', 'have', 'not', 'been', 'on', 'daily', 'OT', 'for', 'pain', 'for', 'more', 'than', '3', 'months', ',', 'which', 'topics', 'to', 'consider', 'for', 'educating', 'or', 're', '-', 'educating', 'them', '?']","['non', '-', 'opioid', 'management', ',', 'self', '-', 'management', 'to', 'improve', 'function', 'and', 'quality', 'of', 'life', ',', 'realistic', 'expectations', 'and', 'limitations', 'of', 'medical', 'treatment']",34,23
In which areas the National Pain Strategy made recommendations?,Which,39,"prevention and  care, professional education and training, and population research",Background,1,1.0,"['In', 'which', 'areas', 'the', 'National', 'Pain', 'Strategy', 'made', 'recommendations', '?']","['prevention', 'and', ' ', 'care', ',', 'professional', 'education', 'and', 'training', ',', 'and', 'population', 'research']",10,13
It is inadvisable to prescribe opioids to which patients?,Which,20,patients who already have had an adequate opioid trial (of sufficient dose and duration to determine whether or not it will optimize benefit) without a  positive response,Background,1,1.0,"['It', 'is', 'inadvisable', 'to', 'prescribe', 'opioids', 'to', 'which', 'patients', '?']","['patients', 'who', 'already', 'have', 'had', 'an', 'adequate', 'opioid', 'trial', '(', 'of', 'sufficient', 'dose', 'and', 'duration', 'to', 'determine', 'whether', 'or', 'not', 'it', 'will', 'optimize', 'benefit', ')', 'without', 'a', ' ', 'positive', 'response']",10,30
"Throughout the VA/DoD OT CPG, particular attention is paid regarding which factors?",Which,34,"specific risk factors such as risk for suicide, SUD, and other medical and mental health co-occurring conditions that may complicate the management of pain for these patients",Background,0,0.8936170212765957,"['Throughout', 'the', 'VA', '/', 'DoD', 'OT', 'CPG', ',', 'particular', 'attention', 'is', 'paid', 'regarding', 'which', 'factors', '?']","['specific', 'risk', 'factors', 'such', 'as', 'risk', 'for', 'suicide', ',', 'SUD', ',', 'and', 'other', 'medical', 'and', 'mental', 'health', 'co', '-', 'occurring', 'conditions', 'that', 'may', 'complicate', 'the', 'management', 'of', 'pain', 'for', 'these', 'patients']",16,31
In which way the U.S. is in the midst of cultural transformation?,Which,131,in the way pain is viewed and treated,Background,0,0.8333333333333333,"['In', 'which', 'way', 'the', 'U.S.', 'is', 'in', 'the', 'midst', 'of', 'cultural', 'transformation', '?']","['in', 'the', 'way', 'pain', 'is', 'viewed', 'and', 'treated']",13,8
Under which circumstances risks of opioid therapy outweigh benefits?,Which,144,"lack of clinically meaningful improvement in function, concomitant use of medications that increase risk of overdose, co-occurring medical or mental health conditions that increase risk, concerns about OUD or other SUD, patient non-compliance with opioid safety measures and opioid risk mitigation strategies, patient non-participation in a comprehensive pain care plan, prescribed dose higher than the maximal recommended dose, pain condition not effectively treated with opioids (e.g., back pain with normal MRI; fibromyalgia), medical or mental health comorbidities that increase risk, improvement in the underlying pain condition being treated, unmanageable side effects",Algorithm,0,0.02247191011235955,"['Under', 'which', 'circumstances', 'risks', 'of', 'opioid', 'therapy', 'outweigh', 'benefits', '?']","['lack', 'of', 'clinically', 'meaningful', 'improvement', 'in', 'function', ',', 'concomitant', 'use', 'of', 'medications', 'that', 'increase', 'risk', 'of', 'overdose', ',', 'co', '-', 'occurring', 'medical', 'or', 'mental', 'health', 'conditions', 'that', 'increase', 'risk', ',', 'concerns', 'about', 'OUD', 'or', 'other', 'SUD', ',', 'patient', 'non', '-', 'compliance', 'with', 'opioid', 'safety', 'measures', 'and', 'opioid', 'risk', 'mitigation', 'strategies', ',', 'patient', 'non', '-', 'participation', 'in', 'a', 'comprehensive', 'pain', 'care', 'plan', ',', 'prescribed', 'dose', 'higher', 'than', 'the', 'maximal', 'recommended', 'dose', ',', 'pain', 'condition', 'not', 'effectively', 'treated', 'with', 'opioids', '(', 'e.g.', ',', 'back', 'pain', 'with', 'normal', 'MRI', ';', 'fibromyalgia', ')', ',', 'medical', 'or', 'mental', 'health', 'comorbidities', 'that', 'increase', 'risk', ',', 'improvement', 'in', 'the', 'underlying', 'pain', 'condition', 'being', 'treated', ',', 'unmanageable', 'side', 'effects']",10,111
For which patients the VA/DoD Suicide CPG recommends restricting the availability of lethal means?,Which,25,"patients considered to be at intermediate or high acute risk of suicide (determined by presence and severity of suicidal ideation, level of intention to act, existence of risk factors, limited or absent protective factors, etc.)",Recommendations,0,0.5106382978723404,"['For', 'which', 'patients', 'the', 'VA', '/', 'DoD', 'Suicide', 'CPG', 'recommends', 'restricting', 'the', 'availability', 'of', 'lethal', 'means', '?']","['patients', 'considered', 'to', 'be', 'at', 'intermediate', 'or', 'high', 'acute', 'risk', 'of', 'suicide', '(', 'determined', 'by', 'presence', 'and', 'severity', 'of', 'suicidal', 'ideation', ',', 'level', 'of', 'intention', 'to', 'act', ',', 'existence', 'of', 'risk', 'factors', ',', 'limited', 'or', 'absent', 'protective', 'factors', ',', 'etc', '.', ')']",17,42
For which patients the first recommendation should be for medication assisted treatment (MAT) for OUD?,Which,127,patients who develop OUD and progress to intravenous drug use,Recommendations,0,0.9523809523809523,"['For', 'which', 'patients', 'the', 'first', 'recommendation', 'should', 'be', 'for', 'medication', 'assisted', 'treatment', '(', 'MAT', ')', 'for', 'OUD', '?']","['patients', 'who', 'develop', 'OUD', 'and', 'progress', 'to', 'intravenous', 'drug', 'use']",18,10
On which kind of opioids the use of the distribution of naloxone does not have established clinical efficacy?,Which,162,long-acting opioids such as methadone or  exceptionally potent opioids,Recommendations,1,1.0,"['On', 'which', 'kind', 'of', 'opioids', 'the', 'use', 'of', 'the', 'distribution', 'of', 'naloxone', 'does', 'not', 'have', 'established', 'clinical', 'efficacy', '?']","['long', '-', 'acting', 'opioids', 'such', 'as', 'methadone', 'or', ' ', 'exceptionally', 'potent', 'opioids']",19,12
On which kind of opioids the use of the distribution of naloxone has established clinical efficacy?,Which,166,short-acting opioids,Recommendations,1,1.0,"['On', 'which', 'kind', 'of', 'opioids', 'the', 'use', 'of', 'the', 'distribution', 'of', 'naloxone', 'has', 'established', 'clinical', 'efficacy', '?']","['short', '-', 'acting', 'opioids']",17,4
"For which patients close monitoring, including engagement in substance use disorder treatment, and discontinuation of opioid therapy for pain with appropriate tapering are recommended?",Which,177,patients currently on long-term opioid therapy with evidence of untreated substance use  disorder,Recommendations,1,1.0,"['For', 'which', 'patients', 'close', 'monitoring', ',', 'including', 'engagement', 'in', 'substance', 'use', 'disorder', 'treatment', ',', 'and', 'discontinuation', 'of', 'opioid', 'therapy', 'for', 'pain', 'with', 'appropriate', 'tapering', 'are', 'recommended', '?']","['patients', 'currently', 'on', 'long', '-', 'term', 'opioid', 'therapy', 'with', 'evidence', 'of', 'untreated', 'substance', 'use', ' ', 'disorder']",27,16
Depending on which factors monitoring standards with administration of OT for acute pain vary?,Which,195,"the setting, specifics of the painful insult, patient medical factors, and selected medication  potency/dose/route of administration/adjunct selection",Recommendations,1,1.0,"['Depending', 'on', 'which', 'factors', 'monitoring', 'standards', 'with', 'administration', 'of', 'OT', 'for', 'acute', 'pain', 'vary', '?']","['the', 'setting', ',', 'specifics', 'of', 'the', 'painful', 'insult', ',', 'patient', 'medical', 'factors', ',', 'and', 'selected', 'medication', ' ', 'potency', '/', 'dose', '/', 'route', 'of', 'administration', '/', 'adjunct', 'selection']",15,27
The lowest dose of opioids is prescribed indicated by which factor?,Which,19,patient-specific risks and benefits,Recommendations,1,1.0,"['The', 'lowest', 'dose', 'of', 'opioids', 'is', 'prescribed', 'indicated', 'by', 'which', 'factor', '?']","['patient', '-', 'specific', 'risks', 'and', 'benefits']",12,6
The recommendation against LOT for patients with SUD does not refer to which patients?,Which,94,patients whose sole  SUD relates to tobacco misuse,Recommendations,1,1.0,"['The', 'recommendation', 'against', 'LOT', 'for', 'patients', 'with', 'SUD', 'does', 'not', 'refer', 'to', 'which', 'patients', '?']","['patients', 'whose', 'sole', ' ', 'SUD', 'relates', 'to', 'tobacco', 'misuse']",15,9
In which topics the goals of the OSI is related to?,Which,129,"increased education, monitoring, use of safe and effective prescribing and  management methods, tool development, collaboration, and use of alternative pain treatment",Background,1,1.0,"['In', 'which', 'topics', 'the', 'goals', 'of', 'the', 'OSI', 'is', 'related', 'to', '?']","['increased', 'education', ',', 'monitoring', ',', 'use', 'of', 'safe', 'and', 'effective', 'prescribing', 'and', ' ', 'management', 'methods', ',', 'tool', 'development', ',', 'collaboration', ',', 'and', 'use', 'of', 'alternative', 'pain', 'treatment']",12,27
Based on which factors providers will need to determine whether a telephone or in-clinic appointment is appropriate?,Which,124,the risk category of the Veteran,Specifications,1,1.0,"['Based', 'on', 'which', 'factors', 'providers', 'will', 'need', 'to', 'determine', 'whether', 'a', 'telephone', 'or', 'in', '-', 'clinic', 'appointment', 'is', 'appropriate', '?']","['the', 'risk', 'category', 'of', 'the', 'Veteran']",20,6
In which instances more rapid tapers may be required?,Which,148,"drug diversion, illegal activities, or situations where the risks of continuing the opioid outweigh the risks of a rapid taper",Specifications,1,1.0,"['In', 'which', 'instances', 'more', 'rapid', 'tapers', 'may', 'be', 'required', '?']","['drug', 'diversion', ',', 'illegal', 'activities', ',', 'or', 'situations', 'where', 'the', 'risks', 'of', 'continuing', 'the', 'opioid', 'outweigh', 'the', 'risks', 'of', 'a', 'rapid', 'taper']",10,22
To which modalities should the patient have access?,Which,188,"physical, psychological, and pain rehabilitation modalities",Recommendations,0,0.9090909090909091,"['To', 'which', 'modalities', 'should', 'the', 'patient', 'have', 'access', '?']","['physical', ',', 'psychological', ',', 'and', 'pain', 'rehabilitation', 'modalities']",9,8
"For NSAIDs, be cautious for which patients?",Which,193,"patients with risk of GI bleed, renal compromise, cardiac disease",Specifications,1,1.0,"['For', 'NSAIDs', ',', 'be', 'cautious', 'for', 'which', 'patients', '?']","['patients', 'with', 'risk', 'of', 'GI', 'bleed', ',', 'renal', 'compromise', ',', 'cardiac', 'disease']",9,12
"Among patients on OT, a prevalence of self inflicted injuries was significantly higher among which patients?",Which,235,patients with a history of PTSD (with or  without other mental health diagnoses) as compared to patients with other (or no) mental  health diagnoses,Background,1,1.0,"['Among', 'patients', 'on', 'OT', ',', 'a', 'prevalence', 'of', 'self', 'inflicted', 'injuries', 'was', 'significantly', 'higher', 'among', 'which', 'patients', '?']","['patients', 'with', 'a', 'history', 'of', 'PTSD', '(', 'with', 'or', ' ', 'without', 'other', 'mental', 'health', 'diagnoses', ')', 'as', 'compared', 'to', 'patients', 'with', 'other', '(', 'or', 'no', ')', 'mental', ' ', 'health', 'diagnoses']",18,30
On which basis the frequency of follow-ups with a patient on OT should be considered?,Which,301,"patient risk factors (e.g., 1-4 weeks with any dose change; up to every 3 months without dose change if clinically and functionally stable)",Algorithm,0,0.23076923076923078,"['On', 'which', 'basis', 'the', 'frequency', 'of', 'follow', '-', 'ups', 'with', 'a', 'patient', 'on', 'OT', 'should', 'be', 'considered', '?']","['patient', 'risk', 'factors', '(', 'e.g.', ',', '1', '-', '4', 'weeks', 'with', 'any', 'dose', 'change', ';', 'up', 'to', 'every', '3', 'months', 'without', 'dose', 'change', 'if', 'clinically', 'and', 'functionally', 'stable', ')']",18,29
Alternatives should be considered for which opioid pain medications?,Which,317,methadone and transdermal fentanyl,Algorithm,1,1.0,"['Alternatives', 'should', 'be', 'considered', 'for', 'which', 'opioid', 'pain', 'medications', '?']","['methadone', 'and', 'transdermal', 'fentanyl']",10,4
"Based on the study, which factors influence the rates of opioid-use continuation in Veterans?",Which,332,"age, marital status, race,  geography, mental health comorbidity, and dosage",Background,1,1.0,"['Based', 'on', 'the', 'study', ',', 'which', 'factors', 'influence', 'the', 'rates', 'of', 'opioid', '-', 'use', 'continuation', 'in', 'Veterans', '?']","['age', ',', 'marital', 'status', ',', 'race', ',', ' ', 'geography', ',', 'mental', 'health', 'comorbidity', ',', 'and', 'dosage']",18,16
"If take-home opioids are prescribed, why is it recommended to have opioid therapy reassessment no later than 3-5 days?",Why,97,to determine if adjustments or continuing opioid therapy is indicated,Recommendations,1,1.0,"['If', 'take', '-', 'home', 'opioids', 'are', 'prescribed', ',', 'why', 'is', 'it', 'recommended', 'to', 'have', 'opioid', 'therapy', 'reassessment', 'no', 'later', 'than', '3', '-', '5', 'days', '?']","['to', 'determine', 'if', 'adjustments', 'or', 'continuing', 'opioid', 'therapy', 'is', 'indicated']",25,10
"According to CDC, how often the state database system needs to be checked?",How,48,at least quarterly,Recommendations,1,1.0,"['According', 'to', 'CDC', ',', 'how', 'often', 'the', 'state', 'database', 'system', 'needs', 'to', 'be', 'checked', '?']","['at', 'least', 'quarterly']",15,3
For how long should the determined rate of the slowest opioid taper be followed?,How,92,until off the morphine or the desired dose of opioid is reached,Specifications,1,1.0,"['For', 'how', 'long', 'should', 'the', 'determined', 'rate', 'of', 'the', 'slowest', 'opioid', 'taper', 'be', 'followed', '?']","['until', 'off', 'the', 'morphine', 'or', 'the', 'desired', 'dose', 'of', 'opioid', 'is', 'reached']",15,12
"In a 2013 medication take back event in a Michigan community, how many containers were collected in four hours?",How,0,"3,633 containers containing 345  different prescription medications",Recommendations,0,0.25,"['In', 'a', '2013', 'medication', 'take', 'back', 'event', 'in', 'a', 'Michigan', 'community', ',', 'how', 'many', 'containers', 'were', 'collected', 'in', 'four', 'hours', '?']","['3,633', 'containers', 'containing', '345', ' ', 'different', 'prescription', 'medications']",21,8
"For patients at risk for overdose, how to address the harms of opioid use?",How,92,"Offer risk mitigation strategies, including naloxone",Specifications,1,1.0,"['For', 'patients', 'at', 'risk', 'for', 'overdose', ',', 'how', 'to', 'address', 'the', 'harms', 'of', 'opioid', 'use', '?']","['Offer', 'risk', 'mitigation', 'strategies', ',', 'including', 'naloxone']",16,7
"In 2012, how many benzodiazepine prescriptions were written by healthcare providers for every 100 persons in the U.S.?",How,1,37.6,Background,1,1.0,"['In', '2012', ',', 'how', 'many', 'benzodiazepine', 'prescriptions', 'were', 'written', 'by', 'healthcare', 'providers', 'for', 'every', '100', 'persons', 'in', 'the', 'U.S.', '?']",['37.6'],20,1
"In 2012, how many opioid prescriptions were written by healthcare providers for every 100 persons in the U.S.?",How,3,82.5,Background,1,1.0,"['In', '2012', ',', 'how', 'many', 'opioid', 'prescriptions', 'were', 'written', 'by', 'healthcare', 'providers', 'for', 'every', '100', 'persons', 'in', 'the', 'U.S.', '?']",['82.5'],20,1
"If a Veteran is currently taking morphine SR 60 mg, 1 tablet every 8 hours and the goal is to reduce the dose of morphine to SR 30 mg every 8 hours using a slow taper, how to reduce opioid dose?",How,99,15 mg every 10 days,Specifications,0,0.6666666666666666,"['If', 'a', 'Veteran', 'is', 'currently', 'taking', 'morphine', 'SR', '60', 'mg', ',', '1', 'tablet', 'every', '8', 'hours', 'and', 'the', 'goal', 'is', 'to', 'reduce', 'the', 'dose', 'of', 'morphine', 'to', 'SR', '30', 'mg', 'every', '8', 'hours', 'using', 'a', 'slow', 'taper', ',', 'how', 'to', 'reduce', 'opioid', 'dose', '?']","['15', 'mg', 'every', '10', 'days']",44,5
"Most commonly, tapering involves dose reduction of how much every 4 weeks?",How,141,5% to 20%,Specifications,1,1.0,"['Most', 'commonly', ',', 'tapering', 'involves', 'dose', 'reduction', 'of', 'how', 'much', 'every', '4', 'weeks', '?']","['5', '%', 'to', '20', '%']",14,5
Tapering will involve dose reduction of how much?,How,155,5% to 20% every 4 weeks,Specifications,1,1.0,"['Tapering', 'will', 'involve', 'dose', 'reduction', 'of', 'how', 'much', '?']","['5', '%', 'to', '20', '%', 'every', '4', 'weeks']",9,8
"As found from a survey of patients prescribed opioids for chronic non-cancer pain and their family members, how many patients reported that they used the medication to relieve day-to-day stress?",How,277,22%,Background,1,1.0,"['As', 'found', 'from', 'a', 'survey', 'of', 'patients', 'prescribed', 'opioids', 'for', 'chronic', 'non', '-', 'cancer', 'pain', 'and', 'their', 'family', 'members', ',', 'how', 'many', 'patients', 'reported', 'that', 'they', 'used', 'the', 'medication', 'to', 'relieve', 'day', '-', 'to', '-', 'day', 'stress', '?']","['22', '%']",38,2
"As found from a survey of patients prescribed opioids for chronic non-cancer pain and their family members, how many patients reported that they used the medication for fun or to get high?",How,283,34%,Background,1,1.0,"['As', 'found', 'from', 'a', 'survey', 'of', 'patients', 'prescribed', 'opioids', 'for', 'chronic', 'non', '-', 'cancer', 'pain', 'and', 'their', 'family', 'members', ',', 'how', 'many', 'patients', 'reported', 'that', 'they', 'used', 'the', 'medication', 'for', 'fun', 'or', 'to', 'get', 'high', '?']","['34', '%']",36,2
"As found from a survey of patients prescribed opioids for chronic non-cancer pain and their family members, how many patients reported that they thought they were addicted/dependent on opioid pain medication?",How,286,34%,Background,1,1.0,"['As', 'found', 'from', 'a', 'survey', 'of', 'patients', 'prescribed', 'opioids', 'for', 'chronic', 'non', '-', 'cancer', 'pain', 'and', 'their', 'family', 'members', ',', 'how', 'many', 'patients', 'reported', 'that', 'they', 'thought', 'they', 'were', 'addicted', '/', 'dependent', 'on', 'opioid', 'pain', 'medication', '?']","['34', '%']",37,2
"Compared to patients ≥65 years old, patients 31-40 years old carried how many times the odds of OUD  and overdose?",How,345,5,Recommendations,1,1.0,"['Compared', 'to', 'patients', '≥65', 'years', 'old', ',', 'patients', '31', '-', '40', 'years', 'old', 'carried', 'how', 'many', 'times', 'the', 'odds', 'of', 'OUD', ' ', 'and', 'overdose', '?']",['5'],25,1
"Compared to patients ≥65 years old, patients 18-30 years old carried how many times the odds of OUD  and overdose?",How,353,11,Recommendations,1,1.0,"['Compared', 'to', 'patients', '≥65', 'years', 'old', ',', 'patients', '18', '-', '30', 'years', 'old', 'carried', 'how', 'many', 'times', 'the', 'odds', 'of', 'OUD', ' ', 'and', 'overdose', '?']",['11'],25,1
Is there any evidence of the comparative efficacy of tramadol versus another opioid or a non-opioid comparison such  as non-steroidal anti-inflammatory drugs (NSAIDs) or acetaminophen?,Is there,21,no long-term  evidence,Recommendations,1,1.0,"['Is', 'there', 'any', 'evidence', 'of', 'the', 'comparative', 'efficacy', 'of', 'tramadol', 'versus', 'another', 'opioid', 'or', 'a', 'non', '-', 'opioid', 'comparison', 'such', ' ', 'as', 'non', '-', 'steroidal', 'anti', '-', 'inflammatory', 'drugs', '(', 'NSAIDs', ')', 'or', 'acetaminophen', '?']","['no', 'long', '-', 'term', ' ', 'evidence']",35,6
Is there any evidence that risk of prescription opioid overdose and overdose death exists even at low opioid dosage levels and increases with increasing doses?,Is there,35,There is moderate quality evidence from retrospective cohort and retrospective case-control studies,Recommendations,0,0.9600000000000001,"['Is', 'there', 'any', 'evidence', 'that', 'risk', 'of', 'prescription', 'opioid', 'overdose', 'and', 'overdose', 'death', 'exists', 'even', 'at', 'low', 'opioid', 'dosage', 'levels', 'and', 'increases', 'with', 'increasing', 'doses', '?']","['There', 'is', 'moderate', 'quality', 'evidence', 'from', 'retrospective', 'cohort', 'and', 'retrospective', 'case', '-', 'control', 'studies']",26,14
"Is there any evidence that take-home naloxone programs are effective in improving overdose survival and decreasing mortality, with a low rate of adverse events?",Is there,167,A  systematic review of 22 observational studies provided moderate quality evidence,Recommendations,1,1.0,"['Is', 'there', 'any', 'evidence', 'that', 'take', '-', 'home', 'naloxone', 'programs', 'are', 'effective', 'in', 'improving', 'overdose', 'survival', 'and', 'decreasing', 'mortality', ',', 'with', 'a', 'low', 'rate', 'of', 'adverse', 'events', '?']","['A', ' ', 'systematic', 'review', 'of', '22', 'observational', 'studies', 'provided', 'moderate', 'quality', 'evidence']",28,12
Is there any absolutely safe dose of opioids?,Is there,170,no,Recommendations,1,1.0,"['Is', 'there', 'any', 'absolutely', 'safe', 'dose', 'of', 'opioids', '?']",['no'],9,1
Is there any evidence that certain chronic pain conditions represent an independent risk factor for suicide?,Is there,293,A number of studies suggest,Recommendations,0,0.8571428571428571,"['Is', 'there', 'any', 'evidence', 'that', 'certain', 'chronic', 'pain', 'conditions', 'represent', 'an', 'independent', 'risk', 'factor', 'for', 'suicide', '?']","['A', 'number', 'of', 'studies', 'suggest']",17,5
Is there any evidence that suggests an association with prescribed opioid dose and suicide risk among Veterans receiving OT for CNCP?,Is there,297,A recent large retrospective cohort study,Recommendations,1,1.0,"['Is', 'there', 'any', 'evidence', 'that', 'suggests', 'an', 'association', 'with', 'prescribed', 'opioid', 'dose', 'and', 'suicide', 'risk', 'among', 'Veterans', 'receiving', 'OT', 'for', 'CNCP', '?']","['A', 'recent', 'large', 'retrospective', 'cohort', 'study']",22,6
"In the literature review conducted for this CPG, are there any study evaluating the effectiveness of LOT for outcomes lasting longer than 16 weeks?",Is there,32,no,Recommendations,1,1.0,"['In', 'the', 'literature', 'review', 'conducted', 'for', 'this', 'CPG', ',', 'are', 'there', 'any', 'study', 'evaluating', 'the', 'effectiveness', 'of', 'LOT', 'for', 'outcomes', 'lasting', 'longer', 'than', '16', 'weeks', '?']",['no'],26,1
Is ther any evidence that intensification of monitoring helps mitigate the risk of suicide among patients on LOT?,Is there,191,There is moderate quality evidence,Recommendations,1,1.0,"['Is', 'ther', 'any', 'evidence', 'that', 'intensification', 'of', 'monitoring', 'helps', 'mitigate', 'the', 'risk', 'of', 'suicide', 'among', 'patients', 'on', 'LOT', '?']","['There', 'is', 'moderate', 'quality', 'evidence']",19,5
"Is ther any evidence that, at the facility level, patients on LOT within facilities ordering more drug screens than the comparison group were associated with decreased risk of suicide attempt?",Is there,193,Im et al. (2015) found moderate quality evidence,Recommendations,0,0.5454545454545454,"['Is', 'ther', 'any', 'evidence', 'that', ',', 'at', 'the', 'facility', 'level', ',', 'patients', 'on', 'LOT', 'within', 'facilities', 'ordering', 'more', 'drug', 'screens', 'than', 'the', 'comparison', 'group', 'were', 'associated', 'with', 'decreased', 'risk', 'of', 'suicide', 'attempt', '?']","['I', 'm', 'et', 'al', '.', '(', '2015', ')', 'found', 'moderate', 'quality', 'evidence']",33,12
Was there any study looking at opioid treatment agreements  (OTAs)?,Is there,62,One identified study was a systematic review of 11 studies,Recommendations,1,1.0,"['Was', 'there', 'any', 'study', 'looking', 'at', 'opioid', 'treatment', 'agreements', ' ', '(', 'OTAs', ')', '?']","['One', 'identified', 'study', 'was', 'a', 'systematic', 'review', 'of', '11', 'studies']",14,10
"In there any study on the outcome of population-based rates of opioid overdose mortality by opioid dose, without the use of a presupposed threshold?",Is there,183,"In a prospective cohort study (not included in the evidence review as it did not include information on  acute versus chronic pain in the patient population), Dasgupta et al. (2015) compared residents of North  Carolina who had received an opioid prescription in the last year to residents who had not.",Recommendations,0,0.07407407407407407,"['In', 'there', 'any', 'study', 'on', 'the', 'outcome', 'of', 'population', '-', 'based', 'rates', 'of', 'opioid', 'overdose', 'mortality', 'by', 'opioid', 'dose', ',', 'without', 'the', 'use', 'of', 'a', 'presupposed', 'threshold', '?']","['In', 'a', 'prospective', 'cohort', 'study', '(', 'not', 'included', 'in', 'the', 'evidence', 'review', 'as', 'it', 'did', 'not', 'include', 'information', 'on', ' ', 'acute', 'versus', 'chronic', 'pain', 'in', 'the', 'patient', 'population', ')', ',', 'Dasgupta', 'et', 'al', '.', '(', '2015', ')', 'compared', 'residents', 'of', 'North', ' ', 'Carolina', 'who', 'had', 'received', 'an', 'opioid', 'prescription', 'in', 'the', 'last', 'year', 'to', 'residents', 'who', 'had', 'not', '.']",28,59
Define chronic pain according to the VA/DoD CPG.,What,45,pain lasting three months or more. It is often associated with changes in the  central nervous system (CNS) known as central sensitization.,Background,0,0.4444444444444445,"['Define', 'chronic', 'pain', 'according', 'to', 'the', 'VA', '/', 'DoD', 'CPG', '.']","['pain', 'lasting', 'three', 'months', 'or', 'more', '.', 'It', 'is', 'often', 'associated', 'with', 'changes', 'in', 'the', ' ', 'central', 'nervous', 'system', '(', 'CNS', ')', 'known', 'as', 'central', 'sensitization', '.']",11,27
Define pain according to the VA/DoD CPG.,What,66,"an unpleasant sensory and emotional experience associated with actual or potential  tissue damage, or described in terms of such damage…Pain is always subjective…It is unquestionably a  sensation in a part or parts of the body, but it is also always unpleasant and therefore also an emotional  experience.",Background,0,0.43636363636363634,"['Define', 'pain', 'according', 'to', 'the', 'VA', '/', 'DoD', 'CPG', '.']","['an', 'unpleasant', 'sensory', 'and', 'emotional', 'experience', 'associated', 'with', 'actual', 'or', 'potential', ' ', 'tissue', 'damage', ',', 'or', 'described', 'in', 'terms', 'of', 'such', 'damage', '…', 'Pain', 'is', 'always', 'subjective', '…', 'It', 'is', 'unquestionably', 'a', ' ', 'sensation', 'in', 'a', 'part', 'or', 'parts', 'of', 'the', 'body', ',', 'but', 'it', 'is', 'also', 'always', 'unpleasant', 'and', 'therefore', 'also', 'an', 'emotional', ' ', 'experience', '.']",10,57
Mention some differences in the methodology used between the development of the VA/DoD OT CPG and the CDC guideline.,What,3,"Along with a clinical evidence review, during which the evidence was evaluated using GRADE, the CDC guideline developers also considered the findings of a contextual evidence review. Further, the CDC Core Expert Group, which consisted of subject matter experts,  representatives of primary care professional societies and state agencies, and an expert in guideline methodology, reviewed recommendations drafted by the CDC and evaluated how the evidence was used in the development of the recommendations, rather than developing the recommendations themselves  (as was the VA/DoD OT Work Group’s role in the development of the VA/DoD OT CPG). While experts provided feedback on the CDC recommendations and their development, the CDC determined the final recommendations. CDC also used a review process considering and incorporating feedback from federal partners (e.g., SAMHSA, VA, DoD), stakeholders (e.g., professional organizations, delivery systems,  community organizations), and other constituents (e.g., clinicians, prospective patients).",Background,0,0.29931972789115646,"['Mention', 'some', 'differences', 'in', 'the', 'methodology', 'used', 'between', 'the', 'development', 'of', 'the', 'VA', '/', 'DoD', 'OT', 'CPG', 'and', 'the', 'CDC', 'guideline', '.']","['Along', 'with', 'a', 'clinical', 'evidence', 'review', ',', 'during', 'which', 'the', 'evidence', 'was', 'evaluated', 'using', 'GRADE', ',', 'the', 'CDC', 'guideline', 'developers', 'also', 'considered', 'the', 'findings', 'of', 'a', 'contextual', 'evidence', 'review', '.', 'Further', ',', 'the', 'CDC', 'Core', 'Expert', 'Group', ',', 'which', 'consisted', 'of', 'subject', 'matter', 'experts', ',', ' ', 'representatives', 'of', 'primary', 'care', 'professional', 'societies', 'and', 'state', 'agencies', ',', 'and', 'an', 'expert', 'in', 'guideline', 'methodology', ',', 'reviewed', 'recommendations', 'drafted', 'by', 'the', 'CDC', 'and', 'evaluated', 'how', 'the', 'evidence', 'was', 'used', 'in', 'the', 'development', 'of', 'the', 'recommendations', ',', 'rather', 'than', 'developing', 'the', 'recommendations', 'themselves', ' ', '(', 'as', 'was', 'the', 'VA', '/', 'DoD', 'OT', 'Work', 'Group', '’s', 'role', 'in', 'the', 'development', 'of', 'the', 'VA', '/', 'DoD', 'OT', 'CPG', ')', '.', 'While', 'experts', 'provided', 'feedback', 'on', 'the', 'CDC', 'recommendations', 'and', 'their', 'development', ',', 'the', 'CDC', 'determined', 'the', 'final', 'recommendations', '.', 'CDC', 'also', 'used', 'a', 'review', 'process', 'considering', 'and', 'incorporating', 'feedback', 'from', 'federal', 'partners', '(', 'e.g.', ',', 'SAMHSA', ',', 'VA', ',', 'DoD', ')', ',', 'stakeholders', '(', 'e.g.', ',', 'professional', 'organizations', ',', 'delivery', 'systems', ',', ' ', 'community', 'organizations', ')', ',', 'and', 'other', 'constituents', '(', 'e.g.', ',', 'clinicians', ',', 'prospective', 'patients', ')', '.']",22,183
Should the opioid-naive individuals be prescribed long-acting opioids?,Is there,309,long-acting opioids should not be prescribed for opioid-naive individuals,Algorithm,1,1.0,"['Should', 'the', 'opioid', '-', 'naive', 'individuals', 'be', 'prescribed', 'long', '-', 'acting', 'opioids', '?']","['long', '-', 'acting', 'opioids', 'should', 'not', 'be', 'prescribed', 'for', 'opioid', '-', 'naive', 'individuals']",13,13
